FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ehmen, C
   Medialdea-Carrera, R
   Brown, D
   de Filippis, AMB
   de Sequeira, PC
   Nogueira, RMR
   Brasil, P
   Calvet, GA
   Blessmann, J
   Mallmann, AM
   Sievertsen, J
   Rackow, A
   Schmidt-Chanasit, J
   Emmerich, P
   Schmitz, H
   Deschermeier, C
   Mika, A
AF Ehmen, C.
   Medialdea-Carrera, R.
   Brown, D.
   de Filippis, A. M. Bispo
   de Sequeira, P. Carvalho
   Nogueira, R. M. Ribeiro
   Brasil, P.
   Calvet, G. A.
   Blessmann, J.
   Mallmann, A. -M.
   Sievertsen, J.
   Rackow, A.
   Schmidt-Chanasit, J.
   Emmerich, P.
   Schmitz, H.
   Deschermeier, C.
   Mika, A.
TI Accurate detection of Zika virus IgG using a novel immune complex
   binding ELISA
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article; Early Access
DE Zika virus (ZIKV); flavivirus; immune complex binding (ICB) ELISA;
   diagnostics
ID INFECTION
AB Objectives Accurate serological assays are urgently needed to support public health responses to Zika virus (ZIKV) infection with its potential to cause foetal damage during pregnancy. Current flavivirus serology for ZIKV infections lacks specificity due to cross-reacting antibodies from closely related other flaviviruses. In this study, we evaluated novel serological tests for accurate ZIKV IgG detection.
   Methods Our ELISAs are based on immune complex binding. The high specificity is achieved by the simultaneous incubation of labelled ZIKV antigen and unlabelled flavivirus homolog protein competitors. Two assays were validated with a panel of 406 human samples from PCR-confirmed ZIKV patients collected in Brazil (n = 154), healthy blood donors and other infections from Brazil, Europe, Canada and Colombia (n = 252).
   Results The highest specificity (100% [252/252, 95% confidence interval (CI) 98.5-100.0]) was shown by the ZIKV ED3 ICB ELISA using the ED3 antigen of the ZIKV envelope. A similar test using the NS1 antigen (ZIKV NS1 ICB ELISA) was slightly less specific (92.1% [232/252, 95% CI 88.0-95.1]). The commercial Euroimmun ZIKV ELISA had a specificity of only 82.1% (207/252, 95% CI 76.8-86.7). Sensitivity was high (93-100%) from day 12 after onset of symptoms in all three tests. Seroprevalence of ZIKV IgG was analysed in 87 samples from Laos (Asia) confirming that the ED3 ELISA showed specific reactions in other populations.
   Conclusions The novel ED3 ICB ELISA will be useful for ZIKV-specific IgG detection for seroepidemiological studies and serological diagnosis for case management in travellers and in countries where other flavivirus infections are co-circulating.
C1 [Ehmen, C.; Mallmann, A. -M.; Sievertsen, J.; Rackow, A.; Deschermeier, C.; Mika, A.] Bernhard Nocht Inst Trop Med, Diagnost Dev Lab, Hamburg, Germany.
   [Medialdea-Carrera, R.] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Brown, D.; de Filippis, A. M. Bispo; de Sequeira, P. Carvalho; Nogueira, R. M. Ribeiro] Fundacao Oswaldo Cruz, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
   [Brasil, P.; Calvet, G. A.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
   [Blessmann, J.] Bernhard Nocht Inst Trop Med, Dept Infect Dis Epidemiol, Hamburg, Germany.
   [Schmidt-Chanasit, J.; Emmerich, P.; Schmitz, H.] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany.
   [Emmerich, P.] Univ Rostock, Dept Trop Med & Infect Dis, Ctr Internal Med 2, Rostock, Germany.
RP Mika, A (corresponding author), Bernhard Nocht Inst Trop Med, Diagnost Dev Lab, Hamburg, Germany.
EM mika@bnitm.de
RI Calvet, Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238
FU European Regional Development Fund (EFRE (Europ_aischer Fonds f_ur
   Regionale Entwicklung))European Union (EU)
   [BWF/H/52228/2012/13.10.10-1/3.4,6]; EXIST Forschungstransfer program
   [03EFFHH016]; BNITM (Bernhard Nocht Institute for Tropical Medicine)
   Translational Fonds; Vereinigung der Freunde des Tropeninstituts Hamburg
   eV; European UnionEuropean Union (EU) [734857, 734548]; Faperj (Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/2002.930/2016]
FX Funding was provided by the European Regional Development Fund (EFRE
   (Europ_aischer Fonds f_ur Regionale Entwicklung),
   http://www.hamburg.de/efre/, project no.
   BWF/H/52228/2012/13.10.10-1/3.4,6; A.M., A.M.M., A.R., C.D.), the EXIST
   Forschungstransfer program (http://www.exist.de/DE/Home/inhalt.html,
   project no. 03EFFHH016; A.M.M., C.D., C.E.). A.R. was supported by BNITM
   (Bernhard Nocht Institute for Tropical Medicine) Translational Fonds and
   the,Vereinigung der Freunde des Tropeninstituts Hamburg
   eV"(https://www.b nitm.de). A.M.B.F., D.B., P.C.S., R.M.R.N. received
   funding by European Union's Horizon 2020 program (grant agreements
   ZIKACTION no. 734857 and ZIKAPLAN no. 734548;
   https://ec.europa.eu/programmes/horizon2020/en), and A.M.B.F., P.C.S.,
   R.M.R.N. were funded by Faperj (Fundacao Carlos Chagas Filho de Amparo
   ~a Pesquisa do Estado do Rio de Janeiro, grant no. E-26/2002.930/2016;
   http://www.faperj.br/).R.M.C.is affiliated to the NIHR HPRU in Emerging
   and Zoonotic Infections at University of Liverpool in partnership with
   PHE, in collaboration with LSTM. The funders had no role in study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Calvert AE, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00234-18, 10.1128/jcm.00234-18]
   Denis J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007747
   Emmerich P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006366
   Emmerich P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002580
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Giovanetti M, 2019, J VIROL, V94
   Nunes PCG, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3255-x
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kareinen L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219474
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Panning M, 2017, EBIOMEDICINE, V16, P12, DOI 10.1016/j.ebiom.2017.01.045
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Peterson LR, 2017, NEW ENGL J MED, V374, P1552
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rackow A, 2019, CLIN CHEM, V65, P451, DOI 10.1373/clinchem.2018.294819
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Schmitz H, 2011, MED MICROBIOL IMMUN, V200, P233, DOI 10.1007/s00430-011-0195-0
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01972-17, 10.1128/JCM.01972-17]
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 27
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
DI 10.1111/tmi.13505
EA NOV 2020
PG 13
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA OP6KR
UT WOS:000588193700001
PM 33012038
OA Other Gold
DA 2020-12-01
ER

PT J
AU Moreira, J
   Barros, J
   Lapouble, O
   Lacerda, MVG
   Felger, I
   Brasil, P
   Dittrich, S
   Siqueira, AM
AF Moreira, Jose
   Barros, Janaina
   Lapouble, Oscar
   Lacerda, Marcus V. G.
   Felger, Ingrid
   Brasil, Patricia
   Dittrich, Sabine
   Siqueira, Andre M.
TI When fever is not malaria in Latin America: a systematic review
SO BMC MEDICINE
LA English
DT Review
DE Non-malaria febrile illness; Malaria; Latin America; Fever; Public
   health
ID ZIKA VIRUS
AB BackgroundIn malaria-endemic countries, febrile episodes caused by diseases other than malaria are a growing concern. However, limited knowledge of the prevalent etiologic agents and their geographic distributions restrict the ability of health services to address non-malarial morbidity and mortality through effective case management. Here, we review the etiology of fever in Latin America (LA) between 1980 and 2015 and map significant pathogens commonly implicated in febrile infectious diseases.
   MethodsA literature search was conducted, without language restrictions, in three distinct databases in order to identify fever etiology studies that report laboratory-confirmed fever-causing pathogens that were isolated from usually sterile body sites. Data analyses and mapping was conducted with Tableau Desktop (version 2018.2.3).
   ResultsInclusion criteria were met by 625 publications corresponding to data relative to 34 countries. Studies using serology (n=339) predominated for viral infections, culture (n=131) for bacteria, and microscopy (n=62) for fungi and parasites. The pathogen groups most frequently reported were viral infections (n=277), bacterial infections (n=265), parasitic infections (n=59), fungal infections (n=47), and more than one pathogen group (n=24). The most frequently reported virus was dengue virus (n=171), followed by other arboviruses (n=55), and hantavirus (n=18). For bacteria, Staphylococcus spp. (n=82), Rickettsia spp. (n=70), and Leptospira spp. (n=55) were frequently reported. Areas with biggest gaps on etiology of fever were apparent.
   ConclusionsThis review provides a landscape of pathogens causing febrile illness other than malaria in LA for over 30years. Our findings highlight the need to standardize protocols and report guidelines for fever etiology studies for better comparability of results and improved interpretation. Lastly, we should improve existing national laboratory surveillance systems, especially from low- to middle-income countries, to inform global fever policy priorities and timely identify emerging infections threats.Study registrationPROSPERO systematic review registration number: CRD42016049281
C1 [Moreira, Jose; Barros, Janaina; Brasil, Patricia; Siqueira, Andre M.] Fundacao Oswaldo Cruz, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Moreira, Jose; Brasil, Patricia; Siqueira, Andre M.] Fundacao Oswaldo Cruz, Programa Posgrad Pesquisa Clin Doencas Infecc, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Lapouble, Oscar] Pan Amer Hlth Org Off Suriname, Paramaribo, Suriname.
   [Lapouble, Oscar; Lacerda, Marcus V. G.] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.
   [Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Inst Pesquisa Clin Carlos Borborema, Manaus, Amazonas, Brazil.
   [Lacerda, Marcus V. G.] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Dittrich, Sabine] Fdn Innovat New Diagnost, Geneva, Switzerland.
RP Siqueira, AM (corresponding author), Fundacao Oswaldo Cruz, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.; Siqueira, AM (corresponding author), Fundacao Oswaldo Cruz, Programa Posgrad Pesquisa Clin Doencas Infecc, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
EM andre.siqueira@ini.fiocruz.br
FU Foundation for Innovative New Diagnostics (FIND)
FX The review was funded by a grant from Foundation for Innovative New
   Diagnostics (FIND).
CR Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269
   [Anonymous], 2010, EFFECTS STEADYSTATE, P369
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cifuentes SG, 2013, EMERG INFECT DIS, V19, P1642, DOI 10.3201/eid1910.130137
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Denysiuk R, 2017, J INFRASTRUCT SYST, V23, DOI 10.1061/(ASCE)IS.1943-555X.0000355
   Fernandez-Salas I, 2016, CURR OPIN INFECT DIS, V29, P467, DOI 10.1097/QCO.0000000000000304
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6
   Salamera JB, 2011, INFECTIOUS DISEASES: A GEOGRAPHIC GUIDE, P273
   Siqueira AM, 2017, LANCET GLOB HEALTH, V5, pE257, DOI 10.1016/S2214-109X(17)30042-6
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 17
TC 1
Z9 1
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD SEP 21
PY 2020
VL 18
IS 1
AR 294
DI 10.1186/s12916-020-01746-z
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA NV6XS
UT WOS:000574462300001
PM 32951589
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Oliveira, MM
   Fuller, TL
   Brasil, P
   Gabaglia, CR
   Nielsen-Saines, K
AF Monteiro de Oliveira, Mayra
   Fuller, Trevon L.
   Brasil, Patricia
   Gabaglia, Claudia R.
   Nielsen-Saines, Karin
TI Controlling the COVID-19 pandemic in Brazil: a challenge of continental
   proportions
SO NATURE MEDICINE
LA English
DT Letter
C1 [Monteiro de Oliveira, Mayra] Univ Sao Paulo, Fac Odontol, Sao Paulo, Brazil.
   [Fuller, Trevon L.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA.
   [Fuller, Trevon L.; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia R.] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
RP de Oliveira, MM (corresponding author), Univ Sao Paulo, Fac Odontol, Sao Paulo, Brazil.
EM mayra_oliveira@alumni.usp.br
RI ; Fuller, Trevon/B-8087-2014
OI Reis, AlessanRSS/0000-0001-8486-7469; Monteiro de Oliveira,
   Mayra/0000-0003-1400-6713; Fuller, Trevon/0000-0001-9954-4267
CR Adiga A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017353
   Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, 2020, COVID 19 DASHB
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Fancourt D, 2020, LANCET, V396, P464, DOI 10.1016/S0140-6736(20)31690-1
   Jansson J, 2020, MEDIUM
   Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793
   Lau H, 2020, Pulmonology, DOI 10.1016/j.pulmoe.2020.05.015
   Watson O.J., 2020, SEIR TRANSMISSION MO
   Youyang G, 2020, COVID 19 PROJECTIONS
NR 9
TC 0
Z9 0
U1 1
U2 1
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD OCT
PY 2020
VL 26
IS 10
BP 1505
EP 1506
DI 10.1038/s41591-020-1071-5
EA SEP 2020
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA NX8MD
UT WOS:000566066500001
PM 32887951
OA Bronze
DA 2020-12-01
ER

PT J
AU Zhao, ZQ
   Shang, ZW
   Vasconcelos, Z
   Li, CF
   Jiang, YS
   Zu, SL
   Zhang, JY
   Wang, FC
   Yao, L
   Jung, JU
   Brasil, P
   Moreira, ME
   Qin, CF
   Kerin, T
   Nielsen-Saines, K
   Cheng, GH
   Zhang, XH
   Xu, ZH
AF Zhao, Ziqi
   Shang, Ziwei
   Vasconcelos, Zilton
   Li, Chunfeng
   Jiang, Yisheng
   Zu, Shulong
   Zhang, Jingyi
   Wang, Fengchao
   Yao, Li
   Jung, Jae U.
   Brasil, Patricia
   Moreira, Maria Elisabeth
   Qin, Cheng-Feng
   Kerin, Tara
   Nielsen-Saines, Karin
   Cheng, Genhong
   Zhang, Xiaohui
   Xu, Zhiheng
TI Zika Virus Infection Leads to Variable Defects in Multiple Neurological
   Functions and Behaviors in Mice and Children
SO ADVANCED SCIENCE
LA English
DT Article
DE abnormal behaviors; microcephaly; neurological functions; visual
   cortical functions; Zika virus
ID CRITICAL PERIOD PLASTICITY; CORTEX
AB Zika virus (ZIKV) has evolved into a global health threat because of its causal link to congenital Zika syndrome. ZIKV infection of pregnant women may cause a spectrum of abnormalities in children. In the studies in Brazil, a large cohort of children with perinatal exposure to ZIKV is followed, and a spectrum of neurodevelopmental abnormalities is identified. In parallel, it is demonstrated that infection of the mouse neonatal brain by a contemporary ZIKV strain instead of an Asian ancestral strain can cause microcephaly and various abnormal neurological functions. These include defects in social interaction and depression, impaired learning and memory, in addition to severe motor defects, which are present in adult mice as well as in the prospective cohort of children. Importantly, although mouse brains infected later after birth do not have apparent abnormal brain structure, those mice still show significant impairments of visual cortical functions, circuit organization, and experience-dependent plasticity. Thus, the study suggests that special attention should be paid to all children born to ZIKV infected mothers for screening of abnormal behaviors and sensory function during childhood.
C1 [Zhao, Ziqi; Jiang, Yisheng; Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Sch Future Technol, Inst Genet & Dev Biol,State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Shang, Ziwei; Zhang, Jingyi; Wang, Fengchao; Yao, Li; Zhang, Xiaohui] Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.
   [Vasconcelos, Zilton; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz FIOCRUZ, Inst Fernandes Figueira, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Li, Chunfeng] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.
   [Zu, Shulong; Cheng, Genhong] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Zu, Shulong; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Obstet & Gynecol,Div Maternal Fetal Med, Los Angeles, CA 90033 USA.
   [Brasil, Patricia] Fondacao Oswaldo Cruz FIOCRUZ, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Kerin, Tara; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Mattel Childrens Hosp, Los Angeles, CA 90095 USA.
   [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Sch Future Technol, Inst Genet & Dev Biol,State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Zhang, XH (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Li, CF (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Cheng, GH (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Mattel Childrens Hosp, Los Angeles, CA 90095 USA.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM chunfeng@stanford.edu; KNielsen@mednet.ucla.edu; GCheng@mednet.ucla.edu;
   xhzhang@bnu.edu.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China (NSFC) [31921002, 31730108, 91854118,
   U170220023, 81772176, 31670883, 91542201, 81590765]; Chinese Academy of
   SciencesChinese Academy of Sciences [XDB32020100, QYZDJ-SSW-SMC007];
   Beijing Municipal Science & Technology CommissionBeijing Municipal
   Science & Technology Commission [Z181100001518001]; Interdisciplinary
   Research Funds of Beijing Normal University; CAMS Initiative Innovative
   Medicine [2016-I2M-1-005]; Major Project for "Significant New Drugs
   Innovation and Development" [2015ZX09102023]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI140718, AI069120, AI078389, AI028697, AI129534, EY028318]; MOST
   (China)Ministry of Science and Technology, China [2016YFD0500304]
FX This work was supported by the Strategic Priority Research Program and
   Innovation Program of the National Natural Science Foundation of China
   (NSFC) (31921002, 31730108, 91854118, U170220023, 81772176, 31670883,
   91542201, 81590765), the Chinese Academy of Sciences (No. XDB32020100,
   QYZDJ-SSW-SMC007), the Beijing Municipal Science & Technology Commission
   (Z181100001518001), the Interdisciplinary Research Funds of Beijing
   Normal University, the CAMS Initiative Innovative Medicine (No.
   2016-I2M-1-005), Major Project for "Significant New Drugs Innovation and
   Development" (2015ZX09102023), NIH AI140718, AI069120, AI078389,
   AI028697, AI129534, and EY028318 awards, and MOST (China,
   2016YFD0500304). The infant study protocol was approved by the
   institutional review boards at FundacAo Oswaldo Cruz (Fiocruz) and the
   University of California, Los Angeles (UCLA IRB#17-000104). All mothers
   provided written informed consent for themselves and for their children.
   The experimental procedures on mice were performed under biosafety level
   2 (BSL-2) at Beijing Institute of Microbiology and Epidemiology with
   Institutional Biosafety Committee approval. The mouse care and
   experimentation were approved by the Animal Care and Use Committees of
   the Institutional Animal Care and Use Committee at Institute of Genetics
   and Developmental Biology (IGDB), Chinese Academy of Sciences (Renewed
   as AP2020013), Beijing Institute of Microbiology and Epidemiology and
   the State Key Laboratory of Cognitive Neuroscience & Learning at Beijing
   Normal University (IACUC-BNU-NKLCNL-2016-02).
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen XJ, 2014, J NEUROSCI, V34, P2940, DOI 10.1523/JNEUROSCI.2640-13.2014
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009
   Gordon JA, 1996, J NEUROSCI, V16, P3274
   He LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6036
   Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787
   Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002
   Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006
   Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133
   Li C, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0042-1
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 29
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD SEP
PY 2020
VL 7
IS 18
AR 1901996
DI 10.1002/advs.201901996
EA AUG 2020
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA NW6HC
UT WOS:000554488300001
PM 32999822
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Cantelli, CP
   Fumian, TM
   Malta, FC
   da Cunha, DC
   Brasil, P
   Nordgren, J
   Svensson, L
   Miagostovich, MP
   de Moraes, MTB
   Leite, JPG
AF Cantelli, Carina Pacheco
   Fumian, Tulio Machado
   Malta, Fabio Correia
   da Cunha, Denise Cotrim
   Brasil, Patricia
   Nordgren, Johan
   Svensson, Lennart
   Miagostovich, Marize Pereira
   Baroni de Moraes, Marcia Terezinha
   Gagliardi Leite, Jose Paulo
TI Norovirus infection and HBGA host genetic susceptibility in a birth
   community-cohort, Rio de Janeiro, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Norovirus; GII.4 Sydney; Susceptibility; Secretor; Lewis; Birth
   community-cohort
ID BLOOD GROUP ANTIGENS; UNITED-STATES; RECOMBINANT GII.P16-GII.2; ACUTE
   GASTROENTERITIS; EPIDEMIOLOGIC TRENDS; ROTAVIRUS INFECTIONS; NONSENSE
   MUTATION; RT-PCR; CHILDREN; LEWIS
AB Norovirus has emerged as an important viral agent of acute pediatric gastroenteritis, with a growing genetic diversity reported in the last decades. Histo-blood group antigens (HBGAs) present on the surface of enterocytes are susceptibility factors for norovirus infection and differ between populations which could affects the epidemiology and evolution of these viruses. This study investigated the frequency, incidence and genetic diversity of noroviruses in a cohort of rotavirus A vaccinated children in association to the host HBGA (Secretor/Lewis) genetic susceptibility profile. Norovirus genogroups I and II (GI/GII) were screened by RT-qPCR in 569 stool samples from 132 children followed-up from birth to 11 months of age during 2014-2018. Noroviruses were identified in 21.2% of children enrolled in this study, with a norovirus detection rate of 5.6% (32/569), in 17.1% and 4.7% of acute diarrheic episodes (ADE) and non-ADE, respectively. The norovirus incidence was 5.8 infections per 100 child-months. Partial nucleotide sequencing characterized six different norovirus genotypes, with GII.4 Sydney 2012 being detected in 50% associated with three different polymerase genotypes (GII.31, GII.P16 and GII.P4 New Orleans 2009). FUT3 genotyping was yielded seven new mutations in this population. A significant association between symptomatic norovirus infection and secretor profile could be inferred.
C1 [Cantelli, Carina Pacheco] Fiocruz MS, Immunobiol Technol Inst Biomanguinhos, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Cantelli, Carina Pacheco; Fumian, Tulio Machado; Malta, Fabio Correia; Miagostovich, Marize Pereira; Baroni de Moraes, Marcia Terezinha; Gagliardi Leite, Jose Paulo] Fiocruz MS, Lab Comparat & Environm Virol, Oswaldo Cruz Inst, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [da Cunha, Denise Cotrim] Fiocruz MS, Sergio Arouca Publ Hlth Natl Sch, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Brasil, Patricia] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Nordgren, Johan; Svensson, Lennart] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, S-58185 Linkoping, Sweden.
RP Cantelli, CP (corresponding author), Fiocruz MS, Lab Comparat & Environm Virol, Oswaldo Cruz Inst, Ave Brasil 4365, Manguinho, RJ, Brazil.; Cantelli, CP (corresponding author), Fiocruz MS, Lab Comparat & Environm Virol, Oswaldo Cruz Inst, Av Brasil,4365 Pav Helio & Peggy Pereira, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM carina.cantelli@gmail.com
OI Pacheco Cantelli, Carina/0000-0002-9171-5022
FU Oswaldo Cruz Institute/Fiocruz/PAEF2; Carlos Chagas Filho Foundation for
   Research Support in the State of Rio de Janeiro" (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); "National Council for Scientific and Technological
   Development" (CNPq)National Council for Scientific and Technological
   Development (CNPq) [424,376/2016-4]
FX This study was funded by "The Oswaldo Cruz Institute/Fiocruz/PAEF2",
   "The Carlos Chagas Filho Foundation for Research Support in the State of
   Rio de Janeiro" (FAPERJ) and, "The National Council for Scientific and
   Technological Development" (CNPq 424,376/2016-4). T.M. Fumian, M.P.
   Miagostovich and J.P.G. Leite are FAPERJ and CNPq fellows.
CR Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4
   Barclay L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060535
   de Moraes MTB, 2019, INFECT GENET EVOL, V70, P61, DOI 10.1016/j.meegid.2019.02.011
   Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001
   Bucardo F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19718-y
   Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426
   Cakir B, 2002, ANN HEMATOL, V81, P558, DOI 10.1007/s00277-002-0508-x
   Cannon JL, 2019, CLIN INFECT DIS, V69, P357, DOI 10.1093/cid/ciy985
   Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17
   Cantelli CP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64025-0
   Cantelli CP, 2019, ARCH VIROL, V164, P1427, DOI 10.1007/s00705-019-04195-z
   Chhabra P, 2019, J GEN VIROL, V100, P1393, DOI 10.1099/jgv.0.001318
   Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14
   Currier RL, 2015, CLIN INFECT DIS, V60, P1631, DOI 10.1093/cid/civ165
   Corvelo TCD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069908
   Elmgren A, 1996, VOX SANG, V70, P97, DOI 10.1111/j.1423-0410.1996.tb01300.x
   Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988
   Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514
   Fumian TM, 2016, J VIROL METHODS, V228, P123, DOI 10.1016/j.jviromet.2015.11.008
   Nguyen GT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008139
   Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588
   Green KY, 2013, FIELDS VIROLOGY
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hata M, 2018, JPN J INFECT DIS, V71, P319, DOI 10.7883/yoken.JJID.2017.520
   Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005
   Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003
   Jiang X, 2004, J INFECT DIS, V190, P1850, DOI 10.1086/425159
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640
   Kindberg E, 2009, FUTURE VIROL, V4, P369, DOI 10.2217/FVL.09.14
   KODA Y, 1993, BLOOD, V82, P2915
   Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9
   Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070
   Krammer EM, 2018, J BIOL CHEM, V293, P11966, DOI 10.1074/jbc.H118.004336
   Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006
   Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Li J, 2018, VIRUS RES, V249, P99, DOI 10.1016/j.virusres.2018.03.016
   Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860
   LINHARES AC, 1989, EPIDEMIOL INFECT, V102, P129, DOI 10.1017/S0950268800029769
   Lopman B, 2014, CLIN INFECT DIS, V58, P492, DOI 10.1093/cid/cit785
   Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672
   Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9
   Mattison CP, 2018, EXPERT REV VACCINES, V17, P773, DOI 10.1080/14760584.2018.1510327
   Medici MC, 2018, NEW MICROBIOL, V41, P71
   Siqueira JAM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178909
   Trang NV, 2015, EPIDEMIOL INFECT, V143, P3292, DOI 10.1017/S095026881500059X
   Newburg DS, 2004, GLYCOBIOLOGY, V14, p13G, DOI 10.1093/glycob/cwh086
   Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]
   Nordgren J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030226
   Nordgren J, 2014, CLIN INFECT DIS, V59, P1567, DOI 10.1093/cid/ciu633
   Nordgren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069557
   O'Ryan ML, 2009, PEDIATR INFECT DIS J, V28, P879, DOI 10.1097/INF.0b013e3181a4bb60
   Olivares A.I.O., 2020, ROTAVIRUS HUMAN NORO
   Pang H, 1998, HUM GENET, V102, P675, DOI 10.1007/s004390050760
   Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021
   Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63
   da Costa STP, 2017, MEM I OSWALDO CRUZ, V112, P391, DOI 10.1590/0074-02760160357
   Barreira DMPG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189504
   Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927
   Qi Rui, 2018, EClinicalMedicine, V2-3, P50, DOI 10.1016/j.eclinm.2018.09.001
   Ramani S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005334
   Rouhani S, 2016, CLIN INFECT DIS, V62, P1210, DOI 10.1093/cid/ciw072
   Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763
   Sang SW, 2018, PEERJ, V6, DOI 10.7717/peerj.4333
   Sharma S, 2020, FOOD ENVIRON VIROL, V12, P28, DOI 10.1007/s12560-019-09410-3
   Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07
   Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127
   Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200
   Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X
   Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005
   Tohma K, 2019, MBIO, V10, DOI 10.1128/mBio.02202-19
   Tohma K, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00187-17
   Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011
   van Beek J, 2018, LANCET INFECT DIS, V18, P545, DOI 10.1016/S1473-3099(18)30059-8
   Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13
   Vicentini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069348
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
NR 78
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD AUG
PY 2020
VL 82
AR 104280
DI 10.1016/j.meegid.2020.104280
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA NR3JB
UT WOS:000571457700006
PM 32165242
DA 2020-12-01
ER

PT J
AU Brasil, P
   Vasconcelos, Z
   Kerin, T
   Gabaglia, CR
   Ribeiro, IP
   Bonaldo, MC
   Damasceno, L
   Pone, MV
   Pone, S
   Zin, A
   Tsui, I
   Adachi, K
   Pereira, JP
   Gaw, SL
   Carvalho, L
   Cunha, DC
   Guida, L
   Rocha, M
   Cherry, JD
   Wang, LL
   Aliyari, S
   Cheng, GH
   Foo, SS
   Chen, WQ
   Jung, J
   Brickley, E
   Moreira, MEL
   Nielsen-Saines, K
AF Brasil, Patricia
   Vasconcelos, Zilton
   Kerin, Tara
   Gabaglia, Claudia Raja
   Ribeiro, Ieda P.
   Bonaldo, Myrna C.
   Damasceno, Luana
   Pone, Marcos V.
   Pone, Sheila
   Zin, Andrea
   Tsui, Irena
   Adachi, Kristina
   Pereira, Jose Paulo, Jr.
   Gaw, Stephanie L.
   Carvalho, Liege
   Cunha, Denise C.
   Guida, Leticia
   Rocha, Mirza
   Cherry, James D.
   Wang, Lulan
   Aliyari, Saba
   Cheng, Genhong
   Foo, Suan-Sin
   Chen, Weiqiang
   Jung, Jae
   Brickley, Elizabeth
   Moreira, Maria Elisabeth L.
   Nielsen-Saines, Karin
TI Zika virus vertical transmission in children with confirmed antenatal
   exposure
SO NATURE COMMUNICATIONS
LA English
DT Article
ID INFECTION; INFANTS; DENGUE
AB We report Zika virus (ZIKV) vertical transmission in 130 infants born to PCR+ mothers at the time of the Rio de Janeiro epidemic of 2015-2016. Serum and urine collected from birth through the first year of life were tested by quantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA. Four hundred and seven specimens are evaluated; 161 sera tested by PCR and IgM assays, 85 urines by PCR. Sixty-five percent of children (N=84) are positive in at least one assay. Of 94 children tested within 3 months of age, 70% are positive. Positivity declines to 33% after 3 months. Five children are PCR+ beyond 200 days of life. Concordance between IgM and PCR results is 52%, sensitivity 65%, specificity 40% (positive PCR results as gold standard). IgM and serum PCR are 61% concordant; serum and urine PCR 55%. Most children (65%) are clinically normal. Equal numbers of children with abnormal findings (29 of 45, 64%) and normal findings (55 of 85, 65%) have positive results, p=0.98. Earlier maternal trimester of infection is associated with positive results (p=0.04) but not clinical disease (p=0.98). ZIKV vertical transmission is frequent but laboratory confirmed infection is not necessarily associated with infant abnormalities. Here, Brasil et al. investigate mother to child Zika virus (ZIKV) transmission rates in a large longitudinal cohort of pregnant ZIKV-positive women with their infants followed from the time of maternal infection through birth and onwards, finding high in utero transmission rates that do not predict clinical outcomes, suggesting follow-up of children with antenatal ZIKV exposure is necessary.
C1 [Brasil, Patricia; Vasconcelos, Zilton; Ribeiro, Ieda P.; Bonaldo, Myrna C.; Damasceno, Luana; Pone, Marcos V.; Pone, Sheila; Zin, Andrea; Pereira, Jose Paulo, Jr.; Carvalho, Liege; Cunha, Denise C.; Guida, Leticia; Rocha, Mirza; Moreira, Maria Elisabeth L.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Wang, Lulan; Aliyari, Saba; Cheng, Genhong; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA 92056 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Foo, Suan-Sin; Chen, Weiqiang; Jung, Jae] Univ Southern Calif, Los Angeles, CA 90007 USA.
   [Brickley, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.; Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
EM patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu
RI ; Brickley, Elizabeth/U-3625-2017
OI Bonaldo, Myrna/0000-0001-9899-3386; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Brickley, Elizabeth/0000-0003-0280-2288
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-17]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [CAPES/88887.116627/2016-01, CAPES
   88881.130684/2016-01]; Brazilian National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq) [CNPq/441098/2016-9, CNPq307282/2017,
   CNPq440865/2016-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro [FAPERJ/E_18/2015TXB, FAPERJ/239224/E032018
   CNE, FAPERJ/E_26/202.862/2018 CNE]; Fondation Christophe and Rodolph
   Merieux; ZikAlliance [734548]; Thrasher Research Fund [20164370];
   National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534, AI140718,
   K08AI141728]; National Eye Institute (NEI) of the National Institutes of
   Health [AI129847]; United Kingdom's Department for International
   Development; Queenan Fellowship from the Foundation for the Society of
   Maternal-Fetal Medicine; ZikaPlan (Preparedness Latin American Network);
   Wellcome TrustWellcome Trust; UK's Department for International
   Development [205377/Z/16/Z]; European UnionEuropean Union (EU) [734584]
FX This study was supported by the Departamento de Ciencia e Tecnologia
   (DECIT/25000.072811/2016-17) do Ministerio da Saude do Brasil (P.B. and
   M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01; CAPES 88881.130684/2016-01); Brazilian
   National Council for Scientific and Technological Development
   CNPq/441098/2016-9; CNPq307282/2017; CNPq440865/2016-6) (P.B., M.E. M.,
   and M.C.B); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ/E_18/2015TXB (M.E.M.); FAPERJ/239224/E032018
   CNE (M.E.M.); FAPERJ/E_26/202.862/2018 CNE (P.B.); Fondation Christophe
   and Rodolph Merieux; ZikAlliance 734548 (P.B.); the Thrasher Research
   Fund (20164370) (K.N.S. and K.A.); the National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of Health AI28697
   (K.N.S.), AI1259534 (K.N.S. and P.B.), AI140718 (K.N.S., P.B., G.C., and
   J.J.), K08AI141728 (S.L.G.), the National Eye Institute (NEI) of the
   National Institutes of Health AI129847 (K.N.S., I.T., and P.B.) and the
   United Kingdom's Department for International Development (M.E.M.); the
   Queenan Fellowship from the Foundation for the Society of Maternal-Fetal
   Medicine (S.L.G.) and the ZikaPlan (Preparedness Latin American Network)
   (M.E.M.); Wellcome Trust & the UK's Department for International
   Development (205377/Z/16/Z; https://wellcome.ac.uk/) and the European
   Union's Horizon 2020 research and innovation program
   (https://ec.europa.eu/programmes/horizon2020/) under ZikaPLAN grant
   agreement No. 734584 (https://zikaplan.tghn.org/) (E.B.) We thank the
   women who enrolled in this study and the Fiocruz Zika Field Team who
   rendered our work possible.
CR Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cherry J. D. B. A, 2019, FEIGIN CHERRYS TXB P, P1601
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harrison G. J, 2019, FEIGIN CHERRYS TXB P, P1429
   Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira JP, 2019, CLIN INFECT DIS, V69, P713, DOI 10.1093/cid/ciz013
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
   Sanchez-Montalva A, 2019, NEW ENGL J MED, V380, P198, DOI 10.1056/NEJMc1814416
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01972-17, 10.1128/JCM.01972-17]
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Vasconcelos Z., 2018, ZIKV DIAGNOSTICS CUR
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Zin AA, 2018, J AAPOS, V22, P452, DOI 10.1016/j.jaapos.2018.07.352
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 32
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL 14
PY 2020
VL 11
IS 1
DI 10.1038/s41467-020-17331-0
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MM3LY
UT WOS:000550062200006
PM 32665616
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Cranston, JS
   Tiene, SF
   Nielsen-Saines, K
   Vasconcelos, Z
   Pone, MV
   Pone, S
   Zin, A
   Salles, TS
   Pereira, JP
   Orofino, D
   Brasil, P
   Kerin, T
   Adachi, K
   Soares, FM
   de Abranches, AD
   da Costa, ACC
   Moreira, MEL
AF Cranston, Jessica S.
   Tiene, Sophia Finn
   Nielsen-Saines, Karin
   Vasconcelos, Zilton
   Pone, Marcos V.
   Pone, Sheila
   Zin, Andrea
   Salles, Tania Saad
   Pereira, Jose Paulo, Jr.
   Orofino, Dulce
   Brasil, Patricia
   Kerin, Tara
   Adachi, Kristina
   Soares, Fernanda Mendes
   Dunshee de Abranches, Andrea
   da Costa, Ana Carolina C.
   Lopes Moreira, Maria Elisabeth
TI Association Between Antenatal Exposure to Zika Virus and Anatomical and
   Neurodevelopmental Abnormalities in Children
SO JAMA NETWORK OPEN
LA English
DT Article
ID BIRTH-DEFECTS; INFECTION; INFANTS; TRANSMISSION; BRAZIL; MANIFESTATIONS;
   EPIDEMIC; UPDATE; GROWTH; STATES
AB This cohort study characterizes the clinical features associated with antenatal exposure to the Zika virus in children and assesses whether an association exists between head circumference at birth and neurodevelopmental outcomes.
   Importance Zika virus (ZIKV) is a mosquito-borne flavivirus recognized as teratogenic since the 2015 to 2016 epidemic. Antenatal ZIKV exposure causes brain anomalies, yet the full spectrum has not been delineated. Objective To characterize the clinical features of ZIKV infection at a pediatric referral center in Rio de Janeiro, Brazil, among children with antenatal ZIKV exposure. Design, Setting, and Participants Retrospective cohort study conducted from May to July 2019 of a prospective cohort of 296 infants with antenatal ZIKV exposure followed up since December 2015 at a tertiary maternity-pediatric hospital. Exposures Zika virus infection during pregnancy. Main Outcomes and Measures Characterization of clinical features with anthropometric, neurologic, cardiologic, ophthalmologic, audiometric, and neuroimaging evaluations in infancy and neurodevelopmental assessments (Bayley Scales of Infant and Toddler Development, Third Edition) from 6 to 42 months of age, stratified by head circumference at birth (head circumference within the reference range, or normocephaly [NC] vs microcephaly [MC]). Results Antenatal exposure to ZIKV was confirmed for 219 of 296 children (74.0%) referred to Instituto Fernandes Figueira with suspected ZIKV infection through positive maternal or neonatal polymerase chain reaction analysis or IgM serology results. Of these children, 110 (50.2%) were boys, ages ranged from 0 to 4 years, and 53 (24.2%) had congenital microcephaly. The anomalies observed in ZIKV-exposed children with MC or NC were failure to thrive (MC: 38 of 53 [71.7%]; NC: 73 of 143 [51.0%]), cardiac malformations (MC: 19 of 46 [41.3%]; NC: 20 of 100 [20.0%]), excess nuchal skin (MC: 16 of 22 [72.7%]; NC: 35 of 93 [37.6%]), auditory abnormalities (MC: 13 of 50 [26.0%]; NC: 14 of 141 [9.9%]), and eye abnormalities (MC: 42 of 53 [79.2%]; NC: 28 of 158 [17.7%]). Although they experienced fewer neurologic abnormalities than children born with MC, those with NC also had frequent neurologic abnormalities (109 of 160 [68.1%]), including hyperreflexia (36 of 136 [26.5%]), abnormal tone (53 of 137 [38.7%]), congenital neuromotor signs (39 of 93 [41.9%]), feeding difficulties (15 of 143 [10.5%]), and abnormal brain imaging results (44 of 150 [29.3%]). Among 112 children with NC with Bayley-III evaluations, 72 (64.3%) had average or above-average scores; 30 (26.8%) scored 1 SD below average in at least 1 domain; and 10 (8.9%) scored 2 SD below average in at least 1 domain. Among 112 children with NC, a smaller head circumference at birth was significantly associated with subsequent below-average cognitive scores (U = 499.5; z = -2.833; P = .004) and language scores (U = 235.5; z = -2.491; P = .01). Conclusions and Relevance Children without MC who were exposed to ZIKV in utero had a high frequency of anatomical and neurodevelopmental abnormalities. The head circumference at birth for children with NC was associated with neurocognitive development. Recognition of the wide spectrum of clinical phenotypes is critical to ensure early referral to rehabilitative interventions.
   Question What is the spectrum of clinical findings associated with antenatal Zika virus exposure, and does an association exist between head circumference at birth and neurodevelopmental outcomes among Zika virus-exposed children with normocephaly? Findings This cohort study of 219 children found that antenatal Zika virus exposure was associated with a wide spectrum of clinical manifestations in normocephalic children beyond those previously described. The head circumference of normocephalic children was associated with neurodevelopmental outcomes. Meaning Recognition of the variety of clinical phenotypes following antenatal Zika virus exposure, including evaluation of head circumference as a continuous variable, may help ensure early intervention, appropriate cross-disciplinary evaluation, and comprehensive therapeutic care.
C1 [Cranston, Jessica S.; Tiene, Sophia Finn; Nielsen-Saines, Karin; Kerin, Tara; Adachi, Kristina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis, 10833 Le Conte Ave,MDCC 22-442, Los Angeles, CA 90095 USA.
   [Vasconcelos, Zilton; Pone, Marcos V.; Pone, Sheila; Zin, Andrea; Salles, Tania Saad; Pereira, Jose Paulo, Jr.; Orofino, Dulce; Brasil, Patricia; Soares, Fernanda Mendes; Dunshee de Abranches, Andrea; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Cranston, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis, 10833 Le Conte Ave,MDCC 22-442, Los Angeles, CA 90095 USA.
EM jcranston@mednet.ucla.edu
RI de Abranches, Andrea Dunshee/ABA-8578-2020
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI28697, AI1259534, AI140718]; National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [AI129847]; Thrasher Foundation; CNPqNational Council for Scientific and
   Technological Development (CNPq) [441098/2016-9, 305090/2016-0];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E_18/2015TXB]
FX Drs Nielsen-Saines and Brasil were supported by grants AI28697,
   AI1259534, and AI140718 from NIAID, grant AI129847 from the National Eye
   Institute, and grants from the Thrasher Foundation; Dr Lopes Moreira was
   supported by awards 441098/2016-9 and 305090/2016-0 from CNPq and award
   E_18/2015TXB from FAPERJ.
CR Adachi K, 2020, CLIN INFECT DIS, V70, P2663, DOI 10.1093/cid/ciz704
   Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Macy K, 2013, ENCY AUTISM SPECTRUM, P399, DOI 10.1007/978-1-4419-1698-3_284
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Valdes V, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14061
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 52
TC 4
Z9 4
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL 7
PY 2020
VL 3
IS 7
DI 10.1001/jamanetworkopen.2020.9303
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA MP3GX
UT WOS:000552096400002
PM 32633763
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Adachi, K
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Aibe, M
   de Aguiar, EB
   Sim, M
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Halai, UA
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Portari, E
   Cherry, JD
   Pone, M
   Moreira, ME
AF Adachi, Kristina
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Aibe, Mitsue
   de Aguiar, Elisa Barroso
   Sim, Myung
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Vasconcelos, Zilton
   Pereira, Jose Paulo
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Portari, Elyzabeth
   Cherry, James D.
   Pone, Marcos
   Moreira, Maria Elisabeth
TI Early Clinical Infancy Outcomes for Microcephaly and/or Small for
   Gestational Age Zika-Exposed Infants
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; congenital Zika syndrome; microcephaly; proportional microcephaly;
   small for gestational age (SGA)
ID LINKED IMMUNOSORBENT ASSAYS; VIRUS-INFECTION; BRAZIL; CYTOMEGALOVIRUS;
   EPIDEMIC; GROWTH; STATE; IGM
AB Background. Zika-exposed infants with microcephaly (proportional or disproportional) and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.Antenatal Zika virus (ZIKV) exposure may lead to adverse infant outcomes including microcephaly and being small for gestational age (SGA). ZIKV-exposed infants with a diagnosis of microcephaly (proportional [PM] or disproportional [DM]) or SGA at birth were evaluated with anthropometric measurements and health outcomes.
   Methods. Infants had laboratory-confirmed ZIKV exposure in Brazil. PM, DM, or SGA classification was based on head circumference and weight. First-year growth parameters and clinical outcomes were recorded with analyses performed.
   Results. Among the 156 ZIKV-exposed infants, 14 (9.0%) were SGA, 13 (8.3%) PM, 13 (8.3%) DM, and 116 (74.4%) were neither SGA nor had microcephaly (NSNM). High rates of any neurologic, ophthalmologic, and hearing abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.001); odds ratio [OR], 3.4 (95% confidence interval [CI], 1.1-10.7) for SGA vs NSNM. Neuroimaging abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); OR 3.9 (95% CI, 1.2-12.8) for SGA vs NSNM. Growth rates by z score, particularly for microcephaly infants, were poor after birth but showed improvement beyond 4 months of life.
   Conclusions. ZIKV-exposed infants with microcephaly (PM and DM) had similarly high rates of adverse outcomes but showed improvement in growth measurements beyond 4 months of life. While SGA infants had fewer adverse outcomes compared with microcephaly infants, notable adverse outcomes were observed in some; their odds of having adverse outcomes were 3 to 4 times greater compared to NSNM infants.
C1 [Adachi, Kristina; Nielsen-Saines, Karin; Cherry, James D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
   [Romero, Tahmineh; Sim, Myung] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Aibe, Mitsue; de Aguiar, Elisa Barroso; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo; Salles, Tania Saad; Barbosa, Claudia Neves; Portari, Elyzabeth; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol, San Francisco, CA USA.
   [Halai, Umme-Aiman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
RP Moreira, ME (corresponding author), Inst Fernandes Figueira IFF, Ave Rui Barbosa 716, BR-22420040 Flamengo Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
OI Moura Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute [AI129847-01, UL1TR001881]; Thrasher Research Fund [20164370];
   UK Department for International Development; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K08AI141728,
   K08AI141728] Funding Source: NIH RePORTER
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01), the National Institute of Allergy and
   Infectious Diseases (AI28697, AI1259534-01) and the National Eye
   Institute (AI129847-01) of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute (UL1TR001881), Thrasher Research Fund (20164370), and the UK
   Department for International Development.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK MAC ELISA, V2019
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   PAHO/WHO, 2017, ZIK CAS CONG SYNDR A
   PAHO WHO, 2016, REG ZIK EP UPD AM
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   PRIMHAK RA, 1982, CLIN PEDIATR, V21, P417, DOI 10.1177/000992288202100705
   Simonazzi G, 2014, PRENATAL DIAG, V34, P765, DOI 10.1002/pd.4362
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yamamoto R, 2013, J OBSTET GYNAECOL RE, V39, P653, DOI 10.1111/j.1447-0756.2012.02012.x
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 26
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2020
VL 70
IS 12
BP 2663
EP 2672
DI 10.1093/cid/ciz704
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA MO4RV
UT WOS:000551516200037
PM 31346616
OA Green Published
DA 2020-12-01
ER

PT J
AU Sobhani, NC
   Avvad-Portari, E
   Nascimento, ACM
   Machado, HN
   Lobato, DSS
   Pereira, JP
   Esquivel, MS
   Vasconcelos, ZC
   Zin, AA
   Tsui, I
   Adachi, K
   Brickley, EB
   Fisher, SJ
   Nielsen-Saines, K
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Sobhani, Nasim C.
   Avvad-Portari, Elyzabeth
   Nascimento, Aline C. M.
   Machado, Heloisa N.
   Lobato, Daniel S. S.
   Pereira, Jose Paulo
   Esquivel, Mikaela S.
   Vasconcelos, Zilton C.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Brickley, Elizabeth B.
   Fisher, Susan J.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Discordant Zika Virus Findings in Twin Pregnancies Complicated by
   Antenatal Zika Virus Exposure: A Prospective Cohort
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome; perinatal infection; TORCH infection; twin;
   vertical transmission
ID PLACENTAL PATHOLOGY; INFECTION; CELLS; INFANTS
AB Background. There are limited data on the natural history of antenatal Zika virus (ZIKV) exposure in twin pregnancies, especially regarding intertwin concordance of prenatal, placental, and infant outcomes.
   Methods. This prospective cohort study included twin pregnancies referred to a single institution from September 2015 to June 2016 with maternal ZIKV. Polymerase chain reaction (PCR) testing of maternal, placental, and neonatal samples was performed. Prenatal ultrasounds were completed for each twin, and histomorphologic analysis was performed for each placenta. Abnormal neonatal outcome was defined as abnormal exam and/or abnormal imaging. Two- to three-year follow-up of infants included physical exams, neuroimaging, and Bayley-III developmental assessment.
   Results. Among 244 pregnancies, 4 twin gestations without coinfection were identified. Zika virus infection occurred at 16-33 weeks gestation. Zika virus PCR testing revealed discordance between dichorionic twins, between placentas in a dichorionic pair, between portions of a monochorionic placenta, and between a neonate and its associated placenta. Of the 8 infants, 3 (38%) had an abnormal neonatal outcome. Of 6 infants with long-term follow-up, 3 (50%) have demonstrated ZIKV-related abnormalities.
   Conclusions. Neonatal PCR testing, placental findings, and infant outcomes can be discordant between co-twins with antenatal ZIKV exposure. These findings demonstrate that each twin should be evaluated independently for vertical transmission.
C1 [Sobhani, Nasim C.; Esquivel, Mikaela S.; Fisher, Susan J.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Avvad-Portari, Elyzabeth; Nascimento, Aline C. M.; Machado, Heloisa N.; Lobato, Daniel S. S.; Pereira, Jose Paulo; Vasconcelos, Zilton C.; Zin, Andrea A.; Brasil, Patricia; Moreira, Maria E.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556 16HSE, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Brickley, Elizabeth/U-3625-2017
OI Brickley, Elizabeth/0000-0003-0280-2288
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K08AI141728]; Foundation for the Society of
   MaternalFetal Medicine Queenan Fellowship for Global Health; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21AI28697,
   R21AI129534]; National Eye Institute (NEI)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318]; Brazilian Ministry of
   Health; Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department
   for International Development [205377/Z/16/Z]; European UnionEuropean
   Union (EU) [734584]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K08AI141728, K08AI141728] Funding Source: NIH RePORTER
FX This work was funded by the following: National Institute of Allergy and
   Infectious Diseases (NIAID) (K08AI141728) and the Foundation for the
   Society of Maternal Fetal Medicine Queenan Fellowship for Global Health
   (to S. L. G.); generous support from Marc and Lynne Benioff (to S. J.
   F.); National Institute of Allergy and Infectious Diseases (R21AI28697
   and R21AI129534) and National Eye Institute (NEI) (R21EY028318) (to K.
   N.-S.); the Brazilian Ministry of Health (to P. B. and M. E. M.);
   Wellcome Trust and the UK's Department for International Development
   (205377/Z/16/Z; to M. E. M. and E. B.); the European Union's Horizon
   2020 Research and Innovation Programme under ZikaPLAN grant agreement
   number 734584 and FAPERJ (to M. E. M.); and the Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ (EAP).
CR AHLFORS K, 1988, EARLY HUM DEV, V18, P125, DOI 10.1016/0378-3782(88)90049-7
   Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dickinson JE, 2006, TWIN RES HUM GENET, V9, P456, DOI 10.1375/twin.9.3.456
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010
   Higgins M, 2011, PEDIATR DEVEL PATHOL, V14, P273, DOI 10.2350/10-07-0872-OA.1
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pereira L, 2017, PLACENTA, V59, pS8, DOI 10.1016/j.placenta.2017.04.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056
   Reyes L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02628
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 27
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2020
VL 221
IS 11
BP 1838
EP 1845
DI 10.1093/infdis/jiz629
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LU0MN
UT WOS:000537458000014
PM 31773163
DA 2020-12-01
ER

PT J
AU Cantelli, CP
   Velloso, AJ
   de Assis, RMS
   Barros, JJ
   Mello, FCD
   da Cunha, DC
   Brasil, P
   Nordgren, J
   Svensson, L
   Miagostovich, MP
   Leite, JPG
   de Moraes, MTB
AF Cantelli, Carina Pacheco
   Velloso, Alvaro Jorge
   Santos de Assis, Rosane Maria
   Barros, Jose Junior
   do Amaral Mello, Francisco Campello
   da Cunha, Denise Cotrim
   Brasil, Patricia
   Nordgren, Johan
   Svensson, Lennart
   Miagostovich, Marize Pereira
   Gagliardi Leite, Jose Paulo
   de Moraes, Marcia Terezinha Baroni
TI Rotavirus A shedding and HBGA host genetic susceptibility in a birth
   community-cohort, Rio de Janeiro, Brazil, 2014-2018
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BLOOD GROUP ANTIGENS; VACCINE; LEWIS; SECRETOR; FUT2; PREVALENCE;
   INFECTION; VP8(STAR); AMERICAN; STRAINS
AB Recent studies have investigated whether the human histo-blood group antigen (HBGAs) could affect the effectiveness of the oral rotavirus vaccines, suggesting secretor positive individuals develop a more robust response. We investigated the Rotavirus A (RVA) shedding in association with the host susceptibility profile in children from a birth community-cohort in Rio de Janeiro, Brazil, from 2014 to 2018. A total of 132 children were followed-up between 0 to 11-month-old, stool samples were collected before/after the 1(st)/2(nd) RV1 vaccination doses and saliva samples were collected during the study. RVA shedding was screened by RT-qPCR and G/P genotypes determined by multiplex RT-PCR and/or Sanger nucleotide sequencing. The sequencing indicated an F167L amino acid change in the RV1 VP8* P[8] in 20.5% of shedding follow-ups and these mutant subpopulations were quantified by pyrosequencing. The HBGA/secretor status was determined and 80.3% of the children were secretors. Twenty-one FUT2 gene SNPs were identified and two new mutations were observed. The mutant F167L RV1 VP8* P[8] was detected significantly more in Le (a+b+) secretors (90.5%) compared to non-secretors and even to secretors Le (a-b+) (9.5%). The study highlights the probable association between RV1 shedding and HBGAs as a marker for evaluating vaccine strain host susceptibility.
C1 [Cantelli, Carina Pacheco; Velloso, Alvaro Jorge] Fiocruz MS, Immunobiol Technol Inst Biomanguinhos, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [Cantelli, Carina Pacheco; Santos de Assis, Rosane Maria; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; de Moraes, Marcia Terezinha Baroni] Fiocruz MS, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [Barros, Jose Junior] Fiocruz MS, Lab Mol Virol, Inst Oswaldo Cruz, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [do Amaral Mello, Francisco Campello] Fiocruz MS, Lab Viral Hepatitis, Inst Oswaldo Cruz, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [da Cunha, Denise Cotrim] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [Nordgren, Johan; Svensson, Lennart] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.
RP Cantelli, CP (corresponding author), Fiocruz MS, Immunobiol Technol Inst Biomanguinhos, Ave Brasil 4365, Rio De Janeiro, Brazil.; Cantelli, CP; Miagostovich, MP (corresponding author), Fiocruz MS, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, Rio De Janeiro, Brazil.
EM carina.cantelli@gmail.com; marizepm@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Miagostovich, Marize/0000-0003-3470-8093; Pacheco Cantelli,
   Carina/0000-0002-9171-5022; Barros, Jose/0000-0002-4288-8680
FU Oswaldo Cruz Institute/Fiocruz/PAEF; "The Carlos Chagas Filho Foundation
   for Research Support in the State of Rio de Janeiro" (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/202.968/2015]; "The National Council for
   Scientific and Technological Development" (CNPq)National Council for
   Scientific and Technological Development (CNPq) [424376/2016-4];
   "Coordination for the Improvement of Higher Education Personnel -
   CAPES"- PrInt-Fiocruz-CAPESCAPES; PROGRAMA DE PROFESSOR VISITANTE NO
   EXTERIOR [88881.337140/2019-01]
FX We would like to thank the parents and infants who participated in this
   study. We would like to thank MiriA Alves Goncalves Trindade for her
   help with the collection of specimens and clinical data, and Messias da
   Silva, Sergio da Silva e Mouta Junior, Alexandre Madi Fialho, Fabio
   Correia Malta, Yan Cardoso Pimenta and Leticia Campos for the
   laboratorial support. We would like to thank the staff members of "the
   FIOCRUZ Institutional Platform for DNA sequencing (PDTIS)" and of "the
   Quality Control of the Bio-Manguinhos (DEQUA)" for technical support
   including the batch of rotavirus vaccine (RV1) supplied. Special thanks
   to Bruno Baroni de Moraes e Souza for the English revision of this
   manuscript. This study was funded by "The Oswaldo Cruz
   Institute/Fiocruz/PAEF", "The Carlos Chagas Filho Foundation for
   Research Support in the State of Rio de Janeiro" (FAPERJ
   E-26/202.968/2015) and "The National Council for Scientific and
   Technological Development" (CNPq 424376/2016-4), "Coordination for the
   Improvement of Higher Education Personnel - CAPES"- PrInt-Fiocruz-CAPES
   and "PROGRAMA DE PROFESSOR VISITANTE NO EXTERIOR
   (88881.337140/2019-01)". M.P.M. and J.P.G.L. are researchers at the
   "Scientist from Our State" (CNE/FAPERJ).
CR Anderson EJ, 2008, LANCET INFECT DIS, V8, P642, DOI 10.1016/S1473-3099(08)70231-7
   Armah GE, 2019, J INFECT DIS, V219, P746, DOI 10.1093/infdis/jiy573
   Banyai K, 2018, LANCET, V392, P175, DOI 10.1016/S0140-6736(18)31128-0
   de Moraes MTB, 2019, INFECT GENET EVOL, V70, P61, DOI 10.1016/j.meegid.2019.02.011
   Braeckman T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4752
   Bucardo F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47166-9
   Bucardo F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19718-y
   Cooling L., 2011, HENRYS CLIN DIAGNOSI, P674
   Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14
   Daniels G, 2013, HUMAN BLOOD GROUPS
   de Oliveira LH, 2015, VACCINE, V33, pA248, DOI 10.1016/j.vaccine.2014.11.060
   Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002
   Doro R, 2014, INFECT GENET EVOL, V28, P446, DOI 10.1016/j.meegid.2014.08.017
   Elmgren A, 1996, VOX SANG, V70, P97, DOI 10.1111/j.1423-0410.1996.tb01300.x
   Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108
   Gautam Rashi, 2016, J Vaccines Vaccin, V7, DOI 10.4172/2157-7560.1000341
   Gozalbo-Rovira R, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007865
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Heggelund JE, 2017, CURR OPIN STRUC BIOL, V44, P190, DOI 10.1016/j.sbi.2017.04.001
   HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x
   Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996
   Huang PW, 2012, J VIROL, V86, P4833, DOI 10.1128/JVI.05507-11
   do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024
   Kambhampati A, 2016, CLIN INFECT DIS, V62, P11, DOI 10.1093/cid/civ873
   Kazi AM, 2017, J INFECT DIS, V215, P786, DOI 10.1093/infdis/jix028
   KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640
   Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0
   Lanzieri TM, 2011, INT J INFECT DIS, V15, pE206, DOI 10.1016/j.ijid.2010.11.007
   Le Pendu J., 2004, EXPT MED BIOL, V554
   Lee B, 2018, J INFECT DIS, V217, P1399, DOI 10.1093/infdis/jiy054
   Liu Y, 2012, J VIROL, V86, P9899, DOI 10.1128/JVI.00979-12
   Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672
   Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238
   Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9
   Mokomane M, 2019, VACCINE, V37, P6324, DOI 10.1016/j.vaccine.2019.09.022
   MOLTHAN L, 1980, VOX SANG, V39, P327
   Nordgren J, 2014, CLIN INFECT DIS, V59, P1567, DOI 10.1093/cid/ciu633
   Patton JT, 2012, DISCOV MED, V13, P85
   Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164
   Pedro RS, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00023918, 10.1590/0102-311x00023918]
   Phua KB, 2005, J INFECT DIS, V192, pS6, DOI 10.1086/431511
   Pollock L, 2018, CLIN INFECT DIS
   Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015
   ROTA Council, 2019, GLOB INTR STAT
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sun X, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.06.007
   Sun XM, 2016, VIROLOGY, V495, P129, DOI 10.1016/j.virol.2016.05.010
   Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960
   Tsugawa T, 2015, J GEN VIROL, V96, P590, DOI 10.1099/vir.0.071373-0
   Turin Christie G, 2014, Curr Trop Med Rep, V1, P97
   Vicentini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069348
   Ward RL, 2006, J INFECT DIS, V194, P1729, DOI 10.1086/509623
   WHO, 2019, MAN ROT DET CHAR MET
   Yang TA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06686-y
   Zeller M, 2017, PEERJ, V5, DOI 10.7717/peerj.2733
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 56
TC 2
Z9 2
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 24
PY 2020
VL 10
IS 1
AR 6965
DI 10.1038/s41598-020-64025-0
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NA4EK
UT WOS:000559768300001
PM 32332841
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Rueda-Lopes, FC
   Soares, CN
   Vieira, IF
   Mendonca, S
   Martins, EB
   Lant, S
   Sequeira, PC
   Solomon, T
   de Filippis, AMB
   Calvet, G
   Brasil, P
AF Rueda-Lopes, Fernanda Cristina
   Soares, Cristiane N.
   Vieira, Iracema Forni
   Mendonca, Silvana
   Martins, Ezequias Batista
   Lant, Suzannah
   Sequeira, Patricia C.
   Solomon, Tom
   Bispo de Filippis, Ana Maria
   Calvet, Guilherme
   Brasil, Patricia
TI Bilateral median nerve neuritis after chikungunya virus infection
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Rueda-Lopes, Fernanda Cristina; Mendonca, Silvana] DASA, Diagnost Amer, Rio De Janeiro, Brazil.
   [Soares, Cristiane N.; Vieira, Iracema Forni; Martins, Ezequias Batista] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Martins, Ezequias Batista; Sequeira, Patricia C.; Bispo de Filippis, Ana Maria; Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, 435, BR-4365 Rio De Janeiro, Brazil.
   [Lant, Suzannah; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, 435, BR-4365 Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI ; Calvet, Guilherme/G-6959-2013
OI Lant, Suzannah/0000-0003-0852-7803; Calvet,
   Guilherme/0000-0002-3545-5238
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-19]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [001/88887.116627/2016-01]; INOVA-Fiocruz
   [VPPCB-008-FIO-18-2-23]; Fondation Christophe e Rodolphe Merieux;
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [307282/2017-1]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro [E-26/202.862/2018]; National Institute for
   Health Research (NIHR) Health Protection Research Unit in Emerging and
   Zoonotic Infections; NIHR Global Health Research Group on Brain
   Infections [17/63/110]; EUEuropean Union (EU) [734584]; NIHRNational
   Institute for Health Research (NIHR) [RP-PG-0108-10048]
FX This study was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil (DECIT/25000.072811/2016-19); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES
   001/88887.116627/2016-01); INOVA-Fiocruz (grant VPPCB-008-FIO-18-2-23);
   and Fondation Christophe e Rodolphe Merieux. PB is supported by
   CNPq307282/2017-1 and Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (E-26/202.862/2018). SL and TS are supported
   by the National Institute for Health Research (NIHR) Health Protection
   Research Unit in Emerging and Zoonotic Infections, the NIHR Global
   Health Research Group on Brain Infections (17/63/110), and the EU's
   Horizon 2020 research and innovation programme ZikaPLAN (Preparedness
   Latin America Network) under grant agreement 734584. TS is also
   supported by NIHR programme grant RP-PG-0108-10048.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2020
VL 20
IS 3
BP 382
EP 382
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA KR7RP
UT WOS:000517813700052
PM 32112769
DA 2020-12-01
ER

PT J
AU Pecanha, PM
   Gomes, SC
   Pone, SM
   Pone, MVD
   Vasconcelos, Z
   Zin, A
   Vilibor, RHH
   Costa, RP
   Meio, MDBB
   Nielsen-Saines, K
   Brasil, P
   Brickley, E
   Moreira, MEL
AF Pecanha, Pedro Massaroni
   Gomes Junior, Saint Clair
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
   Vasconcelos, Zilton
   Zin, Andrea
   Hasue Vilibor, Renata Hydee
   Costa, Roozemeria Pereira
   Barbosa Baker Meio, Maria Dalva
   Nielsen-Saines, Karin
   Brasil, Patricia
   Brickley, Elizabeth
   Lopes Moreira, Maria Elisabeth
TI Neurodevelopment of children exposed intra-uterus by Zika virus: A case
   series
SO PLOS ONE
LA English
DT Article
ID HEAD GROWTH; PRETERM INFANTS; INFECTION; BRAIN; STANDARDS; WEIGHT;
   BRAZIL; NEEDS
AB The main goal of this manuscript was to investigate the neurodevelopment of children exposed by Zika virus in the intrauterine period who are asymptomatic at birth. Newborns with documented Zika virus exposure during the intrauterine period who were asymptomatic at birth were followed in the first two years of life for neurodevelopment using Bayley III test. Children were classified as having normal or delayed neurodevelopment for age based on most recent Bayley III evaluation results. Eighty-four infants were included in the study. The first Bayley III evaluation was performed at a mean chronological age of 9.7 +/- 3.1 month; 13 children (15%) had a delay in one of the three domains, distributed as follow: 10 (12%) in the language domain and 3 (3.5%) in the motor domain. The most recent Bayley III evaluation was performed at a mean age 15.3 +/- 3.1 months; 42 children (50%) had a delay in one of the three domains: 4 (5%) in cognition, 31 (37%) in language, and 20 (24%) in motor performance. There were no statistical differences in Gender, Gestational Age, Birth Weight and Head Circurference at birth between children with normal and delayed neurodevelopment for age. A very high proportion of children exposed ZIKV during pregnancy who were asymptomatic at birth demonstrated a delay in neurodevelopment, mainly in the language domain, the first two years of life.
C1 [Pecanha, Pedro Massaroni; Gomes Junior, Saint Clair; Pone, Sheila Moura; da Silva Pone, Marcos Vinicius; Vasconcelos, Zilton; Zin, Andrea; Costa, Roozemeria Pereira; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
   [Hasue Vilibor, Renata Hydee] Univ Sao Paulo, Sao Paulo, Brazil.
   [Nielsen-Saines, Karin] UCLA, Los Angeles, CA USA.
   [Brasil, Patricia] Inst Nacl Infectol Fiocruz, Rio De Janeiro, Brazil.
   [Brickley, Elizabeth] London Sch Hyg & Trop Med, London, England.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
EM bebethiff@gmail.com
RI Junior, Clair Gomes/F-7579-2012; Hasue, Renata Hydee/B-2328-2013;
   Brickley, Elizabeth/U-3625-2017
OI Junior, Clair Gomes/0000-0002-1554-943X; Massaroni Pecanha,
   Pedro/0000-0002-4151-5508; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Brickley, Elizabeth/0000-0003-0280-2288
FU European UnionEuropean Union (EU) [734584]; Wellcome TrustWellcome Trust
   [205377/Z/16/Z]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPqNational Council for Scientific and Technological
   Development (CNPq) [441098/2016-9]; FaperjCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.979/2017]; PIP2/IFF/Fiocruz [IFF-002Fio1628]; NIH/NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [RO1-AI140718]
FX The author(s) received specific fundings for this work -European Union's
   Horizon 2020 Research and Innovation Programme under ZikaPLAN 734584
   Maria Elisabeth lopes Moreira - Wellcome Trust 205377/Z/16/Z Dr
   Elizabeth Brickley - Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPq 441098/2016-9 Maria Elisabeth lopes Moreira - Faperj
   E-26/202.979/2017 Maria Elisabeth lopes Moreira - PIP2/IFF/Fiocruz
   IFF-002Fio1628 Maria Elisabeth lopes Moreira - NIH/NIAID - RO1-AI140718.
CR Adu-Afarwuah S, 2017, ANN NY ACAD SCI, V1392, P18, DOI 10.1111/nyas.13328
   BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9
   Bayley N., 2006, BAYLEY SCALES INFANT
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atenc Saude, 2016, GUID EARL STIM INF 3
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438
   Coplan J., 1983, ELM SCALE EARLY LANG
   Countryeconomy.com, 2018, BRAZ NAT MIN WAG NMW
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   de Paiva GS, 2010, SAO PAULO MED J, V128, P276, DOI 10.1590/S1516-31802010000500007
   Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilberti LDP, 1999, AN 6 C GOIAN PED GOI
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Kuban KCK, 2009, J PEDIATR-US, V155, P344, DOI 10.1016/j.jpeds.2009.04.002
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Neubauer V, 2013, ACTA PAEDIATR, V102, P883, DOI 10.1111/apa.12319
   OECD, 2018, ED GLANC 2018
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Raghuram K, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0216
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Maria-Mengel MR, 2007, REV LAT-AM ENFERM, V15, P837, DOI 10.1590/S0104-11692007000700019
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Waldorf KMA, 2018, NAT MED
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Wu YH, 2018, CELL REP, V25, P1537, DOI 10.1016/j.celrep.2018.10.025
NR 41
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2020
VL 15
IS 2
AR e0229434
DI 10.1371/journal.pone.0229434
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ8HR
UT WOS:000535239800011
PM 32109947
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Almeida-de-Oliveira, NK
   Lima-Cury, L
   de Abreu-Fernandes, R
   Lavigne, AD
   de Pina-Costa, A
   Perce-da-Silva, DD
   Catanho, M
   Brasil, P
   Daniel-Ribeiro, CT
   Ferreira-da-Cruz, MD
AF Almeida-de-Oliveira, Natalia Ketrin
   Lima-Cury, Lidiane
   de Abreu-Fernandes, Rebecca
   Lavigne, Aline de Rosa
   de Pina-Costa, Anielle
   Perce-da-Silva, Daiana de Souza
   Catanho, Marcos
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Ferreira-da-Cruz, Maria de Fatima
TI Extensive genetic diversity of Plasmodium vivax dbp-II in Rio de Janeiro
   Atlantic Forest and Brazilian Amazon Basin: evidence of positive
   selection
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Plasmodium vivax; Genetic diversity; SNP; DBP; Positive
   selection
ID DUFFY BINDING-PROTEIN; NATURAL-SELECTION; MALARIA; POLYMORPHISM
AB Background Plasmodium vivax is the most widespread human malaria parasite outside Africa and is the predominant parasite in the Americas. Increasing reports of P. vivax disease severity, together with the emergence of drug-resistant strains, underscore the urgency of the development of vaccines against P. vivax. Polymorphisms on DBP-II-gene could act as an immune evasion mechanism and, consequently, limited the vaccine efficacy. This study aimed to investigate the pvdbp-II genetic diversity in two Brazilian regions with different epidemiological patterns: the unstable transmission area in the Atlantic Forest (AF) of Rio de Janeiro and; the fixed malaria-endemic area in Brazilian Amazon (BA). Methods 216 Brazilian P. vivax infected blood samples, diagnosed by microscopic examination and PCR, were investigated. The region flanking pvdbp-II was amplified by PCR and sequenced. Genetic polymorphisms of pvdbp-II were estimated based on the number of segregating sites and nucleotide and haplotype diversities; the degree of differentiation between-regions was evaluated applying Wright's statistics. Natural selection was calculated using the rate of nonsynonymous per synonymous substitutions with the Z-test, and the evolutionary distance was estimated based on the reconstructed tree. Results 79 samples from AF and 137 from BA were successfully sequenced. The analyses showed 28 polymorphic sites distributed in 21 codons, with only 5% of the samples Salvador 1 type. The highest rates of polymorphic sites were found in B- and T cell epitopes. Unexpectedly, the nucleotide diversity in pvdbp-II was higher in AF (0.01) than in BA (0.008). Among the 28 SNPs detected, 18 are shared between P. vivax isolates from AF and BA regions, but 8 SNPs were exclusively detected in AF-I322S, K371N, E385Q, E385T, K386T, K411N, I419L and I419R-and 2 (N375D and I419M) arose exclusively in BA. These findings could suggest the potential of these geographical clusters as population-specific-signatures that may be useful to track the origin of infections. The sample size should be increased in order to confirm this possibility. Conclusions The results highlight that the pvdbp-II polymorphisms are positively selected by host's immune pressure. The characterization of pvdbp-II polymorphisms might be useful for designing effective DBP-II-based vaccines.
C1 [Almeida-de-Oliveira, Natalia Ketrin; Lima-Cury, Lidiane; de Abreu-Fernandes, Rebecca; Lavigne, Aline de Rosa; Perce-da-Silva, Daiana de Souza; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisas Malaria, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Catanho, Marcos] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Genet Mol Microrganismos, Rio De Janeiro, Brazil.
   [Almeida-de-Oliveira, Natalia Ketrin; Lima-Cury, Lidiane; de Abreu-Fernandes, Rebecca; Lavigne, Aline de Rosa; de Pina-Costa, Anielle; Perce-da-Silva, Daiana de Souza; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Brazilian Minist Hlth, SVS, Ctr Pesquisa Diagnost & Treinamento Malaria Refer, Lab Malaria Extra Amazonian Reg, Rio De Janeiro, Brazil.
   [Almeida-de-Oliveira, Natalia Ketrin; Lima-Cury, Lidiane; de Abreu-Fernandes, Rebecca; Lavigne, Aline de Rosa; de Pina-Costa, Anielle; Perce-da-Silva, Daiana de Souza; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle] Ctr Univ Serra Orgaos UNIFESO, Rio De Janeiro, Brazil.
RP Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisas Malaria, Ave Brasil 4365, Rio De Janeiro, Brazil.
EM mffcruz28@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fiocruz/Centro de Integracao Empresa/Escola (CIEE);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX NKAO is recipient of a Doctoral Fellowship from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); RAF is recipient
   of a Scientific Initiation with support of Scholarship from the
   Fiocruz/Centro de Integracao Empresa/Escola (CIEE); PB, CTDR and MFFC
   are recipients of Research Productivity Fellowships from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PB, CTDR
   and MFFC are "Cientistas do Nosso Estado" from the Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ).
CR Auburn Sarah, 2016, Wellcome Open Res, V1, P4, DOI 10.12688/wellcomeopenres.9876.1
   Chootong P, 2014, PARASITOL INT, V63, P858, DOI 10.1016/j.parint.2014.07.014
   Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4
   Costa DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131339
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944
   De Sousa TN, 2014, MEM I O CRUZ, V109, P25
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   George MT, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00194-19
   Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112
   Hoque MR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2425-z
   Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337
   Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200
   Ju HL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-60
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12
   Nei M, 1986, MOL BIOL EVOL, V3, P18
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Premaratne PH, 2011, INFECT GENET EVOL, V11, P1327, DOI 10.1016/j.meegid.2011.04.023
   Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79
   Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Singh SK, 2003, BIOCHEM J, V374, P193, DOI 10.1042/BJ20030622
   Sousa TN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-334
   WHO, 2018, WORLD MAL REP 2018
   WHO, 2015, CONF PLASM VIV MAL
NR 26
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD FEB 19
PY 2020
VL 19
IS 1
AR 81
DI 10.1186/s12936-020-03159-y
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KQ9TP
UT WOS:000517264700001
PM 32075659
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Carvalho, MS
   Freitas, LP
   Cruz, OG
   Brasil, P
   Bastos, LS
AF Carvalho, Marilia Sa
   Freitas, Lais Picinini
   Cruz, Oswaldo Goncalves
   Brasil, Patricia
   Bastos, Leonardo Soares
TI Association of past dengue fever epidemics with the risk of Zika
   microcephaly at the population level in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; DISEASE SEVERITY; VIRUS-INFECTION; ENHANCEMENT;
   PATHOGENESIS
AB Despite all the research done on the first Zika virus (ZIKV) epidemics, it was only after the Brazilian epidemic that the Congenital Zika Syndrome was described. This was made possible due to the large number of babies born with microcephaly in the Northeast region (NE) in a narrow time. We hypothesize that the fivefold difference in the rate of microcephalic neonates between the NE and other regions is partially an effect of the population prior immunity against Dengue viruses (DENV), that cross-react with ZIKV. In this ecological study, we analysed the interaction between dengue fever epidemics from 2001 to 2014 and the 2015/2016 microcephaly epidemic in 400 microregions in Brazil using random-effects models under a Bayesian approach. The estimated effect of the time lag between the most recent large dengue epidemic (>400/100,000 inhabitants) and the microcephaly epidemic ranged from protection (up to 6 years prior) to an increased risk (from 7 to 12 years). This sustained window of protection, larger than described in previous longitudinal studies, is possibly an effect of herd immunity and of multiple exposures to DENV that could boost immunity.
C1 [Carvalho, Marilia Sa; Cruz, Oswaldo Goncalves; Bastos, Leonardo Soares] Fundacao Oswaldo Cruz, Sci Computat Program, Rio De Janeiro, Brazil.
   [Freitas, Lais Picinini] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Postgrad Program Epidemiol Publ Hlth, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP Carvalho, MS (corresponding author), Fundacao Oswaldo Cruz, Sci Computat Program, Rio De Janeiro, Brazil.
EM marilia.carvalho@fiocruz.br
OI CARVALHO, MARILIA/0000-0002-9566-0284; Bastos,
   Leonardo/0000-0002-1406-0122; Freitas, Lais/0000-0001-9012-9382
FU Conselho Nacional de Pesquisa - CNPqNational Council for Scientific and
   Technological Development (CNPq) [304101/2017-6, 307282/2017-1];
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/203.073/2017]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil - CAPES [001];
   Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro
   [E-26/202.862/2018]; Fondation Christophe et Rodolphe Merieux
FX MSC was supported by the Conselho Nacional de Pesquisa - CNPq (grant
   304101/2017-6) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro - FAPERJ (grant E-26/203.073/2017). LPF was
   supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   - Brasil - CAPES (Finance Code 001). PB was supported by Fundacao Carlos
   Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro (grant
   E-26/202.862/2018), Conselho Nacional de Pesquisa - CNPq (grant
   307282/2017-1) and Fondation Christophe et Rodolphe Merieux.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   [Anonymous], 2019, R FDN STAT COMPUTING
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Albuquerque M. de F. P. M., 2018, CADERNOS SAUDE PUBLI, V34
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diaz-Quijano FA, 2018, AM J PUBLIC HEALTH, V108, P514, DOI [10.2105/AJPH.2017.304260, 10.2105/ajph.2017.304260]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Khandia R., 2018, FRONT IMMUNOL, V9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lopez-Camelo J. S., 2015, ECLAMC FINAL DOCUMEN
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   QGIS Development Team, 2019, QGIS GEOGR INF SYST
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rezende AC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5177-3
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez-Barraquer I., 2019, IMPACT PREEXISTING D, V5
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Watanabe S, 2010, J MACH LEARN RES, V11, P3571
   Wen JS, 2017, CELL HOST MICROBE, V21, P557, DOI 10.1016/j.chom.2017.04.006
   Wickham H., 2017, RSTUDIO TIDYVERSE EA
NR 51
TC 2
Z9 2
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 4
PY 2020
VL 10
IS 1
AR 1752
DI 10.1038/s41598-020-58407-7
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NA6MA
UT WOS:000559931400001
PM 32019953
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pezzi, L
   Diallo, M
   Rosa-Freitas, MG
   Vega-Rua, A
   Ng, LFP
   Boyer, S
   Drexler, JF
   Vasilakis, N
   Lourenco-de-Oliveira, R
   Weaver, SC
   Kohl, A
   de Lamballerie, X
   Failloux, AB
   Brasil, P
   Busch, M
   Diamond, MS
   Drebot, MA
   Gallian, P
   Jaenisch, T
   LaBeaud, AD
   Lecui, M
   Neyts, J
   Reusken, CB
   Ribeiro, GS
   Rios, M
   Rodriguez-Morales, AJ
   Sall, A
   Simmons, G
   Simon, F
   Siqueira, AM
AF Pezzi, L.
   Diallo, M.
   Rosa-Freitas, M. G.
   Vega-Rua, A.
   Ng, L. F. P.
   Boyer, S.
   Drexler, J. F.
   Vasilakis, N.
   Lourenco-de-Oliveira, R.
   Weaver, S. C.
   Kohl, A.
   de Lamballerie, X.
   Failloux, A-B
   Brasil, P.
   Busch, M.
   Diamond, M. S.
   Drebot, M. A.
   Gallian, P.
   Jaenisch, T.
   LaBeaud, A. D.
   Lecui, M.
   Neyts, J.
   Reusken, C. B.
   Ribeiro, G. S.
   Rios, M.
   Rodriguez-Morales, A. J.
   Sall, A.
   Simmons, G.
   Simon, F.
   Siqueira, A. M.
CA GloPID-R Chikungunya Onyong-nyong
TI GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5:
   Entomological aspects
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID AEDES-ALBOPICTUS DIPTERA; VECTOR COMPETENCE; YELLOW-FEVER; EXPERIMENTAL
   TRANSMISSION; INVASIVE MOSQUITOS; SKUSE DIPTERA; AEGYPTI; ARBOVIRUSES;
   EPIDEMIC; OUTBREAK
AB The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to investigate natural history, epidemiology and clinical aspects of infection by these viruses. Here, we present a report dedicated to entomological aspects of CHIKV, ONNV and MAYV. Recent global expansion of chikungunya virus has been possible because CHIKV established a transmission cycle in urban settings using anthropophilic vectors such as Aedes albopictus and Aedes aegypti. MAYV and ONNV have a more limited geographic distribution, being confined to Africa (ONNV) and central-southern America (MAYV). ONNV is probably maintained through an enzootic cycle that has not been characterized yet, with Anopheles species as main vectors and humans as amplification hosts during epidemics. MAYV is transmitted by Haemagogus species in an enzootic cycle using non-human primates as the main amplification and maintenance hosts, and humans becoming sporadically infected when venturing in or nearby forest habitats. Here, we focused on the transmission cycle and natural vectors that sustain circulation of these viruses in their respective locations. The knowledge of the natural ecology of transmission and the capacity of different vectors to transmit these viruses is crucial to understand CHIKV emergence, and to assess the risk that MAYV and ONNV will expand on wide scale using anthropophilic mosquito species not normally considered primary vectors. Finally, the experts identified knowledge gaps and provided adapted recommendations, in order to address future entomological investigations in the right direction.
C1 [Pezzi, L.; de Lamballerie, X.] Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Pezzi, L.] Univ Corse, Lab Virol, INSERM, EA7310, Corte, France.
   [Diallo, M.; Sall, A.] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Rosa-Freitas, M. G.; Lourenco-de-Oliveira, R.] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, FIOCRUZ, Rio De Janeiro, Brazil.
   [Vega-Rua, A.] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Vector Control Res, Pointe A Pitre, Guadeloupe, France.
   [Ng, L. F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.
   [Boyer, S.] Inst Pasteur Cambodge, Med Entomol Platform, Phnom Penh, Cambodia.
   [Drexler, J. F.] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Free Univ Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Humboldt Univ, D-10117 Berlin, Germany.
   [Drexler, J. F.] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Drexler, J. F.] German Ctr Infect Res DZIF, Cologne, Germany.
   [Vasilakis, N.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, S. C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, S. C.] Univ Texas Med Branch, Dept Microbiol & Inuramol, Galveston, TX 77555 USA.
   [Kohl, A.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Failloux, A-B] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
   [Brasil, P.; Siqueira, A. M.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Busch, M.; Simmons, G.] Blood Syst Res Inst, San Francisco, CA USA.
   [Busch, M.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Andrew M & Jane M Dusky Ctr Human Immunol & Immun, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Drebot, M. A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Gallian, P.] Etablissement Francais Sang Alpes Mediterranee, Marseille, France.
   [Jaenisch, T.] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [LaBeaud, A. D.] Stanford Univ, Sch Med, Div Infect Dis, Dept Pediat, Stanford, CA 94305 USA.
   [Lecui, M.] Paris Descartes Univ, Necker Enfants Malndys Univ Hosp, AP HP,Dept Infect Dis & Trop Med, Inst Pasteur,Biol Infect Unit,Inserm,U1117,IHU Im, Paris, France.
   [Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, Leuven, Belgium.
   [Reusken, C. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Reusken, C. B.] Erasmus Univ, Dept Virosci, Med Ctr, Rotterdam, Netherlands.
   [Ribeiro, G. S.] Fundacao Oswaldo Cruz, Goncalo Monis Inst, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Rios, M.] US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Simmons, G.] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA.
   [Simon, F.] Laveran Mil Teaching Hosp, Marseille, France.
RP Pezzi, L (corresponding author), Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
EM laura.pezzi3@studio.unibo.it
RI Vasilakis, Nikos/ABE-7318-2020; Ribeiro, Guilherme/B-6624-2008; NEYTS,
   Johan/U-8267-2017
OI Ribeiro, Guilherme/0000-0002-6798-2059; Boyer,
   Sebastien/0000-0002-2946-586X; Pezzi, Laura/0000-0001-7921-9221; NEYTS,
   Johan/0000-0002-0033-7514
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014/8] Funding Source: Medline
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   ADESINA OA, 1991, TROP GEOGR MED, V43, P271
   Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Agarwal A., 2014, PLOS NEGLECTED TROP, V8, P4
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   AITKEN THG, 1959, AM J TROP MED HYG, V8, P41, DOI 10.4269/ajtmh.1959.8.41
   AITKEN THG, 1969, J MED ENTOMOL, V6, P207, DOI 10.1093/jmedent/6.2.207
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alencar J, 2005, J MED ENTOMOL, V42, P981, DOI 10.1603/0022-2585(2005)042[0981:FPOHJD]2.0.CO;2
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103
   [Anonymous], 2003, J MED PRIMATOLOGY WI
   [Anonymous], 2019, CURRENT KNOWN DISTRI
   Apandi Y, 1 ISOLATION CHIKUNGU, V5
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Ba Y., 2006, B SOC PATHOL EXOT, V7
   Baldacchino F, 2017, J MED ENTOMOL, V54, P1266, DOI 10.1093/jme/tjx093
   Bessaud M, 2006, EMERG INFECT DIS, V12, P1604, DOI 10.3201/eid1210.060596
   Bisimwa P., TANZANIA REV MED VET
   Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Bosco-Lauth AM, 2018, AM J TROP MED HYG, V98, P841, DOI 10.4269/ajtmh.17-0730
   Bosco-Lauth AM, 2016, AM J TROP MED HYG, V94, P504, DOI 10.4269/ajtmh.15-0696
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Brustolin M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006895
   Buckley S.M., 1971, ARTHROPOD CELL CULTU, P133
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Ciocchetta S, 2018, PATHOG GLOB HEALTH, V112, P107, DOI 10.1080/20477724.2018.1464780
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   CORNET M, 1968, B WORLD HEALTH ORGAN, V39, P845
   Costa-da-Silva A.L., 2017, PLOS NEGLECTED TROP, V11, P1
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Delisle E., 2014, CHIKUNGUNYA OUTBREAK
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Dickinson D B, 1965, S Afr J Med Sci, V30, P11
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Evans A.M., 1938, ANOPHELINI ADULTS EA
   Farraudiere L, 2017, REV PANAM SALUD PUBL, V41
   FILIPE AR, 1973, T ROY SOC TROP MED H, V67, P400, DOI 10.1016/0035-9203(73)90117-X
   GALINDO P, 1966, AM J TROP MED HYG, V15, P385, DOI 10.4269/ajtmh.1966.15.385
   GALINDO P, 1967, AM J TROP MED HYG, V16, P525, DOI 10.4269/ajtmh.1967.16.525
   Girod R, 2011, TROP MED INT HEALTH, V16, P134, DOI 10.1111/j.1365-3156.2010.02613.x
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GROOT H, 1961, AM J TROP MED HYG, V10, P397, DOI 10.4269/ajtmh.1961.10.397
   Guillaumot L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-247
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Herve J. P., 1986, Instituto Evandro Chagas. 50 anos de contribuicao as ciencias biologicas e a medicina tropical. Volume 1., P409
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Honorio NA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006521
   JOHNSON BK, 1981, T ROY SOC TROP MED H, V75, P239, DOI 10.1016/0035-9203(81)90325-4
   Jupp P., 1988, ARBOVIRUS EPIDEMIOL, V137
   JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Kantor AM, 2019, J MED ENTOMOL, V56, P832, DOI 10.1093/jme/tjy241
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   Konstantinov O.K., 1990, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V43, P15
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kramer LD, 2011, AM J TROP MED HYG, V85, P182, DOI 10.4269/ajtmh.2011.11-0078
   Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008
   LAURENCE B. R., 1960, BULL ENT RES, V51, P491, DOI 10.1017/S0007485300055127
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   LHUILLIER M, 1988, B SOC PATHOL EXOT, V81, P386
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lourenco-de-Oliveira R., 2017, PLOS NEGLECTED TROP, V11, P1
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158, DOI 10.4269/ajtmh.1999.61.158
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Mbanzulu KM, 2017, INT J INFECT DIS, V57, P32, DOI 10.1016/j.ijid.2017.01.016
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   MCINTOSH BM, 1964, ANN TROP MED PARASIT, V58, P45, DOI 10.1080/00034983.1964.11686213
   MCINTOSH BM, 1977, S AFR J SCI, V73, P267
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446
   Mombouli JV, 2013, EMERG INFECT DIS, V19, P1542, DOI 10.3201/eid1909.130451
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   MOORE DL, 1974, ANN TROP MED PARASIT, V68, P59, DOI 10.1080/00034983.1974.11686925
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/msphere.00523-17, 10.1128/mSphere.00523-17]
   Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x
   Mulwa F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006746
   Olaleye O D, 1989, Rev Elev Med Vet Pays Trop, V42, P321
   OSTERRIETH P., 1961, ANN SOC BEIGE MED TROP, V41, P207
   PEIRIS JSM, 1993, J MED PRIMATOL, V22, P240
   Pezzi L, 2019, ANTIVIR RES, V166, P66, DOI 10.1016/j.antiviral.2019.03.009
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2017, PATHOG GLOB HEALTH, V111, P271, DOI 10.1080/20477724.2017.1355431
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x
   ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642, DOI 10.4269/ajtmh.1986.35.642
   Roth A, EURO SURVEILL B EUR, V19
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   SALUZZO JF, 1980, B SOC PATHOL EXOT, V73, P390
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931
   Schaffner F., 2011, VECTOR COMPETENCE AE
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Severini F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006435
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521
   Sudeep AB, 2015, J VECTOR DIS, V52, P153
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Thavara U, 2009, SE ASIAN J TROP MED, V40, P951
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vanlandingham DL, 2006, AM J TROP MED HYG, V74, P663, DOI 10.4269/ajtmh.2006.74.663
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   White S.K., 2018, PLOS ONE, V13, P1
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Williams M.C., 1965, ENTEBBE, V3, P186
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yadav P, 2003, ACTA VIROL, V47, P45
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 150
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2020
VL 174
AR 104670
DI 10.1016/j.antiviral.2019.104670
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RQ
UT WOS:000523596900024
PM 31812638
OA Green Published, Other Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Daumas, RP
   Silva, GAE
   Tasca, R
   Leite, ID
   Brasil, P
   Greco, DB
   Grabois, V
   Campos, GWD
AF Daumas, Regina Paiva
   Azevedo e Silva, Gulnar
   Tasca, Renato
   Leite, Iuri da Costa
   Brasil, Patricia
   Greco, Dirceu B.
   Grabois, Victor
   de Sousa Campos, Gastao Wagner
TI The role of primary care in the Brazilian healthcare system: limits and
   possibilities for fighting COVID-19
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
C1 [Daumas, Regina Paiva; Leite, Iuri da Costa; Grabois, Victor] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
   [Azevedo e Silva, Gulnar] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Tasca, Renato] Org Mundial Saude, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Greco, Dirceu B.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [de Sousa Campos, Gastao Wagner] Univ Estadual Campinas, Fac Ciencias Med, Campinas, Brazil.
RP Leite, ID (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
EM iuri.fiocruz@gmail.com
RI ; DAUMAS, REGINA/M-9387-2013
OI GRABOIS, VICTOR/0000-0003-3310-4212; Azevedo e Silva,
   Gulnar/0000-0001-8734-2799; Greco, Dirceu/0000-0002-4419-5634; tasca,
   renato/0000-0002-1407-5914; DAUMAS, REGINA/0000-0002-8923-7711
CR Altino L., 2020, COM UPAS LOTADAS PAC
   Associacao Brasileira de Saude Coletiva, ENT ENV CART MIN RIS
   Centers for Disease Control and Prevention, OUTP AMB CAR SETT RE
   Centers for Disease Control and Prevention, INT CLIN GUID MAN PA
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Viana ALD, 2018, CIENC SAUDE COLETIVA, V23, P1791, DOI 10.1590/1413-81232018236.05502018
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Giovanella L, 2020, CIENC SAUDE COLETIVA, V25, P1475, DOI 10.1590/1413-81232020254.01842020
   Greenhalgh T, 2020, REV BRAS MED FAM COM, V15, P2461
   Greenstone M, DOES SOCIAL DISTANCI
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Nacoti M, 2020, EPICENTER COVID 19 P, DOI 10.1056/CAT.20.0080
   Negri E. M, 2020, HEPARIN THERAPY IMPR, DOI [10.1101/2020.04.15.20067017v3, DOI 10.1101/2020.04.15.20067017V3]
   Organizacion Panamericana de la Salud, REC PAR REORG AMPL P
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Public Health England, COVID 19 PERS PROT E
   Starfield B., ATENCAO PRIMARIA EQU
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   World Health Organization, 2020, CLIN CAR SEV AC RESP
   World Health Organization, WHO ANN COVID 19 OUT
   World Health Organization, OP CONS CAS MAN COVI
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 22
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 6
AR e00104120
DI 10.1590/0102-311X00104120
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MH3QI
UT WOS:000546647700001
PM 32609166
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Teixeira, DD
   Palma, MF
   Brasil, P
   Zani, STM
AF Teixeira, Daiana da Silva
   Palma, Mayara Feliciano
   Brasil, Patricia
   Maniezo Zani, Sofia Tonoli
TI The philological documents editing process using the Edictor software
SO REVISTA IBERO-AMERICANA DE CIENCIA DA INFORMACAO
LA Portuguese
DT Article
DE women's history; Brazil; Philology; electronics editions; digital
   humanities
AB Starting from the discussion about the so-called Digital Humanities, we want, in this paper, to show how the Women in Portuguese America Project (MAP in Portuguese) fits into this field by working with the digital diffusion of documents written by women or referring to women between 1500-1822. When we search for these documents (of various types, such as letters, inquisitorial processes, requirements, etc.) in archives with digital catalogs (such as the Public Archive of the State of Sao Paulo), as well as archives with a large digitized collection (such as the National Archives of Torre do Tombo de Lisboa), we noticed the lack of a search key that would select them according to the presence of the woman as author or referee. Thus, drawing on the documents already available in these and other collections providing digital reproductions of the documents, MAP proposes the construction of its own catalog, which has been digitally built in XML language. Therefore, we are forming a corpus, bringing together these women authors or referred. So that we can build a catalog with this theme, we are preparing transcriptions and philological editions of these documents. Considering that the purpose is to democratize access by making such writings available online, we use the eDictor software, which consists of a text editor for philological work and which allows linguistic analysis. In addition, it is possible to elaborate modernized editions of manuscripts without losing the relevant philological information of the original text. The development and use of digital technologies such as eDictor, by the MAP Project, are part of the tendency of the humanities to approach the computer sciences. From the results we have obtained, we can say that the use of eDictor favors the quality of the philological editing of manuscripts and allows researchers from various areas and a wider public to access these documents. These advantages give us the perspective of intensifying the use and improvement of the software, in order to expand the possibilities of text corpora construction. Thus, in MAP, digital resources are considered as both applied tools and products, i.e. resources generated by the project.
C1 [Teixeira, Daiana da Silva; Palma, Mayara Feliciano; Brasil, Patricia; Maniezo Zani, Sofia Tonoli] Univ Sao Paulo, Fac Filosofia Letras & Ciencias Humanas, Dept Letras Class & Vernaculas, Sao Paulo, SP, Brazil.
RP Teixeira, DD (corresponding author), Univ Sao Paulo, Fac Filosofia Letras & Ciencias Humanas, Dept Letras Class & Vernaculas, Sao Paulo, SP, Brazil.
EM daiana.teixeira@usp.br; mayara.palma@usp.br;
   patricia.brasil.silva@usp.br; sofia.zani@usp.br
CR ARQUIVO NACIONAL TORRE DO TOMBO, 2011, DEN FRANC LUIS
   do MONTE V. M., 2017, REV DA ABRALIN, V16, P239
   doMONTE V. M., 2018, M A P MULHERES AM PO
   doMONTE V. M., 2017, AGORA ANDAM ME JURAN
   FERREIRA P. T., 2016, FILOLOGIA LINGUISTIC, V18, P231
   PAIXAO DE SOUSA M.C., 2013, E DICTOR VERSION 1 0
   PAIXAO DE SOUSA M.C., 2010, CAMINHOS LINGUISTICA
   PAIXAO DE SOUSA M. C., 2018, M A P MULHERES AM PO
   UNIVERSIDADE DE SAO PAULO, 2019, CAT M A P
NR 9
TC 0
Z9 0
U1 1
U2 1
PU UNIV BRASILIA, DEPT CIENCIA INFORMACAO
PI BRASILIA
PA CAIXA POSTAL 15-3011, BRASILIA, DF 00000, BRAZIL
SN 1983-5213
J9 REV IBERI-AM CIENC I
JI Rev. Ibero-Am. Cienc. Inf.
PD JAN-APR
PY 2020
VL 13
IS 1
BP 360
EP 371
DI 10.26512/rici.v13.n1.2020.29614
PG 12
WC Information Science & Library Science
SC Information Science & Library Science
GA KU3QC
UT WOS:000519625300023
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Avelino-Silva, VI
   Mayaud, P
   Tami, A
   Miranda, MC
   Rosenberger, KD
   Alexander, N
   Nacul, L
   Segurado, A
   Pohl, M
   Bethencourt, S
   Villar, LA
   Viana, IFT
   Rabello, R
   Soria, C
   Salgado, SP
   Gotuzzo, E
   Guzman, MG
   Martinez, PA
   Lopez-Gatell, H
   Hegewisch-Taylor, J
   Borja-Aburto, VH
   Gonzalez, C
   Netto, EM
   Villarroel, PMS
   Hoen, B
   Brasil, P
   Marques, ETA
   Rockx, B
   Koopmans, M
   de Lamballerie, X
   Jaenisch, T
   Jaenisch, T
   Rosenberger, KD
   Morales, I
   Tobian, F
   Uhlmann, L
   Pohl, M
   Schretzmann, J
   Leege, A
   Marques, ETA
   Marques, ETA
   Viana, IFT
   Lins, RD
   de Filippis, AMB
   Duarte, ACM
   Espindola, OD
   Bonaldo, M
   Rabello, R
   Damasceno, L
   Mendes-Correa, MC
   Mayaud, P
   Nacul, L
   Alexander, N
   Netto, EM
   Tami, A
   Bethencourt, S
   Tinedo, MJ
   La Rosa, Y
   Murillo, M
   Villar, LA
   Miranda, MC
   Lozano, A
   Herrera, VM
   Gomez, A
   Gelvez, RM
   Ortiz, R
   Herrera, VM
   Soria, C
   Dimitrakis, L
   Salgado, SP
   Arrata, MR
   Gotuzzo, E
   Allison, HG
   Talledo, M
   Villarroel, PMS
   Torres, EM
   Guzman, MG
   Rodriguez, PAM
   Vera, MA
   Santana, BG
   Reyes, A
   Alvarez, SS
   Dorticos, DF
   Hegewisch-Taylor, J
   Alpuche-Aranda, C
   Lopez-Gatell, H
   Gonzalez-Diaz, E
   Pavia-Ruz, N
   Borja-Aburto, VH
   Gonzalez, C
   Grajales, C
   Rojas, T
   Arriaga, L
   Vallejos, A
   Tynevez, D
   Thirion, L
   Drexler, JF
   Rockx, B
   van Gorp, E
   Koopmans, M
AF Avelino-Silva, Vivian I.
   Mayaud, Philippe
   Tami, Adriana
   Miranda, Maria C.
   Rosenberger, Kerstin D.
   Alexander, Neal
   Nacul, Luis
   Segurado, Aluisio
   Pohl, Moritz
   Bethencourt, Sarah
   Villar, Luis A.
   Viana, Isabelle F. T.
   Rabello, Renata
   Soria, Carmen
   Salgado, Silvia P.
   Gotuzzo, Eduardo
   Guzman, Maria G.
   Martinez, Pedro A.
   Lopez-Gatell, Hugo
   Hegewisch-Taylor, Jennifer
   Borja-Aburto, Victor H.
   Gonzalez, Cesar
   Netto, Eduardo M.
   Villarroel, Paola M. Saba
   Hoen, Bruno
   Brasil, Patricia
   Marques, Ernesto T. A.
   Rockx, Barry
   Koopmans, Marion
   de Lamballerie, Xavier
   Jaenisch, Thomas
   Jaenisch, Thomas
   Rosenberger, Kerstin Daniela
   Morales, Ivonne
   Tobian, Frank
   Uhlmann, Lorenz
   Pohl, Moritz
   Schretzmann, Julius
   Leege, Annika
   Marques, Ernesto T. A.
   Marques, Ernesto T. A.
   Viana, Isabelle F. T.
   Lins, Roberto D.
   Bispo de Filippis, Ana Maria
   Machado Duarte, Ana Claudia
   Espindola, Otavio de Melo
   Bonaldo, Myrna
   Rabello, Renata
   Damasceno, Luana
   Mendes-Correa, Maria Cassia
   Mayaud, Philippe
   Nacul, Luis
   Alexander, Neal
   Netto, Eduardo Martins
   Tami, Adriana
   Bethencourt, Sarah
   Tinedo, Maria Jose
   La Rosa, Yenifer
   Murillo, Marianela
   Angel Villar, Luis
   Consuelo Miranda, Maria
   Lozano, Anyela
   Mauricio Herrera, Victor
   Gomez, Adriana
   Margarita Gelvez, Rosa
   Ortiz, Ricardo
   Mauricio Herrera, Victor
   Soria, Carmen
   Dimitrakis, Lady
   Paola Salgado, Silvia
   Regato Arrata, Mary
   Gotuzzo, Eduardo
   Guerra Allison, Humberto
   Talledo, Michael
   Saba Villarroel, Paola Mariela
   Torres, Eric Martinez
   Guzman, Maria G.
   Martinez Rodriguez, Pedro A.
   Alvarez Vera, Mayling
   Galindo Santana, Belkis
   Reyes, Alicia
   Serrano Alvarez, Silvia
   Ferriol Dorticos, Diana
   Hegewisch-Taylor, Jennifer
   Alpuche-Aranda, Celia
   Lopez-Gatell, Hugo
   Gonzalez-Diaz, Esteban
   Pavia-Ruz, Norma
   Hugo Borja-Aburto, Victor
   Gonzalez, Cesar
   Grajales, Concepcion
   Rojas, Teresita
   Arriaga, Lumumba
   Vallejos, Alfonso
   Tynevez, Dominique
   Thirion, Laurence
   Drexler, Jan Felix
   Rockx, Barry
   van Gorp, Eric
   Koopmans, Marion
CA ZIKAlliance Clinical Study Grp
TI Study protocol for the multicentre cohorts of Zika virus infection in
   pregnant women, infants, and acute clinical cases in Latin America and
   the Caribbean: the ZIKAlliance consortium
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Pregnant women; Children; Cohort; Latin America; Caribbean; Risk;
   Congenital abnormalities; Natural history; Arboviruses; Mosquito-borne
   viruses; Vector-borne viruses
ID EXTERNAL QUALITY ASSESSMENT; GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS;
   SEXUAL TRANSMISSION; MOLECULAR-DETECTION; BRAZIL; EPIDEMIC;
   LABORATORIES; TERRITORIES; OUTCOMES
AB Background: The European Commission (EC) Horizon 2020 (H2020)-funded ZIKAlliance Consortium designed a multicentre study including pregnant women (PW), children (CH) and natural history (NH) cohorts. Clinical sites were selected over a wide geographic range within Latin America and the Caribbean, taking into account the dynamic course of the ZIKV epidemic.
   Methods: Recruitment to the PW cohort will take place in antenatal care clinics. PW will be enrolled regardless of symptoms and followed over the course of pregnancy, approximately every 4 weeks. PW will be revisited at delivery (or after miscarriage/abortion) to assess birth outcomes, including microcephaly and other congenital abnormalities according to the evolving definition of congenital Zika syndrome (CZS). After birth, children will be followed for 2 years in the CH cohort. Follow-up visits are scheduled at ages 1-3, 4-6, 12, and 24 months to assess neurocognitive and developmental milestones. In addition, a NH cohort for the characterization of symptomatic rash/fever illness was designed, including follow-up to capture persisting health problems.
   Blood, urine, and other biological materials will be collected, and tested for ZIKV and other relevant arboviral diseases (dengue, chikungunya, yellow fever) using RT-PCR or serological methods. A virtual, decentralized biobank will be created. Reciprocal clinical monitoring has been established between partner sites. Substudies of ZIKV seroprevalence, transmission clustering, disabilities and health economics, viral kinetics, the potential role of antibody enhancement, and co-infections will be linked to the cohort studies.
   Discussion: Results of these large cohort studies will provide better risk estimates for birth defects and other developmental abnormalities associated with ZIKV infection including possible co-factors for the variability of risk estimates between other countries and regions. Additional outcomes include incidence and transmission estimates of ZIKV during and after pregnancy, characterization of short and long-term clinical course following infection and viral kinetics of ZIKV.
C1 [Jaenisch, Thomas; Rosenberger, Kerstin Daniela; Morales, Ivonne; Tobian, Frank; Uhlmann, Lorenz; Pohl, Moritz; Schretzmann, Julius; Leege, Annika] Univ Heidelberg Hosp, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Viana, Isabelle F. T.; Lins, Roberto D.; Bispo de Filippis, Ana Maria; Machado Duarte, Ana Claudia; Espindola, Otavio de Melo; Bonaldo, Myrna; Rabello, Renata; Damasceno, Luana] Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Recife, PE, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio; Angel Villar, Luis; Consuelo Miranda, Maria] Univ Sao Paulo, Sao Paulo, Brazil.
   [Mayaud, Philippe; Alexander, Neal; Angel Villar, Luis] LSHTM, London, England.
   [Gotuzzo, Eduardo] Fed Univ Bahia UFB, Salvador, BA, Brazil.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Marques, Ernesto T. A.] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Consuelo Miranda, Maria; Lozano, Anyela] Ciudad Hosp Enrique Tejera, Valencia, Spain.
   [La Rosa, Yenifer] Ctr Policlin Valencia Vina, Lab Clin Vina, Valencia, Venezuela.
   [Murillo, Marianela] Inst Especialidades Quirurg Ios Mangos, Valencia, Venezuela.
   [Angel Villar, Luis; Consuelo Miranda, Maria; Lozano, Anyela; Mauricio Herrera, Victor; Gomez, Adriana; Margarita Gelvez, Rosa] Univ Ind Santander, Bucaramanga, Colombia.
   [Ortiz, Ricardo; Mauricio Herrera, Victor] Univ Autonoma Bucaramanga UNAB Hosp Local Norte I, Bucaramanga, Colombia.
   [Soria, Carmen; Dimitrakis, Lady] Univ Catolica Santiago Guayaquil, SOSECALI C Ltda, Guayaquil, Ecuador.
   [Paola Salgado, Silvia; Regato Arrata, Mary] Inst Nacl Invest Salud Publ Dr Leopoldo Izquieta, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo; Guerra Allison, Humberto; Talledo, Michael] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Humboldt, Humboldt, Germany.
   [Saba Villarroel, Paola Mariela] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruz, CA, Bolivia.
   [Torres, Eric Martinez; Guzman, Maria G.; Martinez Rodriguez, Pedro A.; Alvarez Vera, Mayling; Galindo Santana, Belkis; Reyes, Alicia; Serrano Alvarez, Silvia] Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
   [Ferriol Dorticos, Diana] MINSAP, Secc Materno Infantil, Cienfuegos, Cuba.
   [Hegewisch-Taylor, Jennifer; Alpuche-Aranda, Celia; Lopez-Gatell, Hugo] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas Inst, Cuernavaca, Morelos, Mexico.
   [Gonzalez-Diaz, Esteban] Hosp Civil Guadalajara, Unidad Vigilancia Epidemiol Hosp Med Prevent, Fray Antonio Alcalde O P, Mexico.
   [Pavia-Ruz, Norma] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Mexico City, DF, Mexico.
   [Gonzalez, Cesar; Grajales, Concepcion; Rojas, Teresita; Arriaga, Lumumba; Vallejos, Alfonso; Tynevez, Dominique] INSERM, Concepcion, Chile.
   [de Lamballerie, Xavier; Thirion, Laurence] AixMarseille Univ, Inserm 1207, INSERM Gouadelo, IRD 190,Unite Virus Emergents, Marseille, France.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Rockx, Barry; van Gorp, Eric; Koopmans, Marion] Erasmus MC, Rotterdam, Netherlands.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Fac Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Fac Med, Inst Med Trop, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Mayaud, Philippe; Alexander, Neal; Nacul, Luis] London Sch Hyg & Trop Med, London, England.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana; Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Miranda, Maria C.; Villar, Luis A.] Univ Ind Santander, Bucaramanga, Colombia.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, INF 324, D-69120 Heidelberg, Germany.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] German Ctr Infect Res DZIF, Heidelberg Site, Cologne, Germany.
   [Pohl, Moritz] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, Germany.
   [Viana, Isabelle F. T.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Rabello, Renata; Brasil, Patricia] Fundacao Oswaldo Cruz, FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Soria, Carmen] Univ Catolic Santiago Guayaquil, Guayaquil, Ecuador.
   [Soria, Carmen] SOSECALI C Ltda, Guayaquil, Ecuador.
   [Salgado, Silvia P.] Inst Nacl Invest Salud Publ Dr Leopold Izquieta P, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Guzman, Maria G.; Martinez, Pedro A.] Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
   [Lopez-Gatell, Hugo; Hegewisch-Taylor, Jennifer] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
   [Borja-Aburto, Victor H.; Gonzalez, Cesar] Mexican Inst Social Secur, Mexico City, Mexico.
   [Netto, Eduardo M.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Villarroel, Paola M. Saba] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruzde SierraBoliv, Bolivia.
   [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Ctr Invest Clin 1424, INSERM, Pointe A Pitre, France.
   [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe A Pitre, France.
   [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, F-4537 Pointe A Pitre, EA, France.
   [Rockx, Barry; Koopmans, Marion] Erasmus MC, WHO CC Arbovirus & Hemorrhag Fever Viruses Refere, Dept Virosci, Rotterdam, Netherlands.
   [de Lamballerie, Xavier] Aix Marseille Univ, Marseille, France.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Jaenisch, T (corresponding author), Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, INF 324, D-69120 Heidelberg, Germany.; Jaenisch, T (corresponding author), German Ctr Infect Res DZIF, Heidelberg Site, Cologne, Germany.
EM thomas.jaenisch@urz.uni-heidelberg.de
RI Uhlmann, Lorenz/AAL-9839-2020; Herrera, Victor/ABB-4480-2020;
   Avelino-Silva, Vivian I/L-2640-2013; Segurado, Aluisio C/K-2229-2012
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Segurado, Aluisio
   C/0000-0002-6311-8036; Tami, Adriana/0000-0002-1918-9144; Martinez,
   Pedro A./0000-0002-9886-6448
FU European Union's Horizon 2020 Research and Innovation Program under
   ZIKAlliance [734548]; Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG); Ruprecht-Karls-Universitat Heidelberg;
   Baden-Wurttemberg Ministry of Science, Research and the Arts; NATIONAL
   CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863]
   Funding Source: NIH RePORTER
FX This work is supported by the European Union's Horizon 2020 Research and
   Innovation Program under ZIKAlliance Grant Agreement no. 734548; the
   study also received partial funding from Deutsche Forschungsgemeinschaft
   funding programme Open Access Publishing, Baden-Wurttemberg Ministry of
   Science, Research and the Arts and by Ruprecht-Karls-Universitat
   Heidelberg. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayley N., 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECLAMC, 2015, FREQ MICR AO NASC BR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   ICMJE, DEF ROL AUTH CONTR
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Organization W. H., 2016, WHO DIR GEN SUMM OUT
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Squires J, 2009, AGES STAGES QUESTION
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, ZIK VIR INF UPD EV C
NR 85
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 26
PY 2019
VL 19
IS 1
AR 1081
DI 10.1186/s12879-019-4685-9
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA KI2EP
UT WOS:000511160500003
PM 31878895
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Soares, F
   Abranches, AD
   Villela, L
   Lara, S
   Araujo, D
   Nehab, S
   Silva, L
   Amaral, Y
   Junior, SG
   Pone, S
   Lobkowicz, L
   Clemente, NS
   Brasil, P
   Nielsen-Saines, K
   Pone, M
   Brickley, E
   Moreira, ME
AF Soares, Fernanda
   Abranches, Andrea D.
   Villela, Leticia
   Lara, Sarah
   Araujo, Daniele
   Nehab, Sylvia
   Silva, Leila
   Amaral, Yasmin
   Junior, Saint Clair G.
   Pone, Sheila
   Lobkowicz, Ludmila
   Clemente, Nuria Sanchez
   Brasil, Patricia
   Nielsen-Saines, Karin
   Pone, Marcos
   Brickley, Elizabeth
   Moreira, Maria Elisabeth
TI Zika virus infection in pregnancy and infant growth, body composition in
   the first three months of life: a cohort study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AIR-DISPLACEMENT PLETHYSMOGRAPH; BIRTH; OUTBREAK; CHILDREN; WEIGHT;
   BRAZIL; BORN
AB The implications of Zika Virus exposure in pregnancy for early infant growth remains poorly described. The main goal of this study is to compare the growth, body composition, and feeding modality of infants in the first three months of life by prenatal Zika Virus exposure status. We selected an analytical cohort of 115 infants born without microcephaly, comprising 56 infants with qRT-PCR confirmed exposure to ZIKV during gestation and 59 infants born to women with presumptively no evidence of ZIKV in pregnancy. Infants were evaluated at birth, I and 3 months of age in terms of anthropometrics, body composition All the results were adjusted by maternal age, maternal BMI and gestational age. We observe no differences between anthropometric measurements at birth. Mothers in exposed group showed higher BMI. At 1 month and 3 months of age there were differences in mid arm circumference, arm muscle circumference and fat free mass. Weight and length was less in the ZIKV exposed in pregnancy infants and statistically different at 3 month of age. The findings of this investigation provide new evidence that ZIKV exposure in pregnancy may be associated with differences in body body composition.
C1 [Soares, Fernanda; Abranches, Andrea D.; Villela, Leticia; Lara, Sarah; Araujo, Daniele; Nehab, Sylvia; Silva, Leila; Amaral, Yasmin; Junior, Saint Clair G.; Pone, Sheila; Brasil, Patricia; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Lobkowicz, Ludmila; Clemente, Nuria Sanchez; Brickley, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Clemente, Nuria Sanchez] Univ Sao Paulo, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Nielsen-Saines, Karin] UCLA, Univ Calif Pediat Infect Dis, Los Angeles, CA USA.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Lobkowicz, Ludmila/AAM-4279-2020; Clemente, Nuria Sanchez/AAL-4309-2020;
   de Abranches, Andrea Dunshee/ABA-8578-2020; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Lobkowicz, Ludmila/AAR-5878-2020; Brickley,
   Elizabeth/U-3625-2017
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Lobkowicz,
   Ludmila/0000-0002-9915-0361; Moura Pone, Sheila/0000-0002-6246-8915;
   Amaral, Yasmin/0000-0001-8159-0564; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Brickley, Elizabeth/0000-0003-0280-2288
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [441098/2016-9, 305090/2016-0]; FaperjCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [E_18/2015TXB];
   Wellcome TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's
   Department for International Development [205377/Z/16/Z]; European
   UnionEuropean Union (EU) [734584]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI140718, R01AI140718, R21AI129534] Funding Source:
   NIH RePORTER
FX CNPq 441098/2016-9 and 305090/2016-0; Faperj E_18/2015TXB; Wellcome
   Trust & the United Kingdom's Department for International Development
   (205377/Z/16/Z); European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN grant agreement no. 734584.
CR Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Beaudrap P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1135-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fields DA, 2011, OBESITY, V19, P1887, DOI 10.1038/oby.2011.11
   Frisancho A., 1991, CLIN NUTR, V10, P131, DOI DOI 10.1016/0261-5614(91)90103-J
   Fung EB, 2002, J AM DIET ASSOC, V102, P361, DOI 10.1016/S0002-8223(02)90084-2
   Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hortencio Taís Daiene Russo, 2015, Rev. paul. pediatr., V33, P3, DOI 10.1016/j.rpped.2014.11.004
   Kalanda BF, 2005, EARLY HUM DEV, V81, P841, DOI 10.1016/j.earlhumdev.2005.06.006
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x
   Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nicholson L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0386-8
   Organization W. H., 2017, WHO IHR EM COMM ZIK
   Perng W, 2017, AM J CLIN NUTR, V106, P559, DOI 10.3945/ajcn.116.149617
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Walther B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-16
   WHO, 2013, PHYS STAT UINT ANT
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   Yao M, 2003, ACTA DIABETOL, V40, pS55, DOI 10.1007/s00592-003-0027-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 16
PY 2019
VL 9
AR 19198
DI 10.1038/s41598-019-55598-6
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JW6WG
UT WOS:000503189100005
PM 31844129
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU de Abreu, FVS
   dos Santos, E
   Mello, ARL
   Gomes, LR
   de Alvarenga, DAM
   Gomes, MQ
   Vargas, WP
   Bianco, C
   de Pina-Costa, A
   Teixeira, DS
   Romano, APM
   Manso, PPD
   Pelajo-Machado, M
   Brasil, P
   Daniel-Ribeiro, CT
   de Brito, CFA
   Ferreira-da-Cruz, MD
   Lourenco-de-Oliveira, R
AF Santos de Abreu, Filipe Vieira
   dos Santos, Edmilson
   Lavigne Mello, Aline Rosa
   Gomes, Larissa Rodrigues
   Madureira de Alvarenga, Denise Anete
   Gomes, Marcelo Quintela
   Vargas, Waldemir Paixao
   Bianco-Junior, Cesare
   de Pina-Costa, Anielle
   Teixeira, Danilo Simonini
   Martins Romano, Alessandro Pecego
   de Abreu Manso, Pedro Paulo
   Pelajo-Machado, Marcelo
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Alves de Brito, Cristiana Ferreira
   Ferreira-da-Cruz, Maria de Fatima
   Lourenco-de-Oliveira, Ricardo
TI Howler monkeys are the reservoir of malarial parasites causing zoonotic
   infections in the Atlantic forest of Rio de Janeiro
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SIMIAN MALARIA; SAO-PAULO; PLASMODIUM-BRASILIANUM; NEOTROPICAL PRIMATES;
   NATURAL INFECTION; STATE; BRAZIL; VIVAX; TRANSMISSION; POPULATIONS
AB Background A
   lthough malaria cases have substantially decreased in Southeast Brazil, a significant increase in the number of Plasmodium vivax-like autochthonous human cases has been reported in remote areas of the Atlantic Forest in the past few decades in Rio de Janeiro (RJ) state, including an outbreak during 2015-2016. The singular clinical and epidemiological aspects in several human cases, and collectively with molecular and genetic data, revealed that they were due to the non-human primate (NHP) parasite Plasmodium simium; however, the understanding of the autochthonous malarial epidemiology in Southeast Brazil can only be acquired by assessing the circulation of NHP Plasmodium in the foci and determining its hosts.
   Methodology
   A large sampling effort was carried out in the Atlantic forest of RJ and its bordering states (Minas Gerais, Sao Paulo, Espi ' rito Santo) for collecting and examining free-living NHPs. Blood and/or viscera were analyzed for Plasmodium infections via molecular and microscopic techniques.
   Principal findings
   In total, 146 NHPs of six species, from 30 counties in four states, were tested, of which majority were collected from RJ. Howler monkeys (Alouatta clamitans) were the only species found infected. In RJ, 26% of these monkeys tested positive, of which 17% were found to be infected with P. simium. Importantly, specific single nucleotide polymorphisms-the only available genetic markers that differentiate P. simium from P. vivax-were detected in all P. simium infected A. clamitans despite their geographical origin of malarial foci. Interestingly, 71% of P. simium infected NHPs were from the coastal slope of a mountain chain (Serra do Mar), where majority of the human cases were found. Plasmodium brasilianum/malariae was initially detected in 14% and 25% free-living howler monkeys in RJ and in the Espirito Santo (ES) state, respectively. Moreover, the malarial pigment was detected in the spleen fragments of 50% of a subsample comprising dead howler monkeys in both RJ and ES. All NHPs were negative for Plasmodium falciparum.
   Conclusions/Significance
   Our data indicate that howler monkeys act as the main reservoir for the Atlantic forest human malarial parasites in RJ and other sites in Southeast Brazil and reinforce its zoonotic characteristics.
C1 [Santos de Abreu, Filipe Vieira; Gomes, Marcelo Quintela; Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Lab Comportamento Insetos, Salinas, MG, Brazil.
   [dos Santos, Edmilson] Secretaria Saude Rio Grande do Sul, Div Vigilancia Ambiental Saude, Porto Alegre, RS, Brazil.
   [Lavigne Mello, Aline Rosa; Gomes, Larissa Rodrigues; Bianco-Junior, Cesare; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, RJ, Brazil.
   [Lavigne Mello, Aline Rosa; Gomes, Larissa Rodrigues; de Pina-Costa, Anielle; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
   [Madureira de Alvarenga, Denise Anete; Alves de Brito, Cristiana Ferreira] Fiocruz MS, Inst Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.
   [Vargas, Waldemir Paixao] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Grp Pesquisa & Epidemiol Espacial, Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle] UNIFESO, Ctr Univ Serra dos Orgaos, Fac Med Teresopolis, Teresopolis, RJ, Brazil.
   [Teixeira, Danilo Simonini] Univ Estadual Santa Cruz, UESC, Nucleo Atendimento & Pesquisa Anim Silvestres, Ilheus, BA, Brazil.
   [Martins Romano, Alessandro Pecego] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [de Abreu Manso, Pedro Paulo; Pelajo-Machado, Marcelo] Fiocruz MS, Inst Oswaldo Cruz, Lab Patol, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.; Ferreira-da-Cruz, MD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, RJ, Brazil.; Ferreira-da-Cruz, MD; Lourenco-de-Oliveira, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
EM mffcruz28@gmail.com; lourenco@ioc.fiocruz.br
RI Abreu, Filipe/F-6364-2019
OI Abreu, Filipe/0000-0001-9768-4688
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro [E-26/010.001537/2014, E-26/203.064/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309577/2013-6, 312446/2018-7,
   407873/2018-0]; Instituto Oswaldo Cruz [PAEFIOC-008-FIO-15-64];
   Ministerio da Saude, Secretaria de Vigilancia em Saude
   [IOC-0117-FIO-17]; Fundacao de Amparo a Pesquisa de Minas GeraisMinas
   Gerais State Research Foundation (FAPEMIG) [APQ-02620-15]
FX RLO was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (E-26/010.001537/2014 and E-26/
   203.064/2016, http://www.faperj.br/) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (309577/2013-6 and
   312446/2018-7, http://www.cnpq.br/). MFFC was supported by Instituto
   Oswaldo Cruz (PAEFIOC-008-FIO-15-64, http://www.fiocruz.br/ioc). CTDR
   was supported by Ministerio da Saude, Secretaria de Vigilancia em Saude
   (IOC-0117-FIO-17, http://www.saude.gov. br/svs). CFAB was supported by
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (407873/2018-0, www.cnpq.br). CBB was supported by Fundacao de Amparo a
   Pesquisa de Minas Gerais (APQ-02620-15, http://fapemig.br/pt/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alvarenga DAM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1724-0
   Araujo FAA, 2011, EPIDEMIOL SERV SAUDE, V20, P527, DOI 10.5123/S1679-49742011000400012
   [Anonymous], 2017, GUIA VIGILANCIA EPIZ
   [Anonymous], 2018, MONITORAMENTO PERI P, P1
   Araujo MS, 2013, MALARIA J, V12, P1, DOI [10.1186/1475-2875-12-1, DOI 10.1186/1475-2875-12-1]
   Araujo RM, 2008, IHERINGIA SERIE ZOOL
   Barnwell J., 1986, MEM I O CRUZ, V81, P56
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bicca-marques JC, 2017, SCI ADV, P18
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9
   Brasil P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-402
   Brito TT, 2017, METEOROL ATMOS PHYS, V129, P469, DOI 10.1007/s00703-016-0481-x
   Bueno MG, 2013, ECOHEALTH, V10, P48, DOI 10.1007/s10393-012-0809-z
   Bueno MG, 2017, INT J PRIMATOL, V38, P1017, DOI 10.1007/s10764-017-9994-5
   Buery JC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2080-9
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   COATNEY GR, 1971, AM J TROP MED HYG, V20, P795, DOI 10.4269/ajtmh.1971.20.795
   Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578
   COUTINHO J. O., 1966, REV BRASIL MALARIOL DOENCAS TROP, V18, P557
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   da FONSECA FLAVIO, 1951, MEM INST OSWALDO CRUZ, V49, P543, DOI 10.1590/S0074-02761951000100008
   Datasus Ministerio da Saude, TABNET WIN32 3 0 MAL
   de Alencar FEC, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2263-z
   de Alencar FEC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2103-6
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   Deane L.M., 1984, Memorias do Instituto Oswaldo Cruz, V79, P461, DOI 10.1590/S0074-02761984000400011
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   DEANE LM, 1964, B WORLD HEALTH ORGAN, V31, P752
   DEARRUDA M, 1989, AM J TROP MED HYG, V41, P379, DOI 10.4269/ajtmh.1989.41.379
   Dias GD, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2615-0
   Duchiade A., 2018, SCI AM
   ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616
   EYLES DE, 1963, J PARASITOL, V49, P866, DOI 10.2307/3275712
   Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011
   Gomes AD, 2008, REV INST MED TROP SP, V50, P287, DOI 10.1590/S0036-46652008000500008
   GUIMARAES A E, 1985, Memorias do Instituto Oswaldo Cruz, V80, P171, DOI 10.1590/S0074-02761985000200008
   Guimaraes LO, 2012, ACTA TROP, V124, P27, DOI 10.1016/j.actatropica.2012.05.016
   Hristov AD, 2014, MEM I OSWALDO CRUZ, V109, P1014, DOI 10.1590/0074-0276140229
   Kowalewski MM, 2014, HOWLER MONKEYS BEHAV, DOI [10.1007/978-1-4939-1960-4, DOI 10.1007/978-1-4939-1960-4]
   Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033
   Lennert K., 1978, MALIGNANT LYMPHOMAS, P73, DOI 10.1007/978-3-642-81092-3_2
   Lima GFMC, 2018, BLOOD TRANSFUS-ITALY, V16, P17, DOI 10.2450/2016.0118-16
   LOURENCO-DE-OLIVEIRA R, 1990, Memorias do Instituto Oswaldo Cruz, V85, P15
   LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004
   LourencodeOliveira R, 1996, MEM I OSWALDO CRUZ, V91, P687, DOI 10.1590/S0074-02761996000600005
   Machado Roriz Luciano, 2010, Bragantia, V69, P77, DOI 10.1590/S0006-87052010000500009
   de Alvarenga DAM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18216-x
   de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6
   Mayer P., 1903, CAPRELLIDAE SIBOGA E
   Miguel RB, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0537-2018
   Moreno ES, 2015, MEM I OSWALDO CRUZ, V110, P865, DOI 10.1590/0074-02760150075
   Paglia A. P., 2012, LISTA ANOTADA MAMIFE
   Figueiredo MAP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182905
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021
   Rylands A. B., 2012, International Zoo Yearbook, V46, P11, DOI 10.1111/j.1748-1090.2011.00152.x
   Sales ID, 2010, VET PARASITOL, V171, P123, DOI 10.1016/j.vetpar.2010.02.044
   de Abreu FVS, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.23000
   de Abreu FVS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2485-0
   SCOTT N J JR, 1976, Primates, V17, P527, DOI 10.1007/BF02382910
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Volney B, 2002, ACTA TROP, V82, P11, DOI 10.1016/S0001-706X(02)00036-0
   Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x
NR 71
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2019
VL 13
IS 12
AR e0007906
DI 10.1371/journal.pntd.0007906
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA MZ7OY
UT WOS:000559317800034
PM 31815937
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Tsui, I
   Neves, LM
   Adachi, K
   Gaw, SL
   Pereira, JP
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
   Zin, AA
AF Tsui, Irena
   Neves, Luiza M.
   Adachi, Kristina
   Gaw, Stephanie L.
   Pereira Jr, Jose Paulo
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria Elisabeth Lopes
   Zin, Andrea A.
TI Overlapping Spectrum of Retinochoroidal Scarring in Congenital Zika
   Virus and Toxoplasmosis Infections
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OCULAR TOXOPLASMOSIS; GENE POLYMORPHISM; MANIFESTATIONS; INFANTS
AB BACKGROUND AND OBJECTIVE: Antenatal Zika virus (ZIKV) or toxoplasmosis infections may present with isolated eye abnormalities with absence of other apparent birth defects. The purpose of this article is to discuss the overlapping spectrum of clinical presentation and retinochoroidal scarring in congenital ZIKV and toxoplasmosis infections.
   PATIENTS AND METHODS: Prenatal ultrasound abnormalities seen from antenatal ZIKV and toxoplasmosis infections overlap and may include intracranial calcifications, microcephaly, and intrauterine growth restriction. The clinical spectrum of both infections in less severely affected infants and children may include nonspecific neurological impairment such as developmental delay and seizures.
   RESULTS: Inherent limitations in serological testing pose additional barriers in establishing a diagnosis. Retinal pigment epithelium (RPE) mottling in ZIKV infection can occur in isolation or adjacent to retinochoroidal atrophy. In contrast, RPE mottling outside of the borders of retinochoroidal atrophy is not typically seen in toxoplasmosis. To date, postnatal reactivation of congenital eye lesions as seen in toxoplasmosis have not been reported with ZIKV infection.
   CONCLUSIONS: As children infected with congenital ZIKV grow older, subclinical eye abnormalities may be indistinguishable from toxoplasmosis. Brazil has had high prevalence of both diseases with long-term information available on toxoplasmosis only. Surveillance guidelines for asymptomatic eye abnormalities will likely evolve.
C1 [Tsui, Irena] Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
   [Neves, Luiza M.; Pereira Jr, Jose Paulo; Moreira, Maria Elisabeth Lopes; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescent Ferna, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Serv, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Tsui, I (corresponding author), Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
EM itsui@jsei.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-02, R01 AI121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R21AI129534, R01AI121207,
   R21AI129534] Funding Source: NIH RePORTER
FX Funded by the Brazilian National Council for Scientific and
   Technological Development [441098/2016-9], National Eye Institute
   [R21EY028318-02 and [R01 AI121207], and National Institute of Allergy
   and Infectious Diseases [R21AI129534-02]. Dr. Tsui was supported in part
   by an unrestricted Research to Prevent Blindness grant given to the
   Stein Eye Institute. Funding sources had no involvement in design, data
   collection/interpretation, or manuscript preparation.
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Andrade GMQ, 2010, J PEDIAT-BRAZIL, V86, P85, DOI [10.1590/S0021-75572010000100015, 10.2223/JPED.1948]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Cordeiro CA, 2008, BRIT J OPHTHALMOL, V92, P986, DOI 10.1136/bjo.2008.140590
   Cordeiro CA, 2008, INVEST OPHTH VIS SCI, V49, P1979, DOI 10.1167/iovs.07-1393
   Cordeiro CA, 2008, MOL VIS, V14, P1845
   de Albuquerque MC, 2009, MEM I OSWALDO CRUZ, V104, P451, DOI 10.1590/S0074-02762009000300009
   Fonseca ZC, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020026
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536
   Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Haddad Maria Aparecida Onuki, 2006, Clinics, V61, P239, DOI 10.1590/S1807-59322006000300009
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285
   Kimberlin DW, 2018, RED BOOK 2018 REPORT
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Melamed J, 2010, EYE, V24, P528, DOI 10.1038/eye.2009.140
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Montoya JG, 1999, OPHTHALMOLOGY, V106, P1554, DOI 10.1016/S0161-6420(99)90453-0
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   de Paula CHT, 2015, J AAPOS, V19, P252, DOI 10.1016/j.jaapos.2015.03.011
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 40
TC 1
Z9 1
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD DEC
PY 2019
VL 50
IS 12
BP 779
EP 784
DI 10.3928/23258160-20191119-05
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA JZ0XL
UT WOS:000504829700005
PM 31877223
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Pezzi, L
   LaBeaud, AD
   Reusken, CB
   Drexler, JF
   Vasilakis, N
   Diallo, M
   Simon, F
   Jaenisch, T
   Gallian, P
   Sall, A
   Failloux, AB
   Weaver, SC
   de Lamballerie, X
   Boyer, S
   Brasil, P
   Busch, M
   Diamond, MS
   Drebot, MA
   Kohl, A
   Lecuit, M
   Lourenco-de-Oliveira, R
   Neyts, J
   Lfp, N
   Ribeiro, GS
   Rios, M
   Rodriguez-Morales, AJ
   Rosa-Freitas, MG
   Simmons, G
   Siqueira, AM
   Rua, AV
AF Pezzi, L.
   LaBeaud, A. D.
   Reusken, C. B.
   Drexler, J. F.
   Vasilakis, N.
   Diallo, M.
   Simon, F.
   Jaenisch, T.
   Gallian, P.
   Sall, A.
   Failloux, A. B.
   Weaver, S. C.
   de Lamballerie, X.
   Boyer, S.
   Brasil, P.
   Busch, M.
   Diamond, M. S.
   Drebot, M. A.
   Kohl, A.
   Lecuit, M.
   Lourenco-de-Oliveira, R.
   Neyts, J.
   Lfp, Ng
   Ribeiro, G. S.
   Rios, M.
   Rodriguez-Morales, A. J.
   Rosa-Freitas, M. G.
   Simmons, G.
   Siqueira, A. M.
   Rua, A. Vega
CA GloPIDR Chikungunya O'nyongnyong
TI GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2:
   Epidemiological distribution of o'nyong-nyong virus
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID VIRAL-INFECTIONS; FEVER; SEROPREVALENCE; UGANDA
AB The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.
C1 [Pezzi, L.; de Lamballerie, X.] Aix Marseille Univ, Unite Virus Emergents UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Pezzi, L.] Univ Corse, Lab Virol, EA7310, Inserm, Corte, France.
   [LaBeaud, A. D.] Stanford Univ, Dept Pediat, Sch Med, Div Infect Dis, Stanford, CA 94305 USA.
   [Reusken, C. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Reusken, C. B.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
   [Drexler, J. F.] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Free Univ Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Humboldt Univ, D-10117 Berlin, Germany.
   [Drexler, J. F.] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Drexler, J. F.] German Ctr Infect Res DZIF, Braunschweig, Germany.
   [Vasilakis, N.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Diallo, M.; Sall, A.] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Simon, F.] Laveran Mil Teaching Hosp, Marseille, France.
   [Jaenisch, T.] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Gallian, P.] Etab Francais Sang Alpes Mediterranee, Marseille, France.
   [Failloux, A. B.] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
   [Weaver, S. C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, S. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Boyer, S.] Inst Pasteur Cambodge, Med Entomol Platform, Phnom Penh, Cambodia.
   [Brasil, P.; Siqueira, A. M.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Busch, M.; Simmons, G.] Blood Syst Res Inst, San Francisco, CA USA.
   [Busch, M.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Drebot, M. A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Kohl, A.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.
   [Lecuit, M.] Paris Descartes Univ, Dept Infect Dis & Trop Med, Necker Enfants Malad Univ Hosp, APHP,IHU Imagine,Inst Pasteur,Inserm,U1117,Biol I, Paris, France.
   [Lourenco-de-Oliveira, R.; Rosa-Freitas, M. G.] Inst Oswaldo Cruz Fiocruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Lfp, Ng] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Ribeiro, G. S.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Rios, M.] US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Simmons, G.] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA.
   [Rua, A. Vega] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Vector Control Res, Les Abymes, Guadeloupe, France.
RP Pezzi, L (corresponding author), Aix Marseille Univ, Unite Virus Emergents UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
EM laura.pezzi3@studio.unibo.it
RI Vasilakis, Nikos/ABE-7318-2020; Ribeiro, Guilherme/B-6624-2008; Lecuit,
   Marc/M-4126-2019; NEYTS, Johan/U-8267-2017
OI Ribeiro, Guilherme/0000-0002-6798-2059; Lecuit,
   Marc/0000-0002-4491-1063; Pezzi, Laura/0000-0001-7921-9221; Boyer,
   Sebastien/0000-0002-2946-586X; NEYTS, Johan/0000-0002-0033-7514
CR [Anonymous], 2019, GEN ALPH TOG POS SEN
   Bessaud M, 2006, EMERG INFECT DIS, V12, P1248, DOI 10.3201/eid1708.060199
   CORBET P. S., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P463, DOI 10.1016/0035-9203(61)90095-5
   DE ZULUETA J, 1962, Bull World Health Organ, V26, P135
   Fokam E B, 2010, East Afr Med J, V87, P262
   Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038
   HADDOW A. J., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P517, DOI 10.1016/0035-9203(60)90025-0
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   LaBeaud DA, 2015, PLOS NEGLECT TROP D, V9, P1
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   LHUILLIER M, 1988, B SOC PATHOL EXOT, V81, P386
   MARSHALL TFD, 1982, ANN TROP MED PARASIT, V76, P153
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Olaleye O.D., 1988, T R SOC TROP MED HYG
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Pezzi L, 2019, ANTIVIR RES, V166, P66, DOI 10.1016/j.antiviral.2019.03.009
   Posey DL, 2005, AM J TROP MED HYG, V73, P32, DOI 10.4269/ajtmh.2005.73.1.0730032
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Rezza G, 2017, PATHOG GLOB HEALTH, V111, P271, DOI 10.1080/20477724.2017.1355431
   Sanders EJ, 1999, J INFECT DIS, V180, P1436, DOI 10.1086/315073
   Tappe D, 2014, EMERG INFECT DIS, V20, P1766, DOI 10.3201/eid2010.140823
   WHO, HAEM FEV SYNDR
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
NR 24
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104611
DI 10.1016/j.antiviral.2019.104611
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700002
PM 31545982
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Pezzi, L
   Rodriguez-Morales, AJ
   Reusken, CB
   Ribeiro, GS
   LaBeaud, AD
   Lourenco-de-Oliveira, R
   Brasil, P
   Lecuit, M
   Failloux, AB
   Gallian, P
   Jaenisch, T
   Simon, F
   Siqueira, AM
   Rosa-Freitas, MG
   Rua, AV
   Weaver, SC
   Drexler, JF
   Vasilakis, N
   de Lamballerie, X
   Boyer, S
   Busch, M
   Diallo, M
   Diamond, MS
   Drebot, MA
   Kohl, A
   Neyts, J
   Ng, LFP
   Rios, M
   Sall, A
   Simmons, G
AF Pezzi, L.
   Rodriguez-Morales, A. J.
   Reusken, C. B.
   Ribeiro, G. S.
   LaBeaud, A. D.
   Lourenco-de-Oliveira, R.
   Brasil, P.
   Lecuit, M.
   Failloux, A. B.
   Gallian, P.
   Jaenisch, T.
   Simon, F.
   Siqueira, A. M.
   Rosa-Freitas, M. G.
   Rua, A. Vega
   Weaver, S. C.
   Drexler, J. F.
   Vasilakis, N.
   de Lamballerie, X.
   Boyer, S.
   Busch, M.
   Diallo, M.
   Diamond, M. S.
   Drebot, M. A.
   Kohl, A.
   Neyts, J.
   Ng, L. F. P.
   Rios, M.
   Sall, A.
   Simmons, G.
CA GloPIDR Chikungunya O'nyongnyong
TI GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3:
   Epidemiological distribution of Mayaro virus
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID ACUTE FEBRILE ILLNESS; HUMAN-DISEASE AGENT; AMAZON BASIN; RAIN-FOREST;
   INFECTION; BRAZIL; FEVER; OUTBREAK; RESIDENTS; TRAVELER
C1 [Pezzi, L.; de Lamballerie, X.] Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Pezzi, L.] Univ Corse, INSERM, Lab Virol, EA7310, Corte, France.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Reusken, C. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Reusken, C. B.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Ribeiro, G. S.] Univ Fed Bahia, Oswaldo Cruz Fdn, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [LaBeaud, A. D.] Stanford Univ, Sch Med, Div Infect Dis, Dept Pediat, Stanford, CA 94305 USA.
   [Lourenco-de-Oliveira, R.; Rosa-Freitas, M. G.] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Brasil, P.; Siqueira, A. M.] Fundacao Oswaldo Cruz, Inst Nacl Infectologia Evandro Chagas, Rio De Janeiro, Brazil.
   [Lecuit, M.] Paris Descartes Univ, INSERM, U1117,Necker Enfants Malad Univ Hosp,AP HP,IHU Im, Inst Pasteur,Biol Infect Unit,Dept Infect Dis & T, Paris, France.
   [Failloux, A. B.] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
   [Gallian, P.] Etab Francais Sang Alpes Mediterranee, Marseille, France.
   [Jaenisch, T.] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Simon, F.] Laveran Mil Teaching Hosp, Marseille, France.
   [Rua, A. Vega] Inst Pasteur Guadeloupe, Lab Vector Control Res, Environm & Hlth Unit, Les Abymes, Guadeloupe, France.
   [Weaver, S. C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, S. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Drexler, J. F.] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Free Univ Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Humboldt Univ, D-10117 Berlin, Germany.
   [Drexler, J. F.] Berlin Inst Hlth, D-10117 Berlin, Germany.
   [Drexler, J. F.] Inst Virol, D-10117 Berlin, Germany.
   [Drexler, J. F.] German Ctr Infect Res DZIF, Cologne, Germany.
   [Vasilakis, N.] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Pathol, Galveston, TX 77555 USA.
   [Boyer, S.] Inst Pasteur Cambodge, Med Entomol Platform, Phnom Penh, Cambodia.
   [Busch, M.] Univ Calif San Francisco, Dept Lab Med, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Diallo, M.; Sall, A.] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Mol Microbiol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Pathol & Immunol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Drebot, M. A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Kohl, A.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.
   [Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Ng, L. F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Rios, M.] US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Simmons, G.] Blood Syst Res Inst, San Francisco, CA USA.
   [Simmons, G.] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA.
RP Pezzi, L (corresponding author), Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
EM laura.pezzi3@studio.unibo.it
RI Ribeiro, Guilherme/B-6624-2008; Lecuit, Marc/M-4126-2019; Vasilakis,
   Nikos/ABE-7318-2020; NEYTS, Johan/U-8267-2017
OI Ribeiro, Guilherme/0000-0002-6798-2059; Lecuit,
   Marc/0000-0002-4491-1063; Pezzi, Laura/0000-0001-7921-9221; Boyer,
   Sebastien/0000-0002-2946-586X; NEYTS, Johan/0000-0002-0033-7514
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   BLACK FL, 1974, AM J EPIDEMIOL, V100, P230, DOI 10.1093/oxfordjournals.aje.a112032
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Carrera JP, 2018, AM J TROP MED HYG, V98, P1798, DOI 10.4269/ajtmh.17-0679
   CAUSEY OR, 1958, AM J TROP MED HYG, V7, P36, DOI 10.4269/ajtmh.1958.7.36
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   Costa MCD, 2019, ACTA TROP, V190, P395, DOI 10.1016/j.actatropica.2018.12.019
   EVANS AS, 1969, AM J EPIDEMIOL, V90, P292, DOI 10.1093/oxfordjournals.aje.a121073
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   GROOT H, 1959, AM J TROP MED HYG, V8, P175, DOI 10.4269/ajtmh.1959.8.175
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Heath CJ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx234
   Izurieta RO, 2011, J GLOB INFECT DIS, V3, P317, DOI 10.4103/0974-777X.91049
   JONKERS AH, 1965, AM J TROP MED HYG, V14, P304, DOI 10.4269/ajtmh.1965.14.304
   KARBAAT J, 1965, TROP GEOGR MED, V17, P187
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   NEEL JV, 1968, AM J TROP MED HYG, V17, P486, DOI 10.4269/ajtmh.1968.17.486
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   NIEDERMA.JC, 1967, AM J EPIDEMIOL, V86, P319, DOI 10.1093/oxfordjournals.aje.a120742
   Mota MTO, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01341-15
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Pezzi L, 2019, ANTIVIR RES, V166, P66, DOI 10.1016/j.antiviral.2019.03.009
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   SRIHONGSE S, 1973, MIL MED, V138, P422
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Tappe D, 2016, EMERG INFECT DIS, V22, P750, DOI 10.3201/eid2204.151502
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   White SK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006505
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 48
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104610
DI 10.1016/j.antiviral.2019.104610
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700001
PM 31545981
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU de Alvarenga, DAM
   Culleton, R
   de Pina-Costa, A
   Rodrigues, DF
   Bianco, C
   Silva, S
   Nunes, AJD
   de Souza, JC
   Hirano, ZMB
   Moreira, SB
   Pissinatti, A
   de Abreu, FVS
   Areas, ALL
   Lourenco-de-Oliveira, R
   Zalis, MG
   Ferreira-da-Cruz, MD
   Brasil, P
   Daniel-Ribeiro, CT
   de Brito, CFA
AF Madureira de Alvarenga, Denise Anete
   Culleton, Richard
   de Pina-Costa, Anielle
   Rodrigues, Danielle Fonseca
   Bianco, Cesare, Jr.
   Silva, Sidnei
   Dutra Nunes, Ana Julia
   de Souza, Julio Cesar, Jr.
   Braga Hirano, Zelinda Maria
   Moreira, Silvia Bahadian
   Pissinatti, Alcides
   Santos de Abreu, Filipe Vieira
   Lisboa Areas, Andre Luiz
   Lourenco-de-Oliveira, Ricardo
   Zalis, Mariano Gustavo
   Ferreira-da-Cruz, Maria de Fatima
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Alves de Brito, Cristiana Ferreira
TI An assay for the identification of Plasmodium simium infection for
   diagnosis of zoonotic malaria in the Brazilian Atlantic Forest (vol 8,
   86, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [de Pina-Costa, Anielle] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle] Fiocruz MS, IOC, Lab Pesquisa Malaria, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle] Ctr Univ Serra Orgaos UNIFESO, BR-25964004 Teresopolis, RJ, Brazil.
RP de Pina-Costa, A (corresponding author), Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, BR-21040360 Rio De Janeiro, RJ, Brazil.; de Pina-Costa, A (corresponding author), Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21040360 Rio De Janeiro, RJ, Brazil.; de Pina-Costa, A (corresponding author), Fiocruz MS, IOC, Lab Pesquisa Malaria, BR-21040360 Rio De Janeiro, RJ, Brazil.; de Pina-Costa, A (corresponding author), Ctr Univ Serra Orgaos UNIFESO, BR-25964004 Teresopolis, RJ, Brazil.
RI Hirano, Zelinda/AAR-3949-2020
OI Hirano, Zelinda/0000-0003-2903-5509
CR de Alvarenga DAM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18216-x
NR 1
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 21
PY 2019
VL 9
AR 17521
DI 10.1038/s41598-019-53954-0
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JP1RI
UT WOS:000498048900005
PM 31748614
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Moreira, Maria Elisabeth
TI Reply to 'A critical analysis of neurodevelopmental and neurosensory
   outcomes after 2 years for children with in utero Zika virus exposure'
SO NATURE MEDICINE
LA English
DT Letter
C1 [Nielsen-Saines, Karin; Kerin, Tara] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI140718] Funding Source: Medline
CR Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Vouga M, 2019, NAT MED, V25, P1641, DOI 10.1038/s41591-019-0630-0
NR 6
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2019
VL 25
IS 11
BP 1642
EP 1643
DI 10.1038/s41591-019-0631-z
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JT2KI
UT WOS:000500824300009
PM 31649351
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Brasil, P
AF Brasil, Patricia
TI Never shy from infectious-disease mysteries
SO NATURE MEDICINE
LA English
DT Editorial Material
C1 [Brasil, Patricia] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Lab Acute Febrile Illness, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Lab Acute Febrile Illness, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD OCT
PY 2019
VL 25
IS 10
BP 1465
EP 1465
DI 10.1038/s41591-019-0569-1
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JC3GJ
UT WOS:000489166700003
PM 31591581
OA Bronze
DA 2020-12-01
ER

PT J
AU Pereira, JP
   Maykin, MM
   Vasconcelos, Z
   Avvad-Portari, E
   Zin, AA
   Tsui, I
   Brasil, P
   Nielsen-Saines, K
   Moreira, ME
   Gaw, SL
AF Pereira, Jose Paulo, Jr.
   Maykin, Melanie M.
   Vasconcelos, Zilton
   Avvad-Portari, Elyzabeth
   Zin, Andrea A.
   Tsui, Irena
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria E.
   Gaw, Stephanie L.
TI The Role of Amniocentesis in the Diagnosis of Congenital Zika Syndrome
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE ZIKV; TORCH infection; perinatal infection; pregnancy; vertical
   transmission
ID VIRUS-INFECTION; PREGNANCY; FETUSES; BLOOD
AB There are limited data on amniocentesis as a diagnostic tool for congenital Zika syndrome. Here we report on a prospective cohort of 16 women with suspected Zika virus infection in a highly endemic area, and discuss the role of amniocentesis in the prenatal diagnosis of fetal Zika infection.
C1 [Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Avvad-Portari, Elyzabeth; Zin, Andrea A.; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556,HSE16, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Gaw,
   Stephanie/0000-0003-0891-6964
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K12 HD000849,
   R21AI28697, R21AI129534, R21EY028318]; Queenan Fellowship for Global
   Health; Conselho Nacional de Pesquisa-Brazilian National Research
   Council of the Brazilian Ministry of Health (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Apoio a
   Pesquisa do Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); European Union
   European Horizon 2020 Research and Innovation Programme (Zika-PLAN)
   [734584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER
FX This work was supported by the National Institutes of Health (grant
   numbers K12 HD000849 to S.L.G., R21AI28697, R21AI129534, and
   R21EY028318), the Queenan Fellowship for Global Health (to S. L. G.),
   the Conselho Nacional de Pesquisa-Brazilian National Research Council of
   the Brazilian Ministry of Health (CNPq, to M. E. M.); Fundacao de Apoio
   a Pesquisa do Rio de Janeiro (Faperj, to M. E. M); and the European
   Union European Horizon 2020 Research and Innovation Programme (Zika-PLAN
   grant number 734584).
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Besnard M, 2016, EUROSURVEILLANCE, V21, P302
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Herrera K, CASE REP PERINATAL M, V5, P374
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 12
TC 4
Z9 4
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2019
VL 69
IS 4
BP 713
EP 716
DI 10.1093/cid/ciz013
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IW7LJ
UT WOS:000485171100021
PM 30624579
OA Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Damasceno, L
   Pone, M
   de Carvalho, LMA
   Pone, SM
   Zin, AA
   Tsui, I
   Salles, TRS
   da Cunha, DC
   Costa, RP
   Malacarne, J
   Reis, AB
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Gaw, SL
   Adachi, K
   Cherry, JD
   Xu, ZH
   Cheng, GH
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Pone, Marcos
   Abreu de Carvalho, Liege M.
   Pone, Sheila M.
   Zin, Andrea A.
   Tsui, Irena
   Salles, Tania Regina S.
   da Cunha, Denise Cotrim
   Costa, Roozemerie Pereira
   Malacarne, Jociele
   Reis, Ana Beatriz
   Hasue, Renata Hydee
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Einspieler, Christa
   Marschik, Peter B.
   Pereira, Jose Paulo
   Gaw, Stephanie L.
   Adachi, Kristina
   Cherry, James D.
   Xu, Zhiheng
   Cheng, Genhong
   Moreira, Maria Elisabeth
TI Delayed childhood neurodevelopment and neurosensory alterations in the
   second year of life in a prospective cohort of ZIKV-exposed children
SO NATURE MEDICINE
LA English
DT Article
ID INFANT NEUROLOGICAL EXAMINATION; VIRUS-INFECTION; OPHTHALMIC
   MANIFESTATIONS; CEREBRAL-PALSY; BIRTH-DEFECTS; BAYLEY-III; EPIDEMIC;
   OUTCOMES; SEX
AB We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. (1,2)). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children. Complete eye exams (n = 137) and hearing assessments (n = 114) were also performed. Below-average neurodevelopment and/or abnormal eye or hearing assessments were noted in 31.5% of children between 7 and 32 months of age. Among children assessed by Bayley-III, 12% scored below -2 s.d. (score < 70; a score of 100 +/- 2 s.d. is the range) in at least one domain; and 28% scored between -1 and -2 s.d. in any domain (scores < 85-70). Language function was most affected, with 35% of 146 children below average. Improved neurodevelopmental outcomes were noted in female children, term babies, children with normal eye exams and maternal infection later in pregnancy (P = 0.01). We noted resolution of microcephaly with normal neurodevelopment in two of eight children, development of secondary microcephaly in two other children and autism spectrum disorder in three previously healthy children in the second year of life.
C1 [Nielsen-Saines, Karin; Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Cheng, Genhong] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Damasceno, Luana; Pone, Marcos; Abreu de Carvalho, Liege M.; Pone, Sheila M.; Zin, Andrea A.; Salles, Tania Regina S.; da Cunha, Denise Cotrim; Costa, Roozemerie Pereira; Malacarne, Jociele; Reis, Ana Beatriz; Pereira, Jose Paulo; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata Hydee; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
   [Marschik, Peter B.] Univ Med Ctr, Gottingen, Germany.
   [Gaw, Stephanie L.] UCSF Sch Med, San Francisco, CA USA.
   [Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.; Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM knielsen@mednet.ucla.edu; bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Hasue, Renata
   Hydee/B-2328-2013
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Reis, AlessanRSS/0000-0001-8486-7469;
   Moura Pone, Sheila/0000-0002-6246-8915
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-19]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [001/88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq/441098/2016-9, CNPq307282/2017-1]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-18/2015TXB, 239224/E-032018, E-26/202.862/2018]; Fondation
   Christophe e Rodolphe Merieux [734548]; Thrasher Research Fund
   [20164370]; Bill and Melinda gates Foundation Grand Challenges
   ExplorationsBill & Melinda Gates Foundation [OPP112887]; National
   Institute of Allergy and Infectious Diseases (NIAID) of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01,
   AI140718-01]; National Eye Institute (NEI) of the National Institutes of
   Health [AI129847-01]; United Kingdom's Department for International
   Development; ZikaPlan (Preparedness Latin American Network); NATIONAL
   EYE INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P30AI028697, P30AI028697, P30AI028697, K08AI141728, R21AI129534,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI140718, P30AI028697, P30AI028697, P30AI028697, R01AI140718] Funding
   Source: NIH RePORTER
FX This study was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil (DECIT/25000.072811/2016-19, to P.B. and
   M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES 001/88887.116627/2016-01 to PB); Brazilian National Council for
   Scientific and Technological Development (CNPq/441098/2016-9 to M.E.M.
   and CNPq307282/2017-1 to P.B.); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, No. E-18/2015TXB to
   M.E.M., No. 239224/E-032018 to M.E.M. and No. E-26/202.862/2018 to
   P.B.); Fondation Christophe e Rodolphe Merieux to P.B.; ZikAlliance,
   734548 to P.B.; the Thrasher Research Fund (No. 20164370 to K.N.S. and
   K.A.); the Bill and Melinda gates Foundation Grand Challenges
   Explorations (No. OPP112887 to P.B.M.); the National Institute of
   Allergy and Infectious Diseases (NIAID) of the National Institutes of
   Health (No. AI28697 to K.N.S., No. AI1259534-01 to K.N.S. and G.C., No.
   AI140718-01 to K.N.S. and P.B.); the National Eye Institute (NEI) of the
   National Institutes of Health (No. AI129847-01 to K.N.S., I.T. and
   P.B.); the United Kingdom's Department for International Development (to
   M.E.M.); and the ZikaPlan (Preparedness Latin American Network, to
   M.E.M.). We thank the women who enrolled in this study, the Fiocruz Zika
   Field Team who rendered our work possible, and P.F. Augusto and C.B. de
   Souza (Federal University of Sao Paulo), who assisted with
   neurodevelopmental assessments.
CR Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20
   Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Bayley N., 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cherry JD, 2018, FEIGIN CHERRYS TXB P
   da Cunha RDES, 2016, J PEDIAT-BRAZIL, V92, P136, DOI 10.1016/j.jped.2015.04.004
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037
   Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006
   Rossetto J. D., 2018, J AAPOS, V22, pe60
   Souza CT, 2010, BRAZ J PHYS THER, V14, P309
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura C. V, 2016, ARQ BRAS OFTALMOL, V79
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vianna P, 2018, NEUROIMMUNOMODULAT, V25, P320, DOI 10.1159/000495660
   Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 39
TC 41
Z9 41
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2019
VL 25
IS 8
BP 1213
EP +
DI 10.1038/s41591-019-0496-1
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA IQ0BI
UT WOS:000480414600018
PM 31285631
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Hair, GM
   Nobre, FF
   Brasil, P
AF Hair, Gleicy Macedo
   Nobre, Flavio Fonseca
   Brasil, Patricia
TI Characterization of clinical patterns of dengue patients using an
   unsupervised machine learning approach
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Age; Clinical classification; Warning signs; Machine learning
ID RISK
AB BackgroundDespite the greater sensitivity of the new dengue clinical classification proposed by the World Health Organization (WHO) in 2009, there is a need for a better definition of warning signs and clinical progression of dengue cases. Classic statistical methods have been used to evaluate risk criteria in dengue patients, however they usually cannot access the complexity of dengue clinical profiles. We propose the use of machine learning as an alternative tool to identify the possible characteristics that could be used to develop a risk criterion for severity in dengue patients.MethodIn this study, we analyzed the clinical profiles of 523 confirmed dengue cases using self-organizing maps (SOM) and random forest algorithms to identify clusters of patients with similar patterns.ResultsWe identified four natural clusters, two with features of dengue without warning signs or mild disease, one that comprises the severe dengue cases and high frequency of warning signs, and another with intermediate characteristics. Age appeared as the key variable for splitting the data into these four clusters although warning signs such as abdominal pain or tenderness, clinical fluid accumulation, mucosal bleeding, lethargy, restlessness, liver enlargement and increased hematocrit associated with a decrease in platelet counts should also be considered to evaluate severity in dengue patients.ConclusionsThese findings suggest that age must be the first characteristic to be considered in places where dengue is hyperendemic. Our results show that warning signs should be closely monitored, mainly in children. Further studies exploring these results in a longitudinal approach may help to understand the full spectrum of dengue clinical manifestations.
C1 [Hair, Gleicy Macedo; Nobre, Flavio Fonseca] Univ Fed Rio de Janeiro, Programa Engn Biomed COPPE, Ctr Tecnol, Lab Engn Sistemas Saude, Bloco H,Sala H327,Caixa Postal POB 68510, BR-21941972 Rio de Janeiro, RJ, Brazil.
   [Brasil, Patricia] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
RP Hair, GM (corresponding author), Univ Fed Rio de Janeiro, Programa Engn Biomed COPPE, Ctr Tecnol, Lab Engn Sistemas Saude, Bloco H,Sala H327,Caixa Postal POB 68510, BR-21941972 Rio de Janeiro, RJ, Brazil.
EM ghairbioengineer@gmail.com
OI Hair, Gleicy/0000-0002-9106-7424
FU Consellho Nacional de Desenvolvimento e Pesquisa [CNPq/307282/2017-1];
   Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [FAPERJ/E_ 26/202.862/2018 CNE]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [CNPQ/302258/2017-5];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES)CAPES [001F]
FX PB is supported by the Consellho Nacional de Desenvolvimento e Pesquisa
   (CNPq/307282/2017-1) and Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ/E_ 26/202.862/2018 CNE) and FFN has a grant from CNPq
   (CNPQ/302258/2017-5). This study was also financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES) -Finance Code 001F. The funders had no role in this study
   design, data collection, analysis, interpretation, or writing of the
   report. The corresponding author had full access to all data in the
   study and had final responsibility for the decision to submit for
   publication.
CR Afanador NL, 2016, J CHEMOMETR, V30, P232, DOI 10.1002/cem.2790
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Chen N, 2005, LECT NOTES ARTIF INT, V3808, P304
   Faisal T, 2010, MED BIOL ENG COMPUT, V48, P293, DOI 10.1007/s11517-009-0561-x
   Fernandez E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2800-3
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Halstead SB, 2013, AM J TROP MED HYG, V88, P212, DOI 10.4269/ajtmh.12-0197
   HOLM S, 1979, SCAND J STAT, V6, P65
   Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017
   Hsu CC, 2006, IEEE T NEURAL NETWOR, V17, P294, DOI 10.1109/TNN.2005.863415
   KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325
   Kuo HJ, 2018, J MICROBIOL IMMUNOL, V51, P740, DOI 10.1016/j.jmii.2016.08.024
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154772
   Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Olteanu M, 2015, J SFDS, V156, P95
   Olteanu M, 2015, NEUROCOMPUTING, V147, P15, DOI 10.1016/j.neucom.2013.11.047
   Pan American Health Organization (PAHO), 2016, DENGUE GUIDELINES PA
   R Core Team, 2018, R LANG ENV STAT
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Suwarto S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2996-x
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Thomas L, 2012, ANN EMERG MED, V59, P42, DOI 10.1016/j.annemergmed.2011.08.010
   Wakimoto MD, 2015, EXPERT REV ANTI-INFE, V13, P1441, DOI 10.1586/14787210.2015.1100534
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization (WHO), DENG GUID DIAGN TREA
NR 30
TC 0
Z9 0
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 22
PY 2019
VL 19
AR 649
DI 10.1186/s12879-019-4282-y
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA IK6SI
UT WOS:000476718200002
PM 31331271
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pool, KL
   Adachi, K
   Karnezis, S
   Salamon, N
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Boechat, M
   Aibe, M
   da Silva, TG
   Ribeiro, CTM
   Boechat, I
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Daltro, P
   Ribeiro, BG
   Fazecas, T
   da Cruz, LCH
   Nogueira, R
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Chen, WQ
   Foo, SS
   Jung, J
   Moreira, ME
   Pone, M
AF Pool, Kara-Lee
   Adachi, Kristina
   Karnezis, Stellios
   Salamon, Noriko
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Boechat, Marcia
   Aibe, Mitsue
   da Silva, Tallita Gomes
   Martins Ribeiro, Carla Trevisan
   Boechat, Ines
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Daltro, Pedro
   Ribeiro, Bianca Guedes
   Fazecas, Tatiana
   Celso Hygino da Cruz, L.
   Nogueira, Renata
   Vasconcelos, Zilton
   Pereira, Jose Paulo, Jr.
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Chen, Weiqiang
   Foo, Suan-Sin
   Jung, Jae
   Moreira, Maria Elisabeth
   Pone, Marcos
TI Association Between Neonatal Neuroimaging and Clinical Outcomes in
   Zika-Exposed Infants From Rio de Janeiro, Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES
AB IMPORTANCE Congenital Zika virus (ZIKV) infection may present with a spectrum of clinical and neuroradiographic findings.
   OBJECTIVE To determine whether neuroimaging findings for infants with a history of ZIKV exposure are associated with infant clinical outcomes and gestational age at antenatal ZIKV infection.
   DESIGN, SETTING, AND PARTICIPANTS This cohort study retrospectively reviewed neuroimaging results (computed tomography and/or magnetic resonance imaging scans) of 110 ZIKV-exposed infants from a maternity and children's hospital in Rio de Janeiro, Brazil, following the 2015 to 2016 ZIKV epidemic. Neuroimaging from March 1, 2016, to June 30, 2017, was evaluated to determine whether findings were associated with clinical outcomes and the timing of maternal ZIKV infection. Data were analyzed from July 1, 2017, to August 30, 2018.
   EXPOSURES Neuroimaging (computed tomography and/or magnetic resonance imaging) was performed on ZIKV-exposed infants after birth. Blood and/or urine specimens from mothers and infants were tested for ZIKV by polymerase chain reaction assay.
   MAIN OUTCOMES AND MEASURES Neuroimaging studies were evaluated for structural abnormalities and other forms of brain injury.
   RESULTS A total of 110 infants with a mean (SD) gestational age of 38.4 (2.1) weeks had neuroimaging and clinical outcome data reviewed. Of these, 71 (65%) had abnormal neuroimaging findings, with the majority (96%) classified as having severe ZIKV infection at birth. The most common neuroimaging abnormalities were structural abnormalities including brain calcifications, especially at the cortico-subcortical white matter junction, cortex malformations, ventriculomegaly, and reduced brain volumes, followed by brainstem hypoplasia, cerebellar hypoplasia, and corpus callosum abnormalities. Frequency of abnormal imaging was higher in infants with specific clinical findings as opposed to those without them; these findings included fetal brain disruption sequence (100% vs 35%), microcephaly (100% vs 30%), congenital contractures (100% vs 58%), ophthalmologic abnormalities (95% vs 44%), hearing abnormalities (100% vs 58%), and neurologic symptoms (94% vs 10%). Four of 39 infants (10%) without initial evidence of severe ZIKV infection and normal findings on neurologic evaluation at birth had abnormal neuroimaging findings. Neuroimaging abnormalities differed by trimester of maternal ZIKV infection, with 63% of infants born to mothers infected in the first trimester, 13% of infants born to mothers infected in the second trimester, and 1% of infants born to mothers infected in the third trimester exhibiting neuroimaging abnormalities. The odds of abnormal neuroimaging were 7.9 times greater for infants with first trimester ZIKV exposure compared with other trimesters combined (odds ratio, 7.9; 95% CI, 3.0-20.4; P < .001).
   CONCLUSIONS AND RELEVANCE Neuroimaging abnormalities of computed tomography and/or magnetic resonance imaging scans were common in ZIKV-exposed infants. While neuroimaging abnormalities were seen in 10% of infants without clinically severe ZIKV, most occurred almost exclusively among those with clinically severe ZIKV, especially among those with a history of ZIKV exposure in the first trimester.
C1 [Pool, Kara-Lee; Adachi, Kristina; Karnezis, Stellios; Salamon, Noriko; Romero, Tahmineh; Nielsen-Saines, Karin; Boechat, Marcia; Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Boechat, Marcia; Aibe, Mitsue; da Silva, Tallita Gomes; Martins Ribeiro, Carla Trevisan; Brasil, Patricia; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo, Jr.; Salles, Tania Saad; Barbosa, Claudia Neves; Moreira, Maria Elisabeth; Pone, Marcos] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Daltro, Pedro; Ribeiro, Bianca Guedes; Fazecas, Tatiana; Celso Hygino da Cruz, L.; Nogueira, Renata] Clin Diagnost Imagem CDPI, Rio De Janeiro, Brazil.
   [Chen, Weiqiang; Foo, Suan-Sin; Jung, Jae] Univ Southern Calif, Sch Med, Los Angeles, CA 90007 USA.
RP Adachi, K (corresponding author), David Geffen UCLA Sch Med, Dept Pediat, Div Infect Dis, MDCC 22-442,10833 Le Conte Ave, Los Angeles, CA 90049 USA.
EM kadachi@mednet.ucla.edu
OI Moura Pone, Sheila/0000-0002-6246-8915; Martins Ribeiro, Carla
   Trevisan/0000-0002-2478-9144; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Vasconcelos, Zilton/0000-0002-2193-2224
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01,
   AI140718-01]; National Eye Institute of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [AI129847-01]; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute [UL1TR001881]; Thrasher Research Fund [20164370]; United
   Kingdom's Department for International Development; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [441098/2016-9]; Fundo de amparo a
   pesquisa estado do Rio de Janeiro [E_18/2015TXB]; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI140718, R01AI140718] Funding Source: NIH RePORTER
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   CAPES/88887.116627/2016-01); the National Institute of Allergy and
   Infectious Diseases (grants AI28697, AI1259534-01, AI140718-01) and the
   National Eye Institute (grant AI129847-01) of the National Institutes of
   Health; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute (grant UL1TR001881); Thrasher Research Fund (grant 20164370);
   and the United Kingdom's Department for International Development. The
   work was also supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 441098/2016-9) and Fundo de amparo a
   pesquisa estado do Rio de Janeiro (grant E_18/2015TXB).
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chan SRLL, 1992, J OBSTET GYNAECOL, V12, P25, DOI [10.3109/01443619209029914, DOI 10.3109/01443619209029914]
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raymond A, 2018, PEDIATR INFECT DIS J, V37, pE112, DOI 10.1097/INF.0000000000001832
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Uggetti C, 2009, AM J NEURORADIOL, V30, P1971, DOI 10.3174/ajnr.A1694
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 27
TC 6
Z9 6
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL
PY 2019
VL 2
IS 7
AR e198124
DI 10.1001/jamanetworkopen.2019.8124
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0VM
UT WOS:000513150700009
PM 31365112
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Xavier, J
   Giovanetti, M
   Fonseca, V
   Theze, J
   Graf, T
   Fabri, A
   de Jesus, JG
   de Mendonca, MCL
   Rodrigues, CDD
   Mares-Guia, MA
   dos Santos, CC
   Tosta, SFD
   Candido, D
   Nogueira, RMR
   de Abreu, AL
   Oliveira, WK
   de Albuquerque, CFC
   Chieppe, A
   de Oliveira, T
   Brasil, P
   Calvet, G
   Sequeira, PC
   Faria, NR
   de Filippis, AMB
   Alcantara, LCJ
AF Xavier, Joilson
   Giovanetti, Marta
   Fonseca, Vagner
   Theze, Julien
   Graf, Tiago
   Fabri, Allison
   de Jesus, Jaqueline Goes
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Mares-Guia, Maria Angelica
   dos Santos, Carolina Cardoso
   de Oliveira Tosta, Stephane Fraga
   Candido, Darlan
   Ribeiro Nogueira, Rita Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Campelo de Albuquerque, Carlos F.
   Chieppe, Alexandre
   de Oliveira, Tulio
   Brasil, Patricia
   Calvet, Guilherme
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Bispo de Filippis, Ana Maria
   Junior Alcantara, Luiz Carlos
TI Circulation of chikungunya virus East/Central/South African lineage in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; POPULATION; MODEL; ZIKA
AB The emergence of chikungunya virus (CHIKV) has raised serious concerns due to the virus' rapid dissemination into new geographic areas and the clinical features associated with infection. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. Our phylogenetic reconstructions indicated the circulation of the East-Central-South-African (ECSA) lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with CHIKV notified case numbers revealed the ECSA lineage was introduced in Rio de Janeiro around June 2015 (95% Bayesian credible interval: May to July 2015) indicating the virus was circulating unnoticed for 5 months before the first reports of CHIKV autochthonous transmissions in Rio de Janeiro, in November 2015. These findings reinforce that continued genomic surveillance strategies are needed to assist in the monitoring and understanding of arbovirus epidemics, which might help to attenuate public health impact of infectious diseases.
C1 [Xavier, Joilson; de Jesus, Jaqueline Goes] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Xavier, Joilson; Giovanetti, Marta; Fabri, Allison; Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Mares-Guia, Maria Angelica; dos Santos, Carolina Cardoso; Ribeiro Nogueira, Rita Maria; Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; de Oliveira Tosta, Stephane Fraga; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Theze, Julien; Candido, Darlan; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Graf, Tiago; Fabri, Allison] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz; Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Calvet, Guilherme] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP de Filippis, AMB; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM abispo@ioc.fiocruz.br; luiz.alcantara@ioc.fiocruz.br
RI Oliveira, Wanderson/AAF-5182-2019; Giovanetti, Marta/AAK-7408-2020;
   Fonseca, Vagner/R-5813-2019; Calvet, GA/G-6959-2013; Faria, Nuno
   R/I-2975-2012; Graf, Tiago/S-8535-2019
OI Oliveira, Wanderson/0000-0002-9662-1930; Fonseca,
   Vagner/0000-0001-5521-6448; Calvet, GA/0000-0002-3545-5238; Faria, Nuno
   R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975; De Jesus,
   Jaqueline/0000-0002-5404-272X; Theze, Julien/0000-0001-8188-9494;
   Xavier, Joilson/0000-0003-3916-2018; Alcantara, Luiz/0000-0002-6769-9931
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro /FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.930/2016]; Coordenacao de Vigilancia em Saude e Laboratorios
   de Referencia da Fundacao Oswaldo Cruz
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /Faperj over the grant number E-26/202.930/2016
   and by the Coordenacao de Vigilancia em Saude e Laboratorios de
   Referencia da Fundacao Oswaldo Cruz.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Brasil, 2018, B EP MON CAS DENG FE
   Brasil, 2016, B EP ARB CEN EP DENG
   Brasil, 2019, B EP MON CAS DENG FE
   Brasil, 2015, B EP MON CAS DED FEB
   Brasil. Boletim Epidemiologico, 2017, B EP MON CAS DENG FE
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Collado D, 2018, J VIROL
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2017, BRIEF BIOINFORM
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   PAHO/WHO, 2017, NUM CAS REP CHIK PAI
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 46
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR e0217871
DI 10.1371/journal.pone.0217871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000023
PM 31185030
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Hayashida, K
   Orba, Y
   Sequeira, PC
   Sugimoto, C
   Hall, WW
   Eshita, Y
   Suzuki, Y
   Runtuwene, L
   Brasil, P
   Calvet, G
   Rodrigues, CDS
   dos Santos, CC
   Mares-Guia, MAM
   Yamagishi, J
   de Filippis, AMB
   Sawa, H
AF Hayashida, Kyoko
   Orba, Yasuko
   Sequeira, Patricia C.
   Sugimoto, Chihiro
   Hall, William W.
   Eshita, Yuki
   Suzuki, Yutaka
   Runtuwene, Lucky
   Brasil, Patricia
   Calvet, Guilherme
   Rodrigues, Cintia D. S.
   dos Santos, Carolina C.
   Mares-Guia, Maria A. M.
   Yamagishi, Junya
   de Filippis, Ana M. B.
   Sawa, Hirofumi
TI Field diagnosis and genotyping of chikungunya virus using a dried
   reverse transcription loop-mediated isothermal amplification (LAMP)
   assay and MinION sequencing
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK; INFECTION; STRAINS
AB Detection and sequencing of chikungunya virus (CHIKV) genome was performed using a combination of a modified reverse transcription loop-mediated isothermal amplification (RT-LAMP) method and a MinION sequencer. We developed the protocol for drying all the reagents for the RT-LAMP in a single reaction tube. Using this system, the CHIKV genome was effectively amplified under isothermal conditions, and used as a template for MinION sequencing with a laptop computer. Our in-house RT-LAMP method and MinION sequencing system were also validated with RNAs and serum samples from recent outbreaks of CHIKV patients in Brazil. The obtained sequence data confirmed the CHIKV outbreaks and identified the genotype. In summary, our established inexpensive on-site genome detection and sequencing system is applicable for both diagnosis of CHIKV infected patients and genotyping of the CHIKV virus in future outbreak in remote areas.
   Author summary Chikungunya virus has re-emerged as an important pathogen causing several outbreaks in the world. As the clinical symptoms of chikungunya is similar to other mosquito-borne febrile diseases, the definitive diagnosis of the disease is based on the detection of viral genome from the patient blood. Loop-mediated isothermal amplification (LAMP) is a method that rapidly amplify nucleic acids under isothermal condition. In the present work, a simple dried format LAMP test for chikungunya diagnosis was developed which can be directly amplified from human blood. Combining with the portable sequencer MinION sequencing system, a method to identify the viral genotype was also established. The developed on-site diagnosis and genotyping system is easy to perform, sensitive, and rapid. Therefore, it offers great promise as a routine simple tool for diagnosis and disease management of chikungunya.
C1 [Hayashida, Kyoko; Orba, Yasuko; Sugimoto, Chihiro; Eshita, Yuki; Yamagishi, Junya; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.
   [Sequeira, Patricia C.; Rodrigues, Cintia D. S.; dos Santos, Carolina C.; Mares-Guia, Maria A. M.; de Filippis, Ana M. B.] Oswaldo Cruz Fdn Fiocruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Sugimoto, Chihiro; Hall, William W.; Yamagishi, Junya; Sawa, Hirofumi] Hokkaido Univ, Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan.
   [Hall, William W.] Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin, Ireland.
   [Hall, William W.; Brasil, Patricia; Calvet, Guilherme; Sawa, Hirofumi] Global Virus Network, Baltimore, MD USA.
   [Suzuki, Yutaka; Runtuwene, Lucky] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.
   [Brasil, Patricia; Calvet, Guilherme] Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
RP Yamagishi, J; Sawa, H (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.; Yamagishi, J; Sawa, H (corresponding author), Hokkaido Univ, Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan.; Sawa, H (corresponding author), Global Virus Network, Baltimore, MD USA.
EM junya@czc.hokudai.ac.jp; h-sawa@czc.hokudai.ac.jp
RI Sawa, Hirofumi/F-6954-2012; Calvet, Guilherme/G-6959-2013
OI Hayashida, Kyoko/0000-0001-9266-5162; Calvet,
   Guilherme/0000-0002-3545-5238
FU AMED program of the Japan Initiative for Global Research Network on
   Infectious Diseases (J-GRID) [JP18fm0108008]; Research Program on
   Emerging and Re-emerging Infectious Diseases [JP18fk0108108]; Japan
   Society for the Promotion of Science (JSPS) KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [16H05805]; Ministry of Education, Culture, Sports,
   Science and Technology (MEXT) of JapanMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT) [16H06429, 16H06431,
   16K21723]; OSIMO foundation; European Union's Horizon 2020 program
   [734857, 734548]; Faperj (Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]
FX This study was funded by AMED program of the Japan Initiative for Global
   Research Network on Infectious Diseases (J-GRID; JP18fm0108008) and
   Research Program on Emerging and Re-emerging Infectious Diseases
   (JP18fk0108108) and Japan Society for the Promotion of Science (JSPS)
   KAKENHI (16H05805). This study was also supported by Grants-in-Aid for
   Scientific Research on Innovative Areas from the Ministry of Education,
   Culture, Sports, Science and Technology (MEXT) of Japan (16H06429,
   16H06431, 16K21723) and OSIMO foundation. The Flavivirus Laboratory was
   funded by Faperj (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro) under the grant no. E-26/2002.930/2016, by
   European Union's Horizon 2020 program under grant agreements ZIKACTION
   no. 734857 and ZIKAPLAN no. 734548. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abraham R, 2016, INFECT GENET EVOL, V37, P174, DOI 10.1016/j.meegid.2015.11.019
   Auerswald H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0010-0
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Enserink M, 2006, SCIENCE, V311, P1085, DOI 10.1126/science.311.5764.1085a
   Gandelman O, 2011, INT J MOL SCI, V12, P9108, DOI 10.3390/ijms12129108
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hayashida K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1949-8
   Hayashida K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003578
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lim CK, 2009, AM J TROP MED HYG, V81, P865, DOI 10.4269/ajtmh.2009.09-0009
   Lopez-Jimena B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006448
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Meagher RJ, 2018, ANALYST, V143, P1924, DOI 10.1039/c7an01897e
   Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Oliveira H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060292
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rianthavorn P, 2010, INT J INFECT DIS, V14, pE161, DOI 10.1016/j.ijid.2010.01.001
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Souza TMA, 2017, PLOS CURR, V9
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Yamagishi J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03734-5
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 45
TC 3
Z9 3
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2019
VL 13
IS 6
AR e0007480
DI 10.1371/journal.pntd.0007480
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IG4NA
UT WOS:000473779100055
PM 31158221
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pezzi, L
   Reusken, CB
   Weaver, SC
   Drexler, JF
   Busch, M
   LaBeaud, AD
   Diamond, MS
   Vasilakis, N
   Drebot, MA
   Siqueira, AM
   Ribeiro, GS
   Kohl, A
   Lecuit, M
   Ng, LFP
   Gallian, P
   Lamballerie, X
   Boyer, S
   Brasil, P
   Diallo, M
   Failloux, AB
   Jaenisch, T
   Lourenco-De-Oliveira, R
   Neyts, J
   Rios, M
   Rodriguez-Morales, AJ
   Rosa-Freitas, MG
   Sall, A
   Simmons, G
   Simon, F
   Rua, AV
AF Pezzi, L.
   Reusken, C. B.
   Weaver, S. C.
   Drexler, J. F.
   Busch, M.
   LaBeaud, A. D.
   Diamond, M. S.
   Vasilakis, N.
   Drebot, M. A.
   Siqueira, A. M.
   Ribeiro, G. S.
   Kohl, A.
   Lecuit, M.
   Ng, L. F. P.
   Gallian, P.
   de Lamballerie, X.
   Boyer, S.
   Brasil, P.
   Diallo, M.
   Failloux, A. B.
   Jaenisch, T.
   Lourenco-de-Oliveira, R.
   Neyts, J.
   Rios, M.
   Rodriguez-Morales, A. J.
   Rosa-Freitas, M. G.
   Sall, A.
   Simmons, G.
   Simon, F.
   Rua, A. Vega
CA GloPID-R Chikungunya O'nyong-n
TI GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I:
   Biological diagnostics
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Alphavirus; Chikungunya virus; O'nyong-nyong; Mayaro virus; Diagnostics
ID EXTERNAL QUALITY ASSESSMENT; REVERSE TRANSCRIPTION-PCR; POLYMERASE
   CHAIN-REACTION; ACUTE-FEBRILE-ILLNESS; LABORATORY FEATURES;
   AEDES-ALBOPICTUS; REUNION ISLAND; BLOOD-DONORS; EAST-AFRICA; PUERTO-RICO
AB The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.
C1 [Pezzi, L.; de Lamballerie, X.] Aix Marseille Univ, Unite Virus Emergents, INSERM 1207, IRD 190,IHU Mediterranee Infect,UVE, Marseille, France.
   [Pezzi, L.] Univ Corse, INSERM, Lab Virol, EA7310, Corte, France.
   [Reusken, C. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Reusken, C. B.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Weaver, S. C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, S. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Drexler, J. F.] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Free Univ Berlin, D-10117 Berlin, Germany.
   [Drexler, J. F.] Humboldt Univ, D-10117 Berlin, Germany.
   [Drexler, J. F.] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Drexler, J. F.] German Ctr Infect Res DZIF, Hamburg, Germany.
   [Busch, M.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Busch, M.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [LaBeaud, A. D.] Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, M. S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Vasilakis, N.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Drebot, M. A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Siqueira, A. M.] Fundacao Oswaldo Cruz, Inst Natl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ribeiro, G. S.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Kohl, A.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.
   [Lecuit, M.] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP,Biol Infect Unit,INSERM,IHU Imagine, Dept Infect Dis & Trop Med,Inst Pasteur,U1117, Paris, France.
   [Ng, L. F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Gallian, P.] Etab Francais Sang Alpes Mediterranee, Marseille, France.
   [Boyer, S.] Inst Pasteur Cambodge, Med Entomol Platform, Phnom Penh, Cambodia.
   [Brasil, P.] Fundacao Oswaldo Cruz, Inst Natl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Diallo, M.; Sall, A.] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Failloux, A. B.] Inst Pasteur, Arboviruses & Insect Vectors Unit, Dept Virol, Paris, France.
   [Jaenisch, T.] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Lourenco-de-Oliveira, R.; Rosa-Freitas, M. G.] Inst Oswaldo Cruz Fiocruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Dept Microbiol & Immunol, Leuven, Belgium.
   [Rios, M.] US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Simmons, G.] Blood Syst Res Inst, San Francisco, CA USA.
   [Simmons, G.] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA.
   [Simon, F.] Laveran Mil Teaching Hosp, Marseille, France.
   [Rua, A. Vega] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Vector Control Res, Les Abymes, Guadeloupe, France.
RP Pezzi, L (corresponding author), Univ Corse, INSERM, Lab Virol, EA7310, Corte, France.
EM laura.pezzi3@studio.unibo.it
RI Ribeiro, Guilherme/B-6624-2008; Vasilakis, Nikos/ABE-7318-2020; Lecuit,
   Marc/J-4073-2013; Lecuit, Marc/M-4126-2019; Neyts, Johan/U-8267-2017;
   Diamond, Michael/AAH-1733-2019
OI Ribeiro, Guilherme/0000-0002-6798-2059; Lecuit,
   Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Neyts,
   Johan/0000-0002-0033-7514; Diamond, Michael/0000-0002-8791-3165; Boyer,
   Sebastien/0000-0002-2946-586X; Pezzi, Laura/0000-0001-7921-9221;
   Drexler, Jan Felix/0000-0002-3509-0232
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014/8] Funding Source: Medline
CR Althouse BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03332-7
   AMORIM AT, 2017, PEDIATR INFECT DIS J, V17, DOI DOI 10.1186/S12879-017-2835-5
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Anez G, 2015, VOX SANG, V109, P312, DOI 10.1111/vox.12297
   Anez G, 2014, GENOME ANNOUNC, V2
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bessaud M, 2006, EMERG INFECT DIS, V12, P1248, DOI 10.3201/eid1708.060199
   BLACKBURN NK, 1995, RES VIROLOGY, V146, P69, DOI 10.1016/0923-2516(96)80591-7
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   CALISHER CH, 1986, J CLIN MICROBIOL, V23, P155, DOI 10.1128/JCM.23.1.155-159.1986
   Carrera JP, 2018, AM J TROP MED HYG, V98, P1798, DOI 10.4269/ajtmh.17-0679
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   CHANAS AC, 1979, ARCH VIROL, V59, P231, DOI 10.1007/BF01317418
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   Diagnostic Testing, 2017, DIAGN TEST
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Rocha VFD, 2018, OCUL IMMUNOL INFLAMM, V26, P677, DOI 10.1080/09273948.2017.1358378
   Donoso Mantke O, 2007, EUROSURVEILLANCE, V12
   Eastwood G, 2017, AM J TROP MED HYG, V97, P1399, DOI 10.4269/ajtmh.17-0126
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Estofolete CF, 2016, REV SOC BRAS MED TRO, V49, P648, DOI 10.1590/0037-8682-0093-2016
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Grivard P, 2007, MOL SEROLOGICAL DIAG
   HADDOW A. J., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P517, DOI 10.1016/0035-9203(60)90025-0
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Heath CJ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx234
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Hotez P. J, 2017, PLOS NEGL TROP DIS, V11
   Jacobsen S, 2016, J CLIN VIROL, V76, P55, DOI 10.1016/j.jcv.2016.01.008
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Jones P, 2015, J INFECT DIS THER, V3, P1
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   KARABATSOS N, 1975, AM J TROP MED HYG, V24, P527, DOI 10.4269/ajtmh.1975.24.527
   Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462
   Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55
   LaBeaud DA, 2015, PLOS NEGLECT TROP D, V9, P1
   Lanciotti R. S., 2007, EMERG INFECT DIS, V13, P5
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Liu J, 2016, J CLIN MICROBIOL, V54, P49, DOI 10.1128/JCM.02257-15
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Lwande Olivia Wesula, 2015, Infection Ecology & Epidemiology, V5, P30106, DOI 10.3402/iee.v5.30106
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/nejmoa1711038, 10.1056/NEJMoa1711038]
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Nagpal K, 2017, J NEUROVIROL, V23, P501, DOI 10.1007/s13365-017-0515-2
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183
   Oliver M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000374
   PAHO WHO, CHIK DAT MAPS STAT
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Panning M, 2009, J CLIN MICROBIOL, V47, P3014, DOI 10.1128/JCM.01024-09
   Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   PEI Paul-Ehrlich-Institut, PAUL EHRL I INF WHO
   PORTERFIELD J, 1961, B WORLD HEALTH ORGAN, V24, P735
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Prince HE, 2016, CLIN VACCINE IMMUNOL, V23, P825, DOI 10.1128/CVI.00330-16
   Prince HE, 2015, CLIN VACCINE IMMUNOL, V22, P291, DOI 10.1128/CVI.00720-14
   Pyndiah M. N, 2012, MED TROP REV CORPS S, V72
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   Rezza G, 2017, PATHOG GLOB HEALTH, V7724, P1
   Rwaguma EB, 1997, EMERG INFECT DIS, V3, P77, DOI 10.3201/eid0301.970112
   Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931
   SCHMIDT JR, 1959, AM J TROP MED HYG, V8, P479, DOI 10.4269/ajtmh.1959.8.479
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Smith DR, 2009, AM J TROP MED HYG, V81, P679, DOI 10.4269/ajtmh.2009.09-0138
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Smith JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00003-18, 10.1128/msphere.00003-18]
   Soh LT, 2016, WEST PAC SURVEILL RE, V7, P26, DOI [10.5365/WPSAR.2016.7.1.002, 10.5365/wpsar.2016.7.1.002]
   Sow A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx259
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tappe D, 2014, EMERG INFECT DIS, V20, P1766, DOI 10.3201/eid2010.140823
   Taraphdar D, 2015, INDIAN J MED MICROBI, V33, pS153, DOI 10.4103/0255-0857.150946
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Verma P, 2013, CCLM, V52, P297
   Waggoner J, 2017, AM J TROP MED HYG, V97, P121, DOI 10.4269/ajtmh.17-0027
   Waggoner JJ, 2018, J CLIN VIROL, V98, P1, DOI 10.1016/j.jcv.2017.11.006
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   WHO, CHIK
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 123
TC 13
Z9 13
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2019
VL 166
BP 66
EP 81
DI 10.1016/j.antiviral.2019.03.009
PG 16
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IA4GV
UT WOS:000469522900007
PM 30905821
OA Green Published, Green Accepted, Other Gold
DA 2020-12-01
ER

PT J
AU Wilder-Smith, A
   Wei, YH
   de Araujo, TVB
   VanKerkhove, M
   Martelli, CMT
   Turchi, MD
   Teixeira, M
   Tami, A
   Souza, J
   Sousa, P
   Soriano-Arandes, A
   Soria-Segarra, C
   Clemente, NS
   Rosenberger, KD
   Reveiz, L
   Prata-Barbosa, A
   Pomar, L
   Rosado, LEP
   Perez, F
   Passos, SD
   Nogueira, M
   Noel, TP
   da Silva, AM
   Moreira, ME
   Morales, I
   Montoya, MCM
   Miranda, DD
   Maxwell, L
   Macpherson, CNL
   Low, N
   Lan, ZY
   LaBeaud, AD
   Koopmans, M
   Kim, C
   Joao, E
   Jaenisch, T
   Hofer, CB
   Gustafson, P
   Gerardin, P
   Ganz, JS
   Dias, ACF
   Elias, V
   Duarte, G
   Debray, TPA
   Cafferata, ML
   Buekens, P
   Broutet, N
   Brickley, EB
   Brasil, P
   Brant, F
   Bethencourt, S
   Benedetti, A
   Avelino-Silva, VL
   Ximenes, RAD
   da Cunha, AA
   Alger, J
AF Wilder-Smith, Annelies
   Wei, Yinghui
   Barreto de Araujo, Thalia Velho
   VanKerkhove, Maria
   Turchi Martelli, Celina Maria
   Turchi, Marilia Dalva
   Teixeira, Mauro
   Tami, Adriana
   Souza, Joao
   Sousa, Patricia
   Soriano-Arandes, Antoni
   Soria-Segarra, Carmen
   Clemente, Nuria Sanchez
   Rosenberger, Kerstin Daniela
   Reveiz, Ludovic
   Prata-Barbosa, Arnaldo
   Pomar, Leo
   Rosado, Luiza Emylce Pela
   Perez, Freddy
   Passos, Saulo D.
   Nogueira, Mauricio
   Noel, Trevor P.
   da Silva, Antonio Moura
   Moreira, Maria Elisabeth
   Morales, Ivonne
   Miranda Montoya, Maria Consuelo
   Miranda-Filho, Democrito de Barros
   Maxwell, Lauren
   Macpherson, Calum N. L.
   Low, Nicola
   Lan, Zhiyi
   LaBeaud, Angelle Desiree
   Koopmans, Marion
   Kim, Caron
   Joao, Esau
   Jaenisch, Thomas
   Hofer, Cristina Barroso
   Gustafson, Paul
   Gerardin, Patrick
   Ganz, Jucelia S.
   Fialho Dias, Ana Carolina
   Elias, Vanessa
   Duarte, Geraldo
   Alfons Debray, Thomas Paul
   Cafferata, Maria Luisa
   Buekens, Pierre
   Broutet, Nathalie
   Brickley, Elizabeth B.
   Brasil, Patricia
   Brant, Fatima
   Bethencourt, Sarah
   Benedetti, Andrea
   Avelino-Silva, Vivian Lida
   de Alencar Ximenes, Ricardo Arraes
   da Cunha, Antonio Alves
   Alger, Jackeline
CA Zika Virus Individual Participant
TI Understanding the relation between Zika virus infection during pregnancy
   and adverse fetal, infant and child outcomes: a protocol for a
   systematic review and individual participant data meta-analysis of
   longitudinal studies of pregnant women and their infants and children
SO BMJ OPEN
LA English
DT Review
ID MULTIVARIATE METAANALYSIS; PREDICTION MODELS; PATIENT DATA; REGRESSION;
   FRAMEWORK; DENGUE; ENHANCEMENT; PERFORMANCE; DIAGNOSIS; SELECTION
AB Introduction Zika virus (ZIKV) infection during pregnancy is a known cause of microcephaly and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or prophylactics, principal investigators (PIs) and international leaders in ZIKV research have formed the ZIKV Individual Participant Data (IPD) Consortium to identify, collect and synthesise IPD from longitudinal studies of pregnant women that measure ZIKV infection during pregnancy and fetal, infant or child outcomes.
   Methods and analysis We will identify eligible studies through the ZIKV IPD Consortium membership and a systematic review and invite study Pls to participate in the IPD meta-analysis (IPD-MA). We will use the combined dataset to estimate the relative and absolute risk of congenital Zika syndrome (CZS), including microcephaly and late symptomatic congenital infections; identify and explore sources of heterogeneity in those estimates and develop and validate a risk prediction model to identify the pregnancies at the highest risk of CZS or adverse developmental outcomes. The variable accuracy of diagnostic assays and differences in exposure and outcome definitions means that included studies will have a higher level of systematic variability, a component of measurement error, than an IPD-MA of studies of an established pathogen. We will use expert testimony, existing internal and external diagnostic accuracy validation studies and laboratory external quality assessments to inform the distribution of measurement error in our models. We will apply both Bayesian and frequentist methods to directly account for these and other sources of uncertainty.
   Ethics and dissemination The IPD-MA was deemed exempt from ethical review. We will convene a group of patient advocates to evaluate the ethical implications and utility of the risk stratification tool. Findings from these analyses will be shared via national and international conferences and through publication in open access, peer-reviewed journals.
C1 [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wei, Yinghui] Univ Plymouth, Ctr Math Sci, Plymouth, Devon, England.
   [Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [VanKerkhove, Maria] WHO, Hlth Emergencies Programme, Geneva, Switzerland.
   [Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes CPqAM, Dept Collect Hlth, Recife, PE, Brazil.
   [Turchi, Marilia Dalva] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [Teixeira, Mauro; Fialho Dias, Ana Carolina; Brant, Fatima] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Tami, Adriana] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Souza, Joao] Univ Sao Paulo, Dept Social Med, Sao Paulo, Brazil.
   [Sousa, Patricia] Reference Ctr Neurodev Assistance & Rehabil Child, State Dept Hlth Maranhao, Sao Luis, Maranhao, Brazil.
   [Soriano-Arandes, Antoni] Univ Hosp Vall dHebron, Dept Pediat, Barcelona, Spain.
   [Soria-Segarra, Carmen] SOSECALI C Ltda, Guayaquil, Ecuador.
   [Clemente, Nuria Sanchez] Univ Sao Paulo, Dept Epidemiol, Sao Paulo, Brazil.
   [Rosenberger, Kerstin Daniela; Morales, Ivonne; Jaenisch, Thomas] Univ Klinikum Heidelberg, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Reveiz, Ludovic] Pan Amer Hlth Org, Evidence & Intelligence Act Hlth, Washington, DC USA.
   [Prata-Barbosa, Arnaldo] DOr Inst Res & Educ, Dept Pediat, Rio De Janeiro, Brazil.
   [Pomar, Leo] Ctr Hosp Ouest Guyanais, Dept Obstet & Gynecol, St Laurent Du Maroni, French Guiana.
   [Rosado, Luiza Emylce Pela] Goiania State Hlth Secretary, Hosp Materno Infantil Goiania, Goiania, Go, Brazil.
   [Perez, Freddy] Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth Dep, Washington, DC USA.
   [Passos, Saulo D.] FMJ, Dept Pediat, Sao Paulo, Brazil.
   [Nogueira, Mauricio] Fac Med Sao Jose do Rio Preto, Dept Dermatol Dis, Sao Jose Do Rio Preto, Brazil.
   [Noel, Trevor P.; Macpherson, Calum N. L.] St Georges Univ, Windward Isl Res & Educ Fdn, True Blue Point, Grenada.
   [da Silva, Antonio Moura] Univ Fed Maranhao Sao Luis, Dept Publ Hlth, Sao Luis, Maranhao, Brazil.
   [Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Dept Neonatol, Rio De Janeiro, Brazil.
   [Miranda Montoya, Maria Consuelo] Univ Ind Santander, Fac Salud, Bucaramanga, Colombia.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Maxwell, Lauren] WHO, Reprod Hlth & Res, Geneva, Switzerland.
   [Maxwell, Lauren] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Lan, Zhiyi] McGill Univ, Hlth Ctr, Montreal, PQ, Canada.
   [LaBeaud, Angelle Desiree] Stanford Hosp, Pediat Infect Dis, Palo Alto, CA USA.
   [Koopmans, Marion] Erasmus MC, Dept Virol, Rotterdam, Netherlands.
   [Kim, Caron; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Joao, Esau] Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, Brazil.
   [Hofer, Cristina Barroso] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil.
   [Gustafson, Paul] Univ British Columbia, Stat, Vancouver, BC, Canada.
   [Gerardin, Patrick] CHU La Reunion, INSERM, CIC1410, Clin Epidemiol, St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ la Reunion, UM PIMIT 134, CNRS 9192, INSERM U1187,IRD 249, St Clotilde, Reunion, France.
   [Ganz, Jucelia S.] Childrens Hosp Juvencio Matos, Sao Luis, Maranhao, Brazil.
   [Elias, Vanessa] Pan Amer Hlth Org, Sustainable Dev & Environm Hlth, Washington, DC USA.
   [Duarte, Geraldo] Univ Sao Paulo, Dept Gynecol & Obstet, Sao Paulo, Brazil.
   [Alfons Debray, Thomas Paul] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Cafferata, Maria Luisa] Inst Efectividad Clin & Sanitaria, Mother & Children Hlth Res Dept, Buenos Aires, DF, Argentina.
   [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   [Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Benedetti, Andrea] McGill Univ, Dept Med, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Biostat, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada.
   [Avelino-Silva, Vivian Lida] Univ Sao Paulo, Dept Infect & Parasit Dis, Fac Med, Sao Paulo, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [da Cunha, Antonio Alves] Univ Fed Rio de Janeiro, Dept Pediat, Rio De Janeiro, Brazil.
   [Alger, Jackeline] Univ Nacl Autonoma Honduras, Fac Ciencias Med, Tegucigalpa, Honduras.
RP Maxwell, L (corresponding author), WHO, Reprod Hlth & Res, Geneva, Switzerland.; Maxwell, L (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
EM lauren.maxwell.us@gmail.com
RI Prata-Barbosa, Arnaldo/B-2212-2009; Debray, Thomas/J-7413-2012;
   Nogueira, Mauricio L/B-7599-2012; Arandes, Antonio Soriano/Q-3348-2016;
   Passos, Saulo/C-5166-2012; Avelino-Silva, Vivian/L-2640-2013; Brickley,
   Elizabeth/U-3625-2017
OI Prata-Barbosa, Arnaldo/0000-0002-4726-9782; Debray,
   Thomas/0000-0002-1790-2719; Nogueira, Mauricio L/0000-0003-1102-2419;
   Arandes, Antonio Soriano/0000-0001-9613-7228; Passos,
   Saulo/0000-0002-0908-2677; Wei, Yinghui/0000-0002-7873-0009; Sulleiro,
   Elena/0000-0002-9783-6060; Perez, Freddy/0000-0003-2001-0057;
   Avelino-Silva, Vivian/0000-0002-6660-3088; Brickley,
   Elizabeth/0000-0003-0280-2288; Joao, Esau/0000-0002-2412-0627; Koopmans,
   Marion/0000-0002-5204-2312
FU Wellcome TrustWellcome Trust; WHO Department of Reproductive Health and
   Research Human Reproduction Programme [206532/Z/17/]; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI140718,
   R01AI140718, R01AI140718] Funding Source: NIH RePORTER
FX The development of the IPD-MA protocol was supported by a Wellcome Trust
   grant to the WHO Department of Reproductive Health and Research Human
   Reproduction Programme, grant number 206532/Z/17/
CR Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Andrade PE, 2017, J IMMUNOL, V198
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2016, NATURE, V530, P5, DOI 10.1038/530005a
   [Anonymous], 2016, ZIK VIR INF CLIN
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Audigier V, 2017, MULTIPLE IMPUTATION
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Barchfield J., 2016, BOSTON GLOBE
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayley N., 1993, BAYLEY SCALES INFANT
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brodzinsky Sibylla, 2016, GUARDIAN
   Burgess S, 2013, STAT MED, V32, P4499, DOI 10.1002/sim.5844
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheng YKY, 2016, BJOG-INT J OBSTET GY, V123, P48, DOI 10.1111/1471-0528.14008
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Counotte M, 2018, ZIKA VIRUS INFECT CA
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cruz MM, 2017, J IMMUNOL, V198
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2018, LANCET INFECT DIS, V18
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Debray TPA, 2018, STAT METHODS MED RES, V27, P1351, DOI 10.1177/0962280216660741
   Debray TPA, 2015, RES SYNTH METHODS, V6, P293, DOI 10.1002/jrsm.1160
   Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886
   Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732
   Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durbin AP, 2017, J INFECT DIS, V216, pS971, DOI 10.1093/infdis/jix491
   Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533
   ELPUB, 2016, JUP NOT A PUBL FORM
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fernandes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113360
   Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gelman A, 2014, BAYESIAN DATA ANAL
   Gerardin P, 2016, BMJ-BRIT MED J, V354, P4850
   Gomez G, 2003, STAT MED, V22, P409, DOI 10.1002/sim.1326
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Groll A, 2016, PACKAGE GLMMLASSO
   Groll A, 2014, STAT COMPUT, V24, P137, DOI 10.1007/s11222-012-9359-z
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Hansen BB, 2008, BIOMETRIKA, V95, P481, DOI 10.1093/biomet/asn004
   Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43
   Higgins J. P., 2008, COCHRANE HDB SYSTEMA, P481, DOI DOI 10.1002/9780470712184.CH16
   Higgins J. P. T., 2016, COCHRANE DATABASE S1, V10, P29, DOI DOI 10.1002/14651858.CD201601
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Jackson D, 2017, STAT METHODS MED RES, V26, P2853, DOI 10.1177/0962280215611702
   Jaenisch T, 2016, B WHO
   Jarde A, 2013, INT J CLIN HLTH PSYC, V13, P138, DOI 10.1016/S1697-2600(13)70017-6
   Joseph KS, 2018, ACTA OBSTET GYN SCAN, V97, P454, DOI 10.1111/aogs.13194
   Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002
   Kiserud T, 2016, PLOS MED, P1
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   Koopman L, 2008, INT J TECHNOL ASSESS, V24, P358, DOI 10.1017/S0266462308080471
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Lash T. L., 2011, APPL QUANTITATIVE BI
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587
   Marx A, 2003, EVID BASED MED, V8, P36
   Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x
   Menikoff J., 2017, COMMUNICATION
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2
   Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Pacheco O, 2016, N ENGL J MED OVERSEA
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO, P1
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Popay J, 2014, PUBLIC INVOLVEMENT I
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Richardson DB, 2015, INT J EPIDEMIOL, V44, P1660, DOI 10.1093/ije/dyv137
   Riley RD, 2015, RES SYNTH METHODS, V6, P157, DOI 10.1002/jrsm.1129
   Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165
   Riley RD, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3932
   Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221
   Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052
   Sorvillo FJ, 2001, EPIDEMIOLOGIC METHOD, P249
   Squires J, 2009, AGES STAGES QUESTION
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tierney JF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001855
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vander Weele TJ, 2014, EPIDEMIOLOGY, V25, P711, DOI 10.1097/EDE.0000000000000096
   VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei YH, 2013, STAT MED, V32, P2911, DOI 10.1002/sim.5745
   Wellcome Trust, 2016, SHAR DAT ZIK OTH GLO
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x
   World Health Organization, 2016, SCREEN ASS MAN NEON
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183
   Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x
NR 128
TC 6
Z9 6
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD JUN
PY 2019
VL 9
IS 6
AR e026092
DI 10.1136/bmjopen-2018-026092
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA ND7XT
UT WOS:000562117100061
PM 31217315
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU de Abreu, FVS
   Gomes, LR
   Mello, ARL
   Bianco, C
   de Pina-Costa, A
   dos Santos, E
   Teixeira, DS
   Brasil, P
   Daniel-Ribeiro, CT
   Lourenco-de-Oliveira, R
   Ferreira-da-Cruz, MD
AF Santos de Abreu, Filipe Vieira
   Gomes, Larissa Rodrigues
   Lavigne Mello, Aline Rosa
   Bianco-Junior, Cesare
   de Pina-Costa, Anielle
   dos Santos, Edmilson
   Teixeira, Danilo Simonini
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Lourenco-de-Oliveira, Ricardo
   Ferreira-da-Cruz, Maria de Fatima
TI Frozen blood clots can be used forthediagnosis ofdistinct Plasmodium
   species inman andnon-human primates fromtheBrazilian Atlantic Forest
   (vol 17, 338, 2018)
SO MALARIA JOURNAL
LA English
DT Correction
C1 [Santos de Abreu, Filipe Vieira; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais Campus Salinas, Salinas, MG, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne Mello, Aline Rosa; Bianco-Junior, Cesare; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne Mello, Aline Rosa; Bianco-Junior, Cesare; de Pina-Costa, Anielle; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Lourenco-de-Oliveira, Ricardo; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [dos Santos, Edmilson] Secretaria Saude Rio Grande Sul, Div Vigilancia Ambiental Saude, Porto Alegre, RS, Brazil.
   [Teixeira, Danilo Simonini] Univ Brasilia, Fac Agron & Vet, Brasilia, DF, Brazil.
   [de Pina-Costa, Anielle] Ctr Univ Serra Orgaos UNIFESO, BR-25964004 Teresopolis, RJ, Brazil.
RP Lourenco-de-Oliveira, R; Ferreira-da-Cruz, MD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br; mffcruz28@gmail.com
CR de Abreu FVS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2485-0
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAY 14
PY 2019
VL 18
AR 168
DI 10.1186/s12936-019-2804-0
PG 1
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HY4AI
UT WOS:000468068800002
PM 31088475
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Cantelli, CP
   da Silva, MFM
   Fumian, TM
   da Cunha, DC
   de Andrade, JDR
   Malta, FC
   Mouta, SDE
   Fialho, AM
   de Moraes, MTB
   Brasil, P
   Miagostovich, MP
   Leite, JPG
AF Cantelli, Carina Pacheco
   Marques da Silva, Marcelle Figueira
   Fumian, Tulio Machado
   da Cunha, Denise Cotrim
   Ribeiro de Andrade, Juliana da Silva
   Malta, Fabio Correia
   da Silva e Mouta Junior, Sergio
   Fialho, Alexandre Madi
   Baroni de Moraes, Marcia Terezinha
   Brasil, Patricia
   Miagostovich, Marize Pereira
   Gagliardi Leite, Jose Paulo
TI High genetic diversity of noroviruses in children from a community-based
   study in Rio de Janeiro, Brazil, 2014-2018
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; RECOMBINANT GII.P16-GII.2; UNITED-STATES;
   GASTROENTERITIS; PREVALENCE; INFECTION; EPIDEMIOLOGY; EMERGENCE
AB We report on the occurrence and diversity of noroviruses in children (younger than 5 years old of age) from a low-income urban area in Rio de Janeiro, Brazil. Sixty-one stool specimens collected from children between 1 and 4 years old with acute diarrhoeic episodes (ADE) and non-ADE were investigated. RT-qPCR and sequencing of PCR products after conventional RT-PCR analysis were performed. Noroviruses were detected in 29 (47.5%) samples: 21 (46.7%) from cases with ADE and 8 (50%) from non-ADE cases. Molecular characterization showed 10 different genotypes circulating in this community between November 2014 and April 2018.
C1 [Cantelli, Carina Pacheco] Fiocruz MS, Technol Inst Immunobiol Biomanguinhos, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Cantelli, Carina Pacheco; Fumian, Tulio Machado; Ribeiro de Andrade, Juliana da Silva; Malta, Fabio Correia; da Silva e Mouta Junior, Sergio; Fialho, Alexandre Madi; Baroni de Moraes, Marcia Terezinha; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo] Fiocruz MS, Oswaldo Cruz Inst, Lab Comparat & Environm Virol, Ave Brasil 4365, BR-21040360 Manguinho, RJ, Brazil.
   [Marques da Silva, Marcelle Figueira] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Rua 235, Goiania, Go, Brazil.
   [da Cunha, Denise Cotrim] Fiocruz MS, Sergio Arouca Publ Hlth Natl Sch, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Brasil, Patricia] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Ave Brasil 4365, Manguinho, RJ, Brazil.
RP Cantelli, CP (corresponding author), Fiocruz MS, Technol Inst Immunobiol Biomanguinhos, Ave Brasil 4365, Manguinho, RJ, Brazil.; Cantelli, CP (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Lab Comparat & Environm Virol, Ave Brasil 4365, BR-21040360 Manguinho, RJ, Brazil.
EM carina.cantelli@gmail.com
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Silva-Sales,
   Marcelle/D-9809-2015
OI Silva-Sales, Marcelle/0000-0002-4275-9627; Pacheco Cantelli,
   Carina/0000-0002-9171-5022
FU Oswaldo Cruz Institute/Fiocruz; Carlos Chagas Filho Foundation for
   Research Support in the State of Rio de Janeiro [FAPERJ
   E-26/202.968/2015]; National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [CNPq 424376/2016-4]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R01EY026202, R01EY026202,
   R01EY026202, R01EY026202, R01EY026202] Funding Source: NIH RePORTER
FX This study was funded by "The Oswaldo Cruz Institute/Fiocruz", "The
   Carlos Chagas Filho Foundation for Research Support in the State of Rio
   de Janeiro" (FAPERJ E-26/202.968/2015), and "The National Council for
   Scientific and Technological Development" (CNPq 424376/2016-4).
CR Andrade JSR, 2017, INFECT GENET EVOL, V51, P28, DOI 10.1016/j.meegid.2017.03.011
   Ayukekbong JA, 2015, J GEN VIROL, V96, P1983, DOI 10.1099/vir.0.000194
   Banyai K, 2018, LANCET, V392, P175, DOI 10.1016/S0140-6736(18)31128-0
   Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219
   Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17
   Cortes-Penfield NW, 2017, CLIN THER, V39, P1537, DOI 10.1016/j.clinthera.2017.07.002
   Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831
   Garcia C, 2006, J CLIN MICROBIOL, V44, P2997, DOI 10.1128/JCM.00065-06
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hata M, 2018, JPN J INFECT DIS, V71, P319, DOI 10.7883/yoken.JJID.2017.520
   Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005
   Kabue JP, 2016, J CLIN VIROL, V84, P12, DOI 10.1016/j.jcv.2016.09.005
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Li J, 2018, VIRUS RES, V249, P99, DOI 10.1016/j.virusres.2018.03.016
   Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031
   Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287
   Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999
   McAtee CL, 2016, AM J TROP MED HYG, V94, P212, DOI 10.4269/ajtmh.15-0203
   Medici MC, 2018, NEW MICROBIOL, V41, P71
   Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]
   Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652
   Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439
   Barreira DMPG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189504
   Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14
   Rouhani S, 2016, CLIN INFECT DIS, V62, P1210, DOI 10.1093/cid/ciw072
   Sang SW, 2018, PEERJ, V6, DOI 10.7717/peerj.4333
   Shioda K, 2015, VACCINE, V33, P4065, DOI 10.1016/j.vaccine.2015.05.051
   Siebenga JJ, 2008, J INFECT DIS, V198, P994, DOI 10.1086/591627
   Tohma K, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00187-17
   Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589
   Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011
   World Health Organization [WHO], 2017, DIARRH DIS
   Xavier MPTP, 2009, BRAZ J MED BIOL RES, V42, P438, DOI 10.1590/S0100-879X2009000500007
NR 35
TC 7
Z9 7
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAY
PY 2019
VL 164
IS 5
BP 1427
EP 1432
DI 10.1007/s00705-019-04195-z
PG 6
WC Virology
SC Virology
GA HT7PY
UT WOS:000464758100019
PM 30859473
DA 2020-12-01
ER

PT J
AU Botto-Menezes, CHA
   Neto, AM
   Calvet, GA
   Kara, EO
   Lacerda, MVG
   Castilho, MD
   Stroher, U
   de Brito, CAA
   Modjarrad, K
   Broutet, N
   Brasil, P
   de Filippis, AMB
   Franca, RFO
   de Abreu, AL
   Benzaken, AS
   Bermudez, XPD
   Broutet, NJN
   Giozza, SP
   Habib, N
   Landoulsi, S
   Lima, MC
   Lima, N
   de Mello, MB
   de Menezes, AIC
   Meurant, R
   Pimenta, C
   Storme, C
   Thorson, A
   Trautman, L
AF Aguiar Botto-Menezes, Camila Helena
   Neto, Armando Menezes
   Calvet, Guilherme Amaral
   Kara, Edna Oliveira
   Guimaraes Lacerda, Marcus Vinicius
   Castilho, Marcia da Costa
   Stroher, Ute
   Antunes de Brito, Carlos Alexandre
   Modjarrad, Kayvon
   Broutet, Nathalie
   Brasil, Patricia
   Bispo de Filippis, Ana Maria
   Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   Benzaken, Adele Schwartz
   Diaz Bermudez, Ximena Pamela
   Nicole Broutet, Nathalie Jeanne
   Giozza, Silvana Pereira
   Habib, Ndema
   Landoulsi, Sihem
   Lima, Morganna Costa
   Lima, Noemia
   de Mello, Maeve Brito
   Costa de Menezes, Ana Izabel
   Meurant, Robyn
   Pimenta, Cristina
   Storme, Casey
   Thorson, Anna
   Trautman, Lydie
CA ZIKABRA Study Team
TI Zika Virus in Rectal Swab Samples
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We detected Zika virus RNA in rectal swab samples from 10 patients by using real-time reverse transcription PCR, and we isolated the virus from 1 patient. The longest interval from symptom onset to detection was 14 days. These findings are applicable to diagnosis and infection prevention recommendations.
C1 [Aguiar Botto-Menezes, Camila Helena] Amazonas State Univ, Manaus, Amazonas, Brazil.
   [Aguiar Botto-Menezes, Camila Helena; Guimaraes Lacerda, Marcus Vinicius; Castilho, Marcia da Costa] Trop Med Fdn Doctor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Neto, Armando Menezes; Antunes de Brito, Carlos Alexandre; Oliveira Franca, Rafael Freitas] Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Kara, Edna Oliveira; Stroher, Ute; Broutet, Nathalie] WHO, Geneva, Switzerland.
   [Guimaraes Lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Bispo de Filippis, Ana Maria] Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
RP Franca, RFO (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Dept Virol & Expt Therapy, Av Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238; Menezes-Neto,
   Armando/0000-0002-2003-908X; Thorson, Anna/0000-0002-8703-6561
FU Wellcome TrustWellcome Trust [206522/Z/17/Z]; World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction); Brazilian
   Ministry of Health [837059/2016, 25000162039201616]; US National
   Institutes of Health National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI139777]; Henry M. Jackson Foundation
   for the Advancement of Military Medicine [W81XWH-18-2-0040]; US
   Department of the Army [W81XWH-18-2-0040]; US Defense Health Agency
   [0130602D16]; World Health Emergency Programme Organization; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI139777] Funding Source: NIH RePORTER
FX The research leading to these results received funding from Wellcome
   Trust grant no. 206522/Z/17/Z, World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction), World Health
   Emergency Programme Organization, Brazilian Ministry of Health (Convenio
   no. 837059/2016, Processo 25000162039201616), US National Institutes of
   Health National Institute of Allergy and Infectious Diseases (award no.
   R21AI139777). This work was supported by a cooperative agreement
   (W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the
   Advancement of Military Medicine and the US Department of the Army. The
   work was funded by the US Defense Health Agency (0130602D16). The
   funders had no role in study design, data collection, analysis, decision
   to publish, or preparation of the manuscript.
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li CF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0170-6
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
NR 13
TC 4
Z9 4
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2019
VL 25
IS 5
BP 951
EP 954
DI 10.3201/eid2505.180904
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HU0TG
UT WOS:000464983500014
PM 31002058
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Koopmans, M
   de Lamballerie, X
   Jaenisch, T
   Rosenberger, KD
   Morales, I
   Marques, ETA
   Viana, IFT
   Brasil, P
   Rabello, R
   Avelino-Silva, VI
   Segurado, A
   Alexander, N
   Mayaud, P
   Netto, EM
   Tami, A
   Bethencourt, S
   Miranda, MC
   Lozano, A
   Soria, C
   Cisneros, SPS
   Gotuzzo, E
   Guzman, MG
   Rodriguez, PAM
   Lopez-Gatell, H
   Hegewisch-Taylor, J
   Borja-Aburto, VH
   Bonilla, CRG
   Hoen, B
   van Roode, M
   Rockx, B
AF Koopmans, Marion
   de lamballerie, Xavier
   Jaenisch, Thomas
   Rosenberger, Kerstin D.
   Morales, Ivonne
   Marques, Ernesto T. A.
   Viana, Isabelle F. T.
   Brasil, Patricia
   Rabello, Renata
   Avelino-Silva, Vivian I.
   Segurado, Aluisio
   Alexander, Neal
   Mayaud, Philippe
   Netto, Eduardo Martins
   Tami, Adriana
   Bethencourt, Sarah
   Consuelo Miranda, Maria
   Lozano, Anyela
   Soria, Carmen
   Salgado Cisneros, Silvia P.
   Gotuzzo, Eduardo
   Guzman, Maria G.
   Rodriguez, Pedro A. M.
   Lopez-Gatell, Hugo
   Hegewisch-Taylor, Jennifer
   Hugo Borja-Aburto, Victor
   Gonzalez Bonilla, Cesar R.
   Hoen, Bruno
   van Roode, Martine
   Rockx, Barry
CA ZIKAlliance Consortium
TI Familiar barriers still unresolved-a perspective on the Zika virus
   outbreak research response
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
AB Research is an important component of an effective response to the increasing frequency of widespread infectious disease outbreaks. In turn, the ability to do such studies relies on willingness of partners in different regions to collaborate and the capacity to mount a rapid research response. The EU-funded ZIKAlliance Consortium has initiated a multicountry epidemiological, clinical, and laboratory research agenda to determine the incidence, risk factors, and outcomes of Zika virus infection in pregnant women and their children. We reviewed the timeline of patient cohort initiation in relation to the Zika virus epidemic and mapped key events regarding funding, regulatory approvals, and site preparation during this timeline. We then assessed barriers and delays that the international research team experienced through a systematic telephone interview. We have identified three major bottlenecks in the implementation of a swift response: the absence of a timeline for the funding process, delays in regulatory and ethical approval, and the challenging logistics of laboratory support, including diagnostics. These bottlenecks illustrate the clear and urgent need for implementing a strong and permanent global emerging infectious diseases research capacity that has structured funding, enables long-term partnerships, and develops basic clinical and laboratorial research and a response infrastructure that is ready to deploy.
C1 [Koopmans, Marion; van Roode, Martine; Rockx, Barry] Erasmus MC, Rotterdam, Netherlands.
   [de lamballerie, Xavier] Aix Marseille Univ, Unite Virus Emergents, Marseille, France.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Rosenberger, Kerstin D.; Morales, Ivonne] Heidelberg Univ Hosp, Dept Infect Dis, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Viana, Isabelle F. T.; Brasil, Patricia; Rabello, Renata] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Sao Paulo, Brazil.
   [Alexander, Neal; Mayaud, Philippe] London Sch Hyg & Trop Med, London, England.
   [Netto, Eduardo Martins] Univ Fed Bahia, Salvador, BA, Brazil.
   [Tami, Adriana; Bethencourt, Sarah] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana; Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Consuelo Miranda, Maria; Lozano, Anyela] Univ Ind Santander, Bucaramanga, Colombia.
   [Soria, Carmen] Univ Catolica, Santiago De Guayaquil, Guayaqil, Ecuador.
   [Salgado Cisneros, Silvia P.] Inst Nacl Invest Salud Publ Dr Leopoldo Izquieta, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, San Martin De Porres, Peru.
   [Guzman, Maria G.; Rodriguez, Pedro A. M.] Inst Trop Med Pedro Kouri, Havana, Cuba.
   [Lopez-Gatell, Hugo; Hegewisch-Taylor, Jennifer] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Hugo Borja-Aburto, Victor; Gonzalez Bonilla, Cesar R.] Mexican Inst Social Secur, Mexico City, DF, Mexico.
   [Hoen, Bruno] INSERM, Paris, France.
RP Koopmans, M (corresponding author), Erasmus MC, Virosci, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
EM m.koopmans@erasmusmc.nl
RI Segurado, Aluisio C/K-2229-2012; Marques, Ernesto T. A/L-4967-2013;
   Avelino-Silva, Vivian I/L-2640-2013; Netto, Eduardo/D-1432-2013;
   Koopmans, Marion/Y-9170-2019; Viana, Isabelle/M-4435-2017
OI Segurado, Aluisio C/0000-0002-6311-8036; Marques, Ernesto T.
   A/0000-0003-3826-9358; Avelino-Silva, Vivian I/0000-0002-6660-3088;
   Netto, Eduardo/0000-0003-1691-6761; Koopmans,
   Marion/0000-0002-5204-2312; Martinez, Pedro A./0000-0002-9886-6448;
   Hegewisch Taylor, Jennifer/0000-0002-1057-2921; Viana,
   Isabelle/0000-0003-4648-6635; Miranda Montoya, Maria
   Consuelo/0000-0001-5730-0723
FU EU Directorate General for Research [734548]
FX The work described in the manuscript was funded by the EU Directorate
   General for Research grant number 734548 (ZIKAlliance). The sponsor of
   the study had no role in study design, data collection, data analysis,
   data interpretation, or writing of the report. We thank Sandra Kamga for
   her support in collecting information from the questionnaires. We also
   thank Martine van Roode and Barry Rockx that assisted MK in drafting an
   interview with a list of questions for the cohort initiation part of the
   study and, with the help of Sandra Kamga, created interviews to assess
   the list of possible barriers encountered.
CR Alirol E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0201-1
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Lee WT, 2017, J CLIN MICROBIOL, V22, P56
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Paules CI, 2017, ANN INTERN MED, V167, P805, DOI 10.7326/M17-2496
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Reusken CB, 2018, CLIN MICROBIOL INFEC, V24, P221, DOI 10.1016/j.cmi.2017.12.010
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Ribeiro CD, 2018, SCIENCE, V362, P404, DOI 10.1126/science.aau5229
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2019
VL 19
IS 2
BP E59
EP E62
DI 10.1016/S1473-3099(18)30497-3
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA HJ6LD
UT WOS:000457299500006
PM 30420230
DA 2020-12-01
ER

PT J
AU Moreira, J
   Mamani, R
   Brasil, P
   Siqueira, A
AF Moreira, Jose
   Mamani, Roxana
   Brasil, Patricia
   Siqueira, Andre
TI ANTIPYRETIC USE AMONG FEBRILE PATIENTS ATTENDING EMERGENCY DEPARTMENTS
   IN RIO DE JANEIRO, BRAZIL: A CROSS-SECTIONAL, OBSERVATIONAL STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Moreira, Jose; Mamani, Roxana; Brasil, Patricia; Siqueira, Andre] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1142
BP 350
EP 351
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503495
DA 2020-12-01
ER

PT J
AU Moreira, J
   Mamani, R
   Brasil, P
   Siqueira, A
AF Moreira, Jose
   Mamani, Roxana
   Brasil, Patricia
   Siqueira, Andre
TI ANTIBIOTIC PRESCRIPTION IN FEBRILE PATIENTS ATTENDING AN EMERGENCY
   DEPARTMENT IN RIO DE JANEIRO, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Moreira, Jose; Mamani, Roxana; Brasil, Patricia; Siqueira, Andre] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1799
BP 553
EP 554
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504510
DA 2020-12-01
ER

PT J
AU Pedro, RS
   Carvalho, MS
   Girianelli, VR
   Damasceno, LS
   Leal, I
   da Cunha, DC
   de Carvalho, LMA
   Ayllon, T
   Wakimoto, MD
   Salgueiro, JB
   Yakob, L
   Honorio, NA
   Brasil, P
AF Pedro, Renata Saraiva
   Carvalho, Manila Sa
   Girianelli, Vania Reis
   Damasceno, Luana Santana
   Leal, Izabel
   da Cunha, Denise Cotrim
   Abreu de Carvalho, Liege Maria
   Ayllon, Tania
   Wakimoto, Mayumi Duarte
   Salgueiro, Jennifer Braathen
   Yakob, Laith
   Honorio, Nildimar Alves
   Brasil, Patricia
TI A populational-based birth cohort study in a low-income urban area in
   Rio de Janeiro, Brazil: implementation and description of the
   characteristics of the study
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Arbovirus Infections; Cohort Studies; Maternal and Child Health; Vector
   Control
ID DENGUE VIRUS-INFECTIONS; AEDES-AEGYPTI; MOSQUITOS; CULICIDAE; DIPTERA
AB A comprehensive cohort study including an entomological surveillance component can contribute to our knowledge of clinical aspects and transmission patterns of arbovirosis. This article describes the implementation of a populational-based birth cohort study that included an entomological surveillance component, and its associated challenges in a low-income community of Rio de Janeiro, Brazil. The participants were recruited in two periods: from 2012 to 2014, and from 2015 to 2017 The children had scheduled pediatric consultations and in case of fever. Epidemiological, clinical data and biological samples were collected at pediatric visits. Active febrile surveillance was performed by telephone calls, social networking, message apps, and household visits. A total of 387 newborns and 332 new children were included during the first and second recruitment periods, respectively. By July 2017, there were 451 children on follow-up. During the study, 2,759 pediatric visits were performed: 1,783 asymptomatic and 976 febrile/rash consultations. The number of febrile or rash consultations increased 3.5-fold after the use of media tools for surveillance. No temporal pattern, seasonality or peak of febrile cases was observed during the study period. A total of 10,105 adult mosquitoes (including 3,523 Aedes spp. and 6,582 Culex quinquefasciatus) and 46,047 Aedes eggs were collected from households, schools, and key sites. Although challenging, this structured sentinel populational-based birth cohort is relevant to the knowledge of risks and awareness of emerging pathogens.
C1 [Pedro, Renata Saraiva; Damasceno, Luana Santana; Leal, Izabel; Abreu de Carvalho, Liege Maria; Wakimoto, Mayumi Duarte; Salgueiro, Jennifer Braathen; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Av Brasil 4365, BR-21040364 Rio De Janeiro, RJ, Brazil.
   [Carvalho, Manila Sa] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Girianelli, Vania Reis; da Cunha, Denise Cotrim] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Nucleo Operct Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
RP Pedro, RS (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Av Brasil 4365, BR-21040364 Rio De Janeiro, RJ, Brazil.
EM rensape@gmail.com
RI Yakob, Laith/AAD-4521-2019; CARVALHO, MARILIA/AAD-8283-2020; Santiago,
   Tania Ayllon/B-2543-2019
OI Yakob, Laith/0000-0001-8639-4511; CARVALHO, MARILIA/0000-0002-9566-0284;
   Santiago, Tania Ayllon/0000-0002-1195-5078; Wakimoto,
   Mayumi/0000-0001-9380-3387; Leal, Izabel/0000-0002-0013-0126; Salgueiro,
   Jennifer/0000-0001-9142-3735
FU Graduate Studies Coordinating Board (Capes)CAPES; Brazilian National
   Research Council (CNPq)National Council for Scientific and Technological
   Development (CNPq); CNPqNational Council for Scientific and
   Technological Development (CNPq); London School of Hygiene & Tropical
   Medicine
FX We thank the families who participated in the study and the directors of
   the health center at Sergio Arouca National School of Public Health,
   Oswaldo Cruz Foundation, and Victor Valla Family Clinic for the provided
   facilities. We are also grateful to our field team for the commitment
   throughout the study and Monica A. F. M. Magalhaes for the
   georeferencing support. R. S. Pedro is supported by a doctoral
   fellowship from Graduate Studies Coordinating Board (Capes) and T.
   Ayllon by a post-doctoral fellowship Brazilian National Research Council
   (CNPq). The study received financial support from the CNPq and the
   London School of Hygiene & Tropical Medicine.
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Anders KL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-937
   Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Barcellos C, 2014, REV SAUDE PUBL, V48, P94, DOI 10.1590/S0034-8910.2014048004822
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   Engstrom E, EXPERIENCIA TERRITOR
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Gama SR, 2011, CAD SAUDE PUBLICA, V27, P510, DOI 10.1590/S0102-311X2011000300011
   Gibson Gerusa, 2014, Infection Ecology & Epidemiology, V4, P22110, DOI 10.3402/iee.v4.22110
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lwanga SK, SAMPLE SIZE DETERMIN
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Rabello RS, 2016, THESIS
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
NR 30
TC 1
Z9 1
U1 1
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2019
VL 35
IS 5
AR e00023918
DI 10.1590/0102-311X00023918
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IA7TR
UT WOS:000469760300001
PM 31141024
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Einspieler, C
   Utsch, F
   Brasil, P
   Aizawa, CYP
   Peyton, C
   Hasue, RH
   Genovesi, FF
   Damasceno, L
   Moreira, ME
   Adachi, K
   Marschik, PB
   Nielsen-Saines, K
   Bartl-Pokorny, KD
   Krieber-Tomantschger, I
   Krieber-Tomantschger, M
   Langmann, L
   Peharz, R
   Pokorny, FB
   Zhang, DJ
   Ramos, C
   Silva, D
   Reis, A
   Alves, E
   Passos, SA
   Velloso, R
   Dobaja, F
   Pansy, J
   Scheuchenegger, A
AF Einspieler, Christa
   Utsch, Fabiana
   Brasil, Patricia
   Aizawa, Carolina Y. Panvequio
   Peyton, Colleen
   Hasue, Renata Hydee
   Genovesi, Fernanda Francoso
   Damasceno, Luana
   Moreira, Maria Elisabeth
   Adachi, Kristina
   Marschik, Peter B.
   Nielsen-Saines, Karin
   Bartl-Pokorny, Katrin D.
   Krieber-Tomantschger, Iris
   Krieber-Tomantschger, Magdalena
   Langmann, Laura
   Peharz, Robert
   Pokorny, Florian B.
   Zhang, Dajie
   Ramos, Cinthia
   Silva, Diniz
   Reis, Alberto
   Alves, Elaine
   Passos, Sandra Alvarenga
   Velloso Filho, Roberto
   Dobaja, Felicitas
   Pansy, Jasmin
   Scheuchenegger, Anna
CA GM Zika Working Grp
TI Association of Infants Exposed to Prenatal Zika Virus Infection With
   Their Clinical, Neurologic, and Developmental Status Evaluated via the
   General Movement Assessment Tool
SO JAMA NETWORK OPEN
LA English
DT Article
ID CEREBRAL-PALSY; BIRTH
AB IMPORTANCE There is an urgent need to assess neurodevelopment in Zika virus (ZIKV)-exposed infants
   OBJECTIVES To perform general movement assessment (GMA) at 9 to 20 weeks' postterm age and to evaluate whether the findings are associated with neurodevelopmental outcomes at age 12 months in infants prenatally exposed to acute maternal illness with rash in Brazil during the ZIKV outbreak and in age-matched controls.
   DESIGN, SETTING, AND PARTICIPANTS In this cohort study, infants prenatally exposed to acute maternal illness with rash were recruited at medical institutions in Rio de Janeiro and Belo Horizonte, Brazil, from February 1, 2016, to April 30, 2017, while infants without any exposure to maternal illness originated from the Graz University Audiovisual Research Database for the Interdisciplinary Analysis of Neurodevelopment. Participants were 444 infants, including 76 infants without congenital microcephaly, 35 infants with microcephaly, and 333 neurotypical children matched for sex, gestational age at birth, and age at GMA.
   MAIN OUTCOMES AND MEASURES General movement assessment performed at 9 to 20 weeks' postterm age, with negative predictive value, positive predictive value, sensitivity, and specificity generated, as well as clinical, neurologic, and developmental status (Bayley Scales of Infant and Toddler Development, Third Edition [Bayley-III] scores) at age 12 months. Motor Optimality Scores were generated based on the overall quality of the motor repertoire. Adverse outcomes were defined as a Bayley-III score less than 2 SD in at least 1 domain, a score less than 1 SD in at least 2 domains, and/or atypical neurologic findings.
   RESULTS A total of 444 infants were enrolled, including 111 children prenatally exposed to a maternal illness with rash and 333 children without any prenatal exposure to maternal illness (57.7% male and mean [SD] age, 14 [2] weeks for both groups); 82.1%(46 of 56) of ZIKV-exposed infants without congenital microcephaly were healthy at age 12 months. Forty-four of 46 infants were correctly identified by GMA at 3 months, with a negative predictive value of 94%(95% CI, 85%-97%). Seven of 10 ZIKV-exposed children without microcephaly with adverse neurodevelopmental outcomes were identified by GMA. The GMA positive predictive value was 78% (95% CI, 46%-94%), sensitivity was 70%(95% CI, 35%-93%), specificity was 96%(95% CI, 85%-99%), and accuracy was 91%(95% CI, 80%-97%). Children with microcephaly had bilateral spastic cerebral palsy; none had normal movements. The Motor Optimality Score differentiated outcomes: the median Motor Optimality Score was 23 (interquartile range [IQR], 21-26) in children with normal development, 12 (IQR, 8-19) in children with adverse outcomes, and 5 (IQR, 5-6) in children with microcephaly, a significant difference (P=.001).
   CONCLUSIONS AND RELEVANCE This study suggests that although a large proportion of ZIKV-exposed infants without microcephaly develop normally, many do not. The GMA should be incorporated into routine infant assessments to enable early entry into targeted treatment programs.
C1 [Einspieler, Christa; Marschik, Peter B.; Bartl-Pokorny, Katrin D.; Krieber-Tomantschger, Iris; Krieber-Tomantschger, Magdalena; Langmann, Laura; Peharz, Robert; Pokorny, Florian B.; Zhang, Dajie] Med Univ Graz, Interdisciplinary Dev Neurosci iDN, Graz, Austria.
   [Utsch, Fabiana; Ramos, Cinthia; Silva, Diniz; Reis, Alberto; Alves, Elaine; Passos, Sandra Alvarenga; Velloso Filho, Roberto] Rede SARAH Hosp Reabil, Reabil Infantil, Belo Horizonte, MG, Brazil.
   [Brasil, Patricia; Damasceno, Luana] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Aizawa, Carolina Y. Panvequio; Hasue, Renata Hydee; Genovesi, Fernanda Francoso] Univ Sao Paulo, Fac Med, Dept Phys Therapy Commun Sci & Disorders & Occupa, Sao Paulo, Brazil.
   [Peyton, Colleen] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Peyton, Colleen] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.
   [Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Dept Pediat, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Marschik, Peter B.] Univ Med Ctr Gottingen, Dept Child & Adolescent Psychiat & Psychotherapy, Interdisciplinary Dev Neurosci iDN, Gottingen, Germany.
   [Marschik, Peter B.] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders KIND, Stockholm, Sweden.
   [Dobaja, Felicitas; Pansy, Jasmin; Scheuchenegger, Anna] Med Univ Graz, Dept Pediat, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect,Marion Davies Childrens Clin, Room 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Hasue, Renata Hydee/B-2328-2013; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Bartl-Pokorny, Katrin/C-5396-2014; Marschik, Peter
   B/F-8195-2011
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Marschik, Peter
   B/0000-0001-8932-0980
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Thrasher Foundation; Bill and Melinda
   Gates Foundation Grand Challenges ExplorationsBill & Melinda Gates
   Foundation [OPP 1128871]; NATIONAL EYE INSTITUTEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI140718, R01AI140718, R21AI129534, R21AI129534] Funding Source: NIH
   RePORTER
FX Drs Brasil, Moreira, and Nielsen-Saines were supported by grants AI28697
   and AI1259534-01 from the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (NIH), by grant
   AI129847-01 from the National Eye Institute of the NIH, and by the
   Thrasher Foundation. Dr Marschik was supported by the Bill and Melinda
   Gates Foundation Grand Challenges Explorations (grant OPP 1128871).
CR Adde L, 2016, EUR J PAEDIATR NEURO, V20, P918, DOI 10.1016/j.ejpn.2016.07.019
   Bayley N., 2006, BAYLEY SCALES INFANT
   Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burger M, 2009, EUR J PAEDIATR NEURO, V13, P408, DOI 10.1016/j.ejpn.2008.09.004
   Cardoso Jr TF, ARCH DIS CHILD
   Crowle C, 2018, EARLY HUM DEV, V118, P42, DOI 10.1016/j.earlhumdev.2018.02.001
   Einspieler C, 2004, SERIES CLIN DEV MED
   Einspieler C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00406
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palchik AB, 2013, EARLY HUM DEV, V89, P229, DOI 10.1016/j.earlhumdev.2013.02.004
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricci E, 2018, PHYS OCCUP THER PEDI, V38, P269, DOI 10.1080/01942638.2017.1395380
   Soares-Marangoni DA, DEV NEUROREHABIL
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wu SS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00227
   2017, ARCH PATHOL LAB MED, V141, P26, DOI DOI 10.5858/ARPA.2016-0382-RA
   2018, CURR OPIN PEDIATR, V30, P105, DOI DOI 10.1097/MOP.0000000000000582
   2008, EMERG INFECT DIS, V14, P1232, DOI DOI 10.3201/EID1408.080287
   2011, DEV MED CHILD NEUROL, V53, P896, DOI DOI 10.1111/J.1469-8749.2011.04017.X
   2016, LANCET, V388, P891, DOI DOI 10.1016/S0140-6736(16)30902-3
   2008, DEV MED CHILD NEUROL, V50, P744, DOI DOI 10.1111/J.1469-8749.2008.03089.X
   2016, J PAEDIATR CHILD H, V52, P54, DOI DOI 10.1111/JPC.12995
   2018, MMWR-MORBID MORTAL W, V67, P858, DOI DOI 10.15585/MMWR.MM6731E1
   2016, EARLY HUM DEV, V100, P27, DOI DOI 10.1016/J.EARLHUMDEV.2016.03.010
   2015, EARLY HUM DEV, V91, P479, DOI DOI 10.1016/J.EARLHUMDEV.2015.05.007
NR 30
TC 19
Z9 19
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JAN
PY 2019
VL 2
IS 1
AR e187235
DI 10.1001/jamanetworkopen.2018.7235
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA HU6WO
UT WOS:000465422700020
PM 30657537
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU Gomes, LR
   Lavigne, A
   Brasil, P
   Peterka, CL
   Menard, D
   Daniel-Ribeiro, CT
   Ferreira-da-Cruz, MD
AF Gomes, Larissa Rodrigues
   Lavigne, Aline
   Brasil, Patricia
   Peterka, Cassio Leonel
   Menard, Didier
   Daniel-Ribeiro, Claudio Tadeu
   Ferreira-da-Cruz, Maria de Fatima
TI Lack of quadruple and quintuple mutant alleles associated with
   sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from
   Brazilian endemic areas
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE P. vivax; malaria; pvdhfr; pvdhps; chemoresistance
ID DIHYDROPTEROATE SYNTHASE; PVDHFR; CHLOROQUINE; CHEMORESISTANCE;
   POLYMORPHISMS; PREVALENCE; MUTATIONS; DHPS; PCR
AB BACKGROUND AND OBJECTIVE Brazil is responsible for a large number of Plasmodium vivax cases in America. Given the emergence of P. vivax parasites resistant to chloroquine and the effectiveness of antifolates in vivax malaria treatment together with a correlation between mutations in P. vivax dhfr and dhps genes and SP treatment failure, the point mutations in these genes were investigated.
   METHODS Blood samples from 54 patients experiencing vivax malaria symptomatic episodes in the Amazonian Region were investigated. Genomic DNA was extracted using a DNA extraction kit (QIAGEN (TM)). Nested polymerase chain reaction (PCR) amplification was carried out followed by Sanger sequencing to detect single nucleotide polymorphisms (SNPs).
   FINDINGS All tested isolates showed non-synonymous mutations in pvdhfr gene: 117N (54/54, 100%) and 58R (25/54, 46%). Double mutant allele 58R/117N (FRTNI, 28%) was the most frequent followed by triple mutant alleles (58R/117N/173L, FRTNL, 11%; 58R/61M/117N, FRMNI 5% 117N/173L, FSTNL, 4%) and quadruple mutant allele (58R/61M/117N/173L, FRMNL, 2%). A single mutation was observed at codon C383G in pvdhps gene (SGKAV, 48%).
   CONCLUSION No evidence of molecular signatures associated with P. vivax resistance to SP was observed in the Brazilian samples.
C1 [Gomes, Larissa Rodrigues; Lavigne, Aline; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, RJ, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne, Aline; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
   [Peterka, Cassio Leonel] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Prevencao & Controle Malaria, Brasilia, DF, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
   [Menard, Didier] Inst Pasteur Malaria Genet & Resistance Grp, Biol Host Parasite Interact Unit, Paris, France.
RP Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, RJ, Brazil.; Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
EM mffcruz@ioc.fiocruz.br
RI Menard, Didier/O-3294-2013; Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Menard, Didier/0000-0003-1357-4495; Ferreira da Cruz, Maria de
   Fatima/0000-0003-3522-3792
FU POM (Fiocruz), PNCM, Secretaria de Vigilancia em Saude, Ministerio da
   Saude
FX POM (Fiocruz), PNCM, Secretaria de Vigilancia em Saude, Ministerio da
   Saude.
CR Asih PBS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0903-0
   Barnadas C, 2009, AM J TROP MED HYG, V81, P19, DOI 10.4269/ajtmh.2009.81.19
   Brega S, 2004, ANTIMICROB AGENTS CH, V48, P2581, DOI 10.1128/AAC.48.7.2581-2587.2004
   Das S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1445-9
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020
   Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012
   Ganguly S, 2014, ANTIMICROB AGENTS CH, V58, P196, DOI 10.1128/AAC.01171-13
   Hawkins VN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-72
   Huang B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-13
   Imwong M, 2005, ANTIMICROB AGENTS CH, V49, P4393, DOI 10.1128/AAC.49.10.4393-4395.2005
   Korsinczky M, 2004, ANTIMICROB AGENTS CH, V48, P2214, DOI 10.1128/AAC.48.6.2214-2222.2004
   Kuesap J, 2011, MEM I OSWALDO CRUZ, V106, P130, DOI 10.1590/S0074-02762011000900017
   Marfurt J, 2008, J INFECT DIS, V198, P409, DOI 10.1086/589882
   Mint LK, 2012, J ANTIMICROB CHEMOTH, V67, P367, DOI DOI 10.1093/JAC/DKR464
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Thanh PV, 2015, ANTIMICROB AGENTS CH, V59, P7411, DOI 10.1128/AAC.00791-15
   Prajapati SK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-102
   Ranjitkar S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-75
   RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3
   Saralamba N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1543-8
   Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90
   Tantiamornkul K, 2018, INT J PARASITOL-DRUG, V8, P229, DOI 10.1016/j.ijpddr.2018.04.003
   Thongdee P, 2013, ACTA TROP, V128, P137, DOI 10.1016/j.actatropica.2013.07.005
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Zakeri S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-75
NR 26
TC 0
Z9 0
U1 1
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e180425
DI 10.1590/0074-02760180425
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HK4BG
UT WOS:000457863900001
PM 30726345
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Moreira, MEL
   Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Damasceno, L
   Pone, M
   Carvalho, LMA
   Pone, SM
   Vasconcelos, Z
   Ribeiro, IP
   Zin, AA
   Tsui, I
   Adachi, K
   Gaw, SL
   Halai, UA
   Salles, TS
   da Cunha, DC
   Bonaldo, MC
   Gabaglia, CR
   Guida, L
   Malacarne, J
   Costa, RP
   Gomes, SC
   Reis, AB
   Soares, FVM
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Aibe, M
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Portari, EA
   Janzen, C
   Cherry, JD
AF Elisabeth Lopes Moreira, M.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Damasceno, Luana
   Pone, Marcos
   Carvalho, Liege M. A.
   Pone, Sheila M.
   Vasconcelos, Zilton
   Ribeiro, Ieda P.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Salles, Tania S.
   da Cunha, Denise C.
   Bonaldo, Myrna C.
   Gabaglia, Claudia Raja
   Guida, Leticia
   Malacarne, Jociele
   Costa, Roozemerie P.
   Clair Gomes, S., Jr.
   Beatriz Reis, A.
   Soares, Fernanda V. M.
   Hasue, Renata H.
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Aibe, Mitsue
   Einspieler, Christa
   Marschik, Peter B.
   Paulo Pereira, J., Jr.
   Portari, Elyzabeth A.
   Janzen, Carla
   Cherry, James D.
TI Neurodevelopment in Infants Exposed to Zika Virus In Utero
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Elisabeth Lopes Moreira, M.; Brasil, Patricia; Damasceno, Luana; Pone, Marcos; Carvalho, Liege M. A.; Pone, Sheila M.; Vasconcelos, Zilton; Ribeiro, Ieda P.; Zin, Andrea A.; Salles, Tania S.; da Cunha, Denise C.; Bonaldo, Myrna C.; Guida, Leticia; Malacarne, Jociele; Costa, Roozemerie P.; Clair Gomes, S., Jr.; Beatriz Reis, A.; Soares, Fernanda V. M.; Aibe, Mitsue; Paulo Pereira, J., Jr.; Portari, Elyzabeth A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin; Tsui, Irena; Adachi, Kristina; Halai, Umme-Aiman; Janzen, Carla] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata H.; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Hasue, Renata Hydee/B-2328-2013; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Junior, Clair Gomes/F-7579-2012; Vasconcelos,
   Zilton/AAD-5784-2019; Marschik, Peter B/F-8195-2011
OI Junior, Clair Gomes/0000-0002-1554-943X; Vasconcelos,
   Zilton/0000-0002-2193-2224; Reis, AlessanRSS/0000-0001-8486-7469;
   Ribeiro, Ivonizete Pires/0000-0003-0737-5430; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915;
   Marschik, Peter B/0000-0001-8932-0980
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil [25000.072811/2016-17]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; ZIKAlliance; Thrasher Research Fund [20164370]; National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Wellcome TrustWellcome Trust; United
   Kingdom Department for International Development [205377-Z16-Z];
   European Union Horizon 2020 research and innovation program (ZikaPLAN)
   [734584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P30AI028697, R01AI140718, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI140718, P30AI028697, P30AI028697,
   P30AI028697, R01AI140718, P30AI028697, P30AI028697, P30AI028697] Funding
   Source: NIH RePORTER
FX Supported by grants from the Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil (25000.072811/2016-17);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (88887.116627/2016-01); Brazilian National Council for Scientific and
   Technological Development (CNPq) (441098/2016-9); Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   (E_18/2015TXB); ZIKAlliance; the Thrasher Research Fund (20164370); the
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH) (AI28697 and AI1259534-01); the National Eye
   Institute of the NIH (AI129847-01); the Wellcome Trust and the United
   Kingdom Department for International Development (205377-Z16-Z); and the
   European Union Horizon 2020 research and innovation program (ZikaPLAN
   grant agreement no. 734584).
CR Bayley N., 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 5
TC 21
Z9 21
U1 1
U2 10
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 13
PY 2018
VL 379
IS 24
BP 2377
EP 2379
DI 10.1056/NEJMc1800098
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD9HM
UT WOS:000452872600015
PM 30575464
OA Bronze, Green Accepted
DA 2020-12-01
ER

PT J
AU Pereira, JP
   Nielsen-Saines, K
   Sperling, J
   Maykin, MM
   Damasceno, L
   Cardozo, RF
   Valle, HA
   Dutra, BRT
   Gama, HD
   Adachi, K
   Zin, AA
   Tsui, I
   Vasconcelos, Z
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Pereira Jr, Jose Paulo
   Nielsen-Saines, Kann
   Sperling, Jeffrey
   Maykin, Melanie M.
   Damasceno, Luana
   Cardozo, Renan Fonseca
   Valle, Helena Abreu
   Torres Dutra, Beatriz Ribeiro
   Gama, Helder Dona
   Adachi, Kristina
   Zin, Andrea A.
   Tsui, Irena
   Vasconcelos, Zilton
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Association of Prenatal Ultrasonographic Findings With Adverse Neonatal
   Outcomes Among Pregnant Women With Zika Virus Infection in Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID INTERIM GUIDANCE; BIRTH-DEFECTS; INFANTS; DIAGNOSIS; REGISTRY; FETUSES;
   WEIGHT; UPDATE; HEAD
AB IMPORTANCE Congenital Zika virus infection causes a spectrum of adverse birth outcomes, including severe birth defects of the central nervous system. The association of prenatal ultrasonographic findings with adverse neonatal outcomes, beyond structural anomalies such as microcephaly, has not been described to date.
   OBJECTIVE To determine whether prenatal ultrasonographic examination results are associated with abnormal neonatal outcomes in Zika virus-affected pregnancies.
   DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study conducted at a single regional referral center in Rio de Janeiro, Brazil, from September 1, 2015, to May 31, 2016, among 92 pregnant women diagnosed during pregnancy with Zika virus infection by reverse-transcription polymerase chain reaction, who underwent subsequent prenatal ultrasonographic and neonatal evaluation.
   EXPOSURES Prenatal ultrasonography.
   MAIN OUTCOMES AND MEASURES The primary outcome measure was composite adverse neonatal outcome (perinatal death, abnormal finding on neonatal examination, or abnormal finding on postnatal neuroimaging). Secondary outcomes include association of specific findings with neonatal outcomes.
   RESULTS Of 92 mother-neonate dyads (mean [SD] maternal age, 29.4 [6.3] years), 55 (60%) had normal results and 37 (40%) had abnormal results on prenatal ultrasonographic examinations. The median gestational age at delivery was 38.6 weeks (interquartile range, 37.9-39.3). Of the 45 neonates with composite adverse outcome, 23 (51%) had normal results on prenatal ultrasonography. Eleven pregnant women (12%) had a Zika virus-associated finding that was associated with an abnormal result on neonatal examination (adjusted odds ratio [aOR], 11.6; 95% CI, 1.8-72.8), abnormal result on postnatal neuroimaging (aOR, 6.7; 95% CI, 1.1-38.9), and composite adverse neonatal outcome (aOR, 27.2; 95% CI, 2.5-296.6). Abnormal results on middle cerebral artery Doppler ultrasonography were associated with neonatal examination abnormalities (aOR, 12.8; 95% CI, 2.6-63.2), postnatal neuroimaging abnormalities (aOR, 8.8; 95% CI, 1.7-45.9), and composite adverse neonatal outcome (aOR, 20.5; 95% CI, 3.2-132.6). There were 2 perinatal deaths. Abnormal findings on prenatal ultrasonography had a sensitivity of 48.9% (95% CI, 33.7%-64.2%) and a specificity of 68.1% (95% CI, 52.9%-80.1%) for association with composite adverse neonatal outcomes. For a Zika virus-associated abnormal result on prenatal ultrasonography, the sensitivity was lower (22.2%; 95% CI, 11.2%-37.1%) but the specificity was higher (97.9%; 95% CI, 88.7%-99.9%).
   CONCLUSIONS AND RELEVANCE Abnormal results on prenatal ultrasonography were associated with adverse outcomes in congenital Zika infection. The absence of abnormal findings on prenatal ultrasonography was not associated with a normal neonatal outcome. Comprehensive evaluation is recommended for all neonates with prenatal Zika virus exposure.
C1 [Pereira Jr, Jose Paulo; Cardozo, Renan Fonseca; Valle, Helena Abreu; Torres Dutra, Beatriz Ribeiro; Gama, Helder Dona; Zin, Andrea A.; Vasconcelos, Zilton; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Kann; Adachi, Kristina] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Sperling, Jeffrey; Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Damasceno, Luana; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,16HSE Box 0556, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224
FU Reproductive Scientist Development Program of the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development of the National
   Institutes of Health [K12 HD000849]; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude do Brasil [441098/2016-9]; Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI28697, R21AI29534-01]; National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318]; Wellcome TrustWellcome Trust [205377/Z/16/Z]; European
   Union's Horizon 2020 Research and Innovation Programme [734584];
   Burroughs Wellcome Fund for the Reproductive Scientist Development
   Program; Queenan Fellowship from the Foundation for the Society of
   Maternal-Fetal Medicine; UK Department for International Development;
   University of California, San Francisco National Center of Excellence in
   Women's HealthUniversity of California System; EUNICE KENNEDY SHRIVER
   NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [K12HD000849, K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318,
   R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R21AI129534,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R21AI129534, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER
FX This work was supported by grants K12 HD000849 from the Reproductive
   Scientist Development Program of the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development of the National
   Institutes of Health (Dr Gaw), 441098/2016-9 from the Departamento de
   Ciencia e Tecnologia do Ministerio da Saude do Brasil (Dr Moreira),
   E_18/2015TXB from Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Dr Moreira), R21AI28697 and R21AI29534-01 from the National
   Institute of Allergy and Infectious Diseases (Dr Nielsen-Saines),
   R21EY028318 from the National Eye Institute (Drs Nielsen-Saines and
   Tsui), 205377/Z/16/Z from Wellcome Trust (Dr Moreira), and 734584 from
   European Union's Horizon 2020 Research and Innovation Programme (Dr
   Moreira); the Burroughs Wellcome Fund for the Reproductive Scientist
   Development Program (Dr Gaw), the Queenan Fellowship from the Foundation
   for the Society of Maternal-Fetal Medicine (Dr Gaw), UK Department for
   International Development, and the University of California, San
   Francisco National Center of Excellence in Women's Health.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Azam AZ, 2001, OBSTET GYNECOL, V97, P443, DOI 10.1016/S0029-7844(00)01140-6
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Hobbins JC, 2018, OBSTET GYNECOL, V131, P661, DOI 10.1097/AOG.0000000000002538
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 27
TC 5
Z9 5
U1 1
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD DEC
PY 2018
VL 1
IS 8
AR e186529
DI 10.1001/jamanetworkopen.2018.6529
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HI2SJ
UT WOS:000456295400050
PM 30646333
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, JD
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Adachi, K
   Pone, MVD
   Pone, SM
   Molleri, N
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Vasconcelos, Z
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia D.
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Molleri, Natalia
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Vasconcelos, Zilton
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Visual function in infants with antenatal Zika virus exposure
SO JOURNAL OF AAPOS
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; MACULAR ATROPHY; BIRTH; IMPAIRMENT;
   PREGNANCY; CHILDREN; IMPACT
AB PURPOSE To report the findings of a cross-sectional study of visual function in infants with confirmed or suspected antenatal Zika virus (ZIKV) infection seen at a single referral center in Rio de Janeiro.
   METHODS Infants were examined following the ZIKV outbreak period at Instituto Fernandes Figueira/FIOCRUZ. Visual function was considered abnormal if an infant could not fix and follow a standardized high-contrast target (10 cm) by 3-6 months of age. Visual function and associations with structural eye abnormalities, central nervous system (CNS) abnormalities, microcephaly, and nystagmus were assessed. Sensitivity and specificity of screening criteria for structural eye abnormalities was assessed.
   RESULTS A total of 173 infants met inclusion criteria. Abnormal visual function was found in 52 infants (30.0%) and was significantly associated with eye abnormalities (40/52; OR = 44.2; 95% CI, 16.6-117.6), CNS abnormalities (50/52; OR = 64.0; 95% CI, 14.7-277.6), microcephaly (44/52; OR = 31.5; 95% CI, 12.7-77.8), and nystagmus (26/52; OR = 120.0; 95% CI, 15.6-924.5). Using microcephaly as screening criteria for the detection of eye abnormalities provided a sensitivity of 88.9% (95% CI, 76.0-96.3) and specificity of 82.8% (95% CI, 75.1-88.9). Using both abnormal visual function and microcephaly increased sensitivity to 100% (95% CI, 92.1-100.0) and decreased specificity to 80.5% (95% CI, 72.5-86.9).
   CONCLUSIONS Infants with suspected antenatal ZIKV infection and reduced visual function should be referred to an ophthalmologist. Visual function assessments are helpful in screening for antenatal ZIKV exposure in resource-limited settings and can identify infants who may benefit from visual habilitation.
C1 [Zin, Andrea A.; Rossetto, Julia D.; Neves, Luiza M.; Haefeli, Lorena; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Molleri, Natalia; Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Tsui, Irena; Adachi, Kristina; Arumugaswami, Vaithilingaraja; Nielsen-Saines, Karin] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Pesquisa Clin, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM andreazin@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Vasconcelos,
   Zilton/AAD-5784-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-01, R01AI1121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); Queenan Fellowship in Global Health from the Foundation
   for the Society of Maternal Fetal Medicine; UCSF National Center of
   Excellence in Women's Health; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534, R01AI140718,
   R01AI140718] Funding Source: NIH RePORTER
FX Brazilian National Council for Scientific and Technological Development
   (441098/2016-9), National Eye Institute [R21EY028318-01 and
   R01AI1121207], and National Institute of Allergy and Infectious Diseases
   (R21AI129534-02). Dr. Tsui was supported in part by an unrestricted
   Research to Prevent Blindness grant given to the Stein Eye Institute.
   Dr. Gaw was supported in part by the Queenan Fellowship in Global Health
   from the Foundation for the Society of Maternal Fetal Medicine, and the
   UCSF National Center of Excellence in Women's Health. Funding sources
   had no involvement in design, data collection/interpretation, or
   manuscript preparation.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Diretrizes de Atencao a Sande Ocular na Infancia, 2013, DIRETRIZES ATENCAO S
   Donahue SP, 2016, PEDIATRICS, V137
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harvey EM, 1999, INVEST OPHTH VIS SCI, V40, P1565
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Sherrell H, 2018, EUR J OBSTET GYN R B, V225, P26, DOI 10.1016/j.ejogrb.2018.03.059
   Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782
   Sonnander K, 2000, ACTA PAEDIATR, V89, P17, DOI 10.1080/080352500750027358
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 31
TC 2
Z9 3
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2018
VL 22
IS 6
BP 452
EP 456
DI 10.1016/j.jaapos.2018.07.352
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA HE7RQ
UT WOS:000453638000012
PM 30359768
OA Other Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Foo, SS
   Chen, WQ
   Chan, Y
   Lee, WS
   Lee, SA
   Cheng, GH
   Nielsen-Saines, K
   Brasil, P
   Jung, JU
AF Foo, Suan-Sin
   Chen, Weiqiang
   Chan, Yen
   Lee, Wai-Suet
   Lee, Shin-Ae
   Cheng, Genhong
   Nielsen-Saines, Karin
   Brasil, Patricia
   Jung, Jae U.
TI Biomarkers and immunoprofiles associated with fetal abnormalities of
   ZIKV-positive pregnancies
SO JCI INSIGHT
LA English
DT Article
ID VIRUS; MONOCYTES; MICRONESIA; INFECTION; OUTCOMES; STATES
AB BACKGROUND. An intricate fetal-maternal immune crosstalk during pregnancy is essential for a healthy birth. Hence, the infection-induced alterations of maternal immunity often lead to adverse outcomes for mother and/or child. The emergence of Zika virus (ZIKV) infection in pregnant women has been associated with more than 3,000 cases of microcephaly and nervous system malformations.
   METHODS. To explore the potential correlation of ZIKV-induced alteration of maternal immunity with fetal abnormalities, we performed extensive sera immunoprofiling of 74 pregnant women: 30 symptomatic ZIKV(+) pregnant patients and 30 healthy pregnant controls in ZIKV-endemic Rio de Janeiro, along with 14 healthy pregnant controls in non-endemic Los Angeles.
   RESULTS. Extensive multiplexing analysis of 69 cytokines revealed that CXCL10, CCL2, and CCL8 chemokines were specifically associated with symptomatic ZIKV(+) infection during pregnancy, and distinct immunoprofiles were detected at different trimesters in ZIKV-infected pregnant women. Intriguingly, the high CCL2 level and its inverse correlation with CD163, TNFRSF1A, and CCL22 levels was apparently associated with ZIKV-induced abnormal birth.
   CONCLUSION. Our findings provide insights into the alteration of ZIKV-elicited maternal immunity, serving as a potential clinical biomarker platform.
C1 [Foo, Suan-Sin; Chen, Weiqiang; Lee, Wai-Suet; Lee, Shin-Ae; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Chan, Yen] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Obstet & Gynecol,Div Maternal Fetal Med, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Lee, Wai-Suet] Griffith Univ, Inst Glycom, Southport, Qld, Australia.
   [Cheng, Genhong] UCLA, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Dept Microbiol & Mol Genet, Los Angeles, CA USA.
   [Nielsen-Saines, Karin] UCLA, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Div Pediat Infect Dis, Los Angeles, CA USA.
   [Brasil, Patricia] Fiocruz MS, Fondacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
RP Foo, SS; Chen, WQ; Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, 1501 San Pablo St, Los Angeles, CA 90033 USA.
EM foos@usc.edu; weiqchen@usc.edu; jaeujung@med.usc.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI129534-01, R01AI40718, CA200422,
   CA180779, DE023926, AI073099, AI116585, AI129496, AI140705, AI069120,
   AI056154, AI078389, AI28697]; Hastings Foundation; Fletcher Jones
   Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [CAPES/88887.116627/2016-01]; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-17]; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, R35CA200422, R35CA200422, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   R35CA200422, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, R35CA200422, R35CA200422, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI069120, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R21AI129496,
   P30AI028697, R01AI116585, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI069120, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI069120, P30AI028697, R01AI073099, P30AI028697, R01AI056154,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R01AI069120,
   P30AI028697, P30AI028697, P30AI028697, R01AI069120, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI069120, P30AI028697, P30AI028697, R01AI140705, R01AI078389,
   P30AI028697, P30AI028697, P30AI028697, R01AI116585, P30AI028697,
   P30AI028697, P30AI028697, R01AI073099, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R01AI116585,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI069120, R01AI056154, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI069120, P30AI028697, R01AI069120, P30AI028697,
   P30AI028697, R01AI078389, R01AI140705, P30AI028697, P30AI028697,
   R01AI069120, R01AI140705, P30AI028697, P30AI028697, R01AI116585,
   P30AI028697, P30AI028697, R01AI078389, P30AI028697, R01AI078389,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI073099, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI073099, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R21AI129496, P30AI028697, R21AI129534,
   P30AI028697, P30AI028697, R01AI056154, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI073099, R01AI069120, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R21AI129534, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R01AI069120,
   P30AI028697, R01AI116585, P30AI028697, R01AI056154, R01AI078389,
   P30AI028697, P30AI028697, R01AI069120, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI140705, P30AI028697, P30AI028697, P30AI028697, R01AI073099,
   R01AI056154, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R56AI078389, P30AI028697, P30AI028697, R01AI056154,
   P30AI028697, R01AI073099, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI073099, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI073099, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R01AI056154,
   R01AI116585, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI056154, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI073099, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI069120, R01AI056154,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI056154, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Dental & Craniofacial
   Research (NIDCR) [R01DE023926, R01DE023926, R01DE023926, R01DE023926,
   R01DE023926, R01DE023926] Funding Source: NIH RePORTER
FX This work was partly supported by NIH grants CA200422, CA180779,
   DE023926, AI073099, AI116585, AI129496, and AI140705, the Hastings
   Foundation, and the Fletcher Jones Foundation (JUJ); NIH grants
   AI069120, AI056154, AI078389, and AI28697 (GC); NIH grants AI129534-01
   (KNS) and R01AI40718 (JUU, GC, and KNS) and Departamento de Ciencia e
   Tecnologia (DECIT/25000.072811/2016-17) do Ministerio da Saude do Brasil
   and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   CAPES/88887.116627/2016-01 (PB).
CR Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvert C, 2014, NEW ENGL J MED, V371, P1075, DOI 10.1056/NEJMc1408436
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, OUTC PREGN LAB EV PO
   Oliveira RAD, 2017, J CLIN VIROL, V89, P39, DOI 10.1016/j.jcv.2017.02.007
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045
   Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681
   Ginsberg Y, 2017, RAMBAM MAIMONIDES ME, V8, DOI 10.5041/RMMJ.10305
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788
   Kaufman B, 1997, CLIN INFECT DIS, V24, P334, DOI 10.1093/clinids/24.3.334
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   PAHO and WHO, 2015, ZIK SUSP CONF CAS RE
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   WHO:, 2017, GLOB STRAT WOM CHILD
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 7
Z9 7
U1 0
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD NOV 2
PY 2018
VL 3
IS 21
AR e124152
DI 10.1172/jci.insight.124152
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GZ2OG
UT WOS:000449225900016
PM 30385728
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU O'Reilly, KM
   Lowe, R
   Edmunds, WJ
   Mayaud, P
   Kucharski, A
   Eggo, RM
   Funk, S
   Bhatia, D
   Khan, K
   Kraemer, MUG
   Wilder-Smith, A
   Rodrigues, LC
   Brasil, P
   Massad, E
   Jaenisch, T
   Cauchemez, S
   Brady, OJ
   Yakob, L
AF O'Reilly, Kathleen M.
   Lowe, Rachel
   Edmunds, W. John
   Mayaud, Philippe
   Kucharski, Adam
   Eggo, Rosalind M.
   Funk, Sebastian
   Bhatia, Deepit
   Khan, Kamran
   Kraemer, Moritz U. G.
   Wilder-Smith, Annelies
   Rodrigues, Laura C.
   Brasil, Patricia
   Massad, Eduardo
   Jaenisch, Thomas
   Cauchemez, Simon
   Brady, Oliver J.
   Yakob, Laith
TI Projecting the end of the Zika virus epidemic in Latin America: a
   modelling analysis
SO BMC MEDICINE
LA English
DT Article
DE Zika virus; Epidemic; Mathematical modelling; Latin America and the
   Caribbean; Connectivity
ID VECTOR-BORNE TRANSMISSION; INFECTION; BRAZIL; RISK; DYNAMICS; OUTBREAK;
   NUMBER; SIZE
AB Background: Zika virus (ZIKV) emerged in Latin America and the Caribbean (LAC) region in 2013, with serious implications for population health in the region. In 2016, the World Health Organization declared the ZIKV outbreak a Public Health Emergency of International Concern following a cluster of associated neurological disorders and neonatal malformations. In 2017, Zika cases declined, but future incidence in LAC remains uncertain due to gaps in our understanding, considerable variation in surveillance and the lack of a comprehensive collation of data from affected countries.
   Methods: Our analysis combines information on confirmed and suspected Zika cases across LAC countries and a spatio-temporal dynamic transmission model for ZIKV infection to determine key transmission parameters and projected incidence in 90 major cities within 35 countries. Seasonality was determined by spatio-temporal estimates of Aedes aegypti vectorial capacity. We used country and state-level data from 2015 to mid-2017 to infer key model parameters, country-specific disease reporting rates, and the 2018 projected incidence. A 10-fold cross-validation approach was used to validate parameter estimates to out-of-sample epidemic trajectories.
   Results: There was limited transmission in 2015, but in 2016 and 2017 there was sufficient opportunity for wide-spread ZIKV transmission in most cities, resulting in the depletion of susceptible individuals. We predict that the highest number of cases in 2018 would present within some Brazilian States (Sao Paulo and Rio de Janeiro), Colombia and French Guiana, but the estimated number of cases were no more than a few hundred. Model estimates of the timing of the peak in incidence were correlated (p < 0.05) with the reported peak in incidence. The reporting rate varied across countries, with lower reporting rates for those with only confirmed cases compared to those who reported both confirmed and suspected cases.
   Conclusions: The findings suggest that the ZIKV epidemic is by and large over within LAC, with incidence projected to be low in most cities in 2018. Local low levels of transmission are probable, but the estimated rate of infection suggests that most cities have a population with high levels of herd immunity.
C1 [O'Reilly, Kathleen M.; Wilder-Smith, Annelies; Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [O'Reilly, Kathleen M.; Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Brady, Oliver J.; Yakob, Laith] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Rodrigues, Laura C.; Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Bhatia, Deepit; Khan, Kamran] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [Bhatia, Deepit; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Wilder-Smith, Annelies] Umea Univ, Dept Med & Publ Hlth, Umea, Sweden.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Heidelberg Univ, Dept Infect Dis, Dept Infect Dis & Parasitol, Heidelberg, Germany.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
RP O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.; O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
EM kathleen.oreilly@lshtm.ac.uk
RI Brady, Oliver/P-9421-2019; O'Reilly, Kathleen/H-9170-2019; Yakob,
   Laith/AAD-4521-2019; Bhatia, Deepit/AAC-1444-2020
OI Brady, Oliver/0000-0002-3235-2129; O'Reilly,
   Kathleen/0000-0002-4892-8022; Yakob, Laith/0000-0001-8639-4511; Lowe,
   Rachel/0000-0003-3939-7343; Bhatia, Deepit/0000-0001-8168-6873; Eggo,
   Rosalind M/0000-0002-0362-6717; Funk, Sebastian/0000-0002-2842-3406;
   MAYAUD, Philippe/0000-0001-5730-947X
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]; ZikaPLAN Grant [734584]; Royal Society
   Dorothy Hodgkin FellowshipRoyal Society of London; Sir Henry Dale
   Fellowship; Royal SocietyRoyal Society of London [206250/Z/17/Z]; Sir
   Henry Wellcome Fellowship; Wellcome TrustWellcome Trust [206250/Z/17/Z,
   206471/Z/17/Z]; Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious
   Disease Agent Study of the National Institute of General Medical
   Sciences; AXA Research Fund; Branco Weiss Fellowship - Society in
   Science; National Institute of Child Health and Human DevelopmentUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD040128]; National Library of
   Medicine of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM) [R01LM010812, R01LM011965]; EUNICE
   KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128] Funding Source: NIH RePORTER; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY
   OF MEDICINEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812, R01LM010812, R01LM011965, R01LM011965, R01LM010812,
   R01LM010812, R01LM010812, R01LM010812, R01LM011965, R01LM011965,
   R01LM010812, R01LM010812] Funding Source: NIH RePORTER
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548 and ZikaPLAN Grant Agreement No 734584. RL was funded by a Royal
   Society Dorothy Hodgkin Fellowship. AK was funded by a Sir Henry Dale
   Fellowship jointly funded by the Wellcome Trust and the Royal Society
   (grant Number 206250/Z/17/Z). OJB was funded by a Sir Henry Wellcome
   Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z). SC
   was funded by the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, and the AXA Research Fund. MUGK is supported
   by The Branco Weiss Fellowship - Society in Science, administered by the
   ETH Zurich and acknowledges funding from a Training Grant from the
   National Institute of Child Health and Human Development (T32HD040128)
   and the National Library of Medicine of the National Institutes of
   Health (R01LM010812, R01LM011965). The funders had no role in in the
   design of the study, the collection, analysis and interpretation of
   data, or in writing the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Andronico A, 2017, AM J EPIDEMIOL, V16, P1
   Asher J, 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mallet H, 2015, B INFORM SANIT EPIDE
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Nelson B, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.ac6d0f8c9c35e88825c1a1147697531c, DOI 10.1371/CURRENTS.OUTBREAKS.AC6D0F8C9C35E88825C1A1147697531C]
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Roberts MG, 2013, J MATH BIOL, V66, P1463, DOI 10.1007/s00285-012-0540-y
   Rodriguez-Barraquer I, 2016, BIORXIV, DOI [10.1101/041095, DOI 10.1101/041095]
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Sinan B., SISTEMA INFORM AGRAV
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172
   WHO, 2016, ZIK STRAT RESP PLAN
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   World Health Organization, 2017, ZIK SIT REP
   World Health Organization, 2017, WHO VACC PIP TRACK Z
   World Health Organization Fifth Meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 55
TC 24
Z9 24
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD OCT 3
PY 2018
VL 16
AR 180
DI 10.1186/s12916-018-1158-8
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV6DT
UT WOS:000446198400001
PM 30285863
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Gomes, LR
   Lavigne, A
   Peterka, CL
   Brasil, P
   Menard, D
   Daniel-Ribeiro, CT
   Ferreira-da-Cruz, MD
AF Gomes, Larissa Rodrigues
   Lavigne, Aline
   Peterka, Cassio Leonel
   Brasil, Patricia
   Menard, Didier
   Daniel-Ribeiro, Claudio Tadeu
   Ferreira-da-Cruz, Maria de Fatima
TI Absence of K13 Polymorphism in Plasmodium falciparum from Brazilian
   Areas Where the Parasite Is Endemic
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE artemisinin; kelch domain; malaria; P. falciparum; Brazil; K13;
   chemoresistance
ID ILLEGAL GOLD MINERS; ARTEMISININ RESISTANCE; MALARIA; EMERGENCE
AB Plasmodium falciparum artemisinin-resistant parasites can be evaluated by examining polymorphisms in the kelch (PfK13) domain. A total of 69 samples from patients with falciparum malaria were analyzed. All samples were from areas in states in Brazil where the parasite was endemic: Acre (n = 14), Amapa (n = 15), Amazonas (n = 30), and Para (n = 10). After DNA alignment with the 3D7 reference sequence, all samples were found to be wild type. These data provide a baseline for PfK13 and reinforce the pertinence of artemisinin combination therapy in Brazilian areas.
C1 [Gomes, Larissa Rodrigues; Lavigne, Aline; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne, Aline; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.
   [Peterka, Cassio Leonel] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Prevencao & Controle Malaria, Brasilia, DF, Brazil.
   [Brasil, Patricia] Fiocruz MS, Inst Natl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Menard, Didier] Inst Pasteur, Biol Host Parasite Interact Unit, Malaria Genet & Resistance Grp, Paris, France.
RP Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.; Ferreira-da-Cruz, MD (corresponding author), Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.
EM mffcruz@ioc.fiocruz.br
RI Menard, Didier/O-3294-2013; Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Menard, Didier/0000-0003-1357-4495; 
FU National Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Foundation for Research Support in the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); POM (Fiocruz);
   PNCM, Secretary for Health Surveillance, Brazilian Ministry of Health
FX C.T.D.R. and M.F.F.C. are recipients of a Research Productivity
   Fellowship from the National Brazilian Council for Scientific and
   Technological Development (CNPq) and from the Foundation for Research
   Support in the State of Rio de Janeiro (FAPERJ) as Cientistas do Nosso
   Estado. L.R.G. received a doctoral fellowship from FAPERJ.; The work was
   supported by the POM (Fiocruz) and the PNCM, Secretary for Health
   Surveillance, Brazilian Ministry of Health.
CR Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Chenet SM, 2016, J INFECT DIS, V213, P1472, DOI 10.1093/infdis/jiv752
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957
   Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Douine M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1367-6
   Gupta H, 2018, EMERG INFECT DIS, V24, P40, DOI 10.3201/eid2401.170864
   Itoh M, 2018, AM J TROP MED HYG, V98, P88, DOI 10.4269/ajtmh.17-0623
   Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608
   Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689
   Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765
   Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137
   Ministerio da Saude, 2010, 2010 GUIA PRAT TRAT
   Mishra N, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-284
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355
   WHO, 2017, STAT REP ART ACT RES
   Zalis MG, 1996, PARASITOL RES, V82, P612, DOI 10.1007/s004360050173
NR 23
TC 5
Z9 5
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2018
VL 62
IS 10
AR e00354-18
DI 10.1128/AAC.00354-18
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GU6GH
UT WOS:000445405500004
PM 30061292
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Tsui, I
   Moreira, MEL
   Rossetto, JD
   Vasconcelos, Z
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Gomes, SC
   Adachi, K
   Pone, MVD
   Pone, SM
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Brasil, P
   Nielsen-Saines, K
   Zin, AA
AF Tsui, Irena
   Lopes Moreira, Maria Elisabeth
   Rossetto, Julia D.
   Vasconcelos, Zilton
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Gomes, Saint Clair, Jr.
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Brasil, Patricia
   Nielsen-Saines, Karin
   Zin, Andrea A.
TI Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus
   Exposure
SO PEDIATRICS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; OPHTHALMIC MANIFESTATIONS; MACULAR
   ATROPHY; INFECTION; STATES
AB OBJECTIVES:To characterize ophthalmic manifestations of confirmed or suspected antenatal Zika virus (ZIKV) exposure.METHODS:Infants with antenatal ZIKV exposure were referred for evaluation during the 2015-2016 Rio de Janeiro outbreak. Mothers with symptomatic ZIKV infection during pregnancy and/or infants with microcephaly or other findings that were suggestive of suspected antenatal exposure were tested with reverse transcriptase polymerase chain reaction (RT-PCR). Complete eye examinations were performed by pediatric ophthalmologists between January 2016 and February 2017. The main outcome measure was eye abnormalities in RT-PCR-positive and suspected (ie, not tested or RT-PCR-negative) antenatal ZIKV cases.RESULTS:Of 224 infants, 189 had RT-PCR testing performed. Of 189 patients, 156 had positive RT-PCR results in their blood, urine, and/or placenta. Of 224 infants, 90 had central nervous system (CNS) abnormalities, including microcephaly (62 infants). Eye abnormalities were present in 57 of 224 (25.4%) infants. Optic nerve (44 of 57; 77.2%) and retina abnormalities (37 of 57; 64.9%) were the most common. The group with suspected ZIKV infection (68 infants) had proportionally more eye (36.8% vs 20.5%; P = .022) and CNS abnormalities (68.3% vs 28.1%; P = .008), likely because of referral patterns. Eye abnormalities consistent with ZIKV infection were clinically comparable in both RT-PCR-positive and unconfirmed groups, including 4 RT-PCR-positive infants of 5 without any CNS abnormalities.CONCLUSIONS:Similar eye manifestations were identified regardless of laboratory confirmation. Well-appearing infants were also found to have eye abnormalities. Therefore, all infants born after ZIKV outbreaks should be universally screened for eye abnormalities.
C1 [Tsui, Irena; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Opthalmol, Retina Div, Los Angeles, CA USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Lopes Moreira, Maria Elisabeth; Rossetto, Julia D.; Vasconcelos, Zilton; Neves, Luiza M.; Haefeli, Lorena; Gomes, Saint Clair, Jr.; da Silva Pone, Marcos Vinicius; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; Pereira, Jose Paulo, Jr.; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Ophthalmol, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; Vasconcelos, Zilton/AAD-5784-2019;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020; da Silva Pone, Marcos
   Vinicius/N-1285-2019
OI Junior, Clair Gomes/0000-0002-1554-943X; Vasconcelos,
   Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI128697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent BlindnessResearch to Prevent Blindness (RPB);
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318,
   R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI129534, R21AI129534]
   Funding Source: NIH RePORTER
FX Supported by the Brazilian National Council for Scientific and
   Technological Development (grant 441098/2016-9), the National Institute
   of Allergy and Infectious Diseases (grant AI AI128697), and the National
   Eye Institute (grant R21EY028318-01). Dr Tsui was supported in part by a
   Research to Prevent Blindness unrestricted grant given to the Jules
   Stein Eye Institute. Funded by the National Institutes of Health (NIH).
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, PREV COMB DENG CHIUN
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Rifkin LM, 2016, JAMA OPHTHALMOL, V134, P1427, DOI 10.1001/jamaophthalmol.2016.4299
   Secretaria Municipal de Saude, PREF RIO DE JAN
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 7
Z9 7
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD OCT
PY 2018
VL 142
IS 4
AR e20181104
DI 10.1542/peds.2018-1104
PG 8
WC Pediatrics
SC Pediatrics
GA GZ0EU
UT WOS:000449034300029
PM 30213843
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Wakimoto, MD
   Camacho, LAB
   Gonin, ML
   Brasil, P
AF Wakimoto, Mayumi Duarte
   Bastos Camacho, Luiz Antonio
   Gonin, Michelle Luiza
   Brasil, Patricia
TI Clinical and Laboratory Factors Associated with Severe Dengue: A
   Case-Control Study of Hospitalized Children
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE case-control studies; dengue; pediatrics; severe dengue; shock
ID RISK-FACTORS; SHOCK SYNDROME; AGE PATTERN; GUIDELINES; FEVER
AB Background: More than half of the hospitalizations because of dengue in Brazil occurred in children <15 years of age in 2007 and 2008, an unexpected change in the epidemiological pattern. We sought to determine clinical and laboratory parameters associated with severity.
   Methods: A case-control study was conducted in three pediatric hospitals in Rio de Janeiro, Brazil; 233 laboratory-confirmed dengue patients were included: 69 cases and 164 controls. Specific dinical and laboratory factors were assessed using univariate and multivariate logistic regression models.
   Results: Lethargy [adjusted odds ratio (ORa): 9.15, 95% confidence interval (CI): 3.08-27.12], dyspnea (ORa: 8.24, 95% CI: 3.27-20.72) and abdominal pain (ORa: 6.78, 95% CI: 1.44-31.84) were independently associated with severe dengue in children. Lethargy and dyspnea presented as early as 72 and 48 h, respectively, before shock.
   Conclusions: Abdominal pain and lethargy confirmed their role as warning signs, which along with dyspnea might be helpful in identifying cases progressing to severe dengue.
C1 [Wakimoto, Mayumi Duarte; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21040900 Manguinho, RJ, Brazil.
   [Bastos Camacho, Luiz Antonio] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rua Leopoldo Bulhoes 1480, BR-21041210 Manguinho, RJ, Brazil.
   [Gonin, Michelle Luiza] Secretaria Municipal Saude & Def Civil Rio de Jan, Hosp Municipal Jesus, Rua Oito de Dezembro Vila Isabel, BR-20550200 Rio De Janeiro, Brazil.
RP Wakimoto, MD (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21040900 Manguinho, RJ, Brazil.
EM mayumi.wakimoto@ini.fiocruz.br
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [404507/2012-3]
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq) [grant number 404507/2012-3].
CR Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Fleiss JL, 1981, STAT METHODS RATES P
   Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Khilnani P, 2010, INDIAN J CRIT CARE M, V14, P41, DOI 10.4103/0972-5229.63029
   Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101
   Lovera D, 2016, PEDIATR INFECT DIS J, V35, P1294, DOI 10.1097/INF.0000000000001308
   Lum LCSL, 2002, J PEDIATR-US, V140, P629, DOI 10.1067/mpd.2002.123665
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2008, INF EP DENG
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Pan American Health Organization, DESCR EP TRENDS DENG
   PESCE MA, 2007, NELSON TXB PEDIAT, P2943
   Pham T B, 2007, Bull Soc Pathol Exot, V100, P43
   Rosenberger KD, 2016, TROP MED INT HEALTH, V21, P445, DOI 10.1111/tmi.12666
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schlesselman JJ, 1982, CASE CONTROL STUDIES
   Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272
   Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Wakimoto MD, 2015, EXPERT REV ANTI-INFE, V13, P1441, DOI 10.1586/14787210.2015.1100534
   Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 30
TC 1
Z9 2
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD OCT
PY 2018
VL 64
IS 5
BP 373
EP 381
DI 10.1093/tropej/fmx078
PG 9
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA GV5AZ
UT WOS:000446114500004
PM 29059411
OA Bronze
DA 2020-12-01
ER

PT J
AU Calvet, GA
   Brasil, P
   Siqueira, AM
   Zogbi, HE
   Goncalves, BD
   Santos, AD
   Lupi, O
   de Souza, RV
   Rodrigues, CDD
   Bressan, CD
   Wakimoto, MD
   de Araujo, ES
   dos Santos, IC
   Georg, I
   Nogueira, RMR
   Veloso, VG
   de Filippis, AMB
AF Calvet, Guilherme Amaral
   Brasil, Patricia
   Siqueira, Andre Machado
   Zogbi, Heruza Einsfeld
   Goncalves, Bianca de Santis
   Santos, Aline da Silva
   Lupi, Otilia
   de Souza, Rogerio Valls
   dos Santos Rodrigues, Cintia Damasceno
   Bressan, Clarisse da Silveira
   Wakimoto, Mayumi Duarte
   de Araujo, Eliane Saraiva
   dos Santos, Ingrid Cardoso
   Georg, Ingebourg
   Ribeiro Nogueira, Rita Maria
   Veloso, Valdilea Goncalves
   Bispo de Filippis, Ana Maria
TI Zika Virus Infection and Differential Diagnosis in a Cohort of
   HIV-Infected Patients
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE Zika; ZIKV; arboviruses; HIV; Brazil
ID RIO-DE-JANEIRO; PARVOVIRUS B19; DENGUE; LEISHMANIASIS; COINFECTION;
   PREVALENCE; EPIDEMIC; DISEASES; SAMPLES; URINE
AB Background: Zika virus (ZIKV) emergence in South America revealed the lack of knowledge regarding clinical manifestations in HIV-infected individuals.
   Objectives: We described the clinical characteristics, laboratory manifestations, differential diagnosis, and outcome of ZIKV infection in a large, single-center cohort of HIV-infected patients.
   Methods: HIV-infected patients aged 18 years and older with clinical suspected arboviral disease from an ongoing cohort were followed from February 2015 through December 2015. Acute serum samples were tested for ZIKV, dengue virus (DENY), and chikungunya virus by real-time reverse transcriptase polymerase chain reaction, anti-DENV immunoglobulin (IgM/IgG, and syphilis assays; convalescent samples were tested for anti-DENV IgM/IgG; and urine samples were tested for ZIKV by real-time reverse transcriptase polymerase chain reaction. ZIKV disease was defined according to the Pan American Health Organization (PAHO) guidelines.
   Results: Of 101 patients, ZIKV was confirmed in 43 cases and suspected in 34, and another diagnosis was assumed for 24 patients (dengue, secondary/latent syphilis, respiratory infections, human parvovirus B19, adverse drug reaction, musculoskeletal disorders, and acute gastroenteritis). ZIKV-confirmed and ZIKV-suspected patients reported similar signs and symptoms. Pruritic rash was the most common symptom, followed by myalgia, nonpurulent conjunctivitis, arthralgia, prostration, and headache. In the short-term follow-up [median 67.5 days (interquartile range: 32-104.5)], CD4 cell count (Z = -0.831, P = 0.406) and HIV viral load (Z= -0.447, P = 0.655) did not change significantly after ZIKV infection. There were no hospitalizations, complications, or deaths.
   Conclusions: Among HIV-infected patients with suspected arboviral disease, 42.6% were ZIKV-infected. CD4 cell counts and HIV viral load were not different after ZIKV infection. Differential diagnosis with other diseases and adverse drug reaction should be evaluated.
C1 [Calvet, Guilherme Amaral; Brasil, Patricia; Siqueira, Andre Machado; Zogbi, Heruza Einsfeld; Lupi, Otilia; de Souza, Rogerio Valls; Bressan, Clarisse da Silveira; Wakimoto, Mayumi Duarte; dos Santos, Ingrid Cardoso] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia; Siqueira, Andre Machado; Zogbi, Heruza Einsfeld; Lupi, Otilia; de Souza, Rogerio Valls; Bressan, Clarisse da Silveira; Wakimoto, Mayumi Duarte; dos Santos, Ingrid Cardoso] Fiocruz MS, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Goncalves, Bianca de Santis; Santos, Aline da Silva; dos Santos Rodrigues, Cintia Damasceno; de Araujo, Eliane Saraiva; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fiocruz MS, Oswaldo Cruz Inst, Flavivirus Lab, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Georg, Ingebourg] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Immunodiagnost Sect, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Veloso, Valdilea Goncalves] Fiocruz MS, STD AIDS Clin Res Lab, Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
RP Calvet, GA (corresponding author), Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Oswaldo Cruz Fdn, Ave Brasil,4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238
FU Departamento de Ciencia e Tecnologia [DECIT/25000.072811/2016-17];
   Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [CAPES/88887.116627/2016-01]; European Union's
   Horizon 2020 program [734857]; Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-18/2015TXB]
FX Supported by Departamento de Ciencia e Tecnologia
   (DECIT/25000.072811/2016-17), Ministerio da Saude do Brasil, grants from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01), the European Union's Horizon 2020 program
   under grant agreement ZIKACTION No. 734857, and Faperj (Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) grant no.
   E-18/2015TXB.
CR Pereira RFA, 2014, MEM I OSWALDO CRUZ, V109, P168, DOI [10.1590/0074-0276140312, 10.1590/0074-02760130312]
   Anema A, 2005, CAN MED ASSOC J, V172, P1434, DOI 10.1503/cmaj.050511
   Berg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088257
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chen XP, 2003, CHINESE MED J-PEKING, V116, P1810
   DiazGranados CA, 2009, LANCET INFECT DIS, V9, P324, DOI 10.1016/S1473-3099(09)70088-X
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Gonzalez D, 2009, J INFECT DEV COUNTR, V3, P318
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guerra JAO, 2011, AM J TROP MED HYG, V85, P524, DOI 10.4269/ajtmh.2011.11-0075
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81
   Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4
   Joob Beuy, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS568
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   de Azevedo KML, 2012, MEM I OSWALDO CRUZ, V107, P356, DOI 10.1590/S0074-02762012000300010
   Martins-Melo FR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/534649
   Mendes WDS, 2006, AM J TROP MED HYG, V74, P905
   Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59
   Pan American Health Organization/World Health Organization Regional Office for the Americas, 2017, REG ZIK EP UPD AM
   Pang JX, 2015, AM J TROP MED HYG, V92, P1156, DOI 10.4269/ajtmh.15-0031
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Shimelis T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0919-7
   Siong Wong Chia, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P260
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   UNAIDS, GLOB AIDS UPD 2017
   van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yunihastuti E, 2014, ASIA PAC ALLERGY, V4, P54, DOI 10.5415/apallergy.2014.4.1.54
NR 44
TC 2
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD OCT 1
PY 2018
VL 79
IS 2
BP 237
EP 243
DI 10.1097/QAI.0000000000001777
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GT6QR
UT WOS:000444643300017
PM 29912006
OA Bronze
DA 2020-12-01
ER

PT J
AU de Abreu, FVS
   Gomes, LR
   Mello, ARL
   Bianco, C
   de Pina-Costa, A
   dos Santos, E
   Teixeira, DS
   Brasil, P
   Daniel-Ribeiro, CT
   Lourenco-de-Oliveira, R
   Ferreira-da-Cruz, MD
AF Santos de Abreu, Filipe Vieira
   Gomes, Larissa Rodrigues
   Lavigne Mello, Aline Rosa
   Bianco-Junior, Cesare
   de Pina-Costa, Anielle
   dos Santos, Edmilson
   Teixeira, Danilo Simonini
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Lourenco-de-Oliveira, Ricardo
   Ferreira-da-Cruz, Maria de Fatima
TI Frozen blood clots can be used for the diagnosis of distinct Plasmodium
   species in man and non-human primates from the Brazilian Atlantic Forest
SO MALARIA JOURNAL
LA English
DT Article
DE Blood clot; Plasmodium; Alouatta guariba clamitans; Non-human-primates;
   Yellow fever; Atlantic Forest
ID HUMAN MALARIA PARASITES; GENETIC-STRUCTURE; HOWLER MONKEYS; SIMIAN
   MALARIA; DNA ISOLATION; VIVAX; PCR; SENSITIVITY; POPULATION; INFECTION
AB Background: Zoonotic infections with epidemic potential, as non-human primate malaria and yellow fever (YF), can overlap geographically. Optimizing a small blood sample for diagnosis and surveillance is of great importance. Blood are routinely collected for YF diagnosis and blood clots usually discarded after serum obtention. Aiming to take sample advantage, the sensitivity of a PCR using extracted DNA from long-term frozen clots from human and non-human primates for detection of Plasmodium spp. in low parasitaemia conditions was assayed.
   Results: Malaria diagnosis with DNA extracted from blood clots generated results in agreement with samples obtained with whole blood, including mixed Plasmodium vivax/simium and Plasmodium malariae/brasilianum infections.
   Conclusion: Blood clots from human and non-human primates may be an important and low cost source of DNA for malaria surveillance in the Atlantic Forest.
C1 [Santos de Abreu, Filipe Vieira; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Campus Salinas, Montes Claros, MG, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne Mello, Aline Rosa; Bianco-Junior, Cesare; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [Gomes, Larissa Rodrigues; Lavigne Mello, Aline Rosa; Bianco-Junior, Cesare; de Pina-Costa, Anielle; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Lourenco-de-Oliveira, Ricardo; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [dos Santos, Edmilson] Secretaria Saude Rio Grande Sul, Div Vigilancia Ambiental Saude, Porto Alegre, RS, Brazil.
   [Teixeira, Danilo Simonini] Univ Brasilia, Fac Agron & Vet, Brasilia, DF, Brazil.
RP Lourenco-de-Oliveira, R; Ferreira-da-Cruz, MD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br; mffcruz28@gmail.com
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015; TEIXEIRA, DANILO
   Simonini/J-3238-2015
FU National Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Foundation for Research Support in the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); POM [Fiocruz
   IOC-008-FIO-15-64]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/010.001537/2014];
   PNCM, Brazilian Ministry of Health [IOC-0117-FIO-17]
FX CTDR, MFFC and RLO are recipients of a Research Productivity Fellowship
   from the National Brazilian Council for Scientific and Technological
   Development (CNPq) and from the Foundation for Research Support in the
   State of Rio de Janeiro (FAPERJ) as Cientistas do Nosso Estado. LRG
   received a doctoral fellowship from FAPERJ. The work was supported by
   the POM (Fiocruz IOC-008-FIO-15-64), FAPERJ (E-26/010.001537/2014) and
   the PNCM (IOC-0117-FIO-17), Secretary for Health Surveillance, Brazilian
   Ministry of Health. Sponsors had no role in the collection, analysis and
   interpretation of data, in the writing of the manuscript and in the
   decision to submit the manuscript for publication.
CR Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bonvicino CR, 2015, J PRIMATOL, V4, P2
   Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9
   Buery JC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2080-9
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   Fitzwater S, 2008, AM J TROP MED HYG, V79, P768, DOI 10.4269/ajtmh.2008.79.768
   Fuentes-Ramirez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170704
   Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011
   Garg UC, 1996, CLIN CHEM, V42, P647
   Gonzalez JP, 2012, MEN PRIMATES GERMS O, P337
   Oklander LI, 2010, INT J PRIMATOL, V31, P813, DOI 10.1007/s10764-010-9430-6
   Knapp LA, 2013, DEV PRIMATOL-PROG PR, P389, DOI 10.1007/978-1-4614-8839-2_25
   Lundblom K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-229
   de Alvarenga DAM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18216-x
   de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6
   McCulloch E, 2009, J CLIN PATHOL, V62, P539, DOI 10.1136/jcp.2008.063321
   Ministerio da Saude, 2018, MON PER SAZ FEBR AM
   Ministerio Da Saude, 2017, GUIA VIG EP PRIM NAO
   Ministerio da Saude (BR), 2017, MON DOS CAS OB FEBR, V20, P1
   Nascimento FF, 2005, CYTOGENET GENOME RES, V108, P106, DOI 10.1159/000080808
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183
   Ruiz-Garcia M, 2007, FOLIA PRIMATOL, V78, P73, DOI 10.1159/000097058
   Salazar LA, 1998, CLIN CHEM, V44, P1748
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Van Belle S, 2012, AM J PRIMATOL, V74, P948, DOI 10.1002/ajp.22047
   Wong SSF, 2007, CLIN CHEM, V53, P522, DOI 10.1373/clinchem.2006.078212
NR 34
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD SEP 24
PY 2018
VL 17
AR 338
DI 10.1186/s12936-018-2485-0
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GU6MU
UT WOS:000445429100003
PM 30249260
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Delatorre, E
   Miranda, M
   Tschoeke, DA
   de Sequeira, PC
   Sampaio, SA
   Barbosa-Lima, G
   Vieira, YR
   Leomil, L
   Bozza, FA
   Cerbino-Neto, J
   Bozza, PT
   Nogueira, RMR
   Brasil, P
   Thompson, FL
   de Filippis, AMB
   Souza, TML
AF Delatorre, Edson
   Miranda, Milene
   Tschoeke, Diogo A.
   de Sequeira, Patricia Carvalho
   Sampaio, Simone Alves
   Barbosa-Lima, Giselle
   Vieira, Yasmine Rangel
   Leomil, Luciana
   Bozza, Fernando A.
   Cerbino-Neto, Jose
   Bozza, Patricia T.
   Ribeiro Nogueira, Rita Maria
   Brasil, Patricia
   Thompson, Fabiano L.
   de Filippis, Ana M. B.
   Souza, Thiago Moreno L.
TI An observational clinical case of Zika virus-associated neurological
   disease is associated with primary IgG response and enhanced TNF levels
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Zika virus; zika; neurological disease; neurotropism; Brazil; Rio de
   Janeiro
ID ANTIBODY-DEPENDENT ENHANCEMENT; GUILLAIN-BARRE-SYNDROME; PATHOGENESIS;
   INFECTION
AB Descriptive clinical data help to reveal factors that may provoke Zika virus (ZIKV) neuropathology. The case of a 24-year-old female with a ZIKV-associated severe acute neurological disorder was studied. The levels of ZIKV in the cerebrospinal fluid (CSF) were 50 times higher than the levels in other compartments. An acute anti-flavivirus IgG, together with enhanced TNFalpha levels, may have contributed to ZIKV invasion in the CSF, whereas the unbiased genome sequencing [obtained by next-generation sequencing (NGS)] of the CSF revealed that no virus mutations were associated with the anatomic compartments (CSF, serum, saliva and urine).
C1 [Delatorre, Edson] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.
   [Miranda, Milene] Fiocruz MS, IOC, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene; Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene; Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Macae, RJ, Brazil.
   [de Sequeira, Patricia Carvalho; Sampaio, Simone Alves; Ribeiro Nogueira, Rita Maria; de Filippis, Ana M. B.] Fiocruz MS, IOC, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Cerbino-Neto, Jose; Brasil, Patricia; Souza, Thiago Moreno L.] Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Souza, Thiago Moreno L.] Fiocruz MS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
RP Souza, TML (corresponding author), Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Tschoeke, Diogo A/F-9913-2019; Bozza, Fernando A/A-2618-2013; Neto, Jose
   Cerbino/P-3713-2018; Delatorre, Edson/J-8330-2015; Leomil,
   Luciana/O-4860-2019
OI Tschoeke, Diogo A/0000-0001-8134-4259; Bozza, Fernando
   A/0000-0003-4878-0256; Neto, Jose Cerbino/0000-0001-9254-917X;
   Delatorre, Edson/0000-0002-5746-0820; Souza, Thiago/0000-0003-2212-3899;
   Thompson, Fabiano/0000-0002-7562-1683; Bozza,
   Patricia/0000-0001-8349-9529
FU Brazilian Ministry of Health; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa no Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Thanks are due to the Brazilian Ministry of Health, Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ),
   and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) for providing the funding to conduct this research.
CR Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
NR 21
TC 2
Z9 2
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2018
VL 99
IS 7
BP 913
EP 916
DI 10.1099/jgv.0.001080
PG 4
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GL5TT
UT WOS:000437234800008
PM 29771234
OA Bronze
DA 2020-12-01
ER

PT J
AU Ayllon, T
   Camara, DCP
   Morone, FC
   Goncalves, LD
   de Barros, FSM
   Brasil, P
   Carvalho, MS
   Honorio, NA
AF Ayllon, Tania
   Portela Camara, Daniel Cardoso
   Morone, Fernanda Cristina
   Goncalves, Larissa da Silva
   Monteiro de Barros, Fabio Saito
   Brasil, Patricia
   Carvalho, Marilia Sa
   Honorio, Nildimar Alves
TI Dispersion and oviposition of Aedes albopictus in a Brazilian slum:
   Initial evidence of Asian tiger mosquito domiciliation in urban
   environments
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; VECTOR COMPETENCE; AEGYPTI; CULICIDAE; DIPTERA;
   COMPETITION; DENGUE; VIRUS; FEVER; COEXISTENCE
AB Aedes albopictus, originally considered as a secondary vector for arbovirus transmission, especially in areas where this species co-exist with Aedes aegypti, has been described in most regions of the world. Dispersion and domiciliation of Ae. albopictus in a complex of densely urbanized slums in Rio de Janeiro, Southeastern Brazil, was evidenced. In this study, we tested the hypotheses that 1) Ae. albopictus distribution in urban slums is negatively related to distance from vegetation, and 2) these vectors have taken on a domestic life style with a portion of the population feeding, ovipositing, and resting indoors. To do this, we developed an integrated surveillance proposal, aiming to detect the presence and abundance of Aedes mosquitoes. The study, based on a febrile syndrome surveillance system in a cohort of infants living in the slum complex, was performed on a weekly basis between February 2014 and April 2017. A total of 8,418 adult mosquitoes (3,052 Ae. aegypti, 44 Ae. albopictus, 16 Ae. scapularis, 4 Ae. fluviatilis and 5,302 Culex quinquefasciatus) were collected by direct aspiration and 46,047 Aedes spp. eggs were collected by oviposition traps. The Asian tiger mosquito, Ae. albopictus, was aspirated in its adult form (n = 44), and immature forms of this species (n = 12) were identified from the eggs collected by the ovitraps. In most collection sites, co-occurrence of Ae. aegypti and Ae. albopictus was observed. Key-sites, such as junkyards, thrift stores, factories, tire repair shops and garages, had the higher abundance of Ae. albopictus, followed by schools and households. We collected Ae. albopictus at up to 400 meters to the nearest vegetation cover. The log transformed (n+1) number of females Ae. albopictus captured at each collection point was inversely related to the distance to the nearest vegetation border. These results show that Ae. albopictus, a competent vector for important arboviruses and more commonly found in areas with higher vegetation coverage, is present and spread in neglected and densely urbanized areas, being collected at a long distance from the typical encounter areas for this species. Besides, as Ae. albopictus can easily move between sylvatic and urban environment, the entomological monitoring of Ae. albopictus should be an integral part of mosquito surveillance and control. Finally, key sites, characterized by high human influx and presence of potential Aedes breeding sites, should be included in entomological monitoring.
C1 [Ayllon, Tania; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Portela Camara, Daniel Cardoso; Morone, Fernanda Cristina; Goncalves, Larissa da Silva; Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil.
   [Carvalho, Marilia Sa] Fiocruz MS, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil.
RP Ayllon, T (corresponding author), Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.; Ayllon, T; Honorio, NA (corresponding author), Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.; Honorio, NA (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM tasainat@gmail.com; honorio@ioc.fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; Camara, Daniel C. P./S-3504-2018;
   Santiago, Tania Ayllon/B-2543-2019
OI CARVALHO, MARILIA/0000-0002-9566-0284; Camara, Daniel C.
   P./0000-0002-5439-4477; Santiago, Tania Ayllon/0000-0002-1195-5078
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [157464/2015-6]; Programa Estrategico de Apoio a
   Pesquisa em Saude-PAPES VI [407744/2012-6]; Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26 010.001610/2016]; Fundo Nacional de Saude-FNS [TED
   90/2016]
FX This work was supported by grants from: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq (grant nr. 157464/2015-6),
   Programa Estrategico de Apoio a Pesquisa em Saude-PAPES VI (grant nr.
   407744/2012-6), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro-FAPERJ (grant nr. E-26 010.001610/2016) and
   Fundo Nacional de Saude-FNS (grant nr. TED 90/2016). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CONNOR M. E., 1923, American Journal of Tropical Medicine, V3, P9
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   Favoretto S, 2016, 1 DETECTION ZIKA VIR, DOI [10.1101/049395, DOI 10.1101/049395]
   Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007
   FONTENILLE D, 1989, J AM MOSQUITO CONTR, V5, P219
   Foratini OP., 2004, ECOLOGIA EPIDEMIOLOG
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Honorio NA, 2017, BIOL INVASIONS, P1
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   R Core Team, 2016, R LANG ENV STAT COMP
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   RStudio Team, 2012, RSTUDIO INT DEV R
   Smartt C.T., 2017, J MED ENTOMOL, V0, P1, DOI DOI 10.1093/JME/TJW152
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
NR 39
TC 13
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 23
PY 2018
VL 13
IS 4
AR e0195014
DI 10.1371/journal.pone.0195014
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD7AK
UT WOS:000430660600010
PM 29684029
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mehta, R
   Soares, CN
   Medialdea-Carrera, R
   Ellul, M
   da Silva, MTT
   Rosala-Hallas, A
   Jardim, MR
   Burnside, G
   Pamplona, L
   Bhojak, M
   Manohar, R
   da Silva, GAM
   Adriano, MV
   Brasil, P
   Nogueira, RMR
   Dos Santos, CC
   Turtle, L
   de Sequeira, PC
   Brown, DW
   Griffiths, MJ
   de Filippis, AMB
   Solomon, T
AF Mehta, Ravi
   Soares, Cristiane Nascimento
   Medialdea-Carrera, Raquel
   Ellul, Mark
   Texeira da Silva, Marcus Tulius
   Rosala-Hallas, Anna
   Jardim, Marcia Rodrigues
   Burnside, Girvan
   Pamplona, Luciana
   Bhojak, Maneesh
   Manohar, Radhika
   Medeiros da Silva, Gabriel Amorelli
   Adriano, Marcus Vinicius
   Brasil, Patricia
   Ribeiro Nogueira, Rita Maria
   Dos Santos, Carolina Cardoso
   Turtle, Lance
   de Sequeira, Patricia Carvalho
   Brown, David W.
   Griffiths, Michael J.
   Bispo de Filippis, Ana Maria
   Solomon, Tom
TI The spectrum of neurological disease associated with Zika and
   chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION;
   ENCEPHALITIS; MANIFESTATIONS; COLOMBIA
AB Background
   During 2015-16 Brazil experienced the largest epidemic of Zika virus ever reported. This arthropod-borne virus (arbovirus) has been linked to Guillain-Barre syndrome (GBS) in adults but other neurological associations are uncertain. Chikungunya virus has caused outbreaks in Brazil since 2014 but associated neurological disease has rarely been reported here. We investigated adults with acute neurological disorders for Zika, chikungunya and dengue, another arbovirus circulating in Brazil.
   Methods
   We studied adults who had developed a new neurological condition following suspected Zika virus infection between 1st November 2015 and 1st June 2016. Cerebrospinal fluid (CSF), serum, and urine were tested for evidence of Zika, chikungunya, and dengue viruses.
   Results
   Of 35 patients studied, 22 had evidence of recent arboviral infection. Twelve had positive PCR or IgM for Zika, five of whom also had evidence for chikungunya, three for dengue, and one for all three viruses. Five of them presented with GBS; seven had presentations other than GBS, including meningoencephalitis, myelitis, radiculitis or combinations of these syndromes. Additionally, ten patients positive for chikungunya virus, two of whom also had evidence for dengue virus, presented with a similar range of neurological conditions.
   Conclusions
   Zika virus is associated with a wide range of neurological manifestations, including central nervous system disease. Chikungunya virus appears to have an equally important association with neurological disease in Brazil, and many patients had dual infection. To understand fully the burden of Zika we must look beyond GBS, and also investigate for other co-circulating arboviruses, particularly chikungunya.
C1 [Mehta, Ravi; Medialdea-Carrera, Raquel; Ellul, Mark; Turtle, Lance; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Mehta, Ravi; Medialdea-Carrera, Raquel; Ellul, Mark; Turtle, Lance; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Soares, Cristiane Nascimento; Medeiros da Silva, Gabriel Amorelli] Hosp Fed Servidores Estado, Dept Neurol, Rio De Janeiro, Brazil.
   [Ellul, Mark; Bhojak, Maneesh; Manohar, Radhika; Turtle, Lance; Solomon, Tom] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
   [Texeira da Silva, Marcus Tulius] Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Neuroinfeccao, Rio De Janeiro, Brazil.
   [Texeira da Silva, Marcus Tulius] Hosp Clin Niteroi, Dept Neurol, Niteroi, RJ, Brazil.
   [Rosala-Hallas, Anna; Burnside, Girvan] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England.
   [Jardim, Marcia Rodrigues] Hosp Univ Pedro Ernesto, Dept Neurol, Rio De Janeiro, Brazil.
   [Pamplona, Luciana] Hosp Geral Bonsucesso, Dept Neurol, Rio De Janeiro, Brazil.
   [Adriano, Marcus Vinicius] Hosp Barra Dor, Dept Neurol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Dos Santos, Carolina Cardoso; de Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
   [Brown, David W.] Inst Oswaldo Cruz, Influenza Reference Lab, Rio De Janeiro, Brazil.
   [Brown, David W.] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England.
   [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
RP Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.; Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
EM Ravi.mehta@liverpool.ac.uk; tsolomon@liv.ac.uk
RI Burnside, Girvan/AAO-4490-2020
OI Turtle, Lance/0000-0002-0778-1693; Burnside, Girvan/0000-0001-7398-1346;
   Solomon, Tom/0000-0001-7266-6547; Medialdea-Carrera,
   Raquel/0000-0002-0371-5138
FU United Kingdom Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15096]; National Institute for Health Research Health Protection
   Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the
   University of Liverpool; Public Health England (PHE); Liverpool School
   of Tropical Medicine (LSTM); European Union's Horizon 2020 research and
   innovation program [734584]; Medical Research CouncilMedical Research
   Council UK (MRC) [G116/194, MC_PC_15101, MC_PC_15096] Funding Source:
   researchfish; National Institute for Health ResearchNational Institute
   for Health Research (NIHR) [RP-PG-0108-10048, NF-SI-0514-10177,
   CL-2013-07-005, 12/205/28, EME/12/205/28] Funding Source: researchfish
FX This work was supported by the United Kingdom Medical Research Council
   (https://www.mrc.ac.uk/, Grant number MC_PC_15096); the National
   Institute for Health Research Health Protection Research Unit (NIHR
   HPRU, http://www.hpruezi.nihr.ac.uk/) in Emerging and Zoonotic
   Infections at the University of Liverpool, in partnership with Public
   Health England (PHE) and Liverpool School of Tropical Medicine (LSTM);
   and the European Union's Horizon 2020 research and innovation program
   under grant agreement No. 734584
   (https://ec.europa.eu/programmes/horizon2020/). The views expressed are
   those of the authors and not necessarily those of the NHS, the NIHR, the
   Department of Health or Public Health England. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/s1679-49742017000100002, 10.5123/S1679-49742017000100002]
   [Anonymous], 2014, SURV DENG ZIK POL FR
   [Anonymous], 2016, PROT VIG RESP OC MIC
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606
   Brazilian Ministry of Health, 2017, EPIDEMIOLOGICAL B
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, ZIK MAC ELISA INSTR
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Huzly D, 2016, EURO SURVEIL, V21
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mallewa M, 2013, LANCET GLOB HEALTH, V1, pE153, DOI 10.1016/S2214-109X(13)70060-3
   Martins HAL, 2016, J NEUROINFECTIOUS DI, V7
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Molko N, 2017, NEUROLOGY
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Pan American Health Organisation, 2016, CHIK STAT DAT 2016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G., 2017, N ENGL J MED
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Roze B, 2016, EURO SURVEIL, V21
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Steinhagen K, 2016, EURO SURVEILL, V21
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 39
TC 35
Z9 36
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006212
DI 10.1371/journal.pntd.0006212
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700016
PM 29432457
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pone, SM
   Hokerberg, YHM
   Brasil, P
   Nicolai, CCD
   Ferrari, R
   de Oliveira, RDC
AF Pone, Sheila Moura
   Marques Hoekerberg, Yara Hahr
   Brasil, Patricia
   de Araujo Nicolai, Cecilia Carmen
   Ferrari, Rogerio
   Carvalhaes de Oliveira, Raquel de Vasconcellos
TI Socio-demographic inequalities in the clinical characteristics of dengue
   haemorrhagic fever in the city of Rio de Janeiro, Brazil, 2007-2008
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Child; dengue; dengue haemorrhagic fever; spatial analysis
ID NEUROLOGICAL MANIFESTATIONS; CHILDREN; ADULTS; SEVERITY; FEATURES
AB In 2007-2008, the city of Rio de Janeiro underwent an epidemiological change, with increases in the incidence in children and in severe forms of dengue. To describe the clinical profile and spatial distribution of dengue we performed an ecological study based on dengue surveillance data using the Brazilian classification (2005): dengue fever, dengue haemorrhagic fever (DHF) and dengue with complications. chi(2) test was used to describe the clinical and socio-demographic variables (P < 0.05). Spatial distribution of incidence and case-fatality was explored with thematic maps, Moran and Geary indices (P < 0.05). Of the total of 151 527 dengue cases, 38 808 met the inclusion criteria; 42.4% <18 years; 22.9% dengue with complications and 2.7% DHF. Case-fatality was higher in infants (1.4%) and in DHF (7.7%). Bleeding was more frequent in adolescents and adults while plasma leakage was more common in preschoolers and schoolchildren. The highest incidence was found in the West Zone of the city, in a different area from that of the worst case-fatality (P < 0.05). Although the incidence of DHF was higher in schoolchildren, infants showed higher case-fatality. The area with the highest case-fatality did not present the highest incidence, which suggests problems in the organization of health services.
C1 [Pone, Sheila Moura] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Pediat, Rio De Janeiro, Brazil.
   [Marques Hoekerberg, Yara Hahr; Ferrari, Rogerio; Carvalhaes de Oliveira, Raquel de Vasconcellos] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [de Araujo Nicolai, Cecilia Carmen] Secretaria Municipal Saude Rio de Janeiro, Inst Pereira Passos, Rio De Janeiro, Brazil.
RP Hokerberg, YHM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil.
EM yarahahr@ini.fiocruz.br
RI Oliveira, Raquel de V C de/S-7443-2016; hokerberg, yara/K-2880-2016
OI Oliveira, Raquel de V C de/0000-0001-9387-8645; Moura Pone,
   Sheila/0000-0002-6246-8915; hokerberg, yara/0000-0001-7140-7172
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [110.188/2014, E-26/110.964/2013]; Estacio de Sa
   University [1352017]
FX We thank the staff of the Health Department of the Rio de Janeiro city
   who work to improve the quality of the free available databases. This
   work was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro - FAPERJ (Grant number 110.188/2014 and E-26/110.964/2013).
   YHMH was supported by Estacio de Sa University (Pesquisa Produtividade
   1352017).
CR Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4
   Brazilian Ministry of Health, 2006, SIST INF AGR NOT SIN, V80
   Brazilian Ministry of Health, 2006, PORT N 5 22 FEV 2006
   Brazilian Ministry of Health, 2009, GUIA VIGILANCIA EPID, P816
   Brazilian Ministry of Health, 2005, DENG DIAGN MAN CLIN, P24
   Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS 2010
   Joob B, 2014, TRAVEL MED INFECT DI, V12, P195, DOI 10.1016/j.tmaid.2014.02.002
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   MalhAo TA, 2010, THESIS
   Martinez E, 2005, DENGUE
   Monteiro SP, 2012, MEM I OSWALDO CRUZ, V107, P224, DOI 10.1590/S0074-02762012000200012
   Neeraja M, 2014, ARCH VIROL, V159, P1567, DOI 10.1007/s00705-014-2010-x
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   R Core Team, 2015, R LANG ENV STAT COMP
   Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   SPSS Inc, 2007, SPSS WIND VERS 16 0
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Toledo Ana Lucia Araujo de, 2006, Cad. Saúde Pública, V22, P933, DOI 10.1590/S0102-311X2006000500006
   The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679
   United Nations Development Program, 2016, HUMAN DEV REPORT
   Weeratunga PN, 2014, TRAVEL MED INFECT DI, V12, P189, DOI 10.1016/j.tmaid.2013.11.001
   WHO, 1997, DENG HAEM FEV DIAGN, P1
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896
   World Health Organization (WHO), 2012, HDB CLIN MAN DENG, P111
NR 33
TC 0
Z9 0
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD FEB
PY 2018
VL 146
IS 3
BP 359
EP 366
DI 10.1017/S0950268817003119
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FV7CS
UT WOS:000424741000013
PM 29338803
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Calvet, GA
   Kara, EO
   Giozza, SP
   Botto-Menezes, CHA
   Gaillard, P
   Franca, RFD
   de Lacerda, MVG
   Castilho, MD
   Brasil, P
   de Sequeira, PC
   de Mello, MB
   Bermudez, XPD
   Modjarrad, K
   Meurant, R
   Landoulsi, S
   Benzaken, AS
   de Filippis, AMB
   Broutet, NJN
AF Calvet, Guilherme Amaral
   Kara, Edna Oliveira
   Giozza, Silvana Pereira
   Aguiar Botto-Menezes, Camila Helena
   Gaillard, Philippe
   de Oliveira Franca, Rafael Freitas
   Guimaraes de lacerda, Marcus Vinicius
   Castilho, Marcia da Costa
   Brasil, Patricia
   de Sequeira, Patricia Carvalho
   de Mello, Maeve Brito
   Diaz Bermudez, Ximena Pamela
   Modjarrad, Kayvon
   Meurant, Robyn
   Landoulsi, Sihem
   Benzaken, Adele Schwartz
   Bispo de Filippis, Ana Maria
   Nicole Broutet, Nathalie Jeanne
CA ZIKABRA Study Team
TI Study on the persistence of Zika virus (ZIKV) in body fluids of patients
   with ZIKV infection in Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Arbovirus; Flavivirus; Zika virus; Body fluids; Persistence; Rt-Pcr;
   Emerging infectious diseases
ID SEXUAL TRANSMISSION; EPIDEMIC; STATES; RNA
AB Background: Zika virus (ZIKV) has been identified in several body fluids of infected individuals. In most cases, it remained detected in blood from few days to 1 week after the onset of symptoms, and can persist longer in urine and in semen. ZIKV infection can have dramatic consequences such as microcephaly and Guillain-Barre syndrome. ZIKV sexual transmission has been documented. A better understanding of ZIKV presence and persistence across biologic compartments is needed to devise rational measures to prevent its transmission.
   Methods: This observational cohort study will recruit non-pregnant participants aged 18 years and above with confirmed ZIKV infection [positive reverse transcriptase-polymerase chain reaction (RT-PCR) test in blood and/or urine]: symptomatic men and women in ZIKV infection acute phase, and their symptomatic or asymptomatic household/sexual infected contacts. Specimens of blood, urine, semen, vaginal secretion/menstrual blood, rectal swab, oral fluids, tears, sweat, urine and breast milk (if applicable) will be collected at pre-established intervals and tested for ZIKV RNA presence by RT-PCR, other co-infection (dengue, Chikungunya, HIV, hepatitis B and C, syphilis), antibody response (including immunoglobulins M and G), plaque reduction neutralization test (if simultaneously positive for ZIKV and dengue), and ZIKV culture and RNA sequencing. Data on socio-demographic characteristics and comorbidities will be collected in parallel. Participants will be followed up for 12 months.
   Discussion: This prolonged longitudinal follow-up of ZIKV infected persons with regular biologic testing and data collection will offer a unique opportunity to investigate the presence and persistence of ZIKV in various biologic compartments, their clinical and immunological correlates as well as the possibility of ZIKV reactivation/reinfection over time. This valuable information will substantially contribute to the body of knowledge on ZIKV infection and serve as a base for the development of more effective recommendation on the prevention of ZIKV transmission.
C1 [Calvet, Guilherme Amaral; Brasil, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
   [Kara, Edna Oliveira; Gaillard, Philippe; Meurant, Robyn; Landoulsi, Sihem; Nicole Broutet, Nathalie Jeanne] WHO, Geneva, Switzerland.
   [Giozza, Silvana Pereira; Benzaken, Adele Schwartz] Minist Hlth Brazil, Secretary Hlth Surveillance, Dept STI AIDS & Viral Hepatitis, Brasilia, DF, Brazil.
   [Aguiar Botto-Menezes, Camila Helena; Guimaraes de lacerda, Marcus Vinicius; Castilho, Marcia da Costa; Benzaken, Adele Schwartz] Trop Med Fdn Doctor Heitor Vieira Dourado FMT HVD, Manaus, Amazonas, Brazil.
   [de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [de Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Flavivirus Lab, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Mello, Maeve Brito] Pan Amer Hlth Org, WHO, Dept Communicable Dis & Hlth Anal, Washington, DC USA.
   [Diaz Bermudez, Ximena Pamela] Univ Brasilia, Publ Hlth Dept, Pan Amer Hlth Org, WHO, Brasilia, DF, Brazil.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
RP Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Calvet, GA/G-6959-2013; amsalu, ribka/G-8780-2019; Gaillard,
   Philippe/E-7256-2019
OI Calvet, GA/0000-0002-3545-5238; Thorson, Anna/0000-0002-8703-6561; Diaz
   Bermudez, Ximena Pamela Claudia/0000-0002-3771-7684;
   /0000-0002-8529-4022; Trautmann, Lydie/0000-0002-3012-0009
FU Brazilian Ministry of Health; World Health OrganizationWorld Health
   Organization; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of
   Research, Development and Research Training in Human Reproduction (HRP)
   from the WHO; Wellcome TrustWellcome Trust; Walter Reed Army Institute
   of Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21AI139777, R21AI139777] Funding Source: NIH RePORTER
FX Funding was provided by the Brazilian Ministry of Health, the World
   Health Organization, the UNDP-UNFPA-UNICEF-WHO-World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP) from the WHO, the Wellcome Trust and Walter Reed Army
   Institute of Research.
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ognjan A, 2002, JAMA-J AM MED ASSOC, V288, P1976
   Pan American Health Organisation, 2015, NEUR SYNDR CONG MALF
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Prefeitura do Rio de Janeiro, CLIN FAM NOV RED AT
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO Emergencies, 2016, ZIK SIT REP
   WHO Interim Guidance, 2016, BREASTF CONT ZIK VIR
   WHO Media Center, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, FACT SHEET
NR 35
TC 14
Z9 14
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 22
PY 2018
VL 18
AR 49
DI 10.1186/s12879-018-2965-4
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA FT4GR
UT WOS:000423112300001
PM 29357841
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Alvarenga, DAM
   Culleton, R
   de Pina-Costa, A
   Rodrigues, DF
   Bianco, C
   Silva, S
   Nunes, AJD
   de Souza, JC
   Hirano, ZMB
   Moreira, SB
   Pissinatti, A
   de Abreu, FVS
   Areas, ALL
   Lourenco-de-Oliveira, R
   Zalis, MG
   Ferreira-da-Cruz, MD
   Brasil, P
   Daniel-Ribeiro, CT
   de Brito, CFA
AF Madureira de Alvarenga, Denise Anete
   Culleton, Richard
   de Pina-Costa, Anielle
   Rodrigues, Danielle Fonseca
   Bianco, Cesare, Jr.
   Silva, Sidnei
   Dutra Nunes, Ana Julia
   de Souza, Julio Cesar, Jr.
   Braga Hirano, Zelinda Maria
   Moreira, Silvia Bahadian
   Pissinatti, Alcides
   Santos de Abreu, Filipe Vieira
   Lisboa Areas, Andre Luiz
   Lourenco-de-Oliveira, Ricardo
   Zalis, Mariano Gustavo
   Ferreira-da-Cruz, Maria de Fatima
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Alves de Brito, Cristiana Ferreira
TI An assay for the identification of Plasmodium simium infection for
   diagnosis of zoonotic malaria in the Brazilian Atlantic Forest
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANOPHELES KERTESZIA; NATURAL INFECTION; KNOWLESI; MONKEYS; VIVAX;
   BRASILIANUM; PARASITE; DIPTERA; HUMANS; AMAZON
AB Zoonotic malaria poses a unique problem for malaria control. Autochthonous cases of human malaria in the Atlantic Forest have recently been attributed to Plasmodium simium, a parasite that commonly infects non-human primates in this Brazilian biome. However, due to its close similarity at both the morphological and molecular level to Plasmodium vivax, the diagnosis of P. simium in this region remains problematic. Therefore, a diagnostic assay able to accurately identify P. simium is important for malaria surveillance. Based on mitochondrial genome sequences, primers were designed to amplify a region containing a SNP specific to P. simium. This region can then be digested with the restriction enzyme HpyCH4III, which results in digestion of P. simium sequences, but not of any other malaria parasite. Fifty-two human and monkey blood samples from different regions and infected with different Plasmodium species were used to validate this protocol. This easy and inexpensive tool can be used for the diagnosis of P. simium in non-human primates and human infections from the Atlantic Forest region to monitor zoonotic malaria transmission in Brazil.
C1 [Madureira de Alvarenga, Denise Anete; Rodrigues, Danielle Fonseca; Alves de Brito, Cristiana Ferreira] Fiocruz MS, IRR, Grp Pesquisa Biol Mol & Imunol Malaria, Fundacao Oswaldo Cruz, BR-30190009 Belo Horizonte, MG, Brazil.
   [Culleton, Richard] Nagasaki Univ, Inst Trop Med, Dept Pathol, Malaria Unit, Nagasaki 8528523, Japan.
   [de Pina-Costa, Anielle; Silva, Sidnei; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle; Bianco, Cesare, Jr.; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle; Bianco, Cesare, Jr.; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, IOC, Lab Pesquisa Malaria, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Dutra Nunes, Ana Julia] Nucleo Educ Ambiental Fabio Perini, Perini Business Pk, BR-89219600 Joinville, SC, Brazil.
   [de Souza, Julio Cesar, Jr.; Braga Hirano, Zelinda Maria] Ctr Pesquisas Biol Indaial, BR-89130000 Indaial, SC, Brazil.
   [de Souza, Julio Cesar, Jr.; Braga Hirano, Zelinda Maria] Univ Reg Blumenau FURB, BR-89012900 Blumenau, SC, Brazil.
   [Moreira, Silvia Bahadian; Pissinatti, Alcides] Ctr Primatol Rio de Janeiro CPRJ INEA, BR-25940000 Guapimirim, RJ, Brazil.
   [Pissinatti, Alcides] Ctr Univ Serra Orgaos UNIFESO, BR-25964004 Teresopolis, RJ, Brazil.
   [Santos de Abreu, Filipe Vieira; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Lab Mosquitos Transmissores Hematozoarios, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Lisboa Areas, Andre Luiz; Zalis, Mariano Gustavo] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Infectol & Parasitol Mol, BR-21941901 Rio De Janeiro, RJ, Brazil.
RP de Brito, CFA (corresponding author), Fiocruz MS, IRR, Grp Pesquisa Biol Mol & Imunol Malaria, Fundacao Oswaldo Cruz, BR-30190009 Belo Horizonte, MG, Brazil.
EM cristiana@cpqrr.fiocruz.br
RI Brito, cristiana F/D-4145-2011; Hirano, Zelinda/AAR-3949-2020;
   Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Brito, cristiana F/0000-0002-8888-5477; Hirano,
   Zelinda/0000-0003-2903-5509; 
FU Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenacao de
   aperfeicoamento de pessoal de nivel superior (CAPES)CAPES; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de amparo a pesquisa do estado do Rio de janeiro
   (Faperj)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Cientistas do nosso estado; Japan Society
   for the Promotion of ScienceMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT)Japan Society for the Promotion of
   Science [JP16K21233]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do estado de Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); JSPSMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science
   [16K21233]; Secretary for Health Surveillance (SVS) of the Ministry of
   Health, Global Fund; PRONEX Program of the CNPq
FX This study was financially supported by the Fundacao de Amparo a
   Pesquisa do estado de Minas Gerais (Fapemig), Coordenacao de
   aperfeicoamento de pessoal de nivel superior (CAPES) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). CNPq
   supports RLO, CFAB, MFFC and CTDR with a research productivity
   fellowship. RLO, MFFC and CTDR are also supported by Fundacao de amparo
   a pesquisa do estado do Rio de janeiro (Faperj) with Cientistas do nosso
   estado. RC was supported by a grant (JP16K21233) from the Japan Society
   for the Promotion of Science. The authors thank Dr. Karin Kirchgatter
   (USP) for kindly providing Plasmodium malariae samples. The authors also
   thank people involved in the maintenance of non-human primates at Centro
   de Primatologia do Rio de Janeiro, at Conservation center in Perini
   Business Park and at the Centro de pesquisas biologicas de Indaial
   (Cepesbi). Fundacao Carlos Chagas Filho de Amparo a Pesquisa do estado
   de Rio de Janeiro (Faperj), Fundacao de Amparo a Pesquisa do estado de
   Minas Gerais (Fapemig), the Brazilian National Council for Scientific
   and Technological Development (CNPq), JSPS Grant-in-Aid for scientific
   research (16K21233 to Dr. Culleton), Secretary for Health Surveillance
   (SVS) of the Ministry of Health, Global Fund, and PRONEX Program of the
   CNPq.
CR Alvarenga DAM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1724-0
   Antinori S, 2013, ACTA TROP, V125, P191, DOI 10.1016/j.actatropica.2012.10.008
   ARAGAO MB, 1968, MEM I OSWALDO CRUZ, V66, P227, DOI 10.1590/S0074-02761968000200008
   Azevedo AL, 1997, THESIS
   Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9
   Buery JC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2080-9
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   COLLINS WE, 1969, J PARASITOL, V55, P685, DOI 10.2307/3277324
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578
   Cox-Singh J, 2012, CURR OPIN INFECT DIS, V25, P530, DOI 10.1097/QCO.0b013e3283558780
   de Carvalho-Pinto CJ, 2004, MEM I OSWALDO CRUZ, V99, P471, DOI 10.1590/S0074-02762004000500002
   de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   DEARRUDA M, 1989, AM J TROP MED HYG, V41, P379, DOI 10.4269/ajtmh.1989.41.379
   Duarte AMRC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-58
   Forattini O. P., 1962, ENTOMOLOGIA MED, V1
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033
   Laporta GZ, 2011, MEM I OSWALDO CRUZ, V106, P239, DOI 10.1590/S0074-02762011000900029
   Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146
   LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004
   de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6
   Ministerio da Saude, 2013, B EPIDEMIOLOGICO, V44
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Rodrigues P. T, 2017, BIORXIV, DOI [10.1101/141853, DOI 10.1101/141853]
   Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2
   Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Ueno HM, 2007, REV SAUDE PUBL, V41, P269, DOI 10.1590/S0034-89102007000200014
   Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526
   Yusof R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-168
NR 36
TC 9
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 8
PY 2018
VL 8
AR 86
DI 10.1038/s41598-017-18216-x
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS0CW
UT WOS:000419442500023
PM 29311638
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Figueiredo, J
   Moreira, J
   Brasil, P
   Siqueira, A
AF Figueiredo, Janaina
   Moreira, Jose
   Brasil, Patricia
   Siqueira, Andre
TI GLOBAL RISK ASSESSMENT OF TRAVEL-RELATED YELLOW FEVER SPREAD: A
   SYSTEMATIC REVIEW
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Figueiredo, Janaina; Moreira, Jose; Brasil, Patricia; Siqueira, Andre] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 213
BP 66
EP 66
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602214
DA 2020-12-01
ER

PT J
AU de Pina-Costa, A
   Bonaldo, M
   Bianco, C
   Siqueira, AM
   Abreu, FV
   Ribeiro, IP
   Alvarenga, DA
   Brito, CF
   Lourenco-de-Oliveira, R
   Ferreira-Da-Cruz, MF
   Ribeiro, CT
   Brasil, P
AF de Pina-Costa, Anielle
   Bonaldo, Myrna
   Bianco-Junior, Cesare
   Siqueira, Andre
   Abreu, Filipe
   Ribeiro, Ieda
   Alvarenga, Denise
   Brito, Cristiana
   Lourenco-de-Oliveira, Ricardo
   Ferreira-da-Cruz, Maria
   Ribeiro, Claudio
   Brasil, Patricia
TI SIMULTANEOUS ZOONOTIC MALARIA AND SYLVATIC YELLOW FEVER HUMAN INFECTION
   IN RIO DE JANEIRO ATLANTIC FOREST, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [de Pina-Costa, Anielle; Bonaldo, Myrna; Bianco-Junior, Cesare; Siqueira, Andre; Abreu, Filipe; Ribeiro, Ieda; Lourenco-de-Oliveira, Ricardo; Ferreira-da-Cruz, Maria; Ribeiro, Claudio; Brasil, Patricia] Fiocruz MS, Rio De Janeiro, Brazil.
   [Alvarenga, Denise; Brito, Cristiana] Fiocruz MS, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 371
BP 116
EP 116
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602373
DA 2020-12-01
ER

PT J
AU Moreira, J
   Bautista-Branagan, C
   Lupi, O
   Brasil, P
   Siqueira, A
AF Moreira, Jose
   Bautista-Branagan, Claudio
   Lupi, Otilia
   Brasil, Patricia
   Siqueira, Andre
TI GLOBAL BURDEN OF MALARIA AND DENGUE CO-INFECTION: A SYSTEMATIC REVIEW
   AND META-ANALYSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Moreira, Jose; Bautista-Branagan, Claudio; Lupi, Otilia; Brasil, Patricia; Siqueira, Andre] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1392
BP 438
EP 438
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604092
DA 2020-12-01
ER

PT J
AU Guaraldo, L
   Wakimoto, MD
   Ferreira, H
   Bressan, C
   Calvet, GA
   Pinheiro, GC
   Siqueira, AM
   Brasil, P
AF Guaraldo, Lusiele
   Wakimoto, Mayumi Duarte
   Ferreira, Heloisa
   Bressan, Clarisse
   Calvet, Guilherme Amaral
   Pinheiro, Geraldo Castelar
   Siqueira, Andre Machado
   Brasil, Patricia
TI Treatment of chikungunya musculoskeletal disorders: a systematic review
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Chikungunya fever; musculoskeletal disorders; treatment; systematic
   review; therapeutic evaluation
ID QUALITY-OF-LIFE; VIRUS-INFECTION; CHLOROQUINE; MANAGEMENT; ARTHRITIS;
   DISEASE; PAIN; EPIDEMIC; THERAPY; ISLANDS
AB Introduction: Chikungunya virus is amongst the fastest expanding vector transmissible diseases in recent years and has been causing massive epidemics in Africa, Asia, Latin America and the Caribbean. Despite human infection by this virus being first described in the 1950s, there is a lack of adequate therapeutic evaluations to guide evidence-based recommendations. The current guidelines rely heavily in specialists' opinion and experience instead of using higher rated evidence.
   Areas covered: A systematic review of the literature was performed- not restricted to clinical trials - reporting the therapeutic response against this infection with the intent to gather the best evidence of the treatment options against musculoskeletal disorders following chikungunya fever. The 15 studies included in the analysis were categorized considering the initiation of treatment during the acute, subacute and chronic phase.
   Expert commentary: This review demonstrates the complexity of chikungunya fever and difficulty of therapeutic management. This review found no current evidence-based treatment recommendations for the musculoskeletal disorders following chikungunya fever. To provide an optimal treatment that prevents perpetuation or progression of chikungunya infection to a potentially destructive and permanent condition without causing more harm is an aim that must be pursued by researchers and health professionals working with this disease.
C1 [Guaraldo, Lusiele; Wakimoto, Mayumi Duarte; Ferreira, Heloisa; Bressan, Clarisse; Calvet, Guilherme Amaral; Siqueira, Andre Machado; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Pinheiro, Geraldo Castelar] Univ Estado Rio De Janeiro, Dept Reumatol, Rio De Janeiro, RJ, Brazil.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010; Calvet, GA/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet, GA/0000-0002-3545-5238;
   Pinheiro, Geraldo/0000-0002-7778-569X
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71
   Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316
   Blettery M, 2016, ARTHRITIS RHEUMATOL, V68, P2817, DOI 10.1002/art.39775
   Boers M, 2014, J CLIN EPIDEMIOL, V67, P745, DOI 10.1016/j.jclinepi.2013.11.013
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis, 2015, FISH FISH AUTH, P28
   BRIGHTON SW, 1983, S AFR MED J, V63, P313
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Rivera-Avila RC, 2014, SALUD PUBLICA MEXICO, V56, P402
   Centers for Disease Control and Prevention, 2016, GEOGR DISTR CHIK VIR
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Couderc T, 2009, MICROBES INFECT, V11, P1197, DOI 10.1016/j.micinf.2009.09.002
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   Delogu I, 2011, J MED VIROL, V83, P1058, DOI 10.1002/jmv.22019
   Feldstein LR, 2017, EMERG INFECT DIS, V23, P673, DOI 10.3201/eid2304.161562
   FOURIE ED, 1979, S AFR MED J, V56, P130
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   Javelle E, 2017, TRAVEL MED INFECT DI, V15, P3, DOI 10.1016/j.tmaid.2017.02.002
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Lane HC, 2016, CLIN TRIALS, V13, P92, DOI 10.1177/1740774515618198
   Lui NL, 2012, SINGAP MED J, V53, P241
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Marimoutou C, 2015, CLIN MICROBIOL INFEC, V21, P688, DOI 10.1016/j.cmi.2015.02.024
   Marques CDL, 2017, REV BRAS REUMATOL, V57, P438
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Pan American Health Organization World Health Organization, 2015, NUMB REP CAS CHIK FE
   Pandya S., 2008, INDIAN J RHEUMATOL, V3, P93, DOI DOI 10.1016/S0973-3698(10)60125-2
   Peper SM, 2016, J GEN INTERN MED, V31, P576, DOI 10.1007/s11606-015-3459-3
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Ravindran V, 2017, CLIN RHEUMATOL, V36, P1335, DOI 10.1007/s10067-016-3429-0
   Redel H, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw114
   Alberti PR, 2016, REUMATOL CLIN, V12, P226, DOI 10.1016/j.reuma.2015.08.001
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Saville BR, 2016, CLIN TRIALS, V13, P358, DOI 10.1177/1740774515626362
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Waggoner JJ, 2015, EXPERT REV ANTI-INFE, V13, P291, DOI 10.1586/14787210.2015.995634
   Who, 2017, WHOCC ATC DDD IND
   Wozniacka A, 2006, LUPUS, V15, P268, DOI 10.1191/0961203306lu2299oa
NR 59
TC 6
Z9 6
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PY 2018
VL 16
IS 4
BP 333
EP 344
DI 10.1080/14787210.2018.1450629
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA GD4VL
UT WOS:000430500600007
PM 29533103
DA 2020-12-01
ER

PT J
AU Lowe, R
   Barcellos, C
   Brasil, P
   Cruz, OG
   Honorio, NA
   Kuper, H
   Carvalho, MS
AF Lowe, Rachel
   Barcellos, Christovam
   Brasil, Patricia
   Cruz, Oswaldo G.
   Honorio, Nildimar Alves
   Kuper, Hannah
   Carvalho, Marilia Sa
TI The Zika Virus Epidemic in Brazil: From Discovery to Future Implications
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus; microcephaly; Congenital Zika Syndrome; epidemiology;
   surveillance; vector control; socio-economic impact
ID AEDES-ALBOPICTUS DIPTERA; RIO-DE-JANEIRO; INTELLECTUAL DISABILITIES;
   AEGYPTI; DENGUE; TRANSMISSION; INFECTION; CHIKUNGUNYA; AMERICA;
   INDIVIDUALS
AB The first confirmed case of Zika virus infection in the Americas was reported in Northeast Brazil in May 2015, although phylogenetic studies indicate virus introduction as early as 2013. Zika rapidly spread across Brazil and to more than 50 other countries and territories on the American continent. The Aedesaegypti mosquito is thought to be the principal vector responsible for the widespread transmission of the virus. However, sexual transmission has also been reported. The explosively emerging epidemic has had diverse impacts on population health, coinciding with cases of Guillain-Barre Syndrome and an unexpected epidemic of newborns with microcephaly and other neurological impairments. This led to Brazil declaring a national public health emergency in November 2015, followed by a similar decision by the World Health Organization three months later. While dengue virus serotypes took several decades to spread across Brazil, the Zika virus epidemic diffused within months, extending beyond the area of permanent dengue transmission, which is bound by a climatic barrier in the south and low population density areas in the north. This rapid spread was probably due to a combination of factors, including a massive susceptible population, climatic conditions conducive for the mosquito vector, alternative non-vector transmission, and a highly mobile population. The epidemic has since subsided, but many unanswered questions remain. In this article, we provide an overview of the discovery of Zika virus in Brazil, including its emergence and spread, epidemiological surveillance, vector and non-vector transmission routes, clinical complications, and socio-economic impacts. We discuss gaps in the knowledge and the challenges ahead to anticipate, prevent, and control emerging and re-emerging epidemics of arboviruses in Brazil and worldwide.
C1 [Lowe, Rachel] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Keppel St, London WC1E 7HT, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Doctor Aiguader 88, Barcelona 08003, Spain.
   [Barcellos, Christovam] Oswaldo Cruz Fdn Fiocruz, Inst Hlth Commun & Informat, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Brasil, Patricia] Oswaldo Cruz Fdn Fiocruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Cruz, Oswaldo G.; Carvalho, Marilia Sa] Oswaldo Cruz Fdn Fiocruz, Sci Computat Program, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Inst Oswaldo Cruz Fiocruz, Lab Mosquitos Transmissores Hematozoarios, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London WC1E 7HT, England.
RP Lowe, R (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.; Lowe, R (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Keppel St, London WC1E 7HT, England.; Lowe, R (corresponding author), Barcelona Inst Global Hlth ISGLOBAL, Doctor Aiguader 88, Barcelona 08003, Spain.
EM rachel.lowe@lshtm.ac.uk; xris@fiocruz.br;
   patricia.brasil@ini.fiocruz.br; oswaldo.cruz@fiocruz.br;
   honorio@ioc.fiocruz.br; hannah.kuper@lshtm.ac.uk;
   marilia.carvalho@fiocruz.br
RI Barcellos, Christovam/G-6856-2012; CARVALHO, MARILIA/AAD-8283-2020
OI Barcellos, Christovam/0000-0002-1161-2753; CARVALHO,
   MARILIA/0000-0002-9566-0284; Lowe, Rachel/0000-0003-3939-7343
FU Royal Society Dorothy Hodgkin FellowshipRoyal Society of London;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [306087/2014-6, 200716/2015-8]; Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil [DECIT/25000.072811/2016-17]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; European Union under ZIKAlliance grant
   [734548]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro [E-26/010.001610/2016, E-26/2014-203577]; Fundo Nacional
   de Saude (TED) [90/2016]; Wellcome; DfID; European Union under ZikaPLAN
   grant [734584]
FX R.L. was funded by a Royal Society Dorothy Hodgkin Fellowship; C.B. was
   funded by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (http://www.cnpq.br/, grant#306087/2014-6); P.B. was funded
   by the Departamento de Ciencia e Tecnologia (DECIT/25000.072811/2016-17)
   do Ministerio da Saude do Brasil and grants from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01) and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement
   number 734548; N.A.H. was funded by the Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro
   (http://www.faperj.br/grant#E-26/010.001610/2016) and the Fundo Nacional
   de Saude (TED No. 90/2016 (FNS); H.K. was supported by funding from
   Wellcome and DfID to work on Zika, and has received funding from the
   European Union's Horizon 2020 research and innovation programme, under
   ZikaPLAN grant agreement number 734584.; M.S.C. was funded by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br/, grant#200716/2015-8) and the Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (http://www.faperj.br/, grant#E-26/2014-203577). R.L. is grateful to
   Kathleen O'Reilly, Oliver Brady, Adam Kucharski, and members of ZikaPlan
   and ZikaAlliance for interesting discussions and insights about Zika.
   P.B. acknowledges the London School of Hygiene & Tropical Medicine. The
   authors are grateful to the Brazilian Ministry of Health for the RESP
   and SINAN data.
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Asher J, 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Ayres C, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.86
   Banks L.M., 2013, EC COSTS EXCLUSION G
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Brasil Ministerio da Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   CDC, ZIK VIR HLTH EFF RIS
   Centers for Disease Control and Prevention (CDC), CONG ZIK SYNDR OTH B
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Coelho FC, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00317
   Coeli CM, 2015, CAD SAUDE PUBLICA, V31, P1349, DOI 10.1590/0102-311XED010715
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Castro CatAo R., 2011, HYGIEA, V7, P173
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00017216
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S., 2016, BIORXIV, DOI [10.1101/049395., DOI 10.1101/049395]
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffith GM, 2014, J APPL RES INTELLECT, V27, P401, DOI 10.1111/jar.12073
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Human Rights Watch, NEGL UNPR IMP ZIK OU
   Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144926
   Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lopez-Camelo J. S., 2015, ECLAMC FINAL DOCUMEN
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, DECL FIM EM NAC ZIK
   Ministerio da Saude, DENG CHIK ZIK
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Mirza Nabila, 2013, Online J Public Health Inform, V5, P210, DOI 10.5210/ojphi.v5i2.4703
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Muturi EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0667-y
   Nam SJ, 2017, J MENT HEALTH, V26, P50, DOI 10.1080/09638237.2016.1276538
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Officer Alana, 2011, WORLD REP DIS
   PAHO/WHO, ZIKAEPIDEMIOLOGICAL
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2016, PAHO STAT ZIK VIR TR
   Paz-Bailey G., 2017, NEW ENGL J MED, DOI [10. 1056/NEJMoa1613108 28195756, DOI 10.1056/NEJM0A161310828195756]
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Reis-Castro L, 2012, CROAT MED J, V53, P635, DOI 10.3325/cmj.2012.53.635
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   UN General Assembly, CONV RIGHTS PERS DIS
   United Nations Development Programme (UNDP), 2017, SOC IMP ASS ZIK VIR
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, WHO DIR SUMM OUTC EM
   WHO, INF FEED AR ZIK VIR
   World Health Organization, 2004, PYR DRINK WAT BACKGR
   World Health Organization Fifth Meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 129
TC 78
Z9 81
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2018
VL 15
IS 1
AR 96
DI 10.3390/ijerph15010096
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FU8QZ
UT WOS:000424121200096
PM 29315224
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Barreira, DMPG
   Fumian, TM
   Tonini, MAL
   Volpini, LPB
   Santos, RP
   Ribeiro, ALC
   Leite, JPG
   Souza, MTBDE
   Brasil, P
   da Cunha, DC
   Miagostovich, MP
   Spano, LC
AF Pires Goncalves Barreira, Debora Maria
   Fumian, Tulio Machado
   Loureiro Tonini, Marco Andre
   Bondi Volpini, Lays Paula
   Santos, Rodrigo Pratte
   Chaves Ribeiro, Anezia Lima
   Gagliardi Leite, Jose Paulo
   de Moraes e Souza, Marcia Terezinha Baroni
   Brasil, Patricia
   da Cunha, Denise Cotrim
   Miagostovich, Marize Pereira
   Spano, Liliana Cruz
TI Detection and molecular characterization of the novel recombinant
   norovirus GII.P16-GII.4 Sydney in southeastern Brazil in 2016
SO PLOS ONE
LA English
DT Article
ID EMERGENCE; OUTBREAKS; STRAIN; GASTROENTERITIS; EVOLUTION; INCREASE;
   GII.2; CHINA
AB Noroviruses are the leading cause of acute gastroenteritis (AGE) in all age groups worldwide. Despite the high genetic diversity of noroviruses, most AGE outbreaks are caused by a single norovirus genotype: GII.4. Since 1995, several different variants of norovirus GII.4 have been associated with pandemics, with each variant circulating for 3 to 8 years. The Sydney_2012 variant was first reported in Australia and then in other countries. A new variant, GII.P16-GII.4, was recently described in Japan and South Korea and then in the USA, France, Germany and England. In our study, 190 faecal specimens were collected from children admitted to a paediatric hospital and a public health facility during a surveillance study of sporadic cases of AGE conducted between January 2015 and July 2016. The norovirus was detected by RT-qPCR in 51 samples (26.8%), and in 37 of them (72.5%), the ORF1-2 junction was successfully sequenced. The new recombinant GII.P16-GII.4 Sydney was revealed for the first time in Brazil in 2016 and predominated among other strains (9 GII.Pe-GII.4, 3 GII.P17-GII.17, 1 GII.Pg-GII.1, 1 GII.P16-GII.3 and 1 GII.PNA-GII.4). The epidemiological significance of this new recombinant is still unknown, but continuous surveillance studies may evaluate its impact on the population, its potential to replace the first recombinant GII.Pe-GII.4 Sydney 2012 variant, and the emergence of new recombinant forms of GII.P16.
C1 [Pires Goncalves Barreira, Debora Maria; Loureiro Tonini, Marco Andre; Bondi Volpini, Lays Paula; Santos, Rodrigo Pratte; Spano, Liliana Cruz] Univ Fed Espirito Santo, Hlth Sci Ctr, Pathol Dept, Lab Virol & Infect Gastroenteritis, Av Marechal Campos 1468, Vitoria, ES, Brazil.
   [Fumian, Tulio Machado; Gagliardi Leite, Jose Paulo; de Moraes e Souza, Marcia Terezinha Baroni; Miagostovich, Marize Pereira] Oswaldo Cruz Inst, Lab Comparat & Environm Virol, BR-4365 Rio De Janeiro, RJ, Brazil.
   [Chaves Ribeiro, Anezia Lima] Cent Lab Publ Hlth, Av Marechal Mascarenhas Moraes 2025, Vitoria, ES, Brazil.
   [Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Av Brasil 4365, Rio De Janeiro, RJ, Brazil.
   [da Cunha, Denise Cotrim] Sergio Arouca Publ Hlth Natl Sch, Av Brasil 4365, Rio De Janeiro, RJ, Brazil.
RP Barreira, DMPG (corresponding author), Univ Fed Espirito Santo, Hlth Sci Ctr, Pathol Dept, Lab Virol & Infect Gastroenteritis, Av Marechal Campos 1468, Vitoria, ES, Brazil.
EM deborambarreira@yahoo.com.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
FU Espirito Santo Research Foundation (FAPES)/National Council for
   Scientific and Technological Development (CNPq)/Department of Science
   and Technology (Decit)-Science Technology and Strategic Inputs (SCTIE)
   Health Ministry (MS)/Health (SESA) [10/2013-PPSUS]; PROEP/CNPQ
   [402135/2011-3]; Espirito Santo Research Foundation (FAPES)
FX We would like to thank the Health Surveillance Management and the
   Monitoring Service in Diarrheal Diseases of Espirito Santo state, the
   Technical School of Health of the municipality of Vitoria, and Dr. Alba
   Lilia Rosetti de Almeida (Epidemiological Surveillance Service of the
   Hospital Estadual Infantil Nossa Senhora da Gloria), Oswaldo Cruz
   Institute/Fiocruz, and Carlos Chagas Filho Foundation for Research
   Support in the State of Rio de Janeiro (Faperj). This study was
   supported by Esporito Santo Research Foundation (FAPES)/National Council
   for Scientific and Technological Development (CNPq)/Department of
   Science and Technology (Decit)-Secretary of Science Technology and
   Strategic Inputs (SCTIE)-Health Ministry (MS)/Health's Secretary (SESA)
   (no. 10/2013-PPSUS), and PROEP/CNPQ (no. 402135/2011-3).; This study was
   supported by Espirito Santo Research Foundation (FAPES)/National Council
   for Scientific and Technological Development (CNPq)/Department of
   Science and Technology (Decit)-Secretary of Science Technology and
   Strategic Inputs (SCTIE) Health Ministry (MS)/Health's Secretary (SESA)
   (no.10/2013-PPSUS), and PROEP/CNPQ (no. 402135/2011-3). The first author
   had a scholarship from Espirito Santo Research Foundation (FAPES). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andrade JSR, 2017, INFECT GENET EVOL, V51, P28, DOI 10.1016/j.meegid.2017.03.011
   Ao YY, 2017, EMERG INFECT DIS, V23, P1172, DOI 10.3201/eid2307.170034
   Arana A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098875
   Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002
   Bidalot M, 2017, EURO SURVEILL, V22
   Bull RA, 2005, EMERG INFECT DIS, V11, P1079
   Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0
   Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17
   Chan MCW, 2014, EMERG INFECT DIS, V20, P658, DOI [10.3201/eid2004.13457, 10.3201/eid2004.131457]
   Chan MCW, 2017, GENOME ANNOUNC, V5
   Choi YW, 2016, J ETHNOPHARMACOL, V178, P17, DOI 10.1016/j.jep.2015.12.010
   da Silva LD, 2017, INFECT GENET EVOL, V48, P1, DOI 10.1016/j.meegid.2016.11.027
   da Silva LD, 2013, MEM I OSWALDO CRUZ, V108, P1068, DOI 10.1590/0074-0276130293
   de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178
   Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370
   Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296
   Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12
   Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988
   Fumian TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145391
   Green KY, 2013, FIELDS VIROLOGY, P508
   Hernandez JD, 2016, INFECT GENET EVOL, V39, P365, DOI 10.1016/j.meegid.2016.02.007
   Iritani N, 2012, J MED VIROL, V84, P517, DOI 10.1002/jmv.23211
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9
   Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006
   Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031
   Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12
   Liu LTC, 2017, EMERG INFECT DIS, V23, P1180, DOI 10.3201/eid2307.170212
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Lu J, 2017, EMERG INFECT DIS, V23, P1188, DOI 10.3201/eid2307.170333
   Mans J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-168
   Martin D.P., 2015, VIRUS EVOL, V26
   Matsushima Y, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.26.21173
   Matsushima Y, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01099-16
   Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005
   Mizukoshi F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00705
   Siqueira JA, 2016, INFECT GENET EVOL, V44, P361, DOI 10.1016/j.meegid.2016.07.037
   Mori K, 2017, J MED VIROL, V89, P363, DOI 10.1002/jmv.24624
   Nahar S, 2013, INFECT GENET EVOL, V20, P325, DOI 10.1016/j.meegid.2013.09.021
   Niendorf S, 2017, EURO SURVEILL, V26
   Parra GI, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006136
   Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114
   Ruis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179572
   TAMURA K, 2011, MOL BIOL EVOL, V28, P2731, DOI [DOI 10.1093/molbev/msr121, DOI 10.1093/MOLBEV/MSR121]
   Thanh H Dang, 2016, PLOS ONE, V5
   Hoa-Tran TN, 2015, INFECT GENET EVOL, V30, P27, DOI 10.1016/j.meegid.2014.12.003
   Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0
   Tohma K, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00187-17
   van Beek J, 2013, EUROSURVEILLANCE, V18, P8
   Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
   Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1
   White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746
NR 53
TC 12
Z9 13
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 13
PY 2017
VL 12
IS 12
AR e0189504
DI 10.1371/journal.pone.0189504
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP8HS
UT WOS:000417884100075
PM 29236779
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pedro, RS
   Brasil, P
   Pina-Costa, A
   Machado, CR
   Damasceno, LS
   Daniel-Ribeiro, CT
   Guaraldo, L
AF Pedro, R. S.
   Brasil, P.
   Pina-Costa, A.
   Machado, C. R.
   Damasceno, L. S.
   Daniel-Ribeiro, C. T.
   Guaraldo, L.
TI Pharmacotherapy follow-up: Role in active malaria surveillance in a
   travel medicine centre outside the transmission area in Brazil
SO JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
LA English
DT Article
DE antimalarial drugs; malaria; malaria surveillance; pharmacotherapy
   follow-up; pharmacovigilance
ID PLASMODIUM-VIVAX; ARTEMETHER-LUMEFANTRINE; THERAPEUTIC-EFFICACY;
   CHLOROQUINE; CARE
AB What is known and objectiveMalaria is a potentially severe disease, widespread in tropical and subtropical areas. Apart from parasite drug resistance, which receives the largest share of attention, several factors directly influence the response to antimalarial treatment such as incorrect doses, adverse drug events, lack of adherence to treatment, drug quality and drug-drug interactions. Pharmacotherapy follow-up can be used to monitor and improve the effectiveness of treatment, prevent drug-related problems and ensure patient safety. The aim of this study was to describe the results of the implementation of pharmacotherapy follow-up of patients with malaria seen at a reference centre for malaria diagnosis and treatment (CPD-Mal) located in the city of Rio de Janeiro, an area without malaria transmission.
   MethodsA descriptive study was conducted from January 2009 to September 2013 at the Instituto Nacional de Infectologia Evandro Chagas (INI) of the FundacAo Oswaldo Cruz (Fiocruz). All malaria patients enrolled in the study were treated according to the Brazilian Malaria Therapy Guidelines. Data collected during pharmacotherapy follow-up were recorded in a standardized form. The variables included were age, gender, comorbidities, antimalarials and concomitant medications used, adverse drug reactions (ADR), clinical and parasitological cure times, and treatment outcomes classified as success, recurrence (recrudescence or relapse); and lost to follow-up. The ADR were classified by severity (DAIDS-NIH), organ system affected (WHO-ART) and likelihood to be caused by drugs (Naranjo scale).
   Results and discussionOne hundred thirteen cases of malaria were included. Patients were aged between 13 and 66years and the majority of them (75.2%) were male. Ninety-four ADR were observed, most classified as mild (85.1%), related to disorders of the gastrointestinal system (63.8%), such as nausea and vomiting, and assessed as possibly caused by the antimalarial drugs (91.5%). The majority of clinical (90.9%) and parasitological (87.1%) cure occurred less than 72hours after treatment initiation. Pharmacotherapy follow-up of malaria treatment by surveillance activities is therefore important regarding information about treatment outcomes as well as patient safety, resulting in better patient care and reducing the chance of relapses. The results underscore its use as a tool for monitoring adherence and drug resistance outside an endemic area.
   What is new and conclusionPharmacotherapy follow-up should be considered a useful malaria surveillance tool that can be developed by reference centres for comprehensive health care assistance and monitoring of therapeutic resistance.
C1 [Pedro, R. S.; Brasil, P.; Pina-Costa, A.; Machado, C. R.; Damasceno, L. S.; Guaraldo, L.] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.
   [Pedro, R. S.; Brasil, P.; Pina-Costa, A.; Machado, C. R.; Damasceno, L. S.; Daniel-Ribeiro, C. T.; Guaraldo, L.] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.
   [Pedro, R. S.; Brasil, P.; Pina-Costa, A.; Machado, C. R.; Damasceno, L. S.; Daniel-Ribeiro, C. T.; Guaraldo, L.] MS, SVS, Rio De Janeiro, Brazil.
   [Daniel-Ribeiro, C. T.] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
RP Guaraldo, L (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.
EM lusiele.guaraldo@ini.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), BrazilNational Council for Scientific and
   Technological Development (CNPq); "Cientista do nosso Estado"
FX This work is part of RSP's MSc research and was supported by a
   fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES). CTDR is the recipient of a Productivity Research
   Fellowship from the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Brazil and a "Cientista do nosso Estado" recognized
   by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Faperj), Rio de Janeiro, Brazil.
CR Abuaku B, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1080-x
   Amarante L. C., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P309
   [Anonymous], 2004, DIV AIDS TABL GRAND
   Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008
   Assefa M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0983-x
   Baird JK, 1997, AM J TROP MED HYG, V56, P621, DOI 10.4269/ajtmh.1997.56.621
   Ballut PC, 2013, ACTA TROP, V128, P504, DOI 10.1016/j.actatropica.2013.07.008
   Bharti PK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1555-4
   BOULOS M, 1991, REV I MED TROP, V33, P143, DOI 10.1590/S0036-46651991000200009
   Braga CB, 2015, INTERDISCIP PERSPECT, V2015
   Brasil P, 2007, B FARMACOVIGILANCIA, P4
   Brazil Ministry of Health, 2009, MAN DIAGN LAB MAL
   Brazil Ministry of Health, 2001, MAN TER MAL
   Brazilian Ministry of Health, 2010, GUIA PRAT TRAT MAL B
   Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413
   Costa A. P. R., 2009, THESIS
   Damasceno GS, 2013, CLINICS, V68, P329, DOI 10.6061/clinics/2013(03)OA08
   Daniel-Ribeiro CT, 2008, B SOC PATHOL EXOT, V101, P243
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   Dos-Santos JCK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-280
   Escudero-Vilaplana V, 2017, EUR J CANCER CARE, V26, P1
   Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1
   Garnham PCC, 1966, MALARIA PARASITES OT
   Gomes MDM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0925-7
   Ivama AM, 2002, ATENCAO FARMACEUTICA
   Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955
   Luz Tatiana Chama Borges, 2013, Rev. bras. epidemiol., V16, P409, DOI 10.1590/S1415-790X2013000200016
   Mehta U, 2007, DRUG SAFETY, V30, P899, DOI 10.2165/00002018-200730100-00008
   Micromedex, MICR 2 0 HEALTHC SER
   Montgomery AT, 2008, J CLIN PHARM THER, V33, P653, DOI 10.1111/j.1365-2710.2008.00965.x
   NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154
   Negreiros S, 2016, AM J TROP MED HYG, V95, P1061, DOI 10.4269/ajtmh.16-0075
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Organization WH, 2009, METH SURV ANT DRUG E, P71
   Pan American Health Organization, 2005, RAVR AM NEWSL ABR JU
   Pedro RS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-245
   Pedro RS, 2011, THESIS
   Salazar-Ospina Andrea, 2017, J Manag Care Spec Pharm, V23, P74, DOI 10.18553/jmcp.2017.23.1.74
   Suarez-Mutis MC, 2007, CAD SAUDE PUBLICA, V23, P795, DOI 10.1590/S0102-311X2007000400007
   Thiam S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-54
   Torner MQG, 2012, FARM HOSP, V36, P229
   White NJ, 2012, ADV PARASIT, V80, P113, DOI 10.1016/B978-0-12-397900-1.00002-5
   WHITE NJ, 2003, MANSONS TROPICAL DIS, P1205
   WHO, 2016, WORLD MAL REP 2016
   World Health Organization, 2010, GLOB REP ANT DRUG EF
   World Health Organization, 2015, GUID TREATM MAL
   World Health Organization WHO-ART, 2005, CRIT TERM LIST CURR
NR 47
TC 0
Z9 0
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-4727
EI 1365-2710
J9 J CLIN PHARM THER
JI J. Clin. Pharm. Ther.
PD DEC
PY 2017
VL 42
IS 6
BP 750
EP 757
DI 10.1111/jcpt.12575
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FL9SX
UT WOS:000414599100011
PM 28612497
DA 2020-12-01
ER

PT J
AU Fuller, TL
   Calvet, G
   Estevam, CG
   Angelo, JR
   Abiodun, GJ
   Halai, UA
   De Santis, B
   Sequeira, PC
   Araujo, EM
   Sampaio, SA
   de Mendonca, MCL
   Fabri, A
   Ribeiro, RM
   Harrigan, R
   Smith, TB
   Gabaglia, CR
   Brasil, P
   de Filippis, AMB
   Nielsen-Saines, K
AF Fuller, Trevon L.
   Calvet, Guilherme
   Estevam, Camila Genaro
   Angelo, Jussara Rafael
   Abiodun, Gbenga J.
   Halai, Umme-Aiman
   De Santis, Bianca
   Sequeira, Patricia Carvalho
   Araujo, Eliane Machado
   Sampaio, Simone Alves
   Lima de Mendonca, Marco Cesar
   Fabri, Allison
   Ribeiro, Rita Maria
   Harrigan, Ryan
   Smith, Thomas B.
   Gabaglia, Claudia Raja
   Brasil, Patricia
   Bispo de Filippis, Ana Maria
   Nielsen-Saines, Karin
TI Behavioral, climatic, and environmental risk factors for Zika and
   Chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16
SO PLOS ONE
LA English
DT Article
ID GLOBAL BURDEN; DENGUE; TRANSMISSION; OUTBREAK; DISEASES; STATES
AB The burden of arboviruses in the Americas is high and may result in long-term sequelae with infants disabled by Zika virus infection (ZIKV) and arthritis caused by infection with Chikungunya virus (CHIKV). We aimed to identify environmental drivers of arbovirus epidemics to predict where the next epidemics will occur and prioritize municipalities for vector control and eventual vaccination. We screened sera and urine samples (n = 10,459) from residents of 48 municipalities in the state of Rio de Janeiro for CHIKV, dengue virus (DENV), and ZIKV by molecular PCR diagnostics. Further, we assessed the spatial pattern of arbovirus incidence at the municipal and neighborhood scales and the timing of epidemics and major rainfall events. Lab-confirmed cases included 1,717 infections with ZIKV (43.8%) and 2,170 with CHIKV (55.4%) and only 29 (< 1%) with DENV. ZIKV incidence was greater in neighbor-hoods with little access to municipal water infrastructure (r = -0.47, p = 1.2x10(-8)). CHIKV incidence was weakly correlated with urbanization (r = 0.2, p = 0.02). Rains began in October 2015 and were followed one month later by the largest wave of ZIKV epidemic. ZIKV cases markedly declined in February 2016, which coincided with the start of a CHIKV outbreak. Rainfall predicted ZIKV and CHIKV with a lead time of 3 weeks each time. The association between rainfall and epidemics reflects vector ecology as the larval stages of Aedes aegypti require pools of water to develop. The temporal dynamics of ZIKV and CHIKV may be explained by the shorter incubation period of the viruses in the mosquito vector; 2 days for CHIKV versus 10 days for ZIKV.
C1 [Fuller, Trevon L.; Harrigan, Ryan; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.
   [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Estevam, Camila Genaro] Univ Estadual Sao Paulo, Rio Claro, SP, Brazil.
   [Angelo, Jussara Rafael] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Abiodun, Gbenga J.] Fdn Profess Dev, Pretoria, Gauteng, South Africa.
   [Halai, Umme-Aiman; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil.
   [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.
   [Gabaglia, Claudia Raja] Cty Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Halai, Umme-Aiman] Cty Los Angeles Dept Publ Hlth, Los Angeles, CA USA.
RP Fuller, TL (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.
EM fullertl@ucla.edu
RI Calvet, GA/G-6959-2013; Fuller, Trevon/B-8087-2014
OI Calvet, GA/0000-0002-3545-5238; Fuller, Trevon/0000-0001-9954-4267;
   Genaro Estevam, Camila/0000-0001-6971-9580; Abiodun,
   Gbenga/0000-0002-6805-2128
FU European Union's Horizon research and innovation program (Zika action)
   [734857]; European Union's Horizon research and innovation program (Zika
   plan) [734584]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-18/2015TXB]; National Council for
   Scientific and Technological Development of BrazilNational Council for
   Scientific and Technological Development (CNPq); Oswaldo Cruz
   Foundation/General Coordination of Public Health Laboratories/Ministry
   of Health; National Science FoundationNational Science Foundation (NSF)
   [1243524, AI28697, 1R21AI129534-01, D43TW009343]; University of
   California Global Health Institute; Pan American Health Organization
   Small Grants Programme for Research on the Zika Virus Outbreak in the
   Americas; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW009343, D43TW009343, D43TW009343,
   D43TW009343, D43TW009343, D43TW009343, D43TW009343, D43TW009343,
   D43TW009343, D43TW009343, D43TW009343, D43TW009343, D43TW009343,
   D43TW009343, D43TW009343, D43TW009343, D43TW009343] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source: NIH RePORTER
FX This work was partially supported by: the European Union's Horizon 2020
   research and innovation program (Zika action grant agreement no. 734857
   and Zika plan grant agreement no. 734584), Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro grant no. E-18/2015TXB, National Council for
   Scientific and Technological Development of Brazil, Oswaldo Cruz
   Foundation/General Coordination of Public Health Laboratories/Ministry
   of Health, National Science Foundation grant number 1243524, a
   University of California Global Health Institute grant, National
   Institutes of Health grants AI28697, 1R21AI129534-01, and D43TW009343,
   and by the Pan American Health Organization Small Grants Programme for
   Research on the Zika Virus Outbreak in the Americas.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Battiston D, 2013, SOC INDIC RES, V112, P291, DOI 10.1007/s11205-013-0249-3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   City Health Department of Rio de Janeiro, 2015, CAS CHIK MONTH SYMPT
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   de Lima-Camara TN, 2017, CABI CLIM CHANGE SER, P127, DOI 10.1079/9781780645377.0127
   de Oliveira AF, 2015, CIENC SAUDE COLETIVA, V20, P1027, DOI 10.1590/1413-81232015204.00372014
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Flauzino RF, 2011, SAUDE SOC-SAO PAULO, V20, P225, DOI 10.1590/S0104-12902011000100023
   Flauzino Regina Fernandes, 2009, Rev. Saúde Pública, V43, P1035, DOI [10.1590/S0034-89102009005000064, 10.1590/s0034-89102009005000064]
   Flauzino RF, 2009, REV PANAM SALUD PUBL, V25, P456, DOI 10.1590/S1020-49892009000500012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   INMET, 2017, BANC DAD MET GIC ENS
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360
   Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038
   Keeling M.J., 2008, MODELING INFECT DIS
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Ministerio da Saude, 2013, LEV RAPIND AED AEG L
   Ministerio da Saude, 2017, MON INT ALT CRESC DE
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez-Morales AJ, 2017, RHEUMATOL INT, V37, P1757, DOI 10.1007/s00296-017-3795-1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, P18
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   *WHO, 2016, ZIK STRAT RESP PLAN, DOI DOI 10.1128/CMR.00072-15
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 51
TC 20
Z9 21
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2017
VL 12
IS 11
AR e0188002
DI 10.1371/journal.pone.0188002
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8YO
UT WOS:000415378800048
PM 29145452
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Jaenisch, T
   Rosenberger, K
   Lam, PK
   Nam, NT
   Kumar, V
   See, LLC
   Maron, G
   Laksono, IS
   Ahmed, F
   Brasil, P
   Tovar, R
   Wirths, M
   Guzman, MG
   Quyen, NTH
   Simmons, CP
   Wolbers, M
   Wills, B
AF Jaenisch, Thomas
   Rosenberger, Kerstin
   Phung Khanh Lam
   Nguyen Tran Nam
   Kumar, Varun
   See, Lucy Lum Chai
   Maron, Gabriela
   Laksono, Ida Safitri
   Ahmed, Firoz
   Brasil, Patricia
   Tovar, Robert
   Wirths, Marius
   Guzman, Maria G.
   Nguyen Than Ha Quyen
   Simmons, Cameron P.
   Wolbers, Marcel
   Wills, Bridget
TI IDENTIFICATION OF CLINICAL AND LABORATORY PARAMETERS THAT DISTINGUISH
   BETWEEN DENGUE AND NON-DENGUE ILLNESS WITHIN THE FIRST 72 HOURS OF FEVER
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Jaenisch, Thomas; Rosenberger, Kerstin; Wirths, Marius] Heidelberg Univ Hosp, Heidelberg, Germany.
   [Phung Khanh Lam; Nguyen Tran Nam; Nguyen Than Ha Quyen; Simmons, Cameron P.; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Kumar, Varun] Angkor Hosp Children, Siem Reap, Cambodia.
   [See, Lucy Lum Chai] Univ Malaya, Kuala Lumpur, Malaysia.
   [Maron, Gabriela] Hosp Natl Ninos Benjamin Bloom, San Salvador, El Salvador.
   [Laksono, Ida Safitri] Gadja Madah Univ, Yogyakarta, Indonesia.
   [Ahmed, Firoz] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Tovar, Robert] Univ Carabobo, Valencia, Venezuela.
   [Guzman, Maria G.] Pedro Kouri Inst, Havana, Cuba.
RI Lum, Lucy/Q-9871-2017; Maron, Gabriela M./N-8091-2018
OI Lum, Lucy/0000-0002-7452-4208; Maron, Gabriela M./0000-0001-5247-5399
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 119
BP 40
EP 40
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501119
DA 2020-12-01
ER

PT J
AU Pina-Costa, A
   Siqueira, AM
   Bianco, C
   Machado, CRC
   Lupi, OHR
   Zogbi, H
   de Souza, RV
   Zanini, GM
   Silva, S
   Ferreira-da-Cruz, MD
   Daniel-Ribeiro, CT
   Brasil, P
AF Pina-Costa, Anielle
   Siqueira, Andre M.
   Bianco Junior, Cesare
   Cardoso Machado, Carolina Romero
   Rosa Lupi, Otilia Helena
   Zogbi, Heruza
   de Souza, Rogerio Valls
   Zanini, Graziela Maria
   Silva, Sidnei
   Ferreira-da-Cruz, Maria de Fatima
   Daniel-Ribeiro, Claudio Tadeu
   Brasil, Patricia
TI AN OUTBREAK OF AUTOCHTHONOUS MALARIA IN THE ATLANTIC FOREST, STATE OF
   RIO DE JANEIRO, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Pina-Costa, Anielle; Siqueira, Andre M.; Bianco Junior, Cesare; Cardoso Machado, Carolina Romero; Rosa Lupi, Otilia Helena; Zogbi, Heruza; de Souza, Rogerio Valls; Zanini, Graziela Maria; Silva, Sidnei; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu; Brasil, Patricia] Fiocruz MS, Rio De Janeiro, Brazil.
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 331
BP 103
EP 103
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501331
DA 2020-12-01
ER

PT J
AU Brasil, P
   Marques, ET
   Tami, A
   Sandoval, EP
   Caprara, A
   Magalhaes, T
   Calvet, G
   Bethencourt, S
   Guzman, MG
   Simmons, CP
   Bispo, A
   Cordeiro, MT
   Wills, B
   Rosenberger, K
   Jaenisch, T
AF Brasil, Patricia
   Marques, Ernesto T.
   Tami, Adriana
   Sandoval, Ernesto Pleitess
   Caprara, Andrea
   Magalhaes, Tereza
   Calvet, Guilherme
   Bethencourt, Sarah
   Guzman, Maria G.
   Simmons, Cameron P.
   Bispo, Ana
   Cordeiro, Marli Tenorio
   Wills, Bridget
   Rosenberger, Kerstin
   Jaenisch, Thomas
TI CLINICAL CHARACTERIZATION OF ACUTE ZIKA PATIENTS IN BRAZIL, VENEZUELA,
   AND EL SALVADOR IN 2015/16
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Brasil, Patricia; Calvet, Guilherme; Bispo, Ana] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Ernesto T.; Magalhaes, Tereza; Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Tami, Adriana] Univ Med Ctr Groningen, Groningen, Netherlands.
   [Sandoval, Ernesto Pleitess] Hosp Natl Ninos Benjamin Bloom, San Salvador, El Salvador.
   [Caprara, Andrea] Univ Estadual Ceara, Fortaleza, Ceara, Brazil.
   [Bethencourt, Sarah] Univ Carabobo, Valencia, Venezuela.
   [Guzman, Maria G.] Pedro Kouri Inst, Havana, Cuba.
   [Simmons, Cameron P.; Wills, Bridget] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Rosenberger, Kerstin; Jaenisch, Thomas] Heidelberg Univ Hosp, Heidelberg, Germany.
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Tami,
   Adriana/0000-0002-1918-9144
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 749
BP 236
EP 236
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502272
DA 2020-12-01
ER

PT J
AU Foo, SS
   Chen, WQ
   Chan, Y
   Bowman, JW
   Chang, LC
   Choi, Y
   Yoo, JS
   Ge, JN
   Cheng, GH
   Bonnin, A
   Nielsen-Saines, K
   Brasil, P
   Jung, JU
AF Foo, Suan-Sin
   Chen, Weiqiang
   Chan, Yen
   Bowman, James W.
   Chang, Lin-Chun
   Choi, Younho
   Yoo, Ji Seung
   Ge, Jianning
   Cheng, Genhong
   Bonnin, Alexandre
   Nielsen-Saines, Karin
   Brasil, Patricia
   Jung, Jae U.
TI Asian Zika virus strains target CD14(+) blood monocytes and induce
   M2-skewed immunosuppression during pregnancy
SO NATURE MICROBIOLOGY
LA English
DT Article
ID INFECTION; MACROPHAGES; DIFFERENTIATION; RECRUITMENT; ACTIVATION;
   CLEARANCE; PROFILES; VIREMIA; CXCL10; SYSTEM
AB Blood CD14(+) monocytes are frontline immunomodulators categorized into classical, intermediate or non-classical subsets, and subsequently differentiated into M1 pro-or M2 anti-inflammatory macrophages on stimulation. Although the Zika virus (ZIKV) rapidly establishes viraemia, the target cells and immune responses, particularly during pregnancy, remain elusive. Furthermore, it is unknown whether African-and Asian-lineage ZIKV have different phenotypic impacts on host immune responses. Using human blood infection, we identified CD14(+) monocytes as the primary target for African-or Asian-lineage ZIKV infection. When immunoprofiles of human blood infected with ZIKV were compared, a classical/ intermediate monocytemediated M1-skewed inflammation by the African-lineage ZIKV infection was observed, in contrast to a non-classical monocyte-mediated M2-skewed immunosuppression by the Asian-lineage ZIKV infection. Importantly, infection of the blood of pregnant women revealed an enhanced susceptibility to ZIKV infection. Specifically, Asian-lineage ZIKV infection of pregnant women's blood led to an exacerbated M2-skewed immunosuppression of non-classical monocytes in conjunction with a global suppression of type I interferon-signalling pathway and an aberrant expression of host genes associated with pregnancy complications. Also, 30 ZIKV(+) sera from symptomatic pregnant patients showed elevated levels of M2-skewed immunosuppressive cytokines and pregnancy-complication-associated fibronectin-1. This study demonstrates the differential immunomodulatory responses of blood monocytes, particularly during pregnancy, on infection with different lineages of ZIKV.
C1 [Foo, Suan-Sin; Chen, Weiqiang; Bowman, James W.; Chang, Lin-Chun; Choi, Younho; Yoo, Ji Seung; Ge, Jianning; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Chan, Yen] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med,Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Bonnin, Alexandre] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Div Pediat Infect Dis, 10833 LeConte Ave, Los Angeles, CA 90095 USA.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, 4365 Ave Brasil, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
EM jaeujung@med.usc.edu
RI Yoo, Ji Seung/P-9688-2019; Choi, Younho/Y-7282-2019
OI Yoo, Ji Seung/0000-0002-3708-8240; Choi, Younho/0000-0003-4719-3279
FU Hastings Foundation; Fletcher Jones Foundation; National Institute of
   Allergy and Infectious Diseases/National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [MH106806, 2T90DE021982-06, AI28697, 1R21AI129534-01];
   Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil [CAPES/88887.116627/2016-01]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES;  [CA200422];  [CA180779];  [DE023926]; 
   [AI073099];  [AI116585]; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P01CA180779, R35CA200422,
   R35CA200422, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, R35CA200422,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, R35CA200422, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, P01CA180779, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779, R35CA200422, P01CA180779,
   P01CA180779, P01CA180779, P01CA180779] Funding Source: NIH RePORTER;
   NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R21EY028318, R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI116585, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI073099, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R01AI073099, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI073099, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R01AI073099, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI073099, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI116585, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R21AI129496, P30AI028697,
   P30AI028697, R01AI073099, R01AI073099, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI116585, P30AI028697, R01AI116585,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R21AI129534, P30AI028697, R21AI129534,
   R01AI073099, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI073099, R01AI116585,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R01AI073099, R01AI116585,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, R21AI129496, P30AI028697] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL
   RESEARCHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [R01DE023926, R01DE023926, T90DE021982,
   R01DE023926, R01DE023926, T90DE021982, T90DE021982, T90DE021982,
   T90DE021982, T90DE021982, T90DE021982, T90DE021982, R01DE023926,
   T90DE021982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL
   &CRANIOFACIAL RESEARCHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [T90DE021982] Funding Source:
   NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R01MH106806,
   R01MH106806, R01MH106806, R01MH106806, R01MH106806] Funding Source: NIH
   RePORTER
FX We thank M. Diamond and C. Baronti for providing the ZIKV H/PF/2013
   strain, and all the healthy volunteers for blood donations. This work
   was partly supported by CA200422, CA180779, DE023926, AI073099,
   AI116585, Hastings Foundation and Fletcher Jones Foundation (J.U.J.),
   MH106806 (A.B.) and 2T90DE021982-06 (J.W.B.), AI28697 and
   1R21AI129534-01 from the National Institute of Allergy and Infectious
   Diseases/National Institutes of Health (K.N.S.), and
   CAPES/88887.116627/2016-01 from Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (P.B.).
CR [Anonymous], 2017, ZIK SIT REP 20 JAN 2
   Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008
   Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6
   Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016
   Chaemsaithong P, 2013, J PERINAT MED, V41, P665, DOI 10.1515/jpm-2013-0086
   Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095
   Chen Chun-Kai, 1994, Journal of the Formosan Medical Association, V93, P921
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193
   Halai U. A., 2017, CLIN INFECT DIS, V2017, P472
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hou WQ, 2012, BLOOD, V119, P3128, DOI 10.1182/blood-2011-09-379479
   Ishida J, 2011, J BIOCHEM, V150, P5, DOI 10.1093/jb/mvr069
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mack Ines, 2015, Mol Cell Pediatr, V2, P3, DOI 10.1186/s40348-015-0014-6
   Magatti M, 2017, J TISSUE ENG REGEN M, V11, P2895, DOI 10.1002/term.2193
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palmer C., 2015, J IMMUNOL, V194, P215
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Rasanen J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.052
   Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3
   Robinson TO, 2017, VIROLOGY, V504, P79, DOI 10.1016/j.virol.2017.01.018
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086
   Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 58
TC 67
Z9 67
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2017
VL 2
IS 11
BP 1558
EP 1570
DI 10.1038/s41564-017-0016-3
PG 13
WC Microbiology
SC Microbiology
GA FP9NM
UT WOS:000417975600015
PM 28827581
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Murari-Nascimento, P
   Vargas-Santos, AB
   Fortes, N
   Zogbi, H
   Santos, O
   Brasil, P
   Calvet, G
   Valls, R
   Andrade, C
   Siqueira, A
   Castelar-Pinheiro, G
   Pereira, L
   Chaves-Amorim, RB
AF Murari-Nascimento, Paula
   Vargas-Santos, Ana Beatriz
   Fortes, Natalia
   Zogbi, Heruza
   Santos, Otilia
   Brasil, Patricia
   Calvet, Guilherme
   Valls, Rogerio
   Andrade, Carlos
   Siqueira, Andre
   Castelar-Pinheiro, Geraldo
   Pereira, Leticia
   Chaves-Amorim, Rodrigo B.
TI Follow-up of Patients with Musculoskeletal Manifestations Related to
   Chikungunya Fever
SO ARTHRITIS & RHEUMATOLOGY
LA English
DT Meeting Abstract
C1 [Murari-Nascimento, Paula; Fortes, Natalia; Pereira, Leticia] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Vargas-Santos, Ana Beatriz; Castelar-Pinheiro, Geraldo] Univ Estado Rio De Janeiro, Internal Med Rheumatol, Rio De Janeiro, Brazil.
   [Zogbi, Heruza; Santos, Otilia; Brasil, Patricia; Calvet, Guilherme; Valls, Rogerio; Andrade, Carlos; Siqueira, Andre] Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Chaves-Amorim, Rodrigo B.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
RI Santos, Ana Beatriz Vargas dos/S-4908-2019
OI Santos, Ana Beatriz Vargas dos/0000-0001-5307-0254
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2326-5191
EI 2326-5205
J9 ARTHRITIS RHEUMATOL
JI Arthritis Rheumatol.
PD OCT
PY 2017
VL 69
SU 10
MA 276
PG 2
WC Rheumatology
SC Rheumatology
GA FI2ZP
UT WOS:000411824100276
DA 2020-12-01
ER

PT J
AU Brasil, P
   Zalis, MG
   de Pina-Costa, A
   Siqueira, AM
   Bianco, C
   Silva, S
   Areas, ALL
   Pelajo-Machado, M
   de Alvarenga, DAM
   Santelli, ACFD
   Albuquerque, HG
   Cravo, P
   de Abreu, FVS
   Peterka, CL
   Zanini, GM
   Mutis, MCS
   Pissinatti, A
   Lourenco-de-Oliveira, R
   de Brito, CFA
   Ferreira-da-Cruz, MD
   Culleton, R
   Daniel-Ribeiro, CT
AF Brasil, Patricia
   Zalis, Mariano Gustavo
   de Pina-Costa, Anielle
   Siqueira, Andre Machado
   Bianco Junior, Cesare
   Silva, Sidnei
   Lisboa Areas, Andre Luiz
   Pelajo-Machado, Marcelo
   Madureira de Alvarenga, Denise Anete
   Faria da Silva Santelli, Ana Carolina
   Albuquerque, Hermano Gomes
   Cravo, Pedro
   Santos de Abreu, Filipe Vieira
   Peterka, Cassio Leonel
   Zanini, Graziela Maria
   Mutis, Martha Cecilia Suarez
   Pissinatti, Alcides
   Lourenco-de-Oliveira, Ricardo
   Alves de Brito, Cristiana Ferreira
   Ferreira-da-Cruz, Maria de Fatima
   Culleton, Richard
   Daniel-Ribeiro, Claudio Tadeu
TI Outbreak of human malaria caused by Plasmodium simium in the Atlantic
   Forest in Rio de Janeiro: a molecular epidemiological investigation
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
ID MITOCHONDRIAL GENOME SEQUENCES; BRAZIL; VIVAX; INFECTIONS; TRANSMISSION
AB Background Malaria was eliminated from southern and southeastern Brazil over 50 years ago. However, an increasing number of autochthonous episodes attributed to Plasmodium vivax have recently been reported from the Atlantic Forest region of Rio de Janeiro state. As the P vivax-like non-human primate malaria parasite species Plasmodium simium is locally enzootic, we performed a molecular epidemiological investigation to determine whether zoonotic malaria transmission is occurring.
   Methods We examined blood samples from patients presenting with signs or symptoms suggestive of malaria as well as from local howler monkeys by microscopy and PCR. Samples were included from individuals if they had a history of travel to or resided in areas within the Rio de Janeiro Atlantic Forest, but not if they had malaria prophylaxis, blood transfusion or tissue or organ transplantation, or had travelled to known malaria endemic areas in the preceding year. Additionally, we developed a molecular assay based on sequencing of the parasite mitochondrial genome to distinguish between P vivax and P simium, and applied this assay to 33 cases from outbreaks that occurred in 2015, and 2016.
   Findings A total of 49 autochthonous malaria cases were reported in 2015-16. Most patients were male, with a mean age of 44 years (SD 14.6), and 82% lived in urban areas of Rio de Janeiro state and had visited the Atlantic Forest for leisure or work-related activities. 33 cases were used for mitochondrial DNA sequencing. The assay was successfully performed for 28 samples, and all were shown to be P simium, indicative of zoonotic transmission of this species to human beings in this region. Sequencing of the whole mitochondrial genome of three of these cases showed that P simium is most closely related to P vivax parasites from South America. The malaria outbreaks in this region were caused by P simium, previously considered to be a monkey-specific malaria parasite, related to but distinct from P vivax, and which has never conclusively been shown to infect people before.
   Interpretation This unequivocal demonstration of zoonotic transmission, 50 years after the only previous report of P simium in people, leads to the possibility that this parasite has always infected people in this region, but that it has been consistently misdiagnosed as P vivax because of an absence of molecular typing techniques. Thorough screening of local non-human primates and mosquitoes (Anopheline) is required to evaluate the extent of this newly recognised zoonotic threat to public health and malaria elimination in Brazil. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
C1 [Brasil, Patricia; de Pina-Costa, Anielle; Siqueira, Andre Machado] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Silva, Sidnei; Zanini, Graziela Maria] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas INI, Lab Parasitol, Rio De Janeiro, Brazil.
   [Brasil, Patricia; de Pina-Costa, Anielle; Siqueira, Andre Machado; Bianco Junior, Cesare; Lourenco-de-Oliveira, Ricardo; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.
   [Zalis, Mariano Gustavo; Lisboa Areas, Andre Luiz] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Infectol & Parasitol Mol, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle; Bianco Junior, Cesare; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Inst Oswaldo Cruz IOC, Lab Pesquisa Malaria, BR-21040360 Rio De Janeiro, Brazil.
   [Pelajo-Machado, Marcelo] Fiocruz MS, Inst Oswaldo Cruz IOC, Lab Patol, Rio De Janeiro, Brazil.
   [Albuquerque, Hermano Gomes; Mutis, Martha Cecilia Suarez] Fiocruz MS, Inst Oswaldo Cruz IOC, Lab Doencas Parasitarias, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz IOC, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle; Pissinatti, Alcides] Ctr Univ Serra dos Orgaos UNIFESO, Teresopolis, RJ, Brazil.
   [Madureira de Alvarenga, Denise Anete; Alves de Brito, Cristiana Ferreira] Fiocruz MS, Inst Rene Rachou IRR, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.
   [Faria da Silva Santelli, Ana Carolina; Peterka, Cassio Leonel] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Prevencao & Controle Malaria, Brasilia, DF, Brazil.
   [Cravo, Pedro] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Genoma & Biotecnol GenoBio, Goiania, Go, Brazil.
   [Cravo, Pedro] Univ Nova Lisboa, Inst Higiene & Med Trop, Lisbon, Portugal.
   [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro CPRJ INEA, Rio De Janeiro, Brazil.
   [Culleton, Richard] Nagasaki Univ, Inst Trop Med, Dept Pathol, Malaria Unit, Nagasaki, Japan.
RP Brasil, P; Daniel-Ribeiro, CT (corresponding author), Fiocruz MS, Inst Oswaldo Cruz IOC, Lab Pesquisa Malaria, BR-21040360 Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br; malaria@fiocruz.br
RI Cravo, Pedro VL/G-3532-2012; Siqueira, Andre M/G-1340-2010;
   Daniel-Ribeiro, Claudio Tadeu/G-2216-2015; Su\\xc3\\xa1rez-Mutis,
   Martha/T-9260-2019; Suarez-Mutis, Martha/B-9189-2015
OI Cravo, Pedro VL/0000-0003-1675-4504; Siqueira, Andre
   M/0000-0003-2208-0294; Pelajo Machado, Marcelo/0000-0002-7295-7018;
   Suarez-Mutis, Martha/0000-0003-2809-6799; Zanini,
   Graziela/0000-0003-4466-3124
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de
   Janeiro; Brazilian National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); JSPSMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT)Japan Society for the Promotion of Science;
   Secretary for Health Surveillance of the Brazilian Ministry of Health;
   Global FundUnited States Agency for International Development (USAID);
   Fundacao de amparo a pesquisa do estado de Minas Gerais (Fapemig)Minas
   Gerais State Research Foundation (FAPEMIG); PRONEX Program of the CNPq
FX Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de
   Janeiro, The Brazilian National Council for Scientific and Technological
   Development (CNPq), JSPS Grant-in-Aid for scientific research, Secretary
   for Health Surveillance of the Brazilian Ministry of Health, Global
   Fund, Fundacao de amparo a pesquisa do estado de Minas Gerais (Fapemig),
   and PRONEX Program of the CNPq.
CR Ahmed MA, 2015, ISBT SCI SER, V10, P134, DOI 10.1111/voxs.12115
   Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-402
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Coatney G.R, 1971, PRIMATE MALARIAS
   COATNEY GR, 1971, AM J TROP MED HYG, V20, P795, DOI 10.4269/ajtmh.1971.20.795
   Culleton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029137
   da FONSECA FLAVIO, 1951, MEM INST OSWALDO CRUZ, V49, P543, DOI 10.1590/S0074-02761951000100008
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   GARNHAM PCC, 1966, MALARIA PARASITES OT, P1114
   Iwagami M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-184
   Jongwutiwes S, 2005, MOL BIOL EVOL, V22, P1733, DOI 10.1093/molbev/msi168
   Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x
   de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6
   Miao M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-22
   Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160
   Rodrigues PT, 2014, AM J TROP MED HYG, V90, P1102, DOI 10.4269/ajtmh.13-0588
   Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4
   Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   WANDERLEY DMV, 1994, REV SAUDE PUBL, V28, P192, DOI 10.1590/S0034-89101994000300005
NR 26
TC 54
Z9 56
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD OCT
PY 2017
VL 5
IS 10
BP E1038
EP E1046
DI 10.1016/S2214-109X(17)30333-9
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FG4GY
UT WOS:000410200600025
PM 28867401
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Halai, UA
   Nielsen-Saines, K
   Moreira, ML
   de Sequeira, PC
   Pereira, JP
   Zin, AA
   Cherry, J
   Gabaglia, CR
   Gaw, SL
   Adachi, K
   Tsui, I
   Pilotto, JH
   Nogueira, RR
   de Filippis, AMB
   Brasil, P
AF Halai, Umme-Aiman
   Nielsen-Saines, Karin
   Moreira, Maria Lopes
   de Sequeira, Patricia Carvalho
   Pereira, Jose Paulo Junior
   Zin, Andrea de Araujo
   Cherry, James
   Gabaglia, Claudia Raja
   Gaw, Stephanie L.
   Adachi, Kristina
   Tsui, Irena
   Pilotto, Jose Henrique
   Nogueira, Rita Ribeiro
   de Filippis, Ana Maria Bispo
   Brasil, Patricia
TI Maternal Zika Virus Disease Severity, Virus Load, Prior Dengue
   Antibodies, and Their Relationship to Birth Outcomes
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; dengue; ZIKV; pregnancy; congenital
ID JANUARY 2016; INFECTION; PREGNANCY; RNA; SALIVA; URINE; WOMEN;
   TRANSMISSION; MICRONESIA; EPIDEMIC
AB Background. Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies, or abnormal pregnancy/ infant outcomes.
   Methods. A clinical severity assessment tool was developed based on duration of fever, severity of rash, multisystem involvement, and duration of symptoms during ZIKV infection. ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine. Dengue immunoglobulin G (IgG) antibodies were measured at baseline. Adverse outcomes were defined as fetal loss or a live infant with grossly abnormal clinical or brain imaging findings. Regression models were used to study potential associations.
   Results. 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity, 6 (4.6%) had mild disease, 98 (74.8%) had moderate disease, and 27 (20.6%) severe manifestations of ZIKV infection. There were 58 (46.4%) abnormal outcomes with 9 fetal losses (7.2%) in 125 pregnancies. No associations were found between: disease severity and abnormal outcomes (P =.961; odds ratio [OR]: 1.00; 95% confidence interval [CI]: 0.796-1.270); disease severity and viral load (P =.994); viral load and adverse outcomes (P =.667; OR: 1.02; 95% CI: 0.922-1.135); or existence of prior dengue antibodies (88% subjects) with severity score, ZIKVRNA load or adverse outcomes (P =.667; OR: 0.78; 95% CI: 0.255-2.397).
   Conclusions. Congenital ZIKV syndrome does not appear to be associated with maternal disease severity, ZIKV-RNA load at time of infection or existence of prior dengue antibodies.
C1 [Halai, Umme-Aiman; Nielsen-Saines, Karin; Cherry, James; Adachi, Kristina; Tsui, Irena; de Filippis, Ana Maria Bispo] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Moreira, Maria Lopes; de Sequeira, Patricia Carvalho; Pereira, Jose Paulo Junior; Zin, Andrea de Araujo; Pilotto, Jose Henrique; Nogueira, Rita Ribeiro; Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
RP Halai, UA (corresponding author), David Geffen UCLA Sch Med, Dept Med, CHS 37-121,LeConte Ave, Los Angeles, CA 90049 USA.
EM aiman.shabbir@gmail.com
RI Pilotto, Jose Henrique/AAD-9773-2019; amsalu, ribka/G-8780-2019; Gaw,
   Stephanie/K-4592-2019
OI Pilotto, Jose Henrique/0000-0003-0521-8597; Gaw,
   Stephanie/0000-0003-0891-6964
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/ 88887.116627/2016-01]; National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [AI28697, 1R21AI129534-01]; Thrasher Research Fund
   [20164370]; NATIONAL EYE INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R21EY028318, R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534, R21AI129534] Funding Source: NIH RePORTER
FX This work was supported by the Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/
   88887.116627/2016-01); the National Institute of Allergy and Infectious
   Diseases (NIAID) of the National Institutes of Health (AI28697 and
   1R21AI129534-01) and the Thrasher Research Fund (20164370).
CR ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418
   Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
NR 29
TC 49
Z9 49
U1 0
U2 47
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2017
VL 65
IS 6
BP 877
EP 883
DI 10.1093/cid/cix472
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FF2BY
UT WOS:000408704100001
PM 28535184
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Brasil, P
   Lupi, O
AF Brasil, Patricia
   Lupi, Otilia
TI Dengue infection during pregnancy and risk of preterm birth
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia; Lupi, Otilia] Inst Nacl Infectol Evandro Chagas, BR-21040360 Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Inst Nacl Infectol Evandro Chagas, BR-21040360 Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Nascimento LB, 2017, LANCET INFECT DIS
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Restrepo BN, 2004, REV FAC NAC SALUD PU, V22, P7
   Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002
   Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637
NR 10
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2017
VL 17
IS 9
BP 885
EP 886
DI 10.1016/S1473-3099(17)30298-0
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FE5ST
UT WOS:000408272100006
PM 28528801
OA Green Published
DA 2020-12-01
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, J
   Vasconcelos, Z
   Adachi, K
   Valderramos, S
   Halai, UA
   Pone, MVD
   Pone, SM
   Silveira, JCB
   Aibe, MS
   da Costa, ACC
   Zin, OA
   Belfort, R
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia
   Vasconcelos, Zilton
   Adachi, Kristina
   Valderramos, Stephanie
   Halai, Umme-Aiman
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Barros Silveira Filho, Joel Carlos
   Aibe, Mitsue S.
   da Costa, Ana Carolina C.
   Zin, Olivia A.
   Belfort, Rubens, Jr.
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Screening Criteria for Ophthalmic Manifestations of Congenital Zika
   Virus Infection
SO JAMA PEDIATRICS
LA English
DT Article
ID INFANTS; VIREMIA
AB IMPORTANCE Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero.
   OBJECTIVE To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy.
   DESIGN, SETTING, AND PARTICIPANTS In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil.
   PARTICIPANTS Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus.
   MAIN OUTCOMES AND MEASURES Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection.
   RESULTS Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2).
   CONCLUSIONS AND RELEVANCE Eye abnormalitiesmay be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
C1 [Zin, Andrea A.; Rossetto, Julia; Vasconcelos, Zilton; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Tsui, Irena; Halai, Umme-Aiman] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Rossetto, Julia; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Valderramos, Stephanie] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Aibe, Mitsue S.] Fundacao Oswaldo Cruz, Dept Doencas Infecciosas, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Zin, Olivia A.] Hosp Fed Servidores Estado, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Gaw, Stephanie/K-4592-2019; da Silva Pone, Marcos Vinicius/N-1285-2019;
   Vasconcelos, Zilton/AAD-5784-2019
OI Gaw, Stephanie/0000-0003-0891-6964; Vasconcelos,
   Zilton/0000-0002-2193-2224; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI28697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent Blindness grantResearch to Prevent Blindness (RPB);
   Thrasher Research Fund [20164370]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source:
   NIH RePORTER
FX This study was supported by grant 441098/2016-9 from the Brazilian
   National Council for Scientific and Technological Development, grant AI
   AI28697 from the National Institute of Allergy and Infectious Diseases,
   and grant R21EY028318-01 from the National Eye Institute. Dr Tsui was
   supported in part by an unrestricted Research to Prevent Blindness grant
   given to the Stein Eye Institute. Dr Adachi was supported in part by
   grant 20164370 from the Thrasher Research Fund.
CR [Anonymous], 2016, MMWR MORB MORTA 0819
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maa AY, 2017, TELEMED E-HEALTH, V23, P42, DOI 10.1089/tmj.2016.0039
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pasquel Francisco J, 2015, J Diabetes Sci Technol, V10, P301, DOI 10.1177/1932296815624109
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Sadler T. W., 2015, LANGMANS MED EMBRYOL
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vinekar A, 2015, SEMIN FETAL NEONAT M, V20, P335, DOI 10.1016/j.siny.2015.05.002
NR 26
TC 37
Z9 38
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD SEP
PY 2017
VL 171
IS 9
BP 847
EP 854
DI 10.1001/jamapediatrics.2017.1474
PG 8
WC Pediatrics
SC Pediatrics
GA FG3XL
UT WOS:000410140700011
PM 28715527
OA Green Published
DA 2020-12-01
ER

PT J
AU Cavalcanti, LPD
   Freitas, ARR
   Brasil, P
   da Cunha, RV
AF de Goes Cavalcanti, Luciano Pamplona
   Ribas Freitas, Andre Ricardo
   Brasil, Patricia
   da Cunha, Rivaldo Venancio
TI Surveillance of deaths caused by arboviruses in Brazil: from dengue to
   chikungunya
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Letter
DE surveillance; death; arboviruses; dengue; chikungunya
ID VIRUS; INFECTION
AB Did death occur DUE TO dengue, or in a patient WITH dengue virus infection? It seems a matter of semantics, but in fact, it underscores how challenging it is to distinguish whether the disease contributed to death, or was itself the underlying cause of death. Can a death be attributed to chikungunya virus, when some deaths occur after the acute phase? Did the virus decompensate the underlying diseases, leading to death? Did prolonged hospitalisation lead to infection, resulting in the patient's progression to death? Were there iatrogenic complications during patient care? The dengue question, for which there has not yet been a definitive response, resurfaces prominently under the chikungunya surveillance scenario. We are facing an epidemic of a disease that seems to be more lethal than previously thought. The major challenge ahead is to investigate deaths suspected of occurring due to arbovirus infections and to understand the role of each infection in the unfavourable outcome.
C1 [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Dept Saude Comunitaria, Fortaleza, Ceara, Brazil.
   [Ribas Freitas, Andre Ricardo] Fac Sao Leopoldo Mand, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Secretaria Municipal Saude, Dept Vigilancia Saude, Campinas, SP, Brazil.
   [Brasil, Patricia] Fdn Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [da Cunha, Rivaldo Venancio] Fdn Oswaldo Cruz Fiocruz, Campo Grande, MS, Brazil.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Dept Saude Comunitaria, Fortaleza, Ceara, Brazil.
EM pamplona.luciano@gmail.com
RI Freitas, Andre Ricardo Ribas/L-1969-2016; Cavalcanti,
   Luciano/N-4391-2015
OI Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Cavalcanti,
   Luciano/0000-0002-3440-1182
CR Barbosa da Silva Jarbas Jr, 2002, Epidemiol Bull, V23, P3
   Braga DNM, 2014, THESIS
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Campos KB, 2015, TROP MED INT HEALTH, V20, P211, DOI 10.1111/tmi.12425
   Carvalho FHC, 2016, REVISTA DE MEDICINA, V56, P6
   Coelho GE, 2016, PROTOCOLO INVESTIGAC
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   Cunha RV, 2015, DENGUE TEORIAS PRATI, P221
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   MARIANO Francisco, 1917, Arch. Brasileiros de Med., V7, P272
   MS/ SVS-Ministerio da Saude/Secretaria de Vigilancia em Saude, 2014, PREP RESP INTR VIR C
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Osanai C. H., 1984, THESIS
   PAHO, 2011, PREP RESP CHIK VIR I
   Pedro A., 1923, BRAZIL MED, V1, P174
   Rego JP, 1872, RIO DE JANEIRO TYPHO, V2, P44
   Reis TJ, 1896, GAZETA MED BAHIA, V97, P163
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MG, 1999, INF EPIDEMIOL SUS, V8, P5, DOI DOI 10.5123/S0104-16731999000400002
   VASCONCELOS PFD, 2014, REV PAN-AMAZ SAUDE, V5, P9, DOI DOI 10.5123/S2176-62232014000300001
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 30
TC 17
Z9 17
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2017
VL 112
IS 8
BP 583
EP 585
DI 10.1590/0074-02760160537
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC4JY
UT WOS:000406807300011
PM 28767985
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ayllon, T
   Campos, RD
   Brasil, P
   Morone, FC
   Camara, DCP
   Meira, GLS
   Tannich, E
   Yamamoto, KA
   Carvalho, MS
   Pedro, RS
   Schmidt-Chanasit, J
   Cadar, D
   Ferreira, DF
   Honorio, NA
AF Ayllon, Tania
   Campos, Renata de Mendonca
   Brasil, Patricia
   Morone, Fernanda Cristina
   Portela Camara, Daniel Cardoso
   Silva Meira, Guilherme Louzada
   Tannich, Egbert
   Yamamoto, Kristie Aimi
   Carvalho, Marilia Sa
   Pedro, Renata Saraiva
   Schmidt-Chanasit, Jonas
   Cadar, Daniel
   Ferreira, Davis Fernandes
   Honorio, Nildimar Alves
TI Early Evidence for Zika Virus Circulation among Aedes aegypti
   Mosquitoes, Rio de Janeiro, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
AB During 2014-2016, we conducted mosquito-based Zika virus surveillance in Rio de Janeiro, Brazil. Results suggest that Zika virus was probably introduced into the area during May-November 2013 via multiple in-country sources. Furthermore, our results strengthen the hypothesis that Zika virus in the Americas originated in Brazil during October 2012-May 2013.
C1 [Ayllon, Tania; Brasil, Patricia; Pedro, Renata Saraiva] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Morone, Fernanda Cristina; Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [Campos, Renata de Mendonca; Silva Meira, Guilherme Louzada; Yamamoto, Kristie Aimi; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Tannich, Egbert; Schmidt-Chanasit, Jonas; Cadar, Daniel] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Carvalho, Marilia Sa] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res Hamburg Luebeck Borstel, Hamburg, Germany.
RP Schmidt-Chanasit, J (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM jonassi@gmx.de
RI Azevedo, Renata/V-3130-2019; CARVALHO, MARILIA/AAD-8283-2020; Camara,
   Daniel C. P./S-3504-2018; Santiago, Tania Ayllon/B-2543-2019
OI CARVALHO, MARILIA/0000-0002-9566-0284; Camara, Daniel C.
   P./0000-0002-5439-4477; Santiago, Tania Ayllon/0000-0002-1195-5078;
   Cadar, Daniel/0000-0002-8063-2766
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroFAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [401542/2015-7, E-26/102.241/2013,
   E-26/010.001610/2016]; Fundacao Oswaldo Cruz
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroFAPERJ (grant nos. 401542/2015-7,
   E-26/102.241/2013, and E-26/010.001610/2016) and Fundacao Oswaldo Cruz.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 27
Z9 27
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1411
EP 1412
DI 10.3201/eid2308.162007
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200030
PM 28628464
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, JU
   Bressan, C
   Dalvi, APR
   Calvet, GA
   Daumas, RP
   Rodrigues, N
   Wakimoto, M
   Nogueira, RMR
   Nielsen-Saines, K
   Brito, C
   de Filippis, AMB
   Brasil, P
AF Braga, Jose Ueleres
   Bressan, Clarisse
   Razal Dalvi, Ana Paula
   Amaral Calvet, Guilherme
   Daumas, Regina Paiva
   Rodrigues, Nadia
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita Maria
   Nielsen-Saines, Karin
   Brito, Carlos
   Bispo de Filippis, Ana Maria
   Brasil, Patricia
TI Accuracy of Zika virus disease case definition during simultaneous
   Dengue and Chikungunya epidemics
SO PLOS ONE
LA English
DT Article
ID OUTBREAK; ILLNESS; BRAZIL
AB Background
   Zika is a new disease in the American continent and its surveillance is of utmost importance, especially because of its ability to cause neurological manifestations as Guillain-Barre A syndrome and serious congenital malformations through vertical transmission. The detection of suspected cases by the surveillance system depends on the case definition adopted. As the laboratory diagnosis of Zika infection still relies on the use of expensive and complex molecular techniques with low sensitivity due to a narrow window of detection, most suspected cases are not confirmed by laboratory tests, mainly reserved for pregnant women and new-borns. In this context, an accurate definition of a suspected Zika case is crucial in order for the surveillance system to gauge the magnitude of an epidemic.
   Methodology
   We evaluated the accuracy of various Zika case definitions in a scenario where Dengue and Chikungunya viruses co-circulate. Signs and symptoms that best discriminated PCR confirmed Zika from other laboratory confirmed febrile or exanthematic diseases were identified to propose and test predictive models for Zika infection based on these clinical features.
   Results and discussion
   Our derived score prediction model had the best performance because it demonstrated the highest sensitivity and specificity, 86.6% and 78.3%, respectively. This Zika case definition also had the highest values for auROC (0.903) and R-2 (0.417), and the lowest Brier score 0.096.
   Conclusions
   In areas where multiple arboviruses circulate, the presence of rash with pruritus or conjunctival hyperemia, without any other general clinical manifestations such as fever, petechia or anorexia is the best Zika case definition.
C1 [Braga, Jose Ueleres; Razal Dalvi, Ana Paula; Daumas, Regina Paiva; Rodrigues, Nadia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Bressan, Clarisse; Amaral Calvet, Guilherme; Wakimoto, Mayumi; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Brito, Carlos] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Calvet, GA/G-6959-2013; DAUMAS, REGINA/M-9387-2013; amsalu,
   ribka/G-8780-2019; Barros de Castro, Daniel/J-9358-2016
OI Calvet, GA/0000-0002-3545-5238; DAUMAS, REGINA/0000-0002-8923-7711;
   Barros de Castro, Daniel/0000-0001-5969-544X
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source: NIH RePORTER
FX Funding Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da
   Saude do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/88887.116627/2016-01).
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Sande Departamento de Vigilancia das Doencas Transmissiveis, 2016, SECR VIG SANDE DEP V
   Brasil. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2016, SECRETARIA VIGILANCI
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Pan American Health Organization / World Health Organization, 2015, EP UPD ZIK VIR  1016
   Pan American Health Organization / World Health Organization (PAHO / WHO), 2014, EP AL CHIK DENG FEV
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Solet J. L., 2007, PLOS BIOL, V77, P727
   WHO, 2017, SIT REP
   World Health Organization, 2016, ZIKA VIRUS DIS  0212
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 17
TC 30
Z9 30
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2017
VL 12
IS 6
AR e0179725
DI 10.1371/journal.pone.0179725
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ2KD
UT WOS:000404537300015
PM 28650987
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Possas, C
   Brasil, P
   Marzochi, MCA
   Tanuri, A
   Martins, RM
   Marques, ETA
   Bonaldo, MC
   Ferreira, AGP
   Lourenco-de-Oliveira, R
   Nogueira, RMR
   Sequeira, PC
   Marzochi, KBF
   Homma, A
AF Possas, Cristina
   Brasil, Patricia
   Marzochi, Mauro C. A.
   Tanuri, Amilcar
   Martins, Reinaldo M.
   Marques, Ernesto T. A.
   Bonaldo, Myrna C.
   Ferreira, Antonio G. P.
   Lourenco-de-Oliveira, Ricardo
   Nogueira, Rita Maria R.
   Sequeira, Patricia C.
   Marzochi, Keyla B. F.
   Homma, Akira
TI Zika puzzle in Brazil: peculiar conditions of viral introduction and
   dissemination - A Review
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE Zika; microcephaly; congenital Zika syndrome; neurological disorders;
   pathogenesis; epidemiology
ID VIRUS-INFECTION; DENGUE VIRUS; SEXUAL TRANSMISSION; AEDES-AEGYPTI;
   PREGNANCY; JANUARY; AMERICA; WOMEN; SEMEN; BIRTH
AB This article discusses the peculiar conditions that favoured the unexpected introduction of Zika virus into the poorest northeastern region of Brazil in 2015, its speed of transmission to other Brazilian states, other Latin American countries and other regions, and the severity of related neurological disorders in newborns and adults. Contrasting with evidence that Zika had so far caused only mild cases in humans in the last six decades, the epidemiological scenario of this outbreak in Brazil indicates dramatic health effects: in 2015, an increase of 20-fold in notified cases of microcephaly and/or central nervous system (CNS) alterations suggestive of Zika congenital infection, followed by an exponential increase in 2016, with 2366 cumulative cases confirmed in the country by the end of December 2016. A significant increase in Guillain-Barre syndrome in adults has also been reported. Factors involved in viral dissemination, neural pathogenesis and routes of transmission in Brazil are examined, such as the role of social and environmental factors and the controversies involved in the hypothesis of antibody-dependent enhancement, to explain the incidence of congenital Zika syndrome in Brazil. Responses to the Zika outbreak and the development of new products are also discussed.
C1 [Possas, Cristina; Martins, Reinaldo M.; Homma, Akira] Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Fdn Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Marzochi, Mauro C. A.; Marzochi, Keyla B. F.] Fdn Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin & Vigilincia Leishmaniose, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Marques, Ernesto T. A.] Fdn Oswaldo Cruz Fiocruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Bonaldo, Myrna C.] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Antonio G. P.] Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Dept Reativos Diagnost, Rio De Janeiro, RJ, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Nogueira, Rita Maria R.; Sequeira, Patricia C.] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
RP Possas, C (corresponding author), Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Rio De Janeiro, RJ, Brazil.
EM cristina.possas@bio.fiocruz.br
RI Martins, Reinaldo/I-3413-2015; Marques, Ernesto T. A/L-4967-2013;
   Possas, Cristina/AAJ-3840-2020
OI Martins, Reinaldo/0000-0002-0667-532X; Marques, Ernesto T.
   A/0000-0003-3826-9358; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FIOCRUZ
FX CNPq, FAPERJ, FIOCRUZ
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bonaldo MC, 2014, HUM VACC IMMUNOTHER, V10, P1256, DOI 10.4161/hv.28117
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Melo Freire CCIA, 2015, BIORXIV
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, BIORXIV
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOLOGICO, V48, P10
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencia em Saude Publica sobre Febre Amarela, 2017, 282017 MS COES
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2017, 572016 MS CTR OP EM
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2016, 282016 MS CTR OP EM
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2016, 562016 MS CTR OP EM
   Munoz LS, 2016, SEMIN REPROD MED
   NIAID/NIH-National Institute of Allergy and Infectious Diseases/National Institutes of Health, 2016, ZIK VIR TREATM RES
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PAHO/WHO-Pan American Health Organization/World Healt Organization, 2016, ZIK EP REP BRAZ
   PAHO/WHO-Pan American Health Organization/World Health Organization, 2016, CAS DEF
   PAHO-Pan American Health Organization, 2017, REG ZIK EP LOG UPD A
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 62
TC 19
Z9 20
U1 0
U2 20
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2017
VL 112
IS 5
BP 319
EP 327
DI 10.1590/0074-02760160510
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ET3EG
UT WOS:000400159600001
PM 28443985
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU He, A
   Brasil, P
   Siqueira, AM
   Calvet, GA
   Kwatra, SG
AF He, Alice
   Brasil, Patricia
   Siqueira, Andre M.
   Calvet, Guilherme A.
   Kwatra, Shawn G.
TI The Emerging Zika Virus Threat: A Guide for Dermatologists
SO AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
LA English
DT Review
ID UNITED-STATES; INFECTION; TRAVELERS; TRANSMISSION; INDONESIA; DENGUE;
   CHIKUNGUNYA; COINFECTION; OUTBREAK; PATIENT
AB We provide a guide for dermatologists to follow if they encounter patients with a rash and clinical history suspicious of Zika virus infection, including diagnostic testing and management options. We also provide an illustrative case report of a patient from Brazil who was diagnosed with Zika virus infection after presenting with a generalized pruritic rash. One of the most prominent symptoms of Zika virus infection is a cutaneous eruption. As such, it is especially necessary for dermatologists to understand this virus so that they may appropriately recognize this entity as a diagnostic consideration in the clinic. The rash associated with Zika virus infection is most commonly an erythematous maculopapular eruption that presents after an initial 3-4 days of fever, headache, and arthralgia or myalgia. The rash typically lasts for an average of 6 days, and can spread to involve any part of the body, including the face, torso, extremities, palms, and soles.
C1 [He, Alice; Kwatra, Shawn G.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.
   [Brasil, Patricia; Siqueira, Andre M.; Calvet, Guilherme A.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP He, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.
EM ahe1@jhmi.edu
RI Siqueira, Andre M/G-1340-2010; Calvet, GA/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet, GA/0000-0002-3545-5238
CR [Anonymous], 2016, CDC NEWSROOM
   [Anonymous], 2016, ZIKA VIRUS HLTH EFFE
   [Anonymous], 2016, ZIKA VIRUS
   [Anonymous], 2015, ZIKA VIRUS DIS US 20
   Besnard M., 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2016, ZIK VIR 2016
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li J., 2016, VENEZUELA        FEB
   Macesis N, 2015, CLIN INFECT DIS, V61, P1485
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sampathkumar P, 2003, MAYO CLIN PROC, V78, P1137, DOI 10.4065/78.9.1137
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EURO SURVEILL, V19
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 53
TC 4
Z9 5
U1 0
U2 4
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1175-0561
EI 1179-1888
J9 AM J CLIN DERMATOL
JI Am. J. Clin. Dermatol.
PD APR
PY 2017
VL 18
IS 2
BP 231
EP 236
DI 10.1007/s40257-016-0243-z
PG 6
WC Dermatology
SC Dermatology
GA ER3RD
UT WOS:000398714400006
PM 28035650
DA 2020-12-01
ER

PT J
AU Jaenisch, T
   Rosenberger, KD
   Brito, C
   Brady, O
   Brasil, P
   Marques, ETA
AF Jaenisch, Thomas
   Rosenberger, Kerstin Daniela
   Brito, Carlos
   Brady, Oliver
   Brasil, Patricia
   Marques, Ernesto T. A.
TI Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
AB Objective To estimate the risk of microcephaly in babies born to women infected by the Zika virus during pregnancy in Brazil in an epidemic between 2015 and 2016.
   Methods We obtained data on the number of notified and confirmed microcephaly cases in each Brazilian state between November 2015 and October 2016 from the health ministry. For Pernambuco State, one of the hardest hit, weekly data were available from August 2015 to October 2016 for different definitions of microcephaly. The absolute risk of microcephaly was calculated using the average number of live births reported in each state in the corresponding time period between 2012 and 2014 and assuming two infection rates: 10% and 50%. The relative risk was estimated using the reported background frequency of microcephaly in Brazil of 1.98 per 10 000 live births.
   Findings The estimated absolute risk of a notified microcephaly case varied from 0.03 to 17.1% according to geographical area, the definition of microcephaly used and the infection rate. Assuming a 50% infection rate, there was an 18-127 fold higher probability of microcephaly in children born to mothers with infection during pregnancy compared with children born to mothers without infection during pregnancy in Pernambuco State. For a 10% infection rate, the probability was.88-635 folds higher.
   Conclusion A large variation in the estimated risk of microcephaly was found in Brazil. Research is needed into possible effect modifiers, reliable measures of Zika virus infection and clear endpoints for congenital malformations.
C1 [Jaenisch, Thomas; Rosenberger, Kerstin Daniela] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
   [Brito, Carlos] Univ Fed Pernambuco, Dept Internal Med, Recife, PE, Brazil.
   [Brady, Oliver] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Ernesto T. A.] Aggeu Magalhaes Res Ctr, Virol & Expt Therapeut Lab, Recife, PE, Brazil.
RP Jaenisch, T (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
EM thomas.jaenisch@urz.uni-heidelberg.de
RI Jaenisch, Thomas/H-3473-2017; Brady, Oliver/P-9421-2019; Marques,
   Ernesto T. A/L-4967-2013
OI Brady, Oliver/0000-0002-3235-2129; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU European Union's Horizon 2020 research and innovation programme
   (ZIKAlliance grant) [734548]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme (ZIKAlliance grant agreement no. 734548) and
   Seventh Framework Programme for Research and Technological Development
   (International Research Consortium on Dengue Risk Assessment, Management
   and Surveillance, IDAMS, grant agreement no. 281803). The manuscript has
   been given the IDAMS publication reference number IDAMS 35.
CR [Anonymous], 2015, MICR BRAZ POT LINK Z
   [Anonymous], 2016, NASC VIV BRAS
   [Anonymous], 2016, HUFFINGTON POST
   [Anonymous], 2015, FREQ MICR NASC BRAS
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65
   Microcefalia e outran alteracOes do sistema nervoso central, 2016, 90 SEVSSESPE MICR OU
   Microcefalia e outras afteracoes do sistema nervoso central, 2016, 70 SEVSSESPE MICR OU
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monitoramento dos casos de microcefalia no Brasil, 2016, 48 MON CAS MICR BRAS
   Pan American Health Organization World Health Organization, 2015, EP AL NEUR SYNDR CON
   Partlow J, 2016, WASHINGTON POST
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silviera M., 2015, NAO ENGRAVIDEM AGORA
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 30
TC 41
Z9 42
U1 0
U2 8
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD MAR
PY 2017
VL 95
IS 3
BP 191
EP 198
DI 10.2471/BLT.16.178608
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN4IX
UT WOS:000395972300008
PM 28250532
OA Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Alvarenga, DAM
   Pina-Costa, A
   Bianco, C
   Moreira, SB
   Brasil, P
   Pissinatti, A
   Daniel-Ribeiro, CT
   Brito, CFA
AF Alvarenga, Denise A. M.
   Pina-Costa, Anielle
   Bianco, Cesare, Jr.
   Moreira, Silvia B.
   Brasil, Patricia
   Pissinatti, Alcides
   Daniel-Ribeiro, Claudio T.
   Brito, Cristiana F. A.
TI New potential Plasmodium brasilianum hosts: tamarin and marmoset monkeys
   (family Callitrichidae)
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Plasmodium brasilianum; Callitrichidae; Callithrix; Mico;
   Leontopithecus; Atlantic forest
ID POLYMERASE-CHAIN-REACTION; RIO-DE-JANEIRO; NATURAL INFECTION; MALARIA
   PARASITES; SIMIAN MALARIA; BRAZILIAN AMAZON; ATLANTIC FOREST; PRIMATES;
   RESERVOIRS; PREVALENCE
AB Background: Non-human primates (NHPs) as a source for Plasmodium infections in humans are a challenge for malaria elimination. In Brazil, two species of Plasmodium have been described infecting NHPs, Plasmodium brasilianum and Plasmodium simium. Both species are infective to man. Plasmodium brasilianum resembles morphologically, genetically and immunologically the human quartan Plasmodium malariae. Plasmodium brasilianum naturally infects species of non-human primates from all New World monkey families from a large geographic area. In the family Callitrichidae only the genus Saguinus has been described infected so far. The present study describes the natural infection of P. brasilianum in tamarins and marmosets of the genera Callithrix, Mico and Leontopithecus in the Atlantic forest.
   Methods: One hundred and twenty-two NHPs of the family Callitrichidae housed in the Primate Centre of Rio de Janeiro (CPRJ) were sampled in June 2015, and January and July 2016. The CPRJ is located in the Atlantic forest in the Guapimirim municipality, in the Rio de Janeiro state, where human autochthonous cases of malaria have been reported. The samples were screened for the presence of Plasmodium using optical microscopy and nested PCR for detection of 18S small subunit rRNA gene. The amplicon was sequenced to confirm the molecular diagnosis.
   Results: The frequency of Plasmodium infections detected by nested PCR in New World monkeys of the family Callitrichidae was 6.6%. For the first time, Callitrichidae primates of genera Callithrix, Mico and Leontopithecus were found naturally infected with P. brasilianum. Infection was confirmed by sequencing a small fragment of 18S rRNA gene, although no parasites were detected in blood smears.
   Conclusions: The reported P. brasilianum infection in NHP species maintained in captivity suggests that infection can be favoured by the presence of vectors and the proximity between known (and unknown) hosts of malaria. Thus, the list of potential malaria reservoirs needs to be further explored.
C1 [Alvarenga, Denise A. M.; Brito, Cristiana F. A.] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisa Rene Rachou CPqRR, Lab Malaria, Belo Horizonte, MG, Brazil.
   [Pina-Costa, Anielle; Brasil, Patricia] INI, Lab Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
   [Pina-Costa, Anielle; Bianco, Cesare, Jr.; Brasil, Patricia; Daniel-Ribeiro, Claudio T.] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPDMa, Rio De Janeiro, RJ, Brazil.
   [Bianco, Cesare, Jr.; Daniel-Ribeiro, Claudio T.] Fiocruz MS, IOC, Lab Pesquisa Malaria, Rio De Janeiro, RJ, Brazil.
   [Moreira, Silvia B.; Pissinatti, Alcides] Ctr Primatol Rio de Janeiro CPRJ INEA, Rio De Janeiro, RJ, Brazil.
   [Pissinatti, Alcides] Ctr Univ Serra Orgaos UNIFESO, Rio De Janeiro, RJ, Brazil.
RP Brito, CFA (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisa Rene Rachou CPqRR, Lab Malaria, Belo Horizonte, MG, Brazil.
EM cristiana@cpqrr.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Fundacao de
   Amparo a Pesquisa do estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/171.271/2006]; Secretary for Health Surveillance (SVS) of
   the Brazilian Ministry of Health, through the Global Fund
   [IOC-005-Fio-13]
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG), Fundacao de Amparo a Pesquisa do estado do
   Rio de Janeiro (FAPERJ-Proc. E-26/171.271/2006) and the Secretary for
   Health Surveillance (SVS) of the Brazilian Ministry of Health, through
   the Global Fund (Agreement IOC-005-Fio-13).
CR Aitken EH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1155-3
   Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406
   Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180
   Azevedo AL, 1997, THESIS, P150
   BAERG DC, 1971, J PARASITOL, V57, P8, DOI 10.2307/3277745
   Bueno MG, 2013, ECOHEALTH, V10, P48, DOI 10.1007/s10393-012-0809-z
   CEPA-Centro de Estudos e Pesquisa em Antropozoonoses do Estado do Rio de Janeiro Maximo da Fonseca Filho, 2009, 1 ENC MACR MAL RIO D
   COATNEY GR, 1971, AM J TROP MED HYG, V20, P795, DOI 10.4269/ajtmh.1971.20.795
   Coatney GR, 1972, THE PRIMATE MALARIAS, P366
   COCHRANE AH, 1985, INFECT IMMUN, V50, P58, DOI 10.1128/IAI.50.1.58-61.1985
   COLLINS WE, 1985, J PARASITOL, V71, P767, DOI 10.2307/3281710
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102
   De Arruda ME., 1985, MEM I O CRUZ, V68, P367
   de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   Deane LM, 1966, REV PAUL MED, V68, P119
   DEARRUDA M, 1989, AM J TROP MED HYG, V41, P379, DOI 10.4269/ajtmh.1989.41.379
   DUNN FL, 1963, J PARASITOL, V49, P316, DOI 10.2307/3276004
   Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168
   FloresMendoza C, 1996, MEM I OSWALDO CRUZ, V91, P265, DOI 10.1590/S0074-02761996000300001
   Garnham PCC, 1966, MALARIA PARASITES OT
   LAL AA, 1988, J BIOL CHEM, V263, P5495
   Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033
   Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004
   de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6
   MARINKELLE CJ, 1968, TROP GEOGR MED, V20, P276
   Ministerio da Saude, 2009, MAN DIAGN LAB MAL
   Ngoubangoye B, 2016, INT J PARASITOL, V46, P737, DOI 10.1016/j.ijpara.2016.06.004
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pina-Costa A., 2016, OUTBREAK AU IN PRESS
   PORTER JA, 1966, J PARASITOL, V52, P669, DOI 10.2307/3276426
   Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   Rylands Anthony B., 2000, Neotropical Primates, V8, P61
   SERRANO JA, 1967, ACTA CIENT VENEZ, V18, P13
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68
   Taliaferro WIH, 1934, AM J HYG, V20, P60, DOI 10.1093/oxfordjournals.aje.a118068
   Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93
   van Roosmalen Marc G.M., 2003, Neotropical Primates, V11, P1
   WEDDERBURN N, 1985, PARASITOLOGY, V90, P573, DOI 10.1017/S0031182000055566
   WHO, 2015, WORLD MAL REP 2015
NR 47
TC 9
Z9 10
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD FEB 10
PY 2017
VL 16
AR 71
DI 10.1186/s12936-017-1724-0
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8QQ
UT WOS:000394188900005
PM 28187764
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ribeiro, CF
   Lopes, VGS
   Brasil, P
   Pires, ARC
   Rohloff, R
   Nogueira, RMR
AF Ribeiro, Christiane Fernandes
   Silami Lopes, Vania Gloria
   Brasil, Patricia
   Cordovil Pires, Andrea Rodrigues
   Rohloff, Roger
   Ribeiro Nogueira, Rita Maria
TI Dengue infection in pregnancy and its impact on the placenta
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE dengue; pregnancy; vertical transmission; placenta
AB A histopathological and immunohistochemical study was conducted in placental tissues and retained products of conception from 24 patients with confirmed dengue infection during pregnancy. The immunohistochemical assay was positive for dengue virus in 19 placental and three ovular remnants analyzed. The light microscopic findings were signs of hypoxia, choriodeciduitis, deciduitis and intervillositis and the viral antigens were found in cytoplasmic of the trophoblast, villous stroma and decidua. Our results suggest that immunohistochemistry could be used as a laboratory confirmation method for dengue in pregnant women, especially in endemic areas when embedded material is the only material available. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Ribeiro, Christiane Fernandes] Univ Fed Fluminense, Dept Maternoinfantil, 303 Marques do Parana St,3 Floor, BR-24033900 Rio De Janeiro, Brazil.
   [Silami Lopes, Vania Gloria] Univ Fed Fluminense, Dept Pathol, 303 Marques do Parana St, BR-24033900 Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fiocruz MS, Evandro Chagas Natl Inst Infectol, Rio De Janeiro, Brazil.
   [Cordovil Pires, Andrea Rodrigues] Univ Fed Fluminense, Dept Pathol, 303 Marques do Parana St, BR-24033900 Rio De Janeiro, Brazil.
   [Rohloff, Roger] Perinatal Laranjeiras & Barra Tijuca, Maternal Fetal Intens Care Unit, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Flavirus Lab, Rio De Janeiro, Brazil.
RP Ribeiro, CF (corresponding author), Univ Fed Fluminense, Dept Maternoinfantil, 303 Marques do Parana St,3 Floor, BR-24033900 Rio De Janeiro, Brazil.
EM chrisribeiro@vm.uff.br; vasilami@oul.com.br;
   patricia.brasil@ini.fiocruz.br; andreapires@fontemd.com.br;
   roger.rohloff@gmail.com; rita@ioc.fiocruz.br
RI amsalu, ribka/G-8780-2019
FU FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX We acknowledge FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro) for funding the laboratory diagnosis. Janice Coelho, Adriana
   Gouveia, Licinio Esmeraldo da Silva and Luca Ugenti Cipiani, for their
   contribution on data collection.
CR Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   APGAR V, 1953, Curr Res Anesth Analg, V32, P260
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0
   Fox H, 2007, PATHOLOGY PLACENTA
   Nunes PCG, 2016, J MED VIROL, V88, P1448, DOI 10.1002/jmv.24479
   Limonta Daniel, 2009, Int J Infect Dis, V13, pe77, DOI 10.1016/j.ijid.2008.06.028
   Ozono K, 1997, PEDIATR PATHOL LAB M, V17, P249, DOI 10.1080/107710497174895
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005
NR 11
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2017
VL 55
BP 109
EP 112
DI 10.1016/j.ijid.2017.01.002
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EP2KN
UT WOS:000397212000021
PM 28088588
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Brasil, P
   Pereira, JP
   Moreira, ME
   Nogueira, RMR
   Damasceno, L
   Wakimoto, M
   Rabello, RS
   Valderramos, SG
   Halai, UA
   Salles, TS
   Zin, AA
   Horovitz, D
   Daltro, P
   Boechat, M
   Gabaglia, CR
   de Sequeira, PC
   Pilotto, JH
   Medialdea-Carrera, R
   da Cunha, DC
   de Carvalho, LMA
   Pone, M
   Siqueira, AM
   Calvet, GA
   Baiao, AER
   Neves, ES
   de Carvalho, PRN
   Hasue, RH
   Marschik, PB
   Einspieler, C
   Janzen, C
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, P.
   Pereira, J. P., Jr.
   Moreira, M. E.
   Ribeiro Nogueira, R. M.
   Damasceno, L.
   Wakimoto, M.
   Rabello, R. S.
   Valderramos, S. G.
   Halai, U. -A.
   Salles, T. S.
   Zin, A. A.
   Horovitz, D.
   Daltro, P.
   Boechat, M.
   Gabaglia, C. Raja
   Carvalho de Sequeira, P.
   Pilotto, J. H.
   Medialdea-Carrera, R.
   Cotrim da Cunha, D.
   Abreu de Carvalho, L. M.
   Pone, M.
   Machado Siqueira, A.
   Calvet, G. A.
   Rodrigues Baiao, A. E.
   Neves, E. S.
   Nassar de Carvalho, P. R.
   Hasue, R. H.
   Marschik, P. B.
   Einspieler, C.
   Janzen, C.
   Cherry, J. D.
   Bispo de Filippis, A. M.
   Nielsen-Saines, K.
TI Zika Virus Infection in Pregnant Women in Rio de Janeiro
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID BRAZIL; TRANSMISSION; RUBELLA
AB BACKGROUND
   Zika virus (ZIKV) has been linked to central nervous system malformations in fetuses. To characterize the spectrum of ZIKV disease in pregnant women and infants, we followed patients in Rio de Janeiro to describe clinical manifestations in mothers and repercussions of acute ZIKV infection in infants.
   METHODS
   We enrolled pregnant women in whom a rash had developed within the previous 5 days and tested blood and urine specimens for ZIKV by reverse-transcriptase-polymerase-chain-reaction assays. We followed women prospectively to obtain data on pregnancy and infant outcomes.
   RESULTS
   A total of 345 women were enrolled from September 2015 through May 2016; of these, 182 women (53%) tested positive for ZIKV in blood, urine, or both. The timing of acute ZIKV infection ranged from 6 to 39 weeks of gestation. Predominant maternal clinical features included a pruritic descending macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (short-term and low-grade). By July 2016, a total of 134 ZIKV-affected pregnancies and 73 ZIKV-unaffected pregnancies had reached completion, with outcomes known for 125 ZIKV-affected and 61 ZIKV-unaffected pregnancies. Infection with chikungunya virus was identified in 42% of women without ZIKV infection versus 3% of women with ZIKV infection (P<0.001). Rates of fetal death were 7% in both groups; overall adverse outcomes were 46% among offspring of ZIKV-positive women versus 11.5% among offspring of ZIKV-negative women (P<0.001). Among 117 live infants born to 116 ZIKV-positive women, 42% were found to have grossly abnormal clinical or brain imaging findings or both, including 4 infants with microcephaly. Adverse outcomes were noted regardless of the trimester during which the women were infected with ZIKV (55% of pregnancies had adverse outcomes after maternal infection in the first trimester, 52% after infection in the second trimester, and 29% after infection in the third trimester).
   CONCLUSIONS
   Despite mild clinical symptoms in the mother, ZIKV infection during pregnancy is deleterious to the fetus and is associated with fetal death, fetal growth restriction, and a spectrum of central nervous system abnormalities. (Funded by Ministerio da Saude do Brasil and others.)
C1 [Brasil, P.; Pereira, J. P., Jr.; Moreira, M. E.; Ribeiro Nogueira, R. M.; Damasceno, L.; Wakimoto, M.; Rabello, R. S.; Salles, T. S.; Zin, A. A.; Horovitz, D.; Boechat, M.; Carvalho de Sequeira, P.; Pilotto, J. H.; Medialdea-Carrera, R.; Cotrim da Cunha, D.; Abreu de Carvalho, L. M.; Pone, M.; Machado Siqueira, A.; Calvet, G. A.; Rodrigues Baiao, A. E.; Neves, E. S.; Nassar de Carvalho, P. R.; Bispo de Filippis, A. M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Daltro, P.] Clin Diagnost Imagem, Rio De Janeiro, Brazil.
   [Valderramos, S. G.; Halai, U. -A.; Janzen, C.; Cherry, J. D.; Nielsen-Saines, K.] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Gabaglia, C. Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, R. H.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Marschik, P. B.; Einspieler, C.] Med Univ Graz, Graz, Austria.
   [Marschik, P. B.] Karolinska Inst, Stockholm, Sweden.
RP Brasil, P (corresponding author), Fiocruz MS, INI, Lab Doencas Febris Agudas, 4365 Av Brasil, BR-21040900 Rio De Janeiro, RJ, Brazil.; Nielsen-Saines, K (corresponding author), UCLA, David Geffen Sch Med, Div Pediat Infectious Dis, MDCC 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Hasue, Renata
   Hydee/B-2328-2013; Siqueira, Andre M/G-1340-2010; Pilotto, Jose
   Henrique/AAD-9773-2019; Calvet, GA/G-6959-2013; Gaw,
   Stephanie/K-4592-2019; Marschik, Peter B/F-8195-2011
OI Siqueira, Andre M/0000-0003-2208-0294; Pilotto, Jose
   Henrique/0000-0003-0521-8597; Calvet, GA/0000-0002-3545-5238; Gaw,
   Stephanie/0000-0003-0891-6964; Marschik, Peter B/0000-0001-8932-0980;
   Medialdea-Carrera, Raquel/0000-0002-0371-5138; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
FU Ministerio da Saude do Brasil; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R21AI129534, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R21AI129534, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697] Funding
   Source: NIH RePORTER; Medical Research CouncilMedical Research Council
   UK (MRC) [MC_PC_15101] Funding Source: researchfish; Bill & Melinda
   Gates Foundation � Grand Challenges Explorations Initiative [OPP1128871]
   Funding Source: researchfish
FX Funded by Ministerio da Saude do Brasil and others.
CR [Anonymous], 2015, EP AL NEUR SYNDR CON
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cherry JD, 2014, FEIGIN CHERRYS TXB P, P741
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088
   GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NAEYE RL, 1965, J AMER MED ASSOC, V194, P1277, DOI 10.1001/jama.194.12.1277
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   PLOTKIN SA, 1965, AM J EPIDEMIOL, V81, P71, DOI 10.1093/oxfordjournals.aje.a120499
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1964, OBSTET GYNECOL, V23, P153
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 846
Z9 872
U1 9
U2 209
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 15
PY 2016
VL 375
IS 24
BP 2321
EP 2334
DI 10.1056/NEJMoa1602412
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF0SO
UT WOS:000390036500004
PM 26943629
OA Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Brasil, P
   Nielsen-Saines, K
AF Brasil, Patricia
   Nielsen-Saines, Karin
TI More pieces to the microcephaly-Zika virus puzzle in Brazil
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia] Fiocruz RJ, BR-22010122 Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.
RP Brasil, P (corresponding author), Fiocruz RJ, BR-22010122 Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
CR Araujo TVB, 2016, LANCET INFECT DIS
   Brasil Ministerio da Satide, 2015, 12015 BARS MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 11
TC 16
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1307
EP 1309
DI 10.1016/S1473-3099(16)30372-3
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800003
PM 27641776
OA Other Gold, Green Published
DA 2020-12-01
ER

PT J
AU Soares, CN
   Brasil, P
   Carrera, RM
   Sequeira, P
   De Filippis, AB
   Borges, VA
   Theophilo, F
   Ellul, MA
   Solomon, T
AF Soares, Cristiane N.
   Brasil, Patricia
   Carrera, Raquel Medialdea
   Sequeira, Patricia
   De Filippis, Ana Bispo
   Borges, Vitor A.
   Theophilo, Fernando
   Ellul, Mark A.
   Solomon, Tom
TI Fatal encephalitis associated with Zika virus infection in an adult
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Encephalitis; Neurological manifestations
AB Background: Zika virus (ZIKV) was first identified in the Americas in 2015, when an outbreak of an exanthematous illness occurred in Brazil. Subsequentely, there was an increase of microcephaly cases, suggesting an association between ZIKV and this neurological complication. Currently, ZIKV has been recognised as causing a wide range of neurological complications including Guillain Barre syndrome, and myelitis.
   Objectives: In this report, we describe the first fatal case of encephalitis in a 47 years old non pregnant woman, infected during the Brazilian zika epidemic of 2016.
   Study design: The diagnosis of encephalitis was determined by the presence of a disturbed level of consciousness and focal neurological signs during an exanthemous viral infection.
   Results: CSF analysis supported the diagnosis of viral encephalitis, revealing lymphocytic pleocytosis, a high protein concentration, and the presence of IgM zika antibodies. RT-PCR analysis for ZIKV was positive in the urine. A brain computed tomography showed massive brain swelling. Our case differs from previous reports, because her neurological picture developed rapidly and in a very aggressive manner leading to brain death after eleven days of admission.
   Conclusion: In endemic areas, ZIKV should be considered as an aetiological agent in cases of encephalitis, and clinicians should be aware of its potential severity. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Soares, Cristiane N.] Hosp Fed Serv Estado, Neurol Serv, Rua Sacadura Cabral 176, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Sequeira, Patricia; De Filippis, Ana Bispo] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Borges, Vitor A.; Theophilo, Fernando] Hosp Badim, Rio De Janeiro, Brazil.
   [Ellul, Mark A.; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Carrera, Raquel Medialdea; Ellul, Mark A.; Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Ellul, Mark A.; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Soares, CN (corresponding author), Hosp Fed Serv Estado, Neurol Serv, Rua Sacadura Cabral 176, Rio De Janeiro, RJ, Brazil.
EM crist_nsoares@yahoo.com.br
OI Ellul, Mark/0000-0002-6115-8245; Solomon, Tom/0000-0001-7266-6547;
   Medialdea-Carrera, Raquel/0000-0002-0371-5138
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [484735/2013-6]; Fundacao de Amparo a Pesquisa no Estado do Rio de
   Janeiro-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/010.001558/2014]; Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15101] Funding
   Source: researchfish; National Institute for Health ResearchNational
   Institute for Health Research (NIHR) [NF-SI-0514-10177, ACF-2013-07-002,
   RP-PG-0108-10048] Funding Source: researchfish
FX The laboratory essay was supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (grant no.
   484735/2013-6) and Fundacao de Amparo a Pesquisa no Estado do Rio de
   Janeiro-FAPERJ (grant no. E-26/010.001558/2014). These funding sources
   had no other role. The corresponding author had full access to the data
   and made the final decision to publish the manuscript.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
NR 12
TC 74
Z9 76
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2016
VL 83
BP 63
EP 65
DI 10.1016/j.jcv.2016.08.297
PG 3
WC Virology
SC Virology
GA DZ7DY
UT WOS:000386026000014
PM 27598870
OA Green Published
DA 2020-12-01
ER

PT J
AU Ferreira-de-Brito, A
   Ribeiro, IP
   de Miranda, RM
   Fernandes, RS
   Campos, SS
   da Silva, KAB
   de Castro, MG
   Bonaldo, MC
   Brasil, P
   Lourenco-de-Oliveira, R
AF Ferreira-de-Brito, Anielly
   Ribeiro, Ieda P.
   de Miranda, Rafaella Moraes
   Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   Bonaldo, Myrna C.
   Brasil, Patricia
   Lourenco-de-Oliveira, Ricardo
TI First detection of natural infection of Aedes aegypti with Zika virus in
   Brazil and throughout South America
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika; Aedes aegypti; natural infection; Culex quinquefasciatus; Aedes
   albopictus
ID MOSQUITOS; TRANSMISSION; ISOLATIONS; STATES; FEVER
AB Zika virus (ZIKV) has caused a major epidemic in Brazil and several other American countries. ZIKV is an arbovirus whose natural vectors during epidemics have been poorly determined. In this study, 1,683 mosquitoes collected in the vicinity of ZIKV suspected cases in Rio de Janeiro, Brazil, from June 2015 to May 2016 were screened for natural infection by using molecular methods. Three pools of Aedes aegypti were found with the ZIKV genome, one of which had only one male. This finding supports the occurrence of vertical and/or venereal transmission of ZIKV in Ae. aegypti in nature. None of the examined Ae. albopictus and Culex quinquefasciatus was positive. This is the first report of natural infection by ZIKV in mosquitoes in Brazil and other South American countries. So far, Ae. aegypti is the only confirmed vector of ZIKV during the ongoing Pan-American epidemics.
C1 [Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Ieda P.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM lourenco@ioc.fiocruz.br
OI Castro, Maria Graciela/0000-0003-2237-2756; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI115595, U01AI115595, U01AI115595, U01AI115595, U01AI115595,
   U01AI115595] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI115595] Funding Source: Medline
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lourenco-de-Oliveira R, 2015, ORG DENGUE TEORIAS P, P127
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO/WHO - Pan American Health Organization/World Health Organization, 2016, ZIK VIR DET AED ALB
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 98
Z9 103
U1 0
U2 19
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2016
VL 111
IS 10
BP 655
EP 658
DI 10.1590/0074-02760160332
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DZ0FY
UT WOS:000385514100009
PM 27706382
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pone, SM
   Hokerberg, YHM
   de Oliveira, RDC
   Daumas, RP
   Pone, TM
   Pone, MVD
   Brasil, P
AF Pone, Sheila Moura
   Marques Hokerberg, Yara Hahr
   Carvalhaes de Oliveira, Raquel de Vasconcellos
   Daumas, Regina Paiva
   Pone, Tamiris Moura
   da Silva Pone, Marcos Vinicius
   Brasil, Patricia
TI Clinical and laboratory signs associated to serious dengue disease in
   hospitalized children
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Dengue; Children; Sensitivity and specificity; Validation studies
ID SHOCK SYNDROME; HEMORRHAGIC-FEVER; RISK-FACTORS; CLASSIFICATION;
   SEVERITY; ACCURACY; ILLNESS
AB Objective: To evaluate the validity of clinical and laboratory signs to serious dengue disease in hospitalized children.
   Methods: Retrospective cohort of children (<18 years) hospitalized with dengue diagnosis (2007-2008). Serious dengue disease was defined as death or use of advanced life support therapy. Accuracy measures and area under the receiver operating characteristic curve were calculated.
   Results: Of the total (n=145), 53.1% were female, 69% aged 2-11 years, and 15.9% evolved to the worse outcome. Lethargy had the best accuracy (positive likelihood ratio >19 and negative likelihood ratio <0.6). Pleural effusion and abdominal distension had higher sensitivity (82.6%). History of bleeding (epistaxis, gingival or gastrointestinal bleeding) and severe hemorrhage (pulmonary or gastrointestinal bleeding) in physical examination were more frequent in serious dengue disease (p < 0.01), but with poor accuracy (positive likelihood ratio = 1.89 and 3.89; negative likelihood ratio = 0.53 and 0.60, respectively). Serum albumin was lower in serious dengue forms (p < 0.01). Despite statistical significance (p < 0.05), both groups presented thrombocytopenia. Platelets count, hematocrit, and hemoglobin parameters had area under the curve <0.5.
   Conclusions: Lethargy, abdominal distension, pleural effusion, and hypoalbuminemia were the best clinical and laboratorial markers of serious dengue disease in hospitalized children, while bleeding, severe hemorrhage, hemoconcentration and thrombocytopenia did not reach adequate diagnostic accuracy. In pediatric referral hospitals, the absence of hemoconcentration does not imply absence of plasma leakage, particularly in children with previous fluid replacement. These findings may contribute to the clinical management of dengue in children at referral hospitals. (C) 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
C1 [Pone, Sheila Moura; Marques Hokerberg, Yara Hahr; Carvalhaes de Oliveira, Raquel de Vasconcellos; Daumas, Regina Paiva; Pone, Tamiris Moura; da Silva Pone, Marcos Vinicius; Brasil, Patricia] Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
RP Pone, SM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
EM spone@iff.fiocruz.br
RI DAUMAS, REGINA/M-9387-2013; da Silva Pone, Marcos Vinicius/N-1285-2019;
   Oliveira, Raquel de V C de/S-7443-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Oliveira, Raquel de V C
   de/0000-0001-9387-8645; Moura Pone, Sheila/0000-0002-6246-8915; da Silva
   Pone, Marcos Vinicius/0000-0002-5152-2242
FU Rede Dengue FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/110.964/2013 - APQ1]
FX This research was supported by Rede Dengue FIOCRUZ and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [grant number
   E-26/110.964/2013 - APQ1].
CR Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Saude, 2005, GUIA VIGILANCIA EPID
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Saude, 2013, DIR TECN GEST DENG D
   Capeding RZ, 2010, AM J TROP MED HYG, V82, P330, DOI 10.4269/ajtmh.2010.09-0542
   Elling R, 2013, PEDIATR INFECT DIS J, V32, P1020, DOI 10.1097/INF.0b013e31829fd0e9
   Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007
   Gupta P, 2010, J INFECT DEV COUNTR, V4, P150, DOI 10.3855/jidc.708
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Halstead S. B., 2009, F1000 MED REP, V1, P73
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045
   Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017
   Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255
   Lora AJM, 2014, AM J TROP MED HYG, V90, P169, DOI 10.4269/ajtmh.13-0440
   Malavige GN, 2006, ARCH DIS CHILD, V91, P396, DOI 10.1136/adc.2005.085191
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Neto RDP, 2013, REV SOC BRAS MED TRO, V46, P765, DOI 10.1590/0037-8682-1716-2013
   Pongpan S, 2013, ISRN PEDIAT, DOI DOI 10.1155/2013/845876
   Potts JA, 2010, AM J TROP MED HYG, V83, P781, DOI 10.4269/ajtmh.2010.10-0135
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196
   Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 30
TC 10
Z9 11
U1 0
U2 4
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2016
VL 92
IS 5
BP 464
EP 471
DI 10.1016/j.jped.2015.12.005
PG 8
WC Pediatrics
SC Pediatrics
GA EA3VN
UT WOS:000386537500005
PM 27112034
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Fernandes, RS
   Campos, SS
   Ferreira-de-Brito, A
   de Miranda, RM
   da Silva, KAB
   de Castro, MG
   Raphael, LMS
   Brasil, P
   Failloux, AB
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Ferreira-de-Brito, Anielly
   de Miranda, Rafaella Moraes
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   Raphael, Lidiane M. S.
   Brasil, Patricia
   Failloux, Anna-Bella
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Culex quinquefasciatus from Rio de Janeiro Is Not Competent to Transmit
   the Local Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI MOSQUITOS; POTENTIAL VECTOR; YELLOW-FEVER; DENGUE;
   ALBOPICTUS; BRAZIL; SPECIFICITY; CHIKUNGUNYA; ISOLATIONS; AMERICA
AB Background
   The Americas have suffered a dramatic epidemic of Zika since May in 2015, when Zika virus (ZIKV) was first detected in Brazil. Mosquitoes belonging to subgenus Stegomyia of Aedes, particularly Aedes aegypti, are considered the primary vectors of ZIKV. However, the rapid spread of the virus across the continent raised several concerns about the transmission dynamics, especially about potential mosquito vectors. The purpose of this work was to assess the vector competence of the house mosquito Culex quinquefasciatus from an epidemic Zika area, Rio de Janeiro, Brazil, for local circulating ZIKV isolates.
   Methodology/Principal Findings
   Culex quinquefasciatus and Ae. aegypti (positive control of ZIKV infection) from Rio de Janeiro were orally exposed to two ZIKV strains isolated from human cases from Rio de Janeiro (Rio-U1 and Rio-S1). Fully engorged mosquitoes were held in incubators at 26 +/- 1 degrees C, 12 h:12 h light: dark cycle and 70 +/- 10% humidity. For each combination mosquito population-ZIKV strain, 30 specimens were examined for infection, dissemination and transmission rates, at 7, 14 and 21 days after virus exposure by analyzing body (thorax plus abdomen), head and saliva respectively. Infection rates were minimal to completely absent in all Cx. quinquefasciatus-virus combinations and were significantly high for Ae. aegypti. Moreover, dissemination and transmission were not detected in any Cx. quinquefasciatus mosquitoes whatever the incubation period and the ZIKV isolate. In contrast, Ae. aegypti ensured high viral dissemination and moderate to very high transmission.
   Conclusions/Significance
   The southern house mosquito Cx. quinquefasciatus from Rio de Janeiro was not competent to transmit local strains of ZIKV. Thus, there is no experimental evidence that Cx. quinquefasciatus likely plays a role in the ZIKV transmission. Consequently, at least in Rio, mosquito control to reduce ZIKV transmission should remain focused on Ae. aegypti.
C1 [Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
RP Lourenco-de-Oliveira, R (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br
FU CAPES-COFECUB COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL
   SUPERIOR [799/14]; Institut Pasteur; French Government's Investissement
   d'Avenir program, aboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/102.351/2013]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309577/2013-6]; National Institut
   of Health [1UO1 AI115595-01]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI115595, U01AI115595,
   U01AI115595, U01AI115595, U01AI115595, U01AI115595] Funding Source: NIH
   RePORTER
FX This work was funded by CAPES-COFECUB COORDENACAO DE APERFEICOAMENTO DE
   PESSOAL DE NIVEL SUPERIOR (grant n. 799/14), the Institut Pasteur, the
   French Government's Investissement d'Avenir program, aboratoire
   d'Excellence "Integrative Biology of Emerging Infectious Diseases"(grant
   n. ANR-10-LABX-62-IBEID), Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (grant n. E-26/102.351/2013),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant n.
   309577/2013-6). National Institut of Health (grant n. 1UO1 AI115595-01).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2015, J INFECT DIS
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lourenco-De-Oliveira R, 2008, MEM I OSWALDO CRUZ, V103, P627, DOI 10.1590/S0074-02762008000700001
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL INFEC
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tognarelli J., 2015, ARCH VIROL
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, REV VECT ZIK AED
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 67
Z9 68
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004993
DI 10.1371/journal.pntd.0004993
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900048
PM 27598421
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Justino, MCA
   Brasil, P
   Abreu, E
   Miranda, Y
   Mascarenhas, JDP
   Guerra, SFS
   Linhares, AC
AF Justino, Maria Cleonice A.
   Brasil, Patricia
   Abreu, Erika
   Miranda, Yllen
   Mascarenhas, Joana D'Arc P.
   Guerra, Sylvia F. S.
   Linhares, Alexandre C.
TI Clinical Severity and Rotavirus Vaccination among Children Hospitalized
   for Acute Gastroenteritis in Belem, Northern Brazil
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE rotavirus; gastroenteritis; severity; vaccination status
ID EFFICACY; SAFETY; IMPACT
AB In March 2006, Brazil introduced the monovalent rotavirus (RV) vaccine (Rotarix (TM)) into the public sector. This study assessed the severity of rotavirus gastroenteritis (RVGE) according to the vaccination status among hospitalized children. We identified 1023 RVGE episodes among not vaccinated (n = 252), partially vaccinated (n = 156) and fully vaccinated (n = 615) children. Very severe gastroenteritis (scored >= 15) was reported in 16.7, 17.9 and 13.5% of not vaccinated, partially vaccinated and fully vaccinated children, respectively. There was a trend for a shorter duration of RV diarrhoea among vaccinated children than in not vaccinated children (p = 0.07). A protective effect of vaccination was noted when mean duration of symptoms and hospital stay are analysed, comparing unvaccinated, partially vaccinated and fully vaccinated children (p < 0.05). We showed a vaccination dose effect trend, with fully vaccinated children having less-severe RVGE than not vaccinated and partially vaccinated children.
C1 [Justino, Maria Cleonice A.; Abreu, Erika; Miranda, Yllen; Mascarenhas, Joana D'Arc P.; Guerra, Sylvia F. S.; Linhares, Alexandre C.] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Pesquisa Clin, BR-21040900 Rio De Janeiro, Brazil.
RP Linhares, AC (corresponding author), Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Belem, Para, Brazil.; Linhares, AC (corresponding author), Rodovia BR 316,Km 7, BR-67030000 Ananindeua, Para, Brazil.
EM alexandrelinhares@iec.pa.gov.br
OI Aguiar Justino, Maria Cleonice/0000-0003-3248-5893
FU Instituto Evandro Chagas, Health Surveillance Secretariat, Brazilian
   Ministry of Health
FX This work was supported by Instituto Evandro Chagas, Health Surveillance
   Secretariat, Brazilian Ministry of Health. AC Linhares was the principal
   investigator of studies with the Human RV Vaccine (Rotarix (R)) in
   Belem, Brazil, and MCA Justino was the clinical coordinator of these
   studies.
CR Brazilian Ministry of Health, 2012, 1932012 BRAZ MIN HLT
   Constenla DO, 2008, J HEALTH POPUL NUTR, V26, P388
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   Guerra SFS, 2015, J MED VIROL, V87, P1303, DOI 10.1002/jmv.24183
   Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2
   Linhares A. C., 2012, Trials in Vaccinology, V1, P36, DOI 10.1016/j.trivac.2012.07.002
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Linhares AC, 2014, EXPERT REV VACCINES, V13, P43, DOI 10.1586/14760584.2014.861746
   O'Ryan M, 2011, EXPERT REV VACCINES, V10, P1645, DOI [10.1586/erv.11.152, 10.1586/ERV.11.152]
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046
   Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   Wang FT, 2013, PEDIATR INFECT DIS J, V32, P278, DOI 10.1097/INF.0b013e318275328f
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P533
NR 15
TC 2
Z9 2
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD AUG
PY 2016
VL 62
IS 4
BP 276
EP 281
DI 10.1093/tropej/fmv098
PG 6
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA DY2QX
UT WOS:000384938200004
PM 26884442
OA Bronze
DA 2020-12-01
ER

PT J
AU Brasil, P
   Calvet, GA
   de Souza, RV
   Siqueira, AM
AF Brasil, Patricia
   Calvet, Guilherme A.
   de Souza, Rogerio V.
   Siqueira, Andre M.
TI Exanthema associated with Zika virus infection
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia; Calvet, Guilherme A.; de Souza, Rogerio V.; Siqueira, Andre M.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Calvet, GA/G-6959-2013; Siqueira, Andre M/G-1340-2010
OI Calvet, GA/0000-0002-3545-5238; Siqueira, Andre M/0000-0003-2208-0294
NR 0
TC 8
Z9 8
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 866
EP 866
DI 10.1016/S1473-3099(16)30117-7
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600043
PM 27352763
OA Bronze
DA 2020-12-01
ER

PT J
AU Calvet, G
   Aguiar, RS
   Melo, ASO
   Sampaio, SA
   de Filippis, I
   Fabri, A
   Araujo, ESM
   de Sequeira, PC
   de Mendonca, MCL
   de Oliveira, L
   Tschoeke, DA
   Schrago, CG
   Thompson, FL
   Brasil, P
   dos Santos, FB
   Nogueira, RMR
   Tanurit, A
   Filippis, AMB
AF Calvet, Guilherme
   Aguiar, Renato S.
   Melo, Adriana S. O.
   Sampaio, Simone A.
   de Filippis, Ivano
   Fabri, Allison
   Araujo, Eliane S. M.
   de Sequeira, Patricia C.
   de Mendonca, Marcos C. L.
   de Oliveira, Louisi
   Tschoeke, Diogo A.
   Schrago, Carlos G.
   Thompson, Fabiano L.
   Brasil, Patricia
   dos Santos, Flavia B.
   Nogueira, Rita M. R.
   Tanurit, Amilcar
   de Filippis, Ana M. B.
TI Detection and sequencing of Zika virus from amniotic fluid of fetuses
   with microcephaly in Brazil: a case study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; INFECTION; OUTBREAK; FEVER
AB Background The incidence of microcephaly in Brazil in 2015 was 20 times higher than in previous years. Congenital microcephaly is associated with genetic factors and several causative agents. Epidemiological data suggest that microcephaly cases in Brazil might be associated with the introduction of Zika virus. We aimed to detect and sequence the Zika virus genome in amniotic fluid samples of two pregnant women in Brazil whose fetuses were diagnosed with microcephaly.
   Methods In this case study, amniotic fluid samples from two pregnant women from the state of Paraiba in Brazil whose fetuses had been diagnosed with microcephaly were obtained, on the recommendation of the Brazilian health authorities, by ultrasound-guided transabdominal amniocentesis at 28 weeks' gestation. The women had presented at 18 weeks' and 10 weeks' gestation, respectively, with clinical manifestations that could have been symptoms of Zika virus infection, including fever, myalgia, and rash. After the amniotic fluid samples were centrifuged, DNA and RNA were extracted from the purified virus particles before the viral genome was identified by quantitative reverse transcription PCR and viral metagenomic next-generation sequencing. Phylogenetic reconstruction and investigation of recombination events were done by comparing the Brazilian Zika virus genome with sequences from other Zika strains and from flaviviruses that occur in similar regions in Brazil.
   Findings We detected the Zika virus genome in the amniotic fluid of both pregnant women. The virus was not detected in their urine or serum. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, Treponema pallidum, and parvovirus B19 were all negative. After sequencing of the complete genome of the Brazilian Zika virus isolated from patient 1, phylogenetic analyses showed that the virus shares 97-100% of its genomic identity with lineages isolated during an outbreak in French Polynesia in 2013, and that in both envelope and NS 5 genomic regions, it clustered with sequences from North and South America, southeast Asia, and the Pacific. After assessing the possibility of recombination events between the Zika virus and other flaviviruses, we ruled out the hypothesis that the Brazilian Zika virus genome is a recombinant strain with other mosquito-borne flaviviruses.
   Interpretation These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil. Moreover, our results suggest that the virus can cross the placental barrier. As a result, Zika virus should be considered as a potential infectious agent for human fetuses. Pathogenesis studies that confirm the tropism of Zika virus for neuronal cells are warranted.
C1 [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, BR-21040900 Rio De Janeiro, Brazil.
   [Sampaio, Simone A.; Fabri, Allison; Araujo, Eliane S. M.; de Sequeira, Patricia C.; de Mendonca, Marcos C. L.; dos Santos, Flavia B.; Nogueira, Rita M. R.; de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Nacl Controle & Qualidade, BR-21040900 Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; de Oliveira, Louisi; Schrago, Carlos G.; Tanurit, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Tschoeke, Diogo A.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Melo, Adriana S. O.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestaotecnol CT2, Rio de Janeiro, Brazil.
RP Filippis, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
EM abispo@ioc.fiocruz.br
RI Schrago, Carlos/E-4612-2012; Calvet, GA/G-6959-2013; de Filippis,
   Ivano/X-8759-2019; Aguiar, Renato S/G-3542-2015; Melo, Adriana S
   O/H-5650-2016; Tschoeke, Diogo A/F-9913-2019; amsalu, ribka/G-8780-2019
OI Schrago, Carlos/0000-0001-6257-8906; Calvet, GA/0000-0002-3545-5238; de
   Filippis, Ivano/0000-0003-0610-8648; Aguiar, Renato
   S/0000-0001-5180-3717; Tschoeke, Diogo A/0000-0001-8134-4259; Thompson,
   Fabiano/0000-0002-7562-1683
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Consellho Nacional de Desenvolvimento e Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, 2016, MINIST SAFICLE INVES
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 568
Z9 592
U1 7
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 653
EP 660
DI 10.1016/S1473-3099(16)00095-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500044
PM 26897108
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Ribeiro, IP
   Lima, NS
   dos Santos, AAC
   Menezes, LSR
   da Cruz, SOD
   de Mello, IS
   Furtado, ND
   de Moura, EE
   Damasceno, L
   da Silva, KAB
   de Castro, MG
   Gerber, AL
   de Almeida, LGP
   Lourenco-de-Oliveira, R
   Vasconcelos, ATR
   Brasil, P
AF Bonaldo, Myrna C.
   Ribeiro, Ieda P.
   Lima, Noemia S.
   dos Santos, Alexandre A. C.
   Menezes, Lidiane S. R.
   da Cruz, Stephanie O. D.
   de Mello, Iasmim S.
   Furtado, Nathalia D.
   de Moura, Elaine E.
   Damasceno, Luana
   da Silva, Kely A. B.
   de Castro, Marcia G.
   Gerber, Alexandra L.
   de Almeida, Luiz G. P.
   Lourenco-de-Oliveira, Ricardo
   Vasconcelos, Ana Tereza R.
   Brasil, Patricia
TI Isolation of Infective Zika Virus from Urine and Saliva of Patients in
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; WEST-NILE-VIRUS; TRANSMISSION; ENCEPHALITIS;
   DENGUE; FLAVIVIRUS; OUTBREAK; SAMPLES
AB Background
   Zika virus (ZIKV) is an emergent threat provoking a worldwide explosive outbreak. Since January 2015, 41 countries reported autochthonous cases. In Brazil, an increase in Guillain-Barre syndrome and microcephaly cases was linked to ZIKV infections. A recent report describing low experimental transmission efficiency of its main putative vector, Ae. aegypti, in conjunction with apparent sexual transmission notifications, prompted the investigation of other potential sources of viral dissemination. Urine and saliva have been previously established as useful tools in ZIKV diagnosis. Here, we described the presence and isolation of infectious ZIKV particles from saliva and urine of acute phase patients in the Rio de Janeiro state, Brazil.
   Methodology/Principal Findings
   Nine urine and five saliva samples from nine patients from Rio de Janeiro presenting rash and other typical Zika acute phase symptoms were inoculated in Vero cell culture and submitted to specific ZIKV RNA detection and quantification through, respectively, NAT-Zika, RT-PCR and RT-qPCR. Two ZIKV isolates were achieved, one from urine and one from saliva specimens. ZIKV nucleic acid was identified by all methods in four patients. Whenever both urine and saliva samples were available from the same patient, urine viral loads were higher, corroborating the general sense that it is a better source for ZIKV molecular diagnostic. In spite of this, from the two isolated strains, each from one patient, only one derived from urine, suggesting that other factors, like the acidic nature of this fluid, might interfere with virion infectivity. The complete genome of both ZIKV isolates was obtained. Phylogenetic analysis revealed similarity with strains previously isolated during the South America outbreak.
   Conclusions/Significance
   The detection of infectious ZIKV particles in urine and saliva of patients during the acute phase may represent a critical factor in the spread of virus. The epidemiological relevance of this finding, regarding the contribution of alternative non-vectorial ZIKV transmission routes, needs further investigation.
C1 [Bonaldo, Myrna C.; Ribeiro, Ieda P.; Lima, Noemia S.; dos Santos, Alexandre A. C.; Menezes, Lidiane S. R.; da Cruz, Stephanie O. D.; de Mello, Iasmim S.; Furtado, Nathalia D.; de Moura, Elaine E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Damasceno, Luana; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [da Silva, Kely A. B.; de Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Gerber, Alexandra L.; de Almeida, Luiz G. P.; Vasconcelos, Ana Tereza R.] Petropolis, Lab Nacl Comp Cient, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI Gerber, Alexandra Lehmkuhl/P-9412-2019; Vasconcelos, Ana Tereza
   R/I-1011-2012; Almeida, Luiz GP/G-5829-2012
OI Gerber, Alexandra Lehmkuhl/0000-0001-5724-6106; Vasconcelos, Ana Tereza
   R/0000-0002-4632-2086; Almeida, Luiz GP/0000-0002-7124-2715; Ribeiro,
   Ivonizete Pires/0000-0003-0737-5430; Bonaldo, Myrna/0000-0001-9899-3386
CR Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barzon L., 2016, EURO SURVEILL, V21
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Besnard M., 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, ZIKA VIRUS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Kumar S, 2016, MOL BIOL EVOL
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lanciotti RS, 2016, EMERG INFECT DIS
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   LUBY JP, 1980, AM J TROP MED HYG, V29, P265, DOI 10.4269/ajtmh.1980.29.265
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nei M.a.K. S, 2000, MOL EVOLUTION PHYLOG, P352
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Organization W. H., 2016, WHO DIR GEN SUMM OUT
   Roze B, 2016, EURO SURVEILL, V21
   Saude M.d., 2016, INFORME EPIDEMIOLOGI
   Shugars DC, 1999, J INFECT DIS, V179, pS431, DOI 10.1086/314799
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Sufiawati I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088803
   Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 113
Z9 117
U1 2
U2 56
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004816
DI 10.1371/journal.pntd.0004816
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200055
PM 27341420
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Wang, L
   Valderramos, SG
   Wu, AP
   Ouyang, SY
   Li, CF
   Brasil, P
   Bonaldo, M
   Coates, T
   Nielsen-Saines, K
   Jiang, TJ
   Aliyari, R
   Cheng, GH
AF Wang, Lulan
   Valderramos, Stephanie G.
   Wu, Aiping
   Ouyang, Songying
   Li, Chunfeng
   Brasil, Patricia
   Bonaldo, Myrna
   Coates, Thomas
   Nielsen-Saines, Karin
   Jiang, Taijiao
   Aliyari, Roghiyh
   Cheng, Genhong
TI From Mosquitos to Humans: Genetic Evolution of Zika Virus
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID STATES
AB Initially isolated in 1947, Zika virus (ZIKV) has recently emerged as a significant public health concern. Sequence analysis of all 41 known ZIKV RNA open reading frames to date indicates that ZIKV has undergone significant changes in both protein and nucleotide sequences during the past half century.
C1 [Wang, Lulan; Valderramos, Stephanie G.; Ouyang, Songying; Li, Chunfeng; Aliyari, Roghiyh; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Valderramos, Stephanie G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   [Ouyang, Songying] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
   [Brasil, Patricia] Inst Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, BR-21040900 Rio De Janeiro, Brazil.
   [Bonaldo, Myrna] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Coates, Thomas] Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90024 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
RP Aliyari, R; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Jiang, TJ; Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
EM jtj@ism.cams.cn; aliyarirs@ucla.edu; gcheng@mednet.ucla.edu
RI Gaw, Stephanie/K-4592-2019
OI Gaw, Stephanie/0000-0003-0891-6964
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI078389, R56 AI078389, R01 AI056154,
   R01 AI069120] Funding Source: Medline; NICHD NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [K12 HD000849] Funding Source: Medline; EUNICE
   KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [K12HD000849,
   K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849, K12HD000849] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [K12HD000849,
   K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849, K12HD000849] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI078389, R01AI069120, R01AI056154, R01AI069120, R01AI069120,
   R01AI069120, R01AI069120, R01AI069120, R01AI056154, R01AI056154,
   R01AI078389, R01AI069120, R01AI056154, R01AI069120, R01AI069120,
   R01AI078389, R01AI056154, R01AI069120, R01AI069120, R01AI056154,
   R01AI056154, R01AI069120, R01AI078389, R01AI078389, R01AI056154,
   R01AI056154, R01AI069120, R56AI078389, R01AI056154, R01AI069120] Funding
   Source: NIH RePORTER
CR Bonaldo M. C., 2016, BIORXIV
   Brasil P, 2016, N ENGL J MED
   Broutet N., 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria N.R., 2016, SCIENCE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lazear HM, 2016, CELL HOST MICROBE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
NR 17
TC 128
Z9 132
U1 0
U2 72
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 561
EP 565
DI 10.1016/j.chom.2016.04.006
PG 5
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500001
PM 27091703
OA Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Furuya-Kanamori, L
   Liang, SH
   Milinovich, G
   Magalhaes, RJS
   Clements, ACA
   Hu, WB
   Brasil, P
   Frentiu, FD
   Dunning, R
   Yakob, L
AF Furuya-Kanamori, Luis
   Liang, Shaohong
   Milinovich, Gabriel
   Magalhaes, Ricardo J. Soares
   Clements, Archie C. A.
   Hu, Wenbiao
   Brasil, Patricia
   Frentiu, Francesca D.
   Dunning, Rebecca
   Yakob, Laith
TI Co-distribution and co-infection of chikungunya and dengue viruses (vol
   3, 16, 2016)
SO BMC INFECTIOUS DISEASES
LA English
DT Correction
C1 [Furuya-Kanamori, Luis; Clements, Archie C. A.] Australian Natl Univ, Res Sch Populat Hlth, Acton, ACT 2601, Australia.
   [Liang, Shaohong] Natl Environm Agcy, Environm Hlth Inst, Singapore 138667, Singapore.
   [Milinovich, Gabriel; Hu, Wenbiao] Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld 4059, Australia.
   [Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia.
   [Magalhaes, Ricardo J. Soares] Univ Queensland, UQ Childrens Hlth Res Ctr, South Brisbane, Qld 4101, Australia.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Frentiu, Francesca D.] Queensland Univ Technol, Sch Biomed Sci, Kelvin Grove, Qld 4059, Australia.
   [Frentiu, Francesca D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Dunning, Rebecca] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.
   [Yakob, Laith] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
RP Furuya-Kanamori, L (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Acton, ACT 2601, Australia.; Yakob, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
EM luis.furuya-kanamori@anu.edu.au; Laith.Yakob@lshtm.ac.uk
RI Magalhaes, Ricardo J. Soares/A-5316-2010; Yakob, Laith/AAD-4521-2019;
   Clements, Archie/ABD-1615-2020
OI Magalhaes, Ricardo J. Soares/0000-0001-9157-8470; Yakob,
   Laith/0000-0001-8639-4511; Frentiu, Francesca/0000-0001-8628-4216; Hu,
   Wenbiao/0000-0001-6422-9240
CR Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
NR 1
TC 4
Z9 4
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 29
PY 2016
VL 16
AR 188
DI 10.1186/s12879-016-1519-x
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DK7BQ
UT WOS:000375080200001
PM 27129475
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Brasil, P
   Sequeira, PC
   Freitas, AD
   Zogbi, HE
   Calvet, GA
   de Souza, RV
   Siqueira, AM
   de Mendonca, MCL
   Nogueira, RMR
   de Filippis, AMB
   Solomon, T
AF Brasil, Patricia
   Sequeira, Patricia Carvalho
   Freitas, Andrea D'Avila
   Zogbi, Heruza Einsfeld
   Calvet, Guilherme Amaral
   de Souza, Rogerio Valls
   Siqueira, Andre Machado
   Lima de Mendonca, Marcos Cesar
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Solomon, Tom
TI Guillain-Barre syndrome associated with Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID DENGUE
C1 [Brasil, Patricia; Freitas, Andrea D'Avila; Zogbi, Heruza Einsfeld; Calvet, Guilherme Amaral; de Souza, Rogerio Valls; Siqueira, Andre Machado] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Sequeira, Patricia Carvalho; Lima de Mendonca, Marcos Cesar; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010; Calvet, GA/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet, GA/0000-0002-3545-5238;
   Solomon, Tom/0000-0001-7266-6547
FU National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [NF-SI-0514-10177, RP-PG-0108-10048] Funding Source:
   researchfish; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15096] Funding Source: Medline; Department of Health
   [RP-PG-0108-10048] Funding Source: Medline
CR Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
NR 5
TC 176
Z9 183
U1 0
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 2
PY 2016
VL 387
IS 10026
BP 1482
EP 1482
DI 10.1016/S0140-6736(16)30058-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0WH
UT WOS:000373217500037
PM 27115821
OA Bronze
DA 2020-12-01
ER

PT J
AU Brasil, P
   Calvet, GA
   Siqueira, AM
   Wakimoto, M
   de Sequeira, PC
   Nobre, A
   Quintana, MDB
   de Mendonca, MCL
   Lupi, O
   de Souza, RV
   Romero, C
   Zogbi, H
   Bressan, CD
   Alves, SS
   Lourenco-de-Oliveira, R
   Nogueira, RMR
   Carvalho, MS
   de Filippis, AMB
   Jaenisch, T
AF Brasil, Patricia
   Calvet, Guilherme Amaral
   Siqueira, Andre Machado
   Wakimoto, Mayumi
   de Sequeira, Patricia Carvalho
   Nobre, Aline
   Borges Quintana, Marcel de Souza
   Lima de Mendonca, Marco Cesar
   Lupi, Otilia
   de Souza, Rogerio Valls
   Romero, Carolina
   Zogbi, Heruza
   Bressan, Clarisse da Silveira
   Alves, Simone Sampaio
   Lourenco-de-Oliveira, Ricardo
   Ribeiro Nogueira, Rita Maria
   Carvalho, Marilia Sa
   Bispo de Filippis, Ana Maria
   Jaenisch, Thomas
TI Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical
   Characterization, Epidemiological and Virological Aspects
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUSES; TRANSMISSION; CHIKUNGUNYA; STATE
AB Background
   In 2015, Brazil was faced with the cocirculation of three arboviruses of major public health importance. The emergence of Zika virus (ZIKV) presents new challenges to both clinicians and public health authorities. Overlapping clinical features between diseases caused by ZIKV, Dengue (DENV) and Chikungunya (CHIKV) and the lack of validated serological assays for ZIKV make accurate diagnosis difficult.
   Methodology/Principal Findings
   The outpatient service for acute febrile illnesses in Fiocruz initiated a syndromic clinical observational study in 2007 to capture unusual presentations of DENV infections. In January 2015, an increase of cases with exanthematic disease was observed. Trained physicians evaluated the patients using a detailed case report form that included clinical assessment and laboratory investigations. The laboratory diagnostic algorithm included assays for detection of ZIKV, CHIKV and DENV. 364 suspected cases of Zika virus disease were identified based on clinical criteria between January and July 2015. Of these, 262 (71.9%) were tested and 119 (45.4%) were confirmed by the detection of ZIKV RNA. All of the samples with sequence information available clustered within the Asian genotype.
   Conclusions / Significance
   This is the first report of a ZIKV outbreak in the state of Rio de Janeiro, based on a large number of suspected (n = 364) and laboratory confirmed cases (n = 119). We were able to demonstrate that ZIKV was circulating in Rio de Janeiro as early as January 2015. The peak of the outbreak was documented in May/June 2015. More than half of the patients reported headache, arthralgia, myalgia, non-purulent conjunctivitis, and lower back pain, consistent with the case definition of suspected ZIKV disease issued by the Pan American Health Organization (PAHO). However, fever, when present, was low-intensity and short-termed. In our opinion, pruritus, the second most common clinical sign presented by the confirmed cases, should be added to the PAHO case definition, while fever could be given less emphasis. The emergence of ZIKV as a new pathogen for Brazil in 2015 underscores the need for clinical vigilance and strong epidemiological and laboratory surveillance.
C1 [Brasil, Patricia; Calvet, Guilherme Amaral; Siqueira, Andre Machado; Wakimoto, Mayumi; Lupi, Otilia; de Souza, Rogerio Valls; Romero, Carolina; Zogbi, Heruza; Bressan, Clarisse da Silveira] Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [de Sequeira, Patricia Carvalho; Lima de Mendonca, Marco Cesar; Alves, Simone Sampaio; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Oswaldo Cruz Fdn Fiocruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nobre, Aline; Carvalho, Marilia Sa] Oswaldo Cruz Fdn Fiocruz, Sci Computat Program, Rio De Janeiro, Brazil.
   [Borges Quintana, Marcel de Souza] Oswaldo Cruz Fdn Fiocruz, Clin Res Platform, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Oswaldo Cruz Fdn Fiocruz, Mosquito Transmitters Hematozoans Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Dis Res, Heidelberg, Germany.
RP Brasil, P (corresponding author), Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Jaenisch, Thomas/H-3473-2017; Calvet, GA/G-6959-2013; Siqueira, Andre
   M/G-1340-2010; CARVALHO, MARILIA S/C-3425-2013; CARVALHO,
   MARILIA/AAD-8283-2020
OI Calvet, GA/0000-0002-3545-5238; Siqueira, Andre M/0000-0003-2208-0294;
   CARVALHO, MARILIA/0000-0002-9566-0284
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [484735/2013-6, 402135/2011-3]; Fundacao de Amparo a Pesquisa no Estado
   do Rio de Janeiro-FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E- 26/010.001558/2014];
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [FP7-21803 IDAMS]
FX We thank the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq (grant no. 484735/2013-6 and 402135/2011-3), the
   Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro-FAPERJ (grant
   no. E- 26/010.001558/2014) and the European Commission, grant FP7-21803
   IDAMS (http://www.idams.eu), for having funded the study. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Besnard M, 2014, INCREASE CEREBRAL CO
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, EURO SURVEILLANCE B, V19
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   R Core Team, 2015, R LANG ENV STAT COMP
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 152
Z9 153
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004636
DI 10.1371/journal.pntd.0004636
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700064
PM 27070912
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Jaenisch, T
   Tam, DTH
   Kieu, NTT
   Ngoc, TV
   Nam, NT
   Kinh, NV
   Yacoub, S
   Chanpheaktra, N
   Kumar, V
   See, LLC
   Sathar, J
   Sandoval, EP
   Alfaro, GMM
   Laksono, IS
   Mahendradhata, Y
   Sarker, M
   Ahmed, F
   Caprara, A
   Benevides, BS
   Marques, ETA
   Magalhaes, T
   Brasil, P
   Netto, M
   Tami, A
   Bethencourt, SE
   Guzman, M
   Simmons, C
   Quyen, NTH
   Merson, L
   Dung, NTP
   Beck, D
   Wirths, M
   Wolbers, M
   Lam, PK
   Rosenberger, K
   Wills, B
AF Jaenisch, Thomas
   Dong Thi Hoai Tam
   Nguyen Tan Thanh Kieu
   Tran Van Ngoc
   Nguyen Tran Nam
   Nguyen Van Kinh
   Yacoub, Sophie
   Chanpheaktra, Ngoun
   Kumar, Varun
   See, Lucy Lum Chai
   Sathar, Jameela
   Sandoval, Ernesto Pleites
   Maron Alfaro, Gabriela Maria
   Laksono, Ida Safitri
   Mahendradhata, Yodi
   Sarker, Malabika
   Ahmed, Firoz
   Caprara, Andrea
   Benevides, Bruno Souza
   Marques, Ernesto T. A.
   Magalhaes, Tereza
   Brasil, Patricia
   Netto, Marco
   Tami, Adriana
   Bethencourt, Sarah E.
   Guzman, Maria
   Simmons, Cameron
   Nguyen Thanh Ha Quyen
   Merson, Laura
   Nguyen Thi Phuong Dung
   Beck, Dorothea
   Wirths, Marius
   Wolbers, Marcel
   Phung Khanh Lam
   Rosenberger, Kerstin
   Wills, Bridget
TI Clinical evaluation of dengue and identification of risk factors for
   severe disease: protocol for a multicentre study in 8 countries
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE Dengue; Asia; Latin America; Diagnosis; Risk prediction; Pathogenesis
ID HEMORRHAGIC-FEVER; PROTEIN NS1; ANTIBODY-RESPONSE; SHOCK SYNDROME;
   VIRUS; CLASSIFICATION; INFECTIONS; VIREMIA; CORRELATE; CHILDREN
AB Background: The burden of dengue continues to increase globally, with an estimated 100 million clinically apparent infections occurring each year. Although most dengue infections are asymptomatic, patients can present with a wide spectrum of clinical symptoms ranging from mild febrile illness through to severe manifestations of bleeding, organ impairment, and hypovolaemic shock due to a systemic vascular leak syndrome. Clinical diagnosis of dengue and identification of which patients are likely to develop severe disease remain challenging. This study aims to improve diagnosis and clinical management through approaches designed a) to differentiate between dengue and other common febrile illness within 72 h of fever onset, and b) among patients with dengue to identify markers that are predictive of the likelihood of evolving to a more severe disease course.
   Method/Design: This is a prospective multi-centre observational study aiming to enrol 7-8000 participants aged >= 5 years presenting with a febrile illness consistent with dengue to outpatient health facilities in 8 countries across Asia and Latin America. Patients presenting within 72 h of fever onset who do not exhibit signs of severe disease are eligible for the study. A broad range of clinical and laboratory parameters are assessed daily for up to 6 days during the acute illness, and also at a follow up visit 1 week later.
   Discussion: Data from this large cohort of patients, enrolled early with undifferentiated fever, will be used to develop a practical diagnostic algorithm and a robust clinical case definition for dengue. Additionally, among patients with confirmed dengue we aim to identify simple clinical and laboratory parameters associated with progression to a more severe disease course. We will also investigate early virological and serological correlates of severe disease, and examine genetic associations in this large heterogeneous cohort. In addition the results will be used to assess the new World Health Organization classification scheme for dengue in practice, and to update the guidelines for "Integrated Management of Childhood Illness" used in dengue-endemic countries.
C1 [Jaenisch, Thomas; Beck, Dorothea; Wirths, Marius; Rosenberger, Kerstin] Univ Heidelberg Hosp, Sect Clin Trop Med, Heidelberg, Germany.
   [Dong Thi Hoai Tam; Nguyen Tan Thanh Kieu; Yacoub, Sophie; Simmons, Cameron; Nguyen Thanh Ha Quyen; Merson, Laura; Nguyen Thi Phuong Dung; Wolbers, Marcel; Phung Khanh Lam; Wills, Bridget] Univ Oxford, Clin Res Unit, 764 Vo Kiet St,Dist 5, Ho Chi Minh City, Vietnam.
   [Dong Thi Hoai Tam] Univ Med & Pharm Ho Chi Minh City, Ho Chi Minh City, Vietnam.
   [Tran Van Ngoc] Hosp Trop Dis, Ho Chi Minh City, Vietnam.
   [Nguyen Tran Nam] Childrens Hosp 2, Ho Chi Minh City, Vietnam.
   [Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam.
   [Yacoub, Sophie] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
   [Chanpheaktra, Ngoun; Kumar, Varun] Angkor Hosp Children, Siem Reap, Cambodia.
   [See, Lucy Lum Chai] Univ Malaya Med Ctr, Kuala Lumpur, Malaysia.
   [Sathar, Jameela] Ampang Hosp, Kuala Lumpur, Malaysia.
   [Sandoval, Ernesto Pleites; Maron Alfaro, Gabriela Maria] Hosp Nacl Ninos Benjamin Bloom, San Salvador, El Salvador.
   [Laksono, Ida Safitri; Mahendradhata, Yodi] Gadjah Mada Univ, Yogyakarta, Indonesia.
   [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
   [Ahmed, Firoz] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.
   [Caprara, Andrea; Benevides, Bruno Souza] Univ Estadual Ceara, Fortaleza, Ceara, Brazil.
   [Marques, Ernesto T. A.; Magalhaes, Tereza] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Netto, Marco] Secretaria Municipal Saude Resende, Rio De Janeiro, Brazil.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana; Bethencourt, Sarah E.] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Guzman, Maria] Inst Pedro Kouri, Havana, Cuba.
   [Simmons, Cameron] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
   [Merson, Laura; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Kumar, Varun] Rwanda Mil Hosp, Kigali, Rwanda.
   [Kumar, Varun] Univ Rwanda Kigali, Kigali, Rwanda.
   [Maron Alfaro, Gabriela Maria] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.
RP Wills, B (corresponding author), Univ Oxford, Clin Res Unit, 764 Vo Kiet St,Dist 5, Ho Chi Minh City, Vietnam.; Wills, B (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
EM bwills@oucru.org
RI Lam, Phung/AAW-4108-2020; Magalhaes, Tereza/V-6632-2019; Caprara,
   Andrea/F-8399-2012; Lum, Lucy/Q-9871-2017; Caprara, Andrea/O-9522-2019;
   Mahendradhata, Yodi/AAQ-9044-2020; Marques, Ernesto T. A/L-4967-2013;
   Maron, Gabriela M./N-8091-2018; Jaenisch, Thomas/H-3473-2017; Caprara,
   Andrea/I-4011-2013
OI Lam, Phung/0000-0001-7968-473X; Caprara, Andrea/0000-0003-1972-8205;
   Lum, Lucy/0000-0002-7452-4208; Caprara, Andrea/0000-0003-1972-8205;
   Mahendradhata, Yodi/0000-0002-4522-1785; Marques, Ernesto T.
   A/0000-0003-3826-9358; Maron, Gabriela M./0000-0001-5247-5399; Caprara,
   Andrea/0000-0003-1972-8205; , Varun/0000-0003-4976-6229; Simmons,
   Cameron P./0000-0002-9039-7392; Merson, Laura/0000-0002-4168-1960;
   Yacoub, Sophie/0000-0002-2910-7819; Tami, Adriana/0000-0002-1918-9144
FU EUEuropean Union (EU) [FP7-281803 IDAMS]
FX We are grateful to all the medical, nursing and laboratory staff
   involved in supporting the study across the various sites, as well as to
   the patients and their families for their willingness to participate. We
   also want to thank all those involved in the administration of the
   project - in particular Jaswinder Kaur and Thomas Wetter at Heidelberg
   University Hospital, and Sarah Barton at OUCRU. Furthermore, we are
   thankful to all the many institutions and health ministries in the
   participating countries who helped to make this study possible. This
   study is funded by EU grant FP7-281803 IDAMS (http://www.idams.eu/) and
   is designated with IDAMS publication reference number IDAMS 31.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Hastie T., 2009, ELEMENTS STAT LEARNI
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7
   Pepe MS, 1997, J AM STAT ASSOC, V92, P991, DOI 10.2307/2965563
   Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172
   Rigau-Perez J G, 1999, P R Health Sci J, V18, P347
   Rizopoulos D, 2011, BIOMETRICS, V67, P819, DOI 10.1111/j.1541-0420.2010.01546.x
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Whitehorn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059067
   WHO, 1986, DENG HAEM FEV DIAGN
   Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 1975, TECHN GUID DIAGN TRE
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 33
TC 28
Z9 28
U1 1
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 11
PY 2016
VL 16
AR 120
DI 10.1186/s12879-016-1440-3
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA DG0UA
UT WOS:000371780000002
PM 26968374
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Furuya-Kanamori, L
   Liang, SH
   Milinovich, G
   Magalhaes, RJS
   Clements, ACA
   Hu, WB
   Brasil, P
   Frentiu, FD
   Dunning, R
   Yakob, L
AF Furuya-Kanamori, Luis
   Liang, Shaohong
   Milinovich, Gabriel
   Magalhaes, Ricardo J. Soares
   Clements, Archie C. A.
   Hu, Wenbiao
   Brasil, Patricia
   Frentiu, Francesca D.
   Dunning, Rebecca
   Yakob, Laith
TI Co-distribution and co-infection of chikungunya and dengue viruses
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya; Dengue; Virus; Coinfection; Review
ID AEDES-ALBOPICTUS; INDIAN-OCEAN; COMPETITIVE SUPPRESSION; CONCURRENT
   ISOLATION; GLOBAL DISTRIBUTION; CLINICAL-FEATURES; HEMORRHAGIC-FEVER;
   AFRICAN GENOTYPE; CO-CIRCULATION; REUNION ISLAND
AB Background: Chikungunya and dengue infections are spatio-temporally related. The current review aims to determine the geographic limits of chikungunya, dengue and the principal mosquito vectors for both viruses and to synthesise current epidemiological understanding of their co-distribution.
   Methods: Three biomedical databases (PubMed, Scopus and Web of Science) were searched from their inception until May 2015 for studies that reported concurrent detection of chikungunya and dengue viruses in the same patient. Additionally, data from WHO, CDC and Healthmap alerts were extracted to create up-to-date global distribution maps for both dengue and chikungunya.
   Results: Evidence for chikungunya-dengue co-infection has been found in Angola, Gabon, India, Madagascar, Malaysia, Myanmar, Nigeria, Saint Martin, Singapore, Sri Lanka, Tanzania, Thailand and Yemen; these constitute only 13 out of the 98 countries/territories where both chikungunya and dengue epidemic/endemic transmission have been reported.
   Conclusions: Understanding the true extent of chikungunya-dengue co-infection is hampered by current diagnosis largely based on their similar symptoms. Heightened awareness of chikungunya among the public and public health practitioners in the advent of the ongoing outbreak in the Americas can be expected to improve diagnostic rigour. Maps generated from the newly compiled lists of the geographic distribution of both pathogens and vectors represent the current geographical limits of chikungunya and dengue, as well as the countries/territories at risk of future incursion by both viruses. These describe regions of co-endemicity in which lab-based diagnosis of suspected cases is of higher priority.
C1 [Furuya-Kanamori, Luis; Clements, Archie C. A.] Australian Natl Univ, Res Sch Populat Hlth, Acton, ACT 2601, Australia.
   [Liang, Shaohong] Natl Environm Agcy, Environm Hlth Inst, Singapore 138667, Singapore.
   [Milinovich, Gabriel; Hu, Wenbiao] Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld 4059, Australia.
   [Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia.
   [Magalhaes, Ricardo J. Soares] Univ Queensland, UQ Childrens Hlth Res Ctr, South Brisbane, Qld 4101, Australia.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Frentiu, Francesca D.] Queensland Univ Technol, Sch Biomed Sci, Kelvin Grove, Qld 4059, Australia.
   [Frentiu, Francesca D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Dunning, Rebecca] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.
   [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
RP Furuya-Kanamori, L (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Acton, ACT 2601, Australia.
EM luis.furuya-kanamori@anu.edu.au
RI Yakob, Laith/AAD-4521-2019; Clements, Archie/ABD-1615-2020; Magalhaes,
   Ricardo J. Soares/A-5316-2010
OI Yakob, Laith/0000-0001-8639-4511; Magalhaes, Ricardo J.
   Soares/0000-0001-9157-8470; Hu, Wenbiao/0000-0001-6422-9240;
   Furuya-Kanamori, Luis/0000-0002-4337-9757; Frentiu,
   Francesca/0000-0001-8628-4216
FU Endeavour Postgraduate Scholarship [3781_2014]; Australian National
   University Higher Degree Scholarship; Fondo para la Innovacion, Ciencia
   y Tecnologia Scholarship [095-FINCyT-BDE-2014]; University of Queensland
   Postdoctoral Research Fellowship (Australia); NHMRC Senior Research
   Fellowship (Australia)National Health and Medical Research Council of
   Australia
FX LFK is funded by an Endeavour Postgraduate Scholarship (#3781_2014), an
   Australian National University Higher Degree Scholarship, and a Fondo
   para la Innovacion, Ciencia y Tecnologia Scholarship
   (#095-FINCyT-BDE-2014). RJSM is supported by a University of Queensland
   Postdoctoral Research Fellowship (Australia). ACAC is supported by a
   NHMRC Senior Research Fellowship (Australia).
CR Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Agarwal J, 2011, CLIN MICROBIOL INFEC, VS4, P253
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Angelini R, 2007, Euro Surveill, V12
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Centers for Disease Control and Prevention, 2015, GEOGR DISTR HAS CHIK
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Chretien JP, 2007, LANCET, V370, P1805, DOI 10.1016/S0140-6736(07)61752-8
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Degallier N, 2010, CLIMATIC CHANGE, V98, P581, DOI 10.1007/s10584-009-9747-3
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Doi SAR, 2014, VALUE HEALTH, V17, P629, DOI 10.1016/j.jval.2014.05.003
   Ellis BR, 2009, CAD SAUDE PUBLICA, V25, pS155, DOI 10.1590/S0102-311X2009001300015
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gunasekaran P, 2012, INT J PHARM BIO SCI, V3, P374
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268
   Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137
   Kalawat U, 2011, INDIAN J PATHOL MICR, V54, P844, DOI 10.4103/0377-4929.91518
   Kalayanarooj S., 1999, Dengue Bulletin, V23, P10
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Kroeger A, 2004, DIS WATCH FOCUS DENG
   Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746
   Kumar K Jagadish, 2012, J Indian Med Assoc, V110, P752
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, P27
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Mayurasakorn S, 2010, SE ASIAN J TROP MED, V41, P858
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   MING CK, 1974, B WORLD HEALTH ORGAN, V51, P227
   Mohanty Indrani, 2013, J Family Med Prim Care, V2, P33, DOI 10.4103/2249-4863.109939
   Murgue B, 2001, EMERG INFECT DIS, V7, P692
   Muturi EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0667-y
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Nayar S K, 2007, Med J Malaysia, V62, P335
   Neeraja M, 2013, J CLIN DIAGN RES, V7, P457, DOI 10.7860/JCDR/2013/4786.2798
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ng KW, 2009, SINGAP MED J, V50, P785
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Omarjee R., 2014, EURO SURVEILL, V19
   Parreira R, 2014, EURO SURVEILL, V19
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sharp T., 2014, DIFFERENTIATING CHIK
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Tomashek KM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003192
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2012, GLOB STRAT DENG PREV
   World Health Organization & Special Programme for Research and Training in Tropical Diseases, 2012, HDB CLIN MAN DENG
   Yakob L., NOVEL ECOSYSTEMS INT
   Yakob L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-157
   Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529
   Zim MAM, 2013, J CLIN VIROL, V56, P141, DOI 10.1016/j.jcv.2012.10.019
NR 94
TC 98
Z9 100
U1 1
U2 31
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 3
PY 2016
VL 16
AR 84
DI 10.1186/s12879-016-1417-2
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA DF5GR
UT WOS:000371380300001
PM 26936191
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Lupi, O
   Ridolfi, F
   da Silva, S
   Zanini, GM
   Lavigne, A
   Nogueira, RMR
   da Cruz, MDF
   Daniel-Ribeiro, CT
   Brasil, P
AF Lupi, Otilia
   Ridolfi, Felipe
   da Silva, Sidnei
   Zanini, Graziela Maria
   Lavigne, Aline
   Ribeiro Nogueira, Rita Maria
   Ferreira da Cruz, Maria de Fatima
   Daniel-Ribeiro, Claudio Tadeu
   Brasil, Patricia
TI Dengue infection as a potential trigger of an imported Plasmodium ovale
   malaria relapse or a long incubation period in a non-endemic malaria
   region
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Malaria; Dengue; Plasmodium ovale wallikeri; Co-infection
ID POLYMERASE CHAIN-REACTION; RETROSPECTIVE MATCHED-PAIR; LOW-GRADE
   PARASITEMIA; CONCURRENT DENGUE; FRENCH-GUIANA; FALCIPARUM-MALARIA;
   BRAZIL; DIAGNOSIS; VIVAX; PCR
AB Objectives: To report that dengue fever (DF) could have triggered Plasmodium ovale wallikeri malaria.
   Methods: A retrospective case report of P. ovale malaria and DF in a single patient in Rio de Janeiro, Brazil, who had lived in Angola, is presented.
   Results: On the second week of illness, the patient was referred to our research service. As symptoms had persisted up to day 14, malaria was also considered, based on the patient's long-standing epidemiological history. On day 16 of illness, a thick blood smear was positive for P. ovale (3480 parasites/mm(3)), PCR for malaria was positive for P. ovale wallikeri, and the kinetics of dengue virus (DENV) antibodies suggested a recent primary dengue infection.
   Conclusions: Concurrent infections of DENV and malaria have rarely been reported; the actual impact of these sequential or simultaneous infections remains unknown. Therefore, DF must be considered as a potential co-morbidity for malaria, because of its influence on fluid electrolyte management. The case presented showed consistent temporal, clinical, and laboratory evidence that the relapse or the long incubation period of P. ovale malaria may have been triggered by a recent DF episode. To the authors' knowledge, this is the first report of DENV and P. ovale co-infection. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Lupi, Otilia; Ridolfi, Felipe; Brasil, Patricia] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Lupi, Otilia; da Silva, Sidnei; Zanini, Graziela Maria; Lavigne, Aline; Ferreira da Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu; Brasil, Patricia] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
   [da Silva, Sidnei; Zanini, Graziela Maria] Inst Nacl Infectol Evandro Chagas, Lab Parasitol, Rio De Janeiro, RJ, Brazil.
   [Lavigne, Aline; Ferreira da Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Pavilhao Leonidas Deane, Rio De Janeiro, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Pavilhao Helio Pereira, Rio De Janeiro, RJ, Brazil.
RP Lupi, O (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.; Lupi, O (corresponding author), Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, RJ, Brazil.
EM otilia.lupi@ini.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Zanini, Graziela/0000-0003-4466-3124
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de
   Rio de Janeiro (FAPERJ) as Cientistas do Nosso Estado; FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/010.001558/2014]
FX RMRN, MFFC, and CTDR are supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) through a Research
   Fellowship and by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado de Rio de Janeiro (FAPERJ) as Cientistas do Nosso Estado. RMRN
   received financial support from FAPERJ (E-26/010.001558/2014). The
   present study received no specific financial support. We thank Dr
   Clarissa Menezes Maya Monteiro, IOC/FIOCRUZ, for the photographic
   records.
CR Alam Anwar, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P416, DOI 10.1016/S2221-1691(13)60087-8
   [Anonymous], 2014, SECR VIG SAUD B EP
   Assir MZK, 2014, INT J INFECT DIS, V18, P41, DOI 10.1016/j.ijid.2013.09.007
   BALLET JJ, 1981, INFECT IMMUN, V33, P758, DOI 10.1128/IAI.33.3.758-762.1981
   BANIC DM, 1991, AM J TROP MED HYG, V44, P571, DOI 10.4269/ajtmh.1991.44.571
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-402
   Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06
   Carme B, 2009, EMERG INFECT DIS, V15, P668, DOI 10.3201/eid1504.080891
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1153, DOI 10.3201/eid1107.041352
   Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   Epelboin L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002420
   Epelboin L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-142
   Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011
   Kaushik RM, 2007, T ROY SOC TROP MED H, V101, P1048, DOI 10.1016/j.trstmh.2007.04.017
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Limongi JE, 2014, J INFECT DEV COUNTR, V8, P554, DOI 10.3855/jidc.4037
   Magalhaes BML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003239
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Mohapatra MK, 2012, J VECTOR DIS, V49, P262
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009
   Mushtaq MB, 2013, CASE REP MED, V2013, DOI DOI 10.1155/2013/520181
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Rojo-Marcos G, 2011, ENFERM INFEC MICR CL, V29, P204, DOI 10.1016/j.eimc.2010.09.004
   ROSENBERG YJ, 1978, NATURE, V274, P170, DOI 10.1038/274170a0
   Santana VD, 2010, REV SOC BRAS MED TRO, V43, P508, DOI 10.1590/S0037-86822010000500007
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Stoler J, 2015, AM J TROP MED HYG, V92, P497, DOI 10.4269/ajtmh.14-0678
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Wangjirapan A, 2014, BMJ CASE REP
   Ward DI, 2006, AM J TROP MED HYG, V75, P182, DOI 10.4269/ajtmh.2006.75.182
   Yong KP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-364
   Zalis MG, 1996, PARASITOL RES, V82, P612, DOI 10.1007/s004360050173
NR 39
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2016
VL 44
BP 20
EP 24
DI 10.1016/j.ijid.2016.01.008
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DK4FV
UT WOS:000374873500006
PM 26809125
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Gomes, LR
   Almeida-de-Oliveira, NK
   de Lavigne, AR
   de Lima, SRF
   de Pina-Costa, A
   Brasil, P
   Daniel-Ribeiro, CT
   Menard, D
   Ferreira-da-Cruz, MD
AF Gomes, Larissa Rodrigues
   Almeida-de-Oliveira, Natylia Ketrin
   de Lavigne, Aline Rosa
   Felix de Lima, Suelen Rezende
   de Pina-Costa, Anielle
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Menard, Didier
   Ferreira-da-Cruz, Maria de Fatima
TI Plasmodium vivax mdr1 genotypes in isolates from successfully cured
   patients living in endemic and non-endemic Brazilian areas
SO MALARIA JOURNAL
LA English
DT Article
DE Plasmodium vivax; Chloroquine resistance; pvmdr1 gene; Brazil
ID PLASMODIUM-VIVAX RESISTANCE; CHLOROQUINE RESISTANCE; DRUG-RESISTANCE;
   PVCRT-O; MOLECULAR MARKERS; MALARIA; PVMDR1; POLYMORPHISMS; GENES;
   FALCIPARUM
AB Background: Plasmodium vivax is the most widely distributed species causing the highest number of malaria cases in the world. In Brazil, P. vivax is responsible for approximately 84 % of reported cases. In the absence of a vaccine, control strategies are based on the management of cases through rapid diagnosis and adequate treatment, in addition to vector control measures. The approaches used to investigate P. vivax resistance to chloroquine (CQ) were exclusively in vivo studies because of the difficulty in keeping parasites in continuous in vitro culture. In view of the limitations related to follow-up of patients and to assessing the plasma dosage of CQ and its metabolites, an alternative approach to monitor chemo-resistance (QR) is to use molecular markers. Single nucleotide polymorphisms (SNPs) in the multidrug resistance gene pvmdr1 are putative determinants of CQ resistance (CQR), but such SNPs in P. vivax isolates from patients with good response to treatment should be further explored. The aim of this study is to investigate the mutations in the gene, supposedly associated to QR, in P. vivax isolates from successfully cured patients, living in Brazilian endemic and non-endemic areas.
   Methods: Blood samples were collected from 49 vivax malaria patients from endemic (Amazon Basin: 45) and non-endemic (Atlantic Forest: four) Brazilian regions and analysed for SNPs in the CQR-related P. vivax gene (pvmdr1), using PCR-based methods.
   Results: Among the 49 isolates genetically characterized for the gene pvmdr1, 34 (70 %) presented at least one mutation. T958M mutant alleles were the most frequent (73 %) followed Y976F (15 %) and F1076L (12 %). Single mutation was detected in 24 (70.5 %) isolates and double mutations in ten (29.5 %). The most common single mutant genotype was the 958M/Y976/F1076 (79 %), followed by 976F/F1076 (21 %) whereas 958M/Y976/1076L (60 %) and 976F/1076L (40 %) double mutant genotypes were detected. Single mutant profile was observed only in isolates from Amazon Basin, although double mutants were found both in the Amazon and Atlantic Forest regions. Interestingly, the genotype 958M/Y976/1076L was present in all isolates from the Atlantic Forest in the Rio de Janeiro State.
   Conclusions: Considering that primaquine (PQ) efficacy is highly dependent on concurrent administration of a blood schizontocidal agent and that PQ could not circumvent CQR, together with the fact that no pvmdr1 mutation should be expected in successfully cured patients, these findings seem to indicate that the pvmdr1 gene is not a reliable marker of CQR. Further investigations are needed to define a reliable molecular marker for monitoring P. vivax CQR in P. vivax populations.
C1 [Gomes, Larissa Rodrigues; Almeida-de-Oliveira, Natylia Ketrin; de Lavigne, Aline Rosa; Felix de Lima, Suelen Rezende; de Pina-Costa, Anielle; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21045900 Rio De Janeiro, Brazil.
   [Gomes, Larissa Rodrigues; Almeida-de-Oliveira, Natylia Ketrin; de Lavigne, Aline Rosa; Felix de Lima, Suelen Rezende; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI IPEC, Lab Doencas Febris Agudas, BR-21045900 Rio De Janeiro, Brazil.
   [Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.
RP Ferreira-da-Cruz, MD (corresponding author), Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21045900 Rio De Janeiro, Brazil.; Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
EM mffcruz28@gmail.com
RI Menard, Didier/O-3294-2013; Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Menard, Didier/0000-0003-1357-4495; 
FU National Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Foundation for Research Support in the State of Rio de Janeiro
   (Faperj) as Cientistas do Nosso Estado; CAPES, Brazilian Ministry of
   EducationCAPES; POM (Fiocruz); PNCM, Secretary for Health Surveillance,
   Brazilian Ministry of Health; Fiocruz-Pasteur network
FX CTDR and MFFC are recipients of a Research Productivity Fellowship from
   the National Brazilian Council for Scientific and Technological
   Development (CNPq) and from the Foundation for Research Support in the
   State of Rio de Janeiro (Faperj) as Cientistas do Nosso Estado. LRG
   receives a doctoral fellowship from CAPES, Brazilian Ministry of
   Education. The work was supported by the POM (Fiocruz), the PNCM,
   Secretary for Health Surveillance, Brazilian Ministry of Health and
   Fiocruz-Pasteur network. Sponsors had no role in the collection,
   analysis and interpretation of data, in the writing of the manuscript
   and in the decision to submit the manuscript for publication.
CR Aguiar ACC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-73
   Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67
   Anez A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0774-4
   Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004
   BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547
   Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08
   Battle KE, 2012, ADV PARASIT, V80, P1, DOI 10.1016/B978-0-12-397900-1.00001-3
   Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830
   Brega S, 2004, ANTIMICROB AGENTS CH, V48, P2581, DOI 10.1128/AAC.48.7.2581-2587.2004
   Chehuan YF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-226
   da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   del Carmen R, 2012, AM J TROP MED HYG, V87, P813, DOI 10.4269/ajtmh.2012.12-0094
   Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55
   Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012
   Goncalves LA, 2014, MEM I OSWALDO CRUZ, V109, P534, DOI 10.1590/0074-0276130579
   Jovel IT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-376
   Lee KS, 2009, AM J TROP MED HYG, V80, P215, DOI 10.4269/ajtmh.2009.80.215
   Lekweiry KM, 2012, J ANTIMICROB CHEMOTH, V67, P367, DOI 10.1093/jac/dkr464
   Lin JT, 2013, AM J TROP MED HYG, V88, P1116, DOI 10.4269/ajtmh.12-0701
   Lu F, 2011, ACTA TROP, V117, P69, DOI 10.1016/j.actatropica.2010.08.011
   Marfurt J, 2008, J INFECT DIS, V198, P409, DOI 10.1086/589882
   Marques MM, 2014, ANTIMICROB AGENTS CH, V58, P342, DOI 10.1128/AAC.02279-12
   Melo GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105922
   Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97
   Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373
   Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79
   Ranjitkar S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-75
   Rungsihirunrat K, 2015, KOREAN J PARASITOL, V53, P43, DOI 10.3347/kjp.2015.53.1.43
   Sa JM, 2005, EXP PARASITOL, V109, P256, DOI 10.1016/j.exppara.2004.12.005
   Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196
   Shalini S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-129
   Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   WHITBY M, 1989, LANCET, V2, P1395, DOI 10.1016/S0140-6736(89)92002-3
NR 41
TC 6
Z9 8
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD FEB 18
PY 2016
VL 15
AR 96
DI 10.1186/s12936-016-1141-9
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DD9OO
UT WOS:000370255500002
PM 26887935
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Siqueira, AM
   Mesones-Lapouble, O
   Marchesini, P
   Sampaio, VD
   Brasil, P
   Tauil, PL
   Fontes, CJ
   Costa, FTM
   Daniel-Ribeiro, CT
   Lacerda, MVG
   Damasceno, CP
   Santelli, ACS
AF Siqueira, Andre M.
   Mesones-Lapouble, Oscar
   Marchesini, Paola
   Sampaio, Vanderson de Souza
   Brasil, Patricia
   Tauil, Pedro L.
   Fontes, Cor Jesus
   Costa, Fabio T. M.
   Daniel-Ribeiro, Claudio Tadeu
   Lacerda, Marcus V. G.
   Damasceno, Camila P.
   Santelli, Ana Carolina S.
TI fPlasmodium vivax Landscape in Brazil: Scenario and Challenges
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PLASMODIUM-VIVAX; AMAZON REGION; PORTO VELHO; MALARIA TRANSMISSION;
   DIPTERA-CULICIDAE; NONENDEMIC AREA; WESTERN AMAZON; RONDONIA STATE;
   ELIMINATION; CHLOROQUINE
AB Brazil is the largest country of Latin America, with a considerable portion of its territoritory within the malaria-endemic Amazon region in the North. Furthermore, a considerable portion of its territory is located within the Amazon region in the north. As a result, Brazil has reported half of the total malaria cases in the Americas in the last four decades. Recent progress in malaria control has been accompanied by an increasing proportion of Plasmodium vivax, underscoring a need for a better understanding of management and control of this species and associated challenges. Among these challenges, the contribution of vivax malaria relapses, earlier production of gametocytes (compared with Plasmodium falciparum), inexistent methods to diagnose hypnozoite carriers, and decreasing efficacy of available antimalarials need to be addressed. Innovative tools, strategies, and technologies are needed to achieve further progress toward sustainable malaria elimination. Further difficulties also arise from dealing with the inherent socioeconomic and environmental particularities of the Amazon region and its dynamic changes.
C1 [Siqueira, Andre M.; Brasil, Patricia] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
   [Siqueira, Andre M.; Sampaio, Vanderson de Souza; Lacerda, Marcus V. G.] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.
   [Mesones-Lapouble, Oscar] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Marchesini, Paola; Damasceno, Camila P.; Santelli, Ana Carolina S.] Minist Saude, Coordenacao Geral Programa Nacl Controle Malaria, Brasilia, DF, Brazil.
   [Sampaio, Vanderson de Souza] Fundacao Vigilancia Saude, Manaus, Amazonas, Brazil.
   [Tauil, Pedro L.] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil.
   [Fontes, Cor Jesus] Univ Fed Mato Grosso, Cuiaba, Brazil.
   [Costa, Fabio T. M.] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Lacerda, Marcus V. G.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Siqueira, AM (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM andre.siqueira@ini.fiocruz.br; oscar.lapouble@gmail.com;
   paola.b.marchesini@gmail.com; vandersons@gmail.com;
   patricia.brasil@ini.fiocruz.br; pltauil@unb.br; corfontes@gmail.com;
   fabiotmc72@gmail.com; ctdr@uol.com.br; marcuslacerda.br@gmail.com;
   camilapdamasceno@gmail.com; anacarolina.santelli@gmail.com
RI Sampaio, Vanderson/M-4337-2015; Sampaio, Vanderson/AAQ-1418-2020;
   Siqueira, Andre M/G-1340-2010; Fontes, Cor JF/G-7331-2018; Costa,
   Fabio/E-1181-2012; Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Siqueira, Andre M/0000-0003-2208-0294;
   Fontes, Cor JF/0000-0003-2756-0588; Costa, Fabio/0000-0001-9969-7300;
   Mesones Lapouble, Oscar/0000-0002-6153-3594
CR Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67
   Alecrim MG, 2006, AM J TROP MED HYG, V74, P20, DOI 10.4269/ajtmh.2006.74.20
   [Anonymous], 2013, B EPIDEMIOL, V44, P1
   Ballut PC, 2013, ACTA TROP, V128, P504, DOI 10.1016/j.actatropica.2013.07.008
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144
   BOULOS M, 1991, REV I MED TROP, V33, P143, DOI 10.1590/S0036-46651991000200009
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Brasil P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-122
   Braz RM, 2013, CAD SAUDE PUBLICA, V29, P935, DOI 10.1590/S0102-311X2013000500011
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122
   Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52
   Cunha MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113357
   de Araujo FCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049871
   Costa KMD, 2010, REV PANAM SALUD PUBL, V28, P353
   de Oliveira FP, 2015, INTERFACE-BOTUCATU, V19, P623, DOI 10.1590/1807-57622014.1142
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   dos Reis IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137521
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   Foley DH, 2014, J VECTOR ECOL, V39, P168, DOI 10.1111/j.1948-7134.2014.12084.x
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Griffing SM, 2015, MEM I OSWALDO CRUZ, V110, P701, DOI 10.1590/0074-02760150041
   Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241
   Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806
   Katsuragawa TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009245
   Katsuragawa TH, 2009, CAD SAUDE PUBLICA, V25, P1486, DOI 10.1590/S0102-311X2009000700006
   KLEIN TA, 1991, AM J TROP MED HYG, V45, P463, DOI 10.4269/ajtmh.1991.45.463
   Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615
   Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12
   Ladeia-Andrade S, 2016, AM J TROP MED HYG, V95, P148, DOI 10.4269/ajtmh.16-0017
   Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452
   Llanos-Cuentas A, 2014, LANCET, V383, P1049, DOI 10.1016/S0140-6736(13)62568-4
   Magalhaes BML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003239
   Martins-Campos KM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-351
   Ministerio da Saude, 2010, GUIA PRAT TRAT MAL B
   Monteiro WM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-70
   Morais SA, 2012, REV INST MED TROP SP, V54, P331, DOI 10.1590/S0036-46652012000600008
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pedro RS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-245
   Pereira EA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-355
   Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017
   Sampaio VS, 2015, REV SOC BRAS MED TRO, V48, P4, DOI 10.1590/0037-8682-0275-2014
   Santana MS, 2013, T ROY SOC TROP MED H, V107, P301, DOI 10.1093/trstmh/trt015
   Santana MS, 2007, REV SOC BRAS MED TRO, V40, P533, DOI 10.1590/S0037-86822007000500008
   Santelli AC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-286
   Santos-Ciminera PD, 2007, EMERG INFECT DIS, V13, P1597, DOI 10.3201/eid1310.070052
   Scarpassa VM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1217-6
   Shanks GD, 2012, ADV PARASIT, V80, P301, DOI 10.1016/B978-0-12-397900-1.00006-2
   Simoes LR, 2014, CAD SAUDE PUBLICA, V30, P1403, DOI 10.1590/0102-311X00169312
   Siqueira AM, 2014, SLEEPLESS LIVER
   Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y
   Siqueira AM, 2014, MEM I OSWALDO CRUZ, V109, P540, DOI 10.1590/0074-0276130068
   Siqueira AM, 2014, MEM I OSWALDO CRUZ, V109, P569, DOI 10.1590/0074-0276140132
   Gil LHS, 2015, REV INST MED TROP SP, V57, P263, DOI 10.1590/S0036-46652015000300014
   Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325
   Val FF, 2014, MEM I OSWALDO CRUZ, V109, P522, DOI 10.1590/0074-0276140240
   Vasconcelos Cíntia Honório, 2006, Cad. Saúde Pública, V22, P517, DOI 10.1590/S0102-311X2006000300006
   Vitor-Silva S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1326-2
   WHO, 2015, WORLD MAL REP 2015
NR 59
TC 27
Z9 27
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2016
VL 95
IS 6
SU S
BP 87
EP 96
DI 10.4269/ajtmh.16-0204
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EW6HU
UT WOS:000402611300009
PM 27708190
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Ribeiro, CF
   Lopes, VGS
   Brasil, P
   da Silva, LE
   Ribeiro, PHFJ
   Ugenti, LC
   Nogueira, RMR
AF Ribeiro, Christiane Fernandes
   Silami Lopes, Vania Gloria
   Brasil, Patricia
   da Silva, Licinio Esmeraldo
   Fernandes Josephson Ribeiro, Pedro Henrique
   Ugenti, Luca Cipriani
   Ribeiro Nogueira, Rita Maria
TI DENGUE DURING PREGNANCY: ASSOCIATION WITH LOW BIRTH WEIGHT AND
   PREMATURITY
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Dengue; Pregnancy; Newborn; Prematurity; Low birth weight
AB The aim of this study was to evaluate the effects of dengue virus infection during pregnancy and its correlation with low birth weight, prematurity, and asphyxia. A non-concurrent cohort study reveals the association of dengue during pregnancy with prematurity and low birth weight, when birth occurred during the maternal-fetal viremia period (p = 0.016 and p < 0.0001, respectively).
C1 [Ribeiro, Christiane Fernandes] Univ Fed Fluminense, Dept Maternoinfantil, Rua Marques do Parana,303-3 Andar, BR-24033900 Niteroi, RJ, Brazil.
   [Silami Lopes, Vania Gloria] Univ Fed Fluminense, Dept Pathology, BR-24033900 Niteroi, RJ, Brazil.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [da Silva, Licinio Esmeraldo] Univ Fed Fluminense, Inst Math & Stat, Dept Stat, Inst Math, Rua Mario Braga Santos S-N,7 Andar, BR-24020140 Niteroi, RJ, Brazil.
   [Fernandes Josephson Ribeiro, Pedro Henrique; Ugenti, Luca Cipriani] Univ Fed Fluminense, Fac Med, Niteroi, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavirus, Rio De Janeiro, RJ, Brazil.
RP Ribeiro, CF (corresponding author), Univ Fed Fluminense, Dept Maternoinfantil, Rua Marques do Parana,303-3 Andar, BR-24033900 Niteroi, RJ, Brazil.
EM chrisribeiro@vm.uff.br; vasilami@oul.com.br;
   patricia.brasil@ini.fiocruz.br; licinio.da.silva@gmail.com;
   pedrojosephson@hotmail.com; lucaugenti@hotmail.com; rita@ioc.fiocruz.br
OI Silva, Licinio Esmeraldo/0000-0003-3861-2806
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   APGAR V, 1953, Curr Res Anesth Analg, V32, P260
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0
   Camargo K R Jr, 2000, Cad Saude Publica, V16, P439
   Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   LUBCHENCO LO, 1963, PEDIATRICS, V32, P793
   PARSONSON IM, 1981, AM J TROP MED HYG, V30, P660, DOI 10.4269/ajtmh.1981.30.660
   WADDY RB, 1948, LANCET, V252, P950, DOI 10.1016/S0140-6736(48)91636-5
   World Health Organization Dengue and dengue hemorrhagic fever, 2002, DENGUE DENGUE HEMORR
NR 13
TC 8
Z9 8
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2016
VL 58
AR 8
DI 10.1590/S1678-9946201658008
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DF1ED
UT WOS:000371080700008
PM 26910454
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Calvet, GA
   Filippis, AMB
   Mendonca, MCL
   Sequeira, PC
   Siqueira, AM
   Veloso, VG
   Nogueira, RM
   Brasil, P
AF Calvet, Guilherme A.
   Filippis, Ana Maria B.
   Mendonca, Marcos Cesar L.
   Sequeira, Patricia C.
   Siqueira, Andre M.
   Veloso, Valdilea G.
   Nogueira, Rita M.
   Brasil, Patricia
TI First detection of autochthonous Zika virus transmission in a
   HIV-infected patient in Rio de Janeiro, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; ZIKV; Arbovirus; HIV; Brazil
ID DENGUE VIRUSES; CHIKUNGUNYA; EXPANSION; FEVER
AB Since May 2015, Brazil's Ministry of Health has reported autochthonous transmission of Zika virus (ZIKV) in some states of the country. Simultaneous circulation of Dengue, Chikungunya and ZIKV in the country hinder both the diagnosis and the therapeutic approach of patients seeking care with acute febrile illnesses especially in patients with comorbidities. The association between HIV infection and endemic diseases has been described especially in tropical regions with varying levels of complications, although there has been no report of ZIKV in HIV-infected patients. We report the first autochthonous case of laboratory confirmed ZIKV infection in a HIV-infected patient in Rio de Janeiro, Brazil. He evolved with only mild symptoms and recovered well without major laboratory abnormalities. Phylogenetic analysis of the ZIKV detected in the patient sera clustered within the Asian clade. To the best of our knowledge, this is the first time that Zika virus co-infection is reported in a HIV-infected patient. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Calvet, Guilherme A.; Siqueira, Andre M.; Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Filippis, Ana Maria B.; Mendonca, Marcos Cesar L.; Sequeira, Patricia C.; Nogueira, Rita M.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Flavivirus Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Veloso, Valdilea G.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, STD AIDS Clin Res Lab, BR-21045360 Rio De Janeiro, Brazil.
RP Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infect Evandro Chagas, Ave Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br; abispo@ioc.fiocruz.br;
   marcosclm@ioc.fiocruz.br; patricia@ioc.fiocruz.br;
   andre.siqueira@ioc.fiocruz.br; valdiled.veloso@gmail.com;
   rita@ioc.fiocruz.br; patricia.brasil@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010; Calvet, GA/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet, GA/0000-0002-3545-5238
FU FAPERJ (Research Foundation of the State of Rio de Janeiro)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/010.001558/2014]; Fiocruz
FX FAPERJ (Research Foundation of the State of Rio de
   Janeiro)[E-26/010.001558/2014] and Fiocruz.
CR Bressan C. L., 2010, THESIS
   Collao X, 2010, AM J TROP MED HYG, V82, P505, DOI 10.4269/ajtmh.2010.09-0435
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McLinden JH, 2008, J INFECT DIS, V198, P860, DOI 10.1086/591254
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Secretaria de Vigilancia em Saude Ministerio da Saude, ZIK SIT EP DAD
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
NR 17
TC 49
Z9 50
U1 0
U2 110
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2016
VL 74
BP 1
EP 3
DI 10.1016/j.jcv.2015.11.014
PG 3
WC Virology
SC Virology
GA CZ9BC
UT WOS:000367391800001
PM 26615388
OA Bronze
DA 2020-12-01
ER

PT J
AU Wakimoto, MD
   Camacho, LAB
   Guaraldo, L
   Damasceno, LS
   Brasil, P
AF Wakimoto, Mayumi Duarte
   Bastos Camacho, Luiz Antonio
   Guaraldo, Lusiele
   Damasceno, Luana Santana
   Brasil, Patricia
TI Dengue in children: a systematic review of clinical and laboratory
   factors associated with severity
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE dengue; severity; shock syndrome; systematic review; children
ID HEMORRHAGIC-FEVER; SHOCK SYNDROME; RISK-FACTORS; INFECTION; EPIDEMIC;
   AMERICA; INFANTS; ADULTS
AB Dengue is a potentially life-threatening illness, and children are at higher risk of severity. This review aimed to systematize the identified clinical and laboratory parameters associated with severe dengue in children, as monitoring these signs and fluid-replacement therapy are actually the cornerstones of dengue treatment. Of the 527 studies initially reviewed, 21 were selected as follows: three cohort studies, three case-control studies, 14 cross-sectional studies and one not defined. Eighteen studies were carried out in Asia and three in the Americas. Hepatomegaly, lethargy, abdominal pain, bleeding, hemoconcentration and thrombocytopenia, all referenced as warning signs in the WHO 2009 Guidelines, were the clinical and laboratory parameters independently associated with severity in more than one study. The recognition of these known warning signs associated to severe dengue disease underlines the usefulness of the WHO 2009 classification.
C1 [Wakimoto, Mayumi Duarte; Guaraldo, Lusiele; Damasceno, Luana Santana; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Bastos Camacho, Luiz Antonio] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM patricia.brasil@ini.fiocruz.br
FU CNPQNational Council for Scientific and Technological Development (CNPq)
   [404507/2012-13]; Fundacao Oswaldo Cruz from the Ministry of Health
FX The production of this manuscript was supported by CNPQ [award number
   404507/2012-13]. MD Wakimoto, LAB Camacho, L Guaraldo and P Brasil are
   supported by the Fundacao Oswaldo Cruz from the Ministry of Health. LS
   Damasceno is fellow of the Conselho Nacional de Desenvolvimento
   Tecnologico (CNPq). The authors have no other affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict.
CR Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   [Anonymous], 2008, INF EP DENG JAN NOV
   [Anonymous], 2015, DENG SEV DENG
   Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bhattacharya M K, 2013, Int J Biomed Sci, V9, P61
   Chacko B, 2008, J TROP PEDIATRICS, V54, P137, DOI 10.1093/tropej/fmm084
   Chuansumrit A, 2010, SE ASIAN J TROP MED, V41, P326
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296
   Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007
   Gomber S, 2001, Indian Pediatr, V38, P477
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020
   Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014
   GUZMAN MG, 1991, MEM I OSWALDO CRUZ, V86, P367, DOI 10.1590/S0074-02761991000300011
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 1997, DENGUE DENGUE HEMORR
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hung NT, 2005, AM J TROP MED HYG, V72, P370
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   Kabra SK, 1999, T ROY SOC TROP MED H, V93, P294, DOI 10.1016/S0035-9203(99)90027-5
   Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378
   Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Lora AJM, 2014, AM J TROP MED HYG, V90, P169, DOI 10.4269/ajtmh.13-0440
   Maron GM, 2010, AM J TROP MED HYG, DOI [10.1016/j.trstmh.2011.07.007, DOI 10.1016/J.TRSTMH.2011.07.007]
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412
   Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Pancharoen C, 2002, J MED ASS THAI S1, V85, P298
   Pham T B, 2007, Bull Soc Pathol Exot, V100, P43
   Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283
   Pongpan S, 2013, INT J CLIN PEDIAT, V2, P12, DOI DOI 10.4021/IJCP73W
   Reddy KRBK, 2013, PEDIATR RADIOL, V43, P971, DOI 10.1007/s00247-013-2642-0
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   SETIAWAN MW, 1995, J CLIN ULTRASOUND, V23, P357, DOI 10.1002/jcu.1870230605
   Setiawan MW, 1998, PEDIATR RADIOL, V28, P1, DOI 10.1007/s002470050281
   Shah I, 2004, J TROP PEDIATRICS, V50, P301, DOI 10.1093/tropej/50.5.301
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   THISYAKORN U, 1993, CLIN INFECT DIS, V16, P295, DOI 10.1093/clind/16.2.295
   The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 56
TC 9
Z9 10
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD DEC 2
PY 2015
VL 13
IS 12
BP 1441
EP 1456
DI 10.1586/14787210.2015.1100534
PG 16
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA CY2PA
UT WOS:000366249400004
PM 26536064
DA 2020-12-01
ER

PT J
AU Pedro, RS
   Girianella, V
   Wakimoto, M
   Penetra, S
   Damasceno, LS
   Carvalho, L
   Cotrim, D
   Salgueiro, JB
   Brasil, P
AF Pedro, Renata Saraiva
   Girianella, Vania
   Wakimoto, Mayumi
   Penetra, Stephanit
   Damasceno, Luana Santana
   Carvalho, Liege
   Cotrim, Denise
   Salgueiro, Jennifer Braathen
   Brasil, Patricia
TI DENGUE INFANT COHORT STUDY IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Pedro, Renata Saraiva; Girianella, Vania; Wakimoto, Mayumi; Penetra, Stephanit; Damasceno, Luana Santana; Carvalho, Liege; Cotrim, Denise; Salgueiro, Jennifer Braathen; Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 1428
BP 436
EP 436
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844103423
DA 2020-12-01
ER

PT J
AU Rozental, T
   Ferreira, MS
   Gomes, R
   Costa, CM
   Barbosa, PRA
   Bezerra, IO
   Garcia, MHO
   Cruz, DMOE
   Galliez, R
   Oliveira, S
   Brasil, P
   Rezende, T
   De Lemos, ERS
AF Rozental, T.
   Ferreira, M. S.
   Gomes, R.
   Costa, C. M.
   Barbosa, P. R. A.
   Bezerra, I. O.
   Garcia, M. H. O.
   Cruz, D. M. Oliveira E.
   Galliez, R.
   Oliveira, S.
   Brasil, P.
   Rezende, T.
   De Lemos, E. R. S.
TI A cluster of Rickettsia rickettsii infection at an animal shelter in an
   urban area of Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Animal shelter; Brazil; cluster; fatal cases; Rickettsia rickettsii;
   spotted fever
ID MOUNTAIN-SPOTTED-FEVER; DOGS; OUTBREAK
AB Rickettsia rickettsii infection is being increasingly recognized as an important cause of fatal acute illness in Brazil, where this tick-borne disease is designated Brazilian spotted fever (BSF). In this study we report five fatal cases of BSF in employees of an animal shelter in an urban area in the municipality of Rio de Janeiro in southeast Brazil after a natural disaster on 11 January 2011. Four of the cases occurred from 27 January to 11 April 2011, while the fifth fatal case was identified in April 2012. Three cases were confirmed by molecular analysis and two by epidemiological linkage. An investigation of BSF was performed in the animal shelter, and blood samples were collected from 115 employees and 117 randomly selected dogs. The presence of high levels (1024-4096) of antibodies against spotted fever group rickettsiae was found in three (26%) employees and 114 (975%) dogs. These findings emphasize the need to consider BSF as a possible cause of undifferentiated febrile illness, especially dengue and leptospirosis, in patients occupationally exposed to dogs heavily infested by ticks, mainly working at kennels and animal shelters that have inadequate space for the animals housed and frequently providing an environment conducive to exposure to pathogens such as R. rickettsii.
C1 [Rozental, T.; Ferreira, M. S.; Gomes, R.; De Lemos, E. R. S.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Costa, C. M.; Barbosa, P. R. A.; Cruz, D. M. Oliveira E.] Ctr Strateg Informat & Hlth Surveillance, Rio De Janeiro, Brazil.
   [Bezerra, I. O.; Garcia, M. H. O.; Rezende, T.] Hlth Secretariat Municipal Rio de Janeiro, Rio De Janeiro, Brazil.
   [Galliez, R.] Sao Sebastiao Infect Dis Inst Rio de Janeiro Stat, Rio De Janeiro, Brazil.
   [Oliveira, S.] Brazilian Publ Hlth Labs Coordinat, Brasilia, DF, Brazil.
   [Brasil, P.] Fiocruz MS, Evandro Chagas Inst Clin Res, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Rozental, T (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Pavilhao Helio Peggy Pereira,1 Andar,Sala B115, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM rozental@ioc.fiocruz.br
RI Galliez, Rafael Mello/AAA-2724-2020
OI Galliez, Rafael Mello/0000-0003-0348-8374; Lemos,
   Elba/0000-0003-3761-0200
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); FIOCRUZ/Brazilian Ministry of Health
FX We thank Adonai Alvino Junior and Endia Almeida for performing the
   rickettsial serological testing. This study was supported by CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and
   FIOCRUZ/Brazilian Ministry of Health.
CR BREITSCHWERDT EB, 1987, AM J VET RES, V48, P1436
   BREITSCHWERDT EB, 1990, AM J VET RES, V51, P1312
   Cinco M, 2006, CLIN MICROBIOL INFEC, V12, P493, DOI 10.1111/j.1469-0691.2006.01385.x
   Eremeeva ME, 2013, INT J INFECT DIS, V17, pE304, DOI 10.1016/j.ijid.2012.11.011
   Fournier PE, 2000, EMERG INFECT DIS, V6, P389, DOI 10.3201/eid0604.000412
   Fournier PE, 2009, ANN NY ACAD SCI, V1166, P1, DOI 10.1111/j.1749-6632.2009.04528.x
   Fritz CL, 2012, ZOONOSES PUBLIC HLTH, V59, P4, DOI 10.1111/j.1863-2378.2011.01414.x
   Jones TF, 1999, CLIN INFECT DIS, V28, P853, DOI 10.1086/515213
   Lamas C, 2008, BRAZ J INFECT DIS, V12, P149, DOI 10.1590/S1413-86702008000200010
   LEMOS ER, 2001, AM J TROP MED HYG, V65, P329
   McQuiston JH, 2011, ZOONOSES PUBLIC HLTH, V58, P85, DOI 10.1111/j.1863-2378.2009.01300.x
   Ortuno A, 2009, CLIN MICROBIOL INFEC, V15, P241, DOI 10.1111/j.1469-0691.2008.02158.x
   Paddock CD, 2002, AM J TROP MED HYG, V66, P197, DOI 10.4269/ajtmh.2002.66.197
   Paddock CD, 2008, AM J TROP MED HYG, V78, P687, DOI 10.4269/ajtmh.2008.78.687
   Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13
   Podsiadly E, 2011, VECTOR-BORNE ZOONOT, V11, P985, DOI 10.1089/vbz.2010.0080
   Rozental T, 2006, ANN NY ACAD SCI, V1078, P257, DOI 10.1196/annals.1374.046
   Silva N, 2011, EMERG INFECT DIS, V17, P275, DOI 10.3201/eid1702.100859
   Tribaldos M, 2011, J INFECT DEV COUNTR, V5, P737, DOI 10.3855/jidc.2189
   Zajc V, 2013, ANN AGR ENV MED, V20, P280
NR 20
TC 8
Z9 8
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 2015
VL 143
IS 11
BP 2446
EP 2450
DI 10.1017/S0950268814003161
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CL9QQ
UT WOS:000357313600021
PM 25483025
DA 2020-12-01
ER

PT J
AU Guerra, SFS
   Linhares, AC
   Mascarenhas, JDP
   Oliveira, A
   Justino, MCA
   Soares, LS
   Muller, EC
   Brasil, P
   Tuboi, S
   Ortega-Barria, E
   Colindres, R
AF Guerra, Sylvia F. S.
   Linhares, Alexandre C.
   Mascarenhas, Joana D'Arc P.
   Oliveira, Alessilva
   Justino, Maria Cleonice A.
   Soares, Luana S.
   Mueller, Elza Caroline
   Brasil, Patricia
   Tuboi, Suely
   Ortega-Barria, Eduardo
   Colindres, Romulo
TI Rotavirus strain surveillance for three years following the introduction
   of rotavirus vaccine into Belem, Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE rotavirus; Belem; Brazil; genotypes; post-vaccination; gastroenteritis
ID GROUP-A ROTAVIRUS; 1ST 2 YEARS; VP4 GENE; DOUBLE-BLIND; GENOTYPES;
   DIVERSITY; CHILDREN; GASTROENTERITIS; IDENTIFICATION; EFFICACY
AB The monovalent human rotavirus (RV) vaccine, RIX4414 (Rotarix, GlaxoSmithKline Biologicals) was introduced into Brazil's Expanded Program on Immunization in March 2006. One year after vaccine introduction, the G2P[4] strain was found to be predominant, with an apparent extinction of many non-G2 strains. This study investigated the diversity of circulating strains in the three years following RIX4414 introduction. Between May 2008 and May 2011, stool samples were collected from children aged 12 weeks who were hospitalized for severe lab confirmed RV-gastroenteritis (3 liquid or semi-liquid motions over a 24-h period for <14 days, requiring 1 overnight hospital stay and intravenous rehydration therapy) in Belem, Brazil. RV-gastroenteritis was detected by ELISA and the G- and P-types were determined by RT-PCR assays. During the first year of surveillance nucleotide sequencing was used for typing those samples not previously typed by RT-PCR. A total of 1,726 of 10,030 severe gastroentertis hospitalizations (17.2%) were due to severe RVGE. G2P[4] was detected in 57.2% of circulating strains over the whole study period, however it predominated during the first 20 months from May 2008 to January 2009. G1P[8] increased in the last part of the study period from May 2010 to May 2011 and represented 36.6% (112/306) of the circulating strains. G2P[4] was the predominant RV strain circulating during the first 20 months of the study, followed by G1P[8]. These findings probably reflect a natural fluctuation in RV strains over time, rather than a vaccine-induced selective pressure. J. Med. Virol. 87:1303-1310, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Guerra, Sylvia F. S.; Linhares, Alexandre C.; Mascarenhas, Joana D'Arc P.; Oliveira, Alessilva; Justino, Maria Cleonice A.; Soares, Luana S.; Mueller, Elza Caroline] Evandro Chagas Inst, Hlth Surveillance Secretariat, Belem, Para, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Clin Res Inst Evandro Chagas, Rio De Janeiro, Brazil.
   [Tuboi, Suely; Colindres, Romulo] GlaxoSmithKline, Rio De Janeiro, Brazil.
   [Ortega-Barria, Eduardo] GlaxoSmithKline, Panama City, Panama.
RP Linhares, AC (corresponding author), Inst Evandro Chagas, BR 316,Km 7, BR-67030000 Ananindeua, Para, Brazil.
EM alexandrelinhares@iec.pa.gov.br
RI Soares, Luana Silva/AAC-9134-2019
OI Soares, Luana Silva/0000-0001-9509-4019; Alves Muller, Elza
   Caroline/0000-0001-8381-5552; Aguiar Justino, Maria
   Cleonice/0000-0003-3248-5893
FU GlaxoSmithKlineGlaxoSmithKline
FX Grant sponsor: GlaxoSmithKline (to S.F.S.G., A.C.L., J.D.P.M., A.O.,
   M.C.A.J., L.S.S., E.C.M.)
CR [Anonymous], 2013, WEEKLY EPIDEMILOGICA, V88, P49
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f
   CDC, 2011, ROT SURV WORLDW
   Sartori AMC, 2008, REV PANAM SALUD PUBL, V23, P92, DOI 10.1590/S1020-49892008000200004
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   DATASUS, IM COB AN REG
   de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825
   Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002
   Dulgheroff ACB, 2012, J CLIN VIROL, V55, P67, DOI 10.1016/j.jcv.2012.06.003
   Esteban LE, 2010, J MED VIROL, V82, P1083, DOI 10.1002/jmv.21745
   Fischer TK, 2005, J CLIN MICROBIOL, V43, P1099, DOI 10.1128/JCM.43.3.1099-1104.2005
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Gentsch JR, 2009, FUTURE MICROBIOL, V4, P1231, DOI 10.2217/FMB.09.105
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30
   GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990
   Grimwood K, 2009, HUM VACCINES, V5, P57, DOI 10.4161/hv.5.2.6924
   Gurgel RQ, 2008, J CLIN VIROL, V43, P1, DOI 10.1016/j.jcv.2008.04.010
   Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810
   Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P898
   Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2
   Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Linhares A. C., 2012, Trials in Vaccinology, V1, P36, DOI 10.1016/j.trivac.2012.07.002
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Linhares AC, 2011, REV MED VIROL, V21, P89, DOI 10.1002/rmv.682
   Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/erv.12.105, 10.1586/ERV.12.105]
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2011, INFECT GENET EVOL, V11, P1396, DOI 10.1016/j.meegid.2011.05.007
   Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137
   Munford V, 2009, J INFECT DIS, V200, pS106, DOI 10.1086/605037
   Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z
   O'Ryan M, 2011, EXPERT REV VACCINES, V10, P1645, DOI [10.1586/erv.11.152, 10.1586/ERV.11.152]
   O'Ryan M, 2009, PEDIATR INFECT DIS J, V28, pS60, DOI 10.1097/INF.0b013e3181967c29
   Oliveira A, 2012, TRIALS VACCINOL, V1, P4
   Safadi MAP, 2010, PEDIATR INFECT DIS J, V29, P1019, DOI 10.1097/INF.0b013e3181e7886a
   Parashar UD, 2006, EMERG INFECT DIS, V12, P304
   Patel M, 2012, PEDIATRICS, V130, pE365, DOI 10.1542/peds.2011-3478
   Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756
   Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f
   Phua KB, 2012, VACCINE, V30, P4552, DOI 10.1016/j.vaccine.2012.03.030
   Program for Appropriate Technologies in Health (PATH), ROT VACC ACC DEL
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Soares LD, 2012, ARCH VIROL, V157, P135, DOI 10.1007/s00705-011-1111-z
   Tate JE, 2014, CLIN INFECT DIS, V59, P1291, DOI 10.1093/cid/ciu564
   Tate JE, 2010, EXPERT REV VACCINES, V9, P395, DOI 10.1586/ERV.10.17
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   van Doorn LJ, 2009, J CLIN MICROBIOL, V47, P2704, DOI 10.1128/JCM.00378-09
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   WHO, IMM PROF BAHR
NR 53
TC 13
Z9 13
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2015
VL 87
IS 8
BP 1303
EP 1310
DI 10.1002/jmv.24183
PG 8
WC Virology
SC Virology
GA CJ8KG
UT WOS:000355748400008
PM 25879653
DA 2020-12-01
ER

PT J
AU Honorio, NA
   Camara, DCP
   Calvet, GA
   Brasil, P
AF Honorio, Nildimar Alves
   Portela Camara, Daniel Cardoso
   Calvet, Guilherme Amaral
   Brasil, Patricia
TI Chikungunya: an arbovirus infection in the process of establishment and
   expansion in Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Editorial Material
ID AEDES-ALBOPICTUS; VIRUS; AEGYPTI
C1 [Honorio, Nildimar Alves; Portela Camara, Daniel Cardoso] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Honorio, Nildimar Alves; Portela Camara, Daniel Cardoso] Nucleo Operac Sentinela Mosquitos Vetores, Rio De Janeiro, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Honorio, NA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM honorio@ioc.fiocruz.br
RI Camara, Daniel C. P./S-3504-2018; Calvet, GA/G-6959-2013
OI Camara, Daniel C. P./0000-0002-5439-4477; Calvet, GA/0000-0002-3545-5238
CR Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Higgs S, 2015, VECTOR BORNE ZOONOTI
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, MON CAS DENG FEBR CH, V12
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Yaseen HM, 2012, EPIDEMIOLOGY OPEN S, VS2, P003
NR 13
TC 34
Z9 35
U1 0
U2 9
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2015
VL 31
IS 5
BP 906
EP 908
DI 10.1590/0102-311XPE020515
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CL0DH
UT WOS:000356608800003
PM 26083166
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Alvarenga, DAM
   de Pina-Costa, A
   de Sousa, TN
   Pissinatti, A
   Zalis, MG
   Suarez-Mutis, MC
   Lourenco-de-Oliveira, R
   Brasil, P
   Daniel-Ribeiro, CT
   de Brito, CFA
AF Madureira de Alvarenga, Denise Anete
   de Pina-Costa, Anielle
   de Sousa, Tais Nobrega
   Pissinatti, Alcides
   Zalis, Mariano G.
   Suarez-Mutis, Martha C.
   Lourenco-de-Oliveira, Ricardo
   Brasil, Patricia
   Daniel-Ribeiro, Claudio Tadeu
   Alves de Brito, Cristiana Ferreira
TI Simian malaria in the Brazilian Atlantic forest: first description of
   natural infection of capuchin monkeys (Cebinae subfamily) by Plasmodium
   simium
SO MALARIA JOURNAL
LA English
DT Article
DE Simian malaria; Plasmodium simium; Plasmodium vivax; Plasmodium
   brasilianum; Plasmodium malariae; Cebinae; Molecular diagnosis; Atlantic
   forest
ID RIO-DE-JANEIRO; VIVAX; ORIGIN; DIVERSITY; RANGE; STATE
AB Background: In Brazil, two species of Plasmodium have been described infecting non-human primates, Plasmodium brasilianum and Plasmodium simium. These species are morphologically, genetically and immunologically indistinguishable from the human Plasmodium malariae and Plasmodium vivax parasites, respectively. Plasmodium simium has been observed naturally infecting monkeys of the genera Alouatta and Brachyteles in a restricted area of the Atlantic Forest in the south and southeast regions of Brazil. However, its reported geographical distribution and the diversity of its vertebrate hosts may be underestimated, since available data were largely based on analyses by microscopic examination of peripheral blood, a method with limited sensitivity, considering the potential sub-patent feature of these infections. The present study describes, for the first time, the natural infection of P. simium in capuchin monkeys from the Brazilian Atlantic Forest.
   Methods: Blood samples from 30 non-human primates belonging to nine species kept in the Primate Centre of Rio de Janeiro were collected. Fragments of spleen and liver from one dead monkey found in the neighborhoods of the Primate Centre were also analysed. Molecular diagnosis was performed by nested PCR (18SSU rRNA) and the amplified fragment was sequenced.
   Results: Thirty per cent of the captive animals were infected with P. simium and/or P. brasilianum. The dead monkey tested positive for DNA of P. simium. For the first time, Cebinae primates (two specimens of genus Cebus and two of genus Sapajos) were found naturally infected by P. simium. The infection was confirmed by sequencing a small fragment of 18SSU rRNA.
   Conclusion: The results highlight the possibility of infection by P. simium in other species of non-human primates whose impact could be significant for the malaria epidemiology among non-human primates and, if it becomes clear that this P. simium is able to infect monkeys and, eventually, man, also for the maintenance of transmission of human malaria in the context of a zoonosis in areas under influence of the Atlantic Forest.
C1 [Madureira de Alvarenga, Denise Anete; de Sousa, Tais Nobrega; Alves de Brito, Cristiana Ferreira] Fundacao Oswaldo Cruz Fiocruz, Lab Malaria, Ctr Pesquisa Rene Rachou CPqRR, Belo Horizonte, MG, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, INI, Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, RJ, Brazil.
   [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro CPRJ INEA, Rio De Janeiro, RJ, Brazil.
   [Pissinatti, Alcides] Ctr Univ Serra Orgaos UNIFESO, Rio De Janeiro, RJ, Brazil.
   [Zalis, Mariano G.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Lab Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Lab Pesquisa Malaria IOC, Rio De Janeiro, RJ, Brazil.
RP de Brito, CFA (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Malaria, Ctr Pesquisa Rene Rachou CPqRR, Belo Horizonte, MG, Brazil.
EM cristiana@cpqrr.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015; de Sousa, Tais
   Nobrega/AAG-6225-2019; Su\\xc3\\xa1rez-Mutis, Martha/T-9260-2019;
   Suarez-Mutis, Martha/B-9189-2015
OI de Sousa, Tais Nobrega/0000-0002-6874-9427; Suarez-Mutis,
   Martha/0000-0003-2809-6799
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Faperj as Cientistas do nosso EstadoCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Coordenacao de Pessoal de Ensino Superior (Capes)CAPES; Secretary for
   Health Surveillance (SVS) through the Global Fund
FX The authors thank the PDTIS sequencing facilities of FIOCRUZ, Gabriela
   Assis and Lara Cotta Amaral for assistance on sequencing experiments and
   the team of the Primate Centre of Rio de Janeiro (CPRJ/INEA). The
   authors are also grateful to the Parc Zoologique et Botanique Ville de
   Mulhouse, France; to Jean Marc Lernould, Zoological Society for the
   Conservation of Species and Populations - Munchen Germany; and to Dr
   Roland Wirth and the Conservation International (CI), for cooperation in
   the program for reproduction of Sapajus from the Brazilian Atlantic
   Forest. CFAB, CTDR and RLO are supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (through a Research
   Fellowship). CTDR and RLO are grateful for the support of the Faperj as
   Cientistas do nosso Estado. APC and DAMA received fellowships from the
   Coordenacao de Pessoal de Ensino Superior (Capes). The study received
   financial support from the Secretary for Health Surveillance (SVS)
   through the Global Fund.
CR Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007
   Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180
   Brown A, 1984, R MUS ARG CIENC NAT, V13, P273
   CARRERIBRUNO GC, 1995, REV SAUDE PUBL, V29, P142, DOI 10.1590/S0034-89101995000200010
   Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9
   COATNEY GR, 1971, AM J TROP MED HYG, V20, P795, DOI 10.4269/ajtmh.1971.20.795
   Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   Deane L. M., 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P287
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1964, B WORLD HEALTH ORGAN, V31, P752
   DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223
   DEARRUDA M, 1989, AM J TROP MED HYG, V41, P379, DOI 10.4269/ajtmh.1989.41.379
   ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616
   Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102
   FEDIGAN LM, 1990, FOLIA PRIMATOL, V54, P196, DOI 10.1159/000156444
   FloresMendoza C, 1996, MEM I OSWALDO CRUZ, V91, P265, DOI 10.1590/S0074-02761996000300001
   Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI
   Freese C.H., 1981, P331
   Garnham PCC, 1966, MALARIA PARASITES OT
   IZAWA K, 1979, Primates, V20, P57, DOI 10.1007/BF02373828
   Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146
   Li J, 2001, EMERG INFECT DIS, V7, P35, DOI 10.3201/eid0701.010105
   Lim CS, 2005, P NATL ACAD SCI USA, V102, P15523, DOI 10.1073/pnas.0507413102
   LOURENCO-DE-OLIVEIRA R, 1990, Memorias do Instituto Oswaldo Cruz, V85, P15
   LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004
   Miguel RB, 2011, THESIS I OSWALDO CRU
   Miguel RB, 2014, MEM I OSWALDO CRUZ, V109, P634, DOI 10.1590/0074-0276130558
   Moreira G. V., 2000, Revista Brasileira de Medicina Veterinaria, V22, P252
   Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pacheco MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-328
   Perkins SL, 2009, J PARASITOL, V95, P424, DOI 10.1645/GE-1750.1
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104
   Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007
   World Health Organization (WHO), 2004, REP TECHN CONS WHO I
   Yusof R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-168
NR 45
TC 21
Z9 24
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD FEB 18
PY 2015
VL 14
AR 81
DI 10.1186/s12936-015-0606-6
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CB9BN
UT WOS:000349926400001
PM 25889933
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Correa, LS
   Hokerberg, YHM
   Daumas, RP
   Brasil, P
AF Correa, Luana Sicuro
   Marques Hoekerberg, Yara Hahr
   Daumas, Regina Paiva
   Brasil, Patricia
TI Translation and cross-cultural adaptation of the World Health
   Organization staff questionnaire on dengue warning signs for use in
   Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Dengue; Questionnaires; Health Personnel
ID CLASSIFICATION; MULTICENTER; INSTRUMENTS; COUNTRIES; INFECTION;
   ATTITUDES; KNOWLEDGE
AB Early recognition of warning signs and treatment of severe dengue cases is the main strategy for reducing case-fatality, especially in children, who usually present few symptoms and can progress rapidly to dengue shock syndrome. The objective of this study was to elaborate the Brazilian version of the World Health Organization (WHO) staff questionnaire on the use and value of dengue warning signs, through translation and back-translation of the WHO questionnaire, followed by an expert panel consensus, pretest (n = 13), and pilot study (n = 20) of the preliminary version. Comparison of the original questionnaire in English and the back-translation showed that 8 of the 49 items had been extensively or completely altered, and three were rephrased. The expert panel added the warning signs listed by the Brazilian Ministry of Health. In the final version of the questionnaire, the item "ranking of warning signs" was rephrased and the answer option "do not know" was excluded. The Brazilian version of the WHO staff questionnaire allows assessing health professionals' experience and perceptions regarding the use of warning signs included in the recent dengue guidelines.
C1 [Correa, Luana Sicuro; Marques Hoekerberg, Yara Hahr; Brasil, Patricia] Fundacao Oswald Cruz, Inst Nacl Infectol Evandro Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswald Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Hokerberg, YHM (corresponding author), Fundacao Oswald Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM yarahahr@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Balasubramanian S, 2012, ARCH DIS CHILD, V97, P907, DOI 10.1136/archdischild-2012-301710
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Brasil, 2011, DENG DIAGN MAN CLIN
   Fundagao Nacional de Saude, 2002, DENG DIAGN MAN CLIN
   Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536
   Kularatne Sam, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1198
   Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533
   Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1
   Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035
   Santos Solange Laurentino dos, 2011, Ciênc. saúde coletiva, V16, P1319, DOI 10.1590/S1413-81232011000700066
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 13
TC 4
Z9 4
U1 0
U2 7
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2015
VL 31
IS 2
BP 247
EP 256
DI 10.1590/0102-311X00213913
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CF6IX
UT WOS:000352661500005
PM 25760159
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Gibson, G
   Souza-Santos, R
   Honorio, N
   Pacheco, A
   Moraes, M
   Kubelka, C
   Brasil, P
   Cruz, OD
   Carvalho, M
AF Gibson, G.
   Souza-Santos, R.
   Honorio, N.
   Pacheco, A.
   Moraes, M.
   Kubelka, C.
   Brasil, P.
   Cruz, O. D.
   Carvalho, M.
TI Receptivity Conditions of the Domicile and Occurrence of Severe Dengue
   Fever in a Endemic area of Brazil.
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Meeting Abstract
CT 20th IEA World Congress of Epidemiology (WCE)
CY AUG 17-21, 2014
CL Anchorage, AK
SP Int Epidemiol Assoc
C1 [Gibson, G.; Souza-Santos, R.] Oswaldo Cruz Fdn FIOCRUZ, Natl Sch Publ Hlth ENSP, Rio De Janeiro, Brazil.
   [Honorio, N.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Pacheco, A.; Brasil, P.] Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
   [Moraes, M.; Kubelka, C.] Oswaldo Cruz Inst IOC, Rio De Janeiro, Brazil.
   [Cruz, O. D.; Carvalho, M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RI Pacheco, Antonio Guilherme/E-6378-2013; CARVALHO, MARILIA/AAD-8283-2020
OI Pacheco, Antonio Guilherme/0000-0003-3095-1774; CARVALHO,
   MARILIA/0000-0002-9566-0284
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PY 2015
VL 44
SU 1
MA 1727
BP 124
EP 124
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM9BV
UT WOS:000376659900301
DA 2020-12-01
ER

PT J
AU de Pina-Costa, A
   Brasil, P
   Di Santi, SM
   de Araujo, MP
   Suarez-Mutis, MC
   Santelli, ACFES
   Oliveira-Ferreira, J
   Lourenco-de-Oliveira, R
   Daniel-Ribeiro, CT
AF de Pina-Costa, Anielle
   Brasil, Patricia
   Di Santi, Silvia Maria
   de Araujo, Mariana Pereira
   Suarez-Mutis, Martha Cecilia
   Faria e Silva Santelli, Ana Carolina
   Oliveira-Ferreira, Joseli
   Lourenco-de-Oliveira, Ricardo
   Daniel-Ribeiro, Claudio Tadeu
TI Malaria in Brazil: what happens outside the Amazonian endemic region
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE malaria; Brazil; Plasmodium vivax; extra-Amazon; simian malaria;
   bromeliads
ID PLASMODIUM-KNOWLESI INFECTION; CIRCUMSPOROZOITE PROTEIN GENE; MOSQUITOS
   DIPTERA-CULICIDAE; RIO-DE-JANEIRO; ATLANTIC FOREST; SIMIAN MALARIA;
   SAO-PAULO; AUTOCHTHONOUS MALARIA; SOUTHEASTERN BRAZIL; NATURAL INFECTION
AB Brazil, a country of continental proportions, presents three profiles of malaria transmission. The first and most important numerically, occurs inside the Amazon. The Amazon accounts for approximately 60% of the nation's territory and approximately 13% of the Brazilian population. This region hosts 99.5% of the nation's malaria cases, which are predominantly caused by Plasmodium vivax (i.e., 82% of cases in 2013). The second involves imported malaria, which corresponds to malaria cases acquired outside the region where the individuals live or the diagnosis was made. These cases are imported from endemic regions of Brazil (i.e., the Amazon) or from other countries in South and Central America, Africa and Asia. Imported malaria comprised 89% of the cases found outside the area of active transmission in Brazil in 2013. These cases highlight an important question with respect to both therapeutic and epidemiological issues because patients, especially those with falciparum malaria, arriving in a region where the health professionals may not have experience with the clinical manifestations of malaria and its diagnosis could suffer dramatic consequences associated with a potential delay in treatment. Additionally, because the Anopheles vectors exist in most of the country, even a single case of malaria, if not diagnosed and treated immediately, may result in introduced cases, causing outbreaks and even introducing or reintroducing the disease to a non-endemic, receptive region. Cases introduced outside the Amazon usually occur in areas in which malaria was formerly endemic and are transmitted by competent vectors belonging to the subgenus Nyssorhynchus (i.e., Anopheles darlingi, Anopheles aquasalis and species of the Albitarsis complex). The third type of transmission accounts for only 0.05% of all cases and is caused by autochthonous malaria in the Atlantic Forest, located primarily along the southeastern Atlantic Coast. They are caused by parasites that seem to be (or to be very close to) P. vivax and, in a less extent, by Plasmodium malariae and it is transmitted by the bromeliad mosquito Anopheles (Kerteszia) cruzii. This paper deals mainly with the two profiles of malaria found outside the Amazon: the imported and ensuing introduced cases and the autochthonous cases. We also provide an update regarding the situation in Brazil and the Brazilian endemic Amazon.
C1 [de Pina-Costa, Anielle; Brasil, Patricia; Lourenco-de-Oliveira, Ricardo; Daniel-Ribeiro, Claudio Tadeu] Brazilian Minist Hlth, Ctr Pesquisa Diagnost & Treinamento Malaria, Reference Lab Malaria Extra Amazonian Reg, Rio De Janeiro, RJ, Brazil.
   [de Pina-Costa, Anielle; Brasil, Patricia] Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
   [Suarez-Mutis, Martha Cecilia] Fiocruz MS, Inst Oswaldo Cruz, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Oliveira-Ferreira, Joseli] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [de Araujo, Mariana Pereira; Faria e Silva Santelli, Ana Carolina] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Controle Malaria, Brasilia, DF, Brazil.
   [Di Santi, Silvia Maria] Secretaria Saude Estado Sao Paulo, Nucleo Estudos Malaria Superintendencia Controle, Sao Paulo, Brazil.
   [Di Santi, Silvia Maria] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
RP de Pina-Costa, A (corresponding author), Brazilian Minist Hlth, Ctr Pesquisa Diagnost & Treinamento Malaria, Reference Lab Malaria Extra Amazonian Reg, Rio De Janeiro, RJ, Brazil.
EM malaria@fiocruz.br; patricia.brasil@ipec.fiocruz.br;
   lourenco@ioc.fiocruz.br
RI Di Santi, Silvia/D-8973-2012; Daniel-Ribeiro, Claudio Tadeu/G-2216-2015;
   Su\\xc3\\xa1rez-Mutis, Martha/T-9260-2019; Suarez-Mutis,
   Martha/B-9189-2015; Oliveira-Ferreira, Joseli/E-7942-2014
OI Di Santi, Silvia/0000-0001-8049-2014; Suarez-Mutis,
   Martha/0000-0003-2809-6799; Oliveira-Ferreira,
   Joseli/0000-0002-6063-465X
FU FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX APC was recipient of a Doctoral Fellowship from the FIOCRUZ, JOF, RLO
   and CTDR are recipients of Research Productivity Fellowships from the
   CNPq, RLO and CTDR are "Cientistas do Nosso Estado" from the FAPERJ, and
   ACFSS coordinates and MPA works at the PNCM, SVS/MS.
CR Marques GRAM, 2008, REV SOC BRAS MED TRO, V41, P386, DOI 10.1590/S0037-86822008000400012
   ANDRADE J C R D, 1986, Revista de Saude Publica, V20, P323
   ARAGAO MB, 1968, MEM I OSWALDO CRUZ, V66, P227, DOI 10.1590/S0074-02761968000200008
   Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180
   Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008
   Azevedo AL, 1997, THESIS
   Barata R C, 1995, Cad Saude Publica, V11, P128
   Barros-Barreto J, 1940, MALARIA DOUTRINA PRA
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Branquinho M S, 1997, Rev Panam Salud Publica, V2, P189, DOI 10.1590/S1020-49891997000900004
   Brasil P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-122
   Brasil P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-402
   Camargo EP, 2003, CIENC CULT, V55, P26
   Carvalho ME, 1985, CAD SAUDE PUBLICA, V1, P250
   CARVALHO ME, 1988, CAD SAUDE PUBLICA, V4, P276
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Cerutti Jr C, 2007, THESIS
   Chagas C, 1935, DISC C RIO JAN NOIT, P191
   Chagas MFB, 2005, REV SOC BRASIL ME S1, V38, P329
   Chaves K M, 1995, Cad Saude Publica, V11, P621, DOI 10.1590/S0102-311X1995000400010
   COCHRANE AH, 1985, INFECT IMMUN, V50, P58, DOI 10.1128/IAI.50.1.58-61.1985
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Costa APCM, 2009, REV SOC BRAS MED TRO, V42, P477
   Couto RD, 2010, REV SOC BRAS MED TRO, V43, P52, DOI 10.1590/S0037-86822010000100012
   Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888
   Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269
   Curado I, 1997, MEM I OSWALDO CRUZ, V92, P235, DOI 10.1590/S0074-02761997000200017
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   da FONSECA FLAVIO, 1951, MEM INST OSWALDO CRUZ, V49, P543, DOI 10.1590/S0074-02761951000100008
   da Silva JMC, 2003, STATE HOTS, P43
   da Silva KS, 2013, J MED ENTOMOL, V50, P24, DOI 10.1603/ME11219
   de Arruda ME, 1985, MEM I O CRUZ, V80, P367, DOI DOI 10.1590/S0074-02761985000300015
   de Carvalho-Pinto CJ, 2004, MEM I OSWALDO CRUZ, V99, P471, DOI 10.1590/S0074-02762004000500002
   de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x
   DEANE L. M., 1948, REV SERV ESPECIAL SAUDE PUBLICA, V1, P827
   DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002
   DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223
   Di Santi Silvia Maria, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P183, DOI 10.1590/S0036-46652004000400002
   Di Santi SM, 2005, REV SOC BRAS MED S1, V38, pS333
   Domingos MF, 2006, B EPIDEMIOLOGICO PAU, V3, P10
   Duarte AMRC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-58
   ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616
   Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124
   Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102
   Fairhust MR, 2009, MANDELL DOUGLAS BENN, P3437
   Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168
   FloresMendoza C, 1996, MEM I OSWALDO CRUZ, V91, P265, DOI 10.1590/S0074-02761996000300001
   Forattini O. P., 1962, ENTOMOLOGIA MED, V1
   Fundacao SOS Mata Atlantica and INPE (Instituto Nacional de Pesquisas Espaciais), 2008, ATL REM FLOR MAT ATL
   Garnham PCC, 1966, MALARIA PARASITES OT
   GOLDMAN IF, 1993, MOL BIOCHEM PARASIT, V57, P177, DOI 10.1016/0166-6851(93)90257-X
   Gomes AC, 2013, REV SOC BRAS MED TRO, V43, P516
   Gomes AD, 2008, REV INST MED TROP SP, V50, P287, DOI 10.1590/S0036-46652008000500008
   Gonder Richard, 1908, Malaria Leipzig, V1
   Guimarães Anthony Érico, 2003, Cad. Saúde Pública, V19, P1107, DOI 10.1590/S0102-311X2003000400032
   Guimaraes LO, 2012, ACTA TROP, V124, P27, DOI 10.1016/j.actatropica.2012.05.016
   Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339
   Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293
   Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180
   Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355
   Kirchgatter K, 2005, BMJ-BRIT MED J, V331, P576
   Laporta GZ, 2011, MEM I OSWALDO CRUZ, V106, P239, DOI 10.1590/S0074-02762011000900029
   Lim CS, 2005, P NATL ACAD SCI USA, V102, P15523, DOI 10.1073/pnas.0507413102
   Limongi JE, 2008, REV SOC BRAS MED TRO, V41, P232, DOI 10.1590/S0037-86822008000300002
   Lorenz C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-257
   LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004
   LOURENCODEOLIVEIRA R, 1989, MEM I OSWALDO CRUZ, V84, P501, DOI 10.1590/S0074-02761989000400008
   LourencodeOliveira R, 1996, MEM I OSWALDO CRUZ, V91, P687, DOI 10.1590/S0074-02761996000600005
   Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407
   Lupi O, 2014, RESEARCH, V1, P613
   Machado Ricardo Luiz Dantas, 2003, Rev. Soc. Bras. Med. Trop., V36, P581, DOI 10.1590/S0037-86822003000500007
   Ribeiro ALM, 2013, REV SOC BRAS MED TRO, V46, P498, DOI 10.1590/0037-8682-1354-2013
   Marques A. C., 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P91
   Martins-Costa DA, 1885, HIST BIBLIO
   Maselli LMF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-224
   Mattos MS, 1993, P 4 REUN NAC PESQ MA, P23
   McKeon SN, 2013, MEM I OSWALDO CRUZ, V108, P605, DOI 10.1590/0074-0276108052013012
   Meneguzzi VC, 2009, MEM I OSWALDO CRUZ, V104, P570, DOI 10.1590/S0074-02762009000400006
   Muller M, 2014, INT J INFECT DIS, V22, P55, DOI 10.1016/j.ijid.2013.12.016
   Neves A, 2013, ACTA TROP, V125, P102, DOI 10.1016/j.actatropica.2012.08.014
   Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Rezende HR, 2013, J MED ENTOMOL, V50, P598, DOI 10.1603/ME12085
   Rezende HR, 2009, NEOTROP ENTOMOL, V38, P272, DOI 10.1590/S1519-566X2009000200017
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021
   Rona LDP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-207
   Scuracchio P, 2011, REV INST MED TROP SP, V53, P55, DOI 10.1590/S0036-46652011000100010
   Silva WG., 2007, Braz. J. Biol., V67, P403, DOI 10.1590/S1519-69842007000300004
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   SUCEN/SES-SP - Superintendencia de Controle de Endemias/Secretaria de Estado de Saude do Estado de Sao Paulo, 1995, AV PROGR CONTR MAL E
   Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68
   Tanizaki R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-128
   Tauil P.L., 1998, Research and Reviews in Parasitology, V58, P163
   Tauil PL, 1985, CAD SAUDE PUBLICA, V1, P71
   Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007
   Ueno HM, 2007, REV SAUDE PUBL, V41, P269, DOI 10.1590/S0034-89102007000200014
   Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249
   Veltri AC, 2011, REV SOC BRAS MED TRO, V44, P89
   White N. J., 2005, HARRISONS PRINCIPLES, P1218
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   WHO - World Health Organization, 1961, WHOPA16461
   Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x
NR 105
TC 70
Z9 72
U1 0
U2 21
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2014
VL 109
IS 5
BP 618
EP 633
DI 10.1590/0074-0276140228
PG 16
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AR5CW
UT WOS:000343603800014
PM 25185003
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Miguel, RB
   Peiter, PC
   de Albuquerque, H
   Coura, JR
   Moza, PG
   Costa, ADP
   Brasil, P
   Suarez-Mutis, MC
AF Miguel, Renata Bortolasse
   Peiter, Paulo Cesar
   de Albuquerque, Hermano
   Coura, Jose Rodrigues
   Moza, Patricia Ganzenmueller
   Costa, Anielle de Pina
   Brasil, Patricia
   Suarez-Mutis, Martha Cecilia
TI Malaria in the state of Rio de Janeiro, Brazil, an Atlantic Forest area:
   an assessment using the health surveillance service
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE malaria; surveillance; Atlantic Forest; P. vivax; P. falciparum
ID SAO-PAULO; AUTOCHTHONOUS MALARIA; EPIDEMIOLOGIC ASPECTS; NATURAL
   INFECTION; DIPTERA-CULICIDAE; REGION; TRANSMISSION; ANOPHELINES; VALE
AB The lethality of malaria in the extra-Amazonian region is more than 70 times higher than in Amazonia itself. Recently, several studies have shown that autochthonous malaria is not a rare event in the Brazilian southeastern states in the Atlantic Forest biome. Information about autochthonous malaria in the state of Rio de Janeiro (RJ) is scarce. This study aims to assess malaria cases reported to the Health Surveillance System of the State of Rio de Janeiro between 2000-2010. An average of 90 cases per year had parasitological malaria confirmation by thick smear. The number of malaria notifications due to Plasmodium falciparum increased over time. Imported cases reported during the period studied were spread among 51% of the municipalities (counties) of the state. Only 35 cases (4.3%) were autochthonous, which represents an average of 3.8 new cases per year. Eleven municipalities reported autochthonous cases; within these, six could be characterised as areas of residual or new foci of malaria from the Atlantic Forest system. The other 28 municipalities could become receptive for transmission reintroduction. Cases occurred during all periods of the year, but 62.9% of cases were in the first semester of each year. Assessing vulnerability and receptivity conditions and vector ecology is imperative to establish the real risk of malaria reintroduction in RJ.
C1 [Miguel, Renata Bortolasse; Peiter, Paulo Cesar; de Albuquerque, Hermano; Coura, Jose Rodrigues; Suarez-Mutis, Martha Cecilia] Inst Oswaldo Cruz, Lab Doencas Parasitarias, Rio De Janeiro, RJ, Brazil.
   [Costa, Anielle de Pina; Brasil, Patricia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Moza, Patricia Ganzenmueller] Estado Rio de Janeiro, Secretaria Saude & Def Civil, Gerencia Doencas Transmitidas Vetores & Zoonoses, Rio De Janeiro, RJ, Brazil.
RP Suarez-Mutis, MC (corresponding author), Inst Oswaldo Cruz, Lab Doencas Parasitarias, Rio De Janeiro, RJ, Brazil.
EM marmutis@ioc.fiocruz.br
RI Su\\xc3\\xa1rez-Mutis, Martha/T-9260-2019; Suarez-Mutis,
   Martha/B-9189-2015
OI Suarez-Mutis, Martha/0000-0003-2809-6799
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CAPESCAPES
FX FAPERJ, CAPES
CR Alves M J, 2000, Rev Soc Bras Med Trop, V33, P53, DOI 10.1590/S0037-86822000000100008
   [Anonymous], 2013, B EPIDEMIOL, V44, P1
   Azevedo AL, 1997, THESIS I O CRUZ FIOC
   Bertoli M, 2001, Rev Soc Bras Med Trop, V34, P43, DOI 10.1590/S0037-86822001000100007
   Branquinho M S, 1997, Rev Panam Salud Publica, V2, P189, DOI 10.1590/S1020-49891997000900004
   Carvalho F. F., 1950, REV BRAS MALARIOL DO, V3, P473
   CEPA - Centro de Estudos e Pesquisa em Antropozoonoses do Estado do Rio de Janeiro Maximo da Fonseca Filho, 2009, ENC MACR MAL RIO DE
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Cerutti Jr C, 2007, THESIS U SAO PAULO S
   Chaves K M, 1995, Cad Saude Publica, V11, P621, DOI 10.1590/S0102-311X1995000400010
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Couto RD, 2010, REV SOC BRAS MED TRO, V43, P52, DOI 10.1590/S0037-86822010000100012
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   da Silva KS, 2013, J MED ENTOMOL, V50, P24, DOI 10.1603/ME11219
   Duarte AMRC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-58
   Falavigna-Guilherme Ana Lucia, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P81, DOI 10.1590/S0036-46652005000200004
   Hochman Gilberto, 2002, Hist. cienc. saude-Manguinhos, V9, P233, DOI 10.1590/S0104-59702002000400011
   IBGE, 2010, PRIM RES CENS 2010
   INEA, 2011, EST AMB IND AMB RIO
   INPE - Instituto Nacional de Pesquisas Espaciais, 2013, TERRAVIEWS 4 1 0
   Laporta GZ, 2011, MEM I OSWALDO CRUZ, V106, P239, DOI 10.1590/S0074-02762011000900029
   Limongi JE, 2008, REV SOC BRAS MED TRO, V41, P232, DOI 10.1590/S0037-86822008000300002
   Linhares S, 2011, HIST ESTADO RIO DE J
   Machado Ricardo Luiz Dantas, 2003, Rev. Soc. Bras. Med. Trop., V36, P581, DOI 10.1590/S0037-86822003000500007
   Mattos MS, 1993, P 4 REUN NAC PESQ MA, P23
   Moraes HF, 1990, SUCAM SUA ORIGEM SUA
   MS/SVS - Ministerio da Saude/Secretaria de Vigilancia em Saude, 2003, PROGR NAC PREV CONTR
   MTE - Ministerio do Trabalho e Emprego, 2009, PERF MIGR BRAS 2009
   Nelder MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076208
   Neves A, 2013, ACTA TROP, V125, P102, DOI 10.1016/j.actatropica.2012.08.014
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Rezende HR, 2013, J MED ENTOMOL, V50, P598, DOI 10.1603/ME12085
   Rezende HR, 2009, NEOTROP ENTOMOL, V38, P272, DOI 10.1590/S1519-566X2009000200017
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   WANDERLEY DMV, 1994, REV SAUDE PUBL, V28, P192, DOI 10.1590/S0034-89101994000300005
   WANDERLEY DMV, 1985, REV SAUDE PUBL, V19, P28, DOI 10.1590/S0034-89101985000100004
   World Health Organization, 2007, GUID EL RES FOC MAL
   Zuckerman JN, 2008, BMJ-BRIT MED J, V337, P62
NR 39
TC 14
Z9 15
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2014
VL 109
IS 5
BP 634
EP 640
DI 10.1590/0074-0276130558
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AR5CW
UT WOS:000343603800015
PM 25185004
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Macedo, GA
   Gonin, MLC
   Pone, SM
   Cruz, OG
   Nobre, FF
   Brasil, P
AF Macedo, Gleicy A.
   Gonin, Michelle Luiza C.
   Pone, Sheila M.
   Cruz, Oswaldo G.
   Nobre, Flavio F.
   Brasil, Patricia
TI Sensitivity and Specificity of the World Health Organization Dengue
   Classification Schemes for Severe Dengue Assessment in Children in Rio
   de Janeiro
SO PLOS ONE
LA English
DT Article
ID INFECTION; DIAGNOSIS; FEVER; SHOCK
AB Background: The clinical definition of severe dengue fever remains a challenge for researchers in hyperendemic areas like Brazil. The ability of the traditional (1997) as well as the revised (2009) World Health Organization (WHO) dengue case classification schemes to detect severe dengue cases was evaluated in 267 children admitted to hospital with laboratory-confirmed dengue.
   Principal Findings: Using the traditional scheme, 28.5% of patients could not be assigned to any category, while the revised scheme categorized all patients. Intensive therapeutic interventions were used as the reference standard to evaluate the ability of both the traditional and revised schemes to detect severe dengue cases. Analyses of the classified cases (n = 183) demonstrated that the revised scheme had better sensitivity (86.8%, P<0.001), while the traditional scheme had better specificity (93.4%, P<0.001) for the detection of severe forms of dengue.
   Conclusions/Significance: This improved sensitivity of the revised scheme allows for better case capture and increased ICU admission, which may aid pediatricians in avoiding deaths due to severe dengue among children, but, in turn, it may also result in the misclassification of the patients' condition as severe, reflected in the observed lower positive predictive value (61.6%, P<0.001) when compared with the traditional scheme (82.6%, P<0.001). The inclusion of unusual dengue manifestations in the revised scheme has not shifted the emphasis from the most important aspects of dengue disease and the major factors contributing to fatality in this study: shock with consequent organ dysfunction.
C1 [Macedo, Gleicy A.; Nobre, Flavio F.] Univ Fed Rio de Janeiro, COPPE, Programa Engn Biomed, Lab Engn Sistemas Saude, Rio de Janeiro, Brazil.
   [Gonin, Michelle Luiza C.] SMSDC RJ, Hosp Municipal Jesus HMMJ, Rio De Janeiro, Brazil.
   [Pone, Sheila M.; Cruz, Oswaldo G.; Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM patricia.brasil@ipec.fiocruz.br
OI Moura Pone, Sheila/0000-0002-6246-8915; Nobre,
   Flavio/0000-0003-4261-8258
FU Rede Dengue FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [10/2008]
FX This work was supported by grants from Rede Dengue FIOCRUZ and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, under notice
   number 10/2008 for supporting research about neglected and reemerging
   diseases. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   COHEN SN, 1966, J PEDIATR-US, V68, P448, DOI 10.1016/S0022-3476(66)80249-4
   de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41
   Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052
   Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071
   Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676
   Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x
   Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172
   Proulx F, 2009, PEDIATR CRIT CARE ME, V10, P12, DOI 10.1097/PCC.0b013e31819370a9
   R Development Core Team, 2008, R LANG ENV STAT COMP
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization (WHO), DENG GUID DIAGN TREA
NR 22
TC 21
Z9 22
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2014
VL 9
IS 4
AR e96314
DI 10.1371/journal.pone.0096314
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW4HM
UT WOS:000346241800031
PM 24777054
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Menezes, JA
   Bandeira, CS
   Quintana, M
   Stat, JCADES
   Calvet, GA
   Brasil, P
AF Menezes, Jacqueline A.
   Bandeira, Carolina S.
   Quintana, Marcel
   Stat, Julio C. A. de Lima e Silva
   Calvet, Guilherme A.
   Brasil, Patricia
TI Impact of a single safety-engineered device on the occurrence of
   percutaneous injuries in a general hospital in Brazil
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Health care workers; Safety lancet; Nurses; Blood glucose testing
ID NEEDLESTICK INJURIES; WORKERS
AB Background: Health care workers are exposed to bloodborne pathogens through occupational injuries, and the replacement of sharps by safety-engineered devices has been recommended as a key preventive measure. This recommendation has been difficult to implement in Brazil.
   Methods: We conducted a retrospective study of selected data from a database of blood and body fluid exposures reported from January 2007 through December 2011 in a public general hospital in Rio de Janeiro where, from the end of 2009, a safety lancet for blood glucose testing (BGT) was introduced. A log-binomial model was used to evaluate the effect of the introduction of the safety lancet on the proportion of percutaneous injuries (PIs) during BGT in the nursing staff.
   Results: Nursing staff had a significant reduction in rate of PIs per 100 full-time equivalents from 2007 to 2011 (P < .001), and medical residents had the highest rate throughout the same period. A reduction of PIs by small-gauge needles was observed since 2009, and injuries during BGT fell abruptly in 2010 and 2011 paralleling the number of purchased safety lancets (P < .001).
   Conclusion: The adoption of a single safety device, which required no training, significantly reduced PIs among the nursing team. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Menezes, Jacqueline A.; Bandeira, Carolina S.] Hosp Fed Servidores Estado, Dept Infect Dis, BR-20221161 Rio De Janeiro, Brazil.
   [Quintana, Marcel; Stat, Julio C. A. de Lima e Silva] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Dept Tech Support Clin Res, BR-21045900 Rio De Janeiro, Brazil.
   [Calvet, Guilherme A.; Brasil, Patricia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
RP Menezes, JA (corresponding author), Hosp Fed Servidores Estado, Infect Dis Res Unit, DIP, Rua Sacadura Cabral 178,Anexo 4,4 Andar, BR-20221161 Rio De Janeiro, Brazil.
EM jacqueline@diphse.com.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238
CR Brazil Ministry of Health Health Surveillance Secretariat, 2011, NAT SYST HLTH SURV S
   Brazil Ministry of Social Security, SAF WORK BRAZ
   JAGGER J, 2002, ADV EXPOS PREV, V6, P7
   McCullagh P, 1989, GEN LINEAR MODELS, P98
   Peate WF, 2001, J OCCUP ENVIRON MED, V43, P554, DOI 10.1097/00043764-200106000-00009
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Sohn S, 2004, INFECT CONT HOSP EP, V25, P536, DOI 10.1086/502436
   *SPSS INC, 2007, STAT PACK SOC SCI SP
   Trape-Cardoso M, 2004, AM J INFECT CONTROL, V32, P301, DOI 10.1016/j.ajic.2003.12.003
   US Department of Labor, 2001, FED REGISTER, V66, P5317
   US Food and Drug Administration, 1992, SAF AL NEEDL OTH RIS
   Whitby M, 2008, AM J INFECT CONTROL, V36, P180, DOI 10.1016/j.ajic.2007.07.009
   Wilburn SQ, 2004, INT J OCCUP ENV HEAL, V10, P451, DOI 10.1179/oeh.2004.10.4.451
NR 13
TC 6
Z9 6
U1 0
U2 10
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD FEB
PY 2014
VL 42
IS 2
BP 174
EP 177
DI 10.1016/j.ajic.2013.07.017
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AA2VO
UT WOS:000330952500019
PM 24360640
DA 2020-12-01
ER

PT J
AU Xavier-Carvalho, C
   Gibson, G
   Brasil, P
   Ferreira, RX
   Santos, RD
   Cruz, OG
   de Oliveira, SA
   Carvalho, MD
   Pacheco, AG
   Kubelka, CF
   Moraes, MO
AF Xavier-Carvalho, Caroline
   Gibson, Gerusa
   Brasil, Patricia
   Ferreira, Ralph X.
   Santos, Reinaldo de Souza
   Cruz, Oswaldo Goncalves
   de Oliveira, Solange Artimos
   Carvalho, Marilia de Sa
   Pacheco, Antonio G.
   Kubelka, Claire F.
   Moraes, Milton O.
TI Single nucleotide polymorphisms in candidate genes and dengue severity
   in children: A case-control, functional and meta-analysis study
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE CLEC5A; DC-SIGN; TNF; Cytokines; Dengue; DHF
ID HUMAN DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; HEMORRHAGIC-FEVER;
   VIRUS-INFECTION; DC-SIGN; LEPROSY SUSCEPTIBILITY; CLINICAL-OUTCOMES;
   MYELOID CELLS; ASSOCIATION; DISEASE
AB Dengue is an arthropod-borne emerging viral disease with high morbidity and mortality risk in tropical countries like Brazil. Clinical manifestations are vast, ranging from asymptomatic to most severe forms of dengue such as shock. Previous data have shown that host genetics play a role in disease susceptibility and severity. Herein, we have tested the association of single nucleotide polymorphisms (SNPs) at TNF, IL10, MIF, DCSIGN, CLEC5A, NOD2, CCR5 and MRC1 as candidate genes using a matched case-control study design including 88 severe children cases of dengue patients and 335 healthy unrelated subjects that was also separated in IgG(+) and IgG(+) controls. We demonstrated that the TT genotype of CLEC5A SNP (rs1285933 C>T) is associated with dengue severity (OR = 2.25; p = 0.03) and that GG genotype of -336G>A DCSIGN (CD209) SNP is associated with protection to severe dengue (OR = 0.12; p = 0.04). Both comparisons were borderline significant when cases were compared with IgG(+) controls subgroup. Nevertheless, genotype-phenotype correlation was also assessed using serum levels of TNF from infected patients at the onset of dengue fever, and CT/TT carriers in CLEC5A secreted higher levels of TNF than CC individuals in 5-7 days of infection. No significant difference was observed in TNF levels between genotypes GG versus AG/AA at DCSIGN promoter. Next, we performed ameta-analysis retrieving results from the literature for -336G>A DCSIGN and -308G>A TNF SNPs demonstrating that the consensus estimates of these SNPs indicated no association with dengue severity (when compared to Dengue fever) in the overall analysis. But, a subgroup analysis in the -336G>A DCSIGN, the G allele was associated with severe dengue susceptibility in Asians (ORallele = 2.77; p = 0.0001; ORcarriers = 2.99; p = 0.0001) and protection in Brazilians (ORallele = 0.66; p=0.013). In summary, our results suggest that genetic variations at CLEC5A increase the risk and regulate TNF secretion in dengue severity among Brazilians. Also, combined data of the literature suggest population-specific effect of the -336 DCSIGN SNP more prominent in Asians and in a different direction than Brazilians. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Xavier-Carvalho, Caroline; Moraes, Milton O.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Gibson, Gerusa; Santos, Reinaldo de Souza] Fiocruz MS, ENSP, Dept Endemias Samuel Pessoa, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas IPEC, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Ralph X.; de Oliveira, Solange Artimos] UFF, Hosp Univ Antonio Pedro, Disciplina Doencas Infecciosas & Parasitarias, Dept Clin Med, Rio De Janeiro, Brazil.
   [Cruz, Oswaldo Goncalves; Carvalho, Marilia de Sa; Pacheco, Antonio G.] Fiocruz MS, Programa Comp Cient PROCC, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Kubelka, Claire F.] Fiocruz MS, Lab Imunol Viral, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Kubelka, CF (corresponding author), Fiocruz MS, Lab Imunol Viral, Inst Oswaldo Cruz, Rio de Janeiro Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM claire@ioc.fiocruz.br; mmoraes@fiocruz.br
RI Pacheco, Antonio Guilherme/E-6378-2013; Moraes, Milton
   Ozorio/G-9753-2011; CARVALHO, MARILIA/AAD-8283-2020; Kubelka, Claire
   F/C-5558-2009
OI Pacheco, Antonio Guilherme/0000-0003-3095-1774; Moraes, Milton
   Ozorio/0000-0003-2653-0037; CARVALHO, MARILIA/0000-0002-9566-0284; 
FU Instituto Oswaldo Cruz/FIOCRUZ; FIOCRUZ/PAPES V (from portuguese,
   Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em
   Saude); FAPERJ (from portuguese: Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro); CNPq (from portuguese, Conselho Nacional de Pesquisa
   e Desenvolvimento Tecnologico)National Council for Scientific and
   Technological Development (CNPq); CNPqNational Council for Scientific
   and Technological Development (CNPq); FAPERJ (JCNE)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We are grateful to Cynthia Chester Cardoso, Lucia Elena Alvarado Arnez
   for technical support and critical reading of the paper and Mariana
   Gandini for TNF measurements. This work was supported by Instituto
   Oswaldo Cruz/FIOCRUZ (internal funds), FIOCRUZ/PAPES V (from portuguese,
   Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude;
   FAPERJ (from portuguese: Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro); and CNPq (from portuguese, Conselho Nacional de Pesquisa e
   Desenvolvimento Tecnologico). M.O.M. is CNPq and FAPERJ (JCNE)
   fellowship researcher.
CR Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025
   Alagarasu K, 2013, HUM IMMUNOL, V74, P610, DOI 10.1016/j.humimm.2013.01.027
   Alagarasu K, 2013, INFECT GENET EVOL, V14, P390, DOI 10.1016/j.meegid.2012.12.021
   Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024
   Alter A, 2010, HUM GENET, V127, P337, DOI 10.1007/s00439-009-0775-x
   Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4
   Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521
   Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/fmb.11.39, 10.2217/FMB.11.39]
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Covas CDF, 2013, CYTOKINE, V61, P168, DOI 10.1016/j.cyto.2012.09.012
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010
   Gomes ALV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011267
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178
   Kavvoura FK, 2008, HUM GENET, V123, P1, DOI 10.1007/s00439-007-0445-9
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   Le Bourhis L, 2007, MICROBES INFECT, V9, P629, DOI 10.1016/j.micinf.2007.01.014
   Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5
   Pereira AC, 2009, GENES IMMUN, V10, P174, DOI 10.1038/gene.2008.97
   Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080
   Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Garcia-Trejo AR, 2011, ACTA TROP, V120, P67, DOI 10.1016/j.actatropica.2011.06.002
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Sierra B, 2010, CYTOKINE, V52, P175, DOI 10.1016/j.cyto.2010.06.010
   Sierra BDC, 2006, VIRAL IMMUNOL, V19, P662, DOI 10.1089/vim.2006.0042
   Silva LK, 2010, EUR J HUM GENET, V18, P1221, DOI 10.1038/ejhg.2010.98
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Torres OA, 2009, HUM IMMUNOL, V70, P543, DOI 10.1016/j.humimm.2009.04.022
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   WHO/TDR, 2009, DENG GUID DIAGN TREA
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
NR 57
TC 29
Z9 30
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD DEC
PY 2013
VL 20
BP 197
EP 205
DI 10.1016/j.meegid.2013.08.017
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA 261YQ
UT WOS:000327701200026
PM 24016730
DA 2020-12-01
ER

PT J
AU Brasil, P
   Costa, AP
   Longo, CL
   da Silva, S
   Ferreira-Da-Cruz, MF
   Daniel-Ribeiro, CT
AF Brasil, Patricia
   Costa, Anielle P.
   Longo, Cecilia L.
   da Silva, Sidnei
   Ferreira-da-Cruz, Maria F.
   Daniel-Ribeiro, Claudio Tadeu
TI Malaria, a difficult diagnosis in a febrile patient with sub-microscopic
   parasitaemia and polyclonal lymphocyte activation outside the endemic
   region, in Brazil
SO MALARIA JOURNAL
LA English
DT Article
DE Atlantic forest; Rio de Janeiro; Fever of unknown origin; Malaria; PCR
   diagnosis; Polyclonal lymphocyte activation
ID B-CELL RESPONSES; SAO-PAULO; EPIDEMIOLOGIC ASPECTS; PLASMODIUM-VIVAX;
   ATLANTIC FOREST; AREA; PCR; STATE; TESTS
AB A case of autochthonous Plasmodium vivax malaria with sub-microscopic parasitaemia and polyclonal B-cell activation (PBA) (as reflected by positive IgM and IgG serology for toxoplasmosis, cytomegalovirus, and antinuclear and rheumatoid factors) was diagnosed by polymerase chain reaction (PCR) after consecutive negative rapid diagnostic test results and blood films. The patient, a 44-year-old man from Rio de Janeiro state, Brazil, had visited the Atlantic Forest, a tourist, non-malaria-endemic area where no autochthonous cases of 'bromeliad malaria` has ever been described. The characteristic pattern of fever, associated with PBA, was the clue to malaria diagnosis, despite consecutive negative thick blood smears. The study highlights a need for changes in clinical and laboratory diagnostic approaches, namely the incorporation of PCR as part of the current routine malaria diagnostic methods in non-endemic areas.
C1 [Brasil, Patricia; Costa, Anielle P.; Longo, Cecilia L.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas IPEC, Lab Doencas Febris Agudas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [da Silva, Sidnei] Fiocruz MS, IPEC, Serv Parasitol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Ferreira-da-Cruz, Maria F.; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, IOC, Lab Pesquisas Malaria, BR-21045900 Rio De Janeiro, Brazil.
   [Brasil, Patricia; Costa, Anielle P.; da Silva, Sidnei; Ferreira-da-Cruz, Maria F.; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Ctr Pesquisa Diagnst & Treinamento Malaria CPD Ma, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Fiocruz MS, Inst Pesquisa Clin Evandro Chagas IPEC, Lab Doencas Febris Agudas, Av Brasil 4365,Manguinhos, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM patricia.brasil@ipec.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
FU IPEC and IOC (Fiocruz); Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Foundation for the Research Support at
   the State of Rio de Janeiro (Faperj) as 'Cientistas do Nosso Estado';
   Fiocruz
FX This work was supported by IPEC and IOC (Fiocruz). CTDR and MFFC
   received a productivity fellowship from the Brazilian National Council
   for Scientific and Technological Development (CNPq) and a grant from the
   Foundation for the Research Support at the State of Rio de Janeiro
   (Faperj) as 'Cientistas do Nosso Estado'. AP received a doctoral
   fellowship from Fiocruz.
CR Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175
   Marques GRAM, 2008, REV SOC BRAS MED TRO, V41, P386, DOI 10.1590/S0037-86822008000400012
   [Anonymous], 2011, SITUACAO EPIDEMIOLOG
   Azevedo AL, 1997, THESIS I O CRUZ FIOC
   BANIC DM, 1991, AM J TROP MED HYG, V44, P571, DOI 10.4269/ajtmh.1991.44.571
   Branquinho M S, 1997, Rev Panam Salud Publica, V2, P189, DOI 10.1590/S1020-49891997000900004
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Costa APCM, 2009, REV SOC BRAS MED TRO, V42, P477
   Curado I, 1997, MEM I OSWALDO CRUZ, V92, P235, DOI 10.1590/S0074-02761997000200017
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1
   Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011
   Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6
   Igreja RP, 2010, CLIN INFECT DIS, V50, P616, DOI 10.1086/650177
   Mahajan B, 2012, TRANSFUSION, V52, P1949, DOI 10.1111/j.1537-2995.2011.03541.x
   Marrelli MT, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-127
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   ROLLAND L, 1992, MEM I OSWALDO CRUZ, V87, P197, DOI 10.1590/S0074-02761992000200005
   ROSENBERG YJ, 1978, NATURE, V274, P170, DOI 10.1038/274170a0
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   Ueno HM, 2007, REV SAUDE PUBL, V41, P269, DOI 10.1590/S0034-89102007000200014
   Veltri AC, 2011, REV SOC BRAS MED TRO, V44, ps89
   WYLER DJ, 1979, INFECT IMMUN, V24, P106, DOI 10.1128/IAI.24.1.106-110.1979
   Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x
NR 25
TC 6
Z9 6
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD NOV 7
PY 2013
VL 12
AR 402
DI 10.1186/1475-2875-12-402
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 281LX
UT WOS:000329104200004
PM 24200365
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ribeiro, CF
   Lopes, VGS
   Brasil, P
   Coelho, J
   Muniz, AG
   Nogueira, RMR
AF Ribeiro, Christiane Fernandes
   Silami Lopes, Vania Gloria
   Brasil, Patricia
   Coelho, Janice
   Muniz, Adriana Gouveia
   Ribeiro Nogueira, Rita Maria
TI Perinatal Transmission of Dengue: A Report of 7 Cases
SO JOURNAL OF PEDIATRICS
LA English
DT Article
AB Perinatal transmission of dengue virus was confirmed by the evidence of virus in fetal tissue, newborn serum, and placenta of pregnant women. Abortion, several different clinical findings, and placental inflammatory findings were documented. No association was seen between severity of maternal dengue and disease of the newborn.
C1 [Ribeiro, Christiane Fernandes] Univ Fed Fluminense, Dept Maternoinfantil, BR-24033900 Niteroi, Rio De Janeiro, Brazil.
   [Silami Lopes, Vania Gloria] Univ Fed Fluminense, Dept Pathol, BR-24033900 Niteroi, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Coelho, Janice; Muniz, Adriana Gouveia] Inst Clin Res Evandro Chagas Fiocruz, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Oswaldo Cruz Inst Fiocruz, Flavirus Lab, Rio De Janeiro, Brazil.
RP Ribeiro, CF (corresponding author), Univ Fed Fluminense, Dept Maternoinfantil, 303,Marques do Parana St,3 Floor, BR-24033900 Niteroi, Rio De Janeiro, Brazil.
EM chrisribeiro@vm.uff.br
RI amsalu, ribka/G-8780-2019
FU Fundo de Amparo a Pesquisa do Estado do Rio de Janeiro (Fund for
   Research Support of the State of Rio de Janeiro) [304872/2011-13];
   Conselho Nacional de Pesquisa (National Research Council
   [E-26/103.149/2011]
FX Funded by Fundo de Amparo a Pesquisa do Estado do Rio de Janeiro (Fund
   for Research Support of the State of Rio de Janeiro; 304872/2011-13) and
   Conselho Nacional de Pesquisa (National Research Council;
   E-26/103.149/2011). The authors declare no conflicts of interest.
CR Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Dabbs D. J., 2006, DIAGNOSTIC IMMUNOHIS
   Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213
   Janjindamai Waricha, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P793
   Salgado DM, 2010, PEDIATR INFECT DIS J, V29, P238, DOI 10.1097/INF.0b013e3181bc3c5b
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
NR 10
TC 22
Z9 28
U1 0
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD NOV
PY 2013
VL 163
IS 5
BP 1514
EP 1516
DI 10.1016/j.jpeds.2013.06.040
PG 3
WC Pediatrics
SC Pediatrics
GA 242WD
UT WOS:000326274600060
PM 23916226
OA Green Published
DA 2020-12-01
ER

PT J
AU Longo, CL
   Brasil, P
   Espindola, OD
   Leite, ACCB
   Nogueira, RMR
   Lupi, O
   Neves, ED
AF Longo, Cecilia Lameirinhas
   Brasil, Patricia
   Espindola, Otavio de Melo
   Celestino Bezerra Leite, Ana Claudia
   Ribeiro Nogueira, Rita Maria
   Lupi, Otilia
   Neves, Elizabeth de Souza
TI Dengue fever and human T-cell lymphotropic virus type 1 infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE HTLV-1; Dengue fever; Co-infection
ID MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; ASYMPTOMATIC CARRIERS; HTLV-1
   INFECTION; PROVIRAL LOAD; TNF-ALPHA; CYTOKINES
AB Globalization has increased both the number of emergent diseases and the diversity of co-infections, which could in turn mutually influence the pathogenesis of well-known infectious diseases. Here, we report the first series of chronic human T-cell lymphotropic virus type 1 (HTLV-1) patients co-infected with the dengue fever virus. As both of these diseases are immuno-mediated, we anticipated interference in the development of both diseases, with atypical clinical and laboratory parameter results. All the patients had classic dengue fever, and the main outstanding abnormality was leukopenia associated with lymphopenia. Although a mutual influence was expected, dengue fever did not affect the clinical course of HTLV-1 infection, and HTLV-1 proviral loads revealed unpredictable patterns of change. (C) 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Longo, Cecilia Lameirinhas; Brasil, Patricia; Lupi, Otilia; Neves, Elizabeth de Souza] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin Doencas Infecciosas, BR-21045900 Rio De Janeiro, Brazil.
   [Espindola, Otavio de Melo] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Patogenia Viral, BR-21045900 Rio De Janeiro, Brazil.
   [Celestino Bezerra Leite, Ana Claudia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin Neuroinfeccao, BR-21045900 Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
RP Neves, ED (corresponding author), Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin Doencas Infecciosas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM elizabeth.neves@ipec.fiocruz.br
OI Espindola, Otavio/0000-0002-4062-3785
CR Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576
   Starling ALB, 2013, ACTA TROP, V125, P75, DOI 10.1016/j.actatropica.2012.09.012
   Cardoso DF, 2009, REV INST MED TROP SP, V51, P325, DOI 10.1590/S0036-46652009000600003
   Demontis MA, 2013, AIDS RES HUM RETROV, V29, P359, DOI [10.1089/aid.2012.0132, 10.1089/AID.2012.0132]
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   KURTZKE JF, 1989, NEUROLOGY, V39, P291, DOI 10.1212/WNL.39.2.291
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   de Oliveira ECL, 2009, REV SOC BRAS MED TRO, V42, P682, DOI 10.1590/S0037-86822009000600014
   Luna T, 2011, BRAZ J MED BIOL RES, V44, P1134, DOI [10.1590/S0100-879X2011007500140, 10.1590/S0100-879X2011001100009]
   Pays J-F, 2011, Bull Soc Pathol Exot, V104, P188, DOI 10.1007/s13149-011-0175-z
   Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004
   Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 14
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2013
VL 17
IS 7
BP E562
EP E564
DI 10.1016/j.ijid.2013.01.014
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA 144XT
UT WOS:000318976300017
PM 23510541
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Machado, CR
   Machado, ES
   Rohloff, RD
   Azevedo, M
   Campos, DP
   de Oliveira, RB
   Brasil, P
AF Machado, Carolina Romero
   Machado, Elizabeth Stankiewicz
   Rohloff, Roger Denis
   Azevedo, Marina
   Campos, Dayse Pereira
   de Oliveira, Robson Bruniera
   Brasil, Patricia
TI Is Pregnancy Associated with Severe Dengue? A Review of Data from the
   Rio de Janeiro Surveillance Information System
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID BRAZIL; OUTCOMES
AB Background: Dengue is a reportable disease in Brazil; however, pregnancy has been included in the application form of the Brazilian notification information system only after 2006. To estimate the severity of maternal dengue infection, the available data that were compiled from January 2007 to December 2008 by the official surveillance information system of the city of Rio de Janeiro were reviewed.
   Methods and Principal Findings: During the study period, 151,604 cases of suspected dengue infection were reported. Five hundred sixty-one women in their reproductive age (15-49 years) presented with dengue infection; 99 (18.1%) pregnant and 447 (81.9%) non-pregnant women were analyzed. Dengue cases were categorized using the 1997 WHO classification system, and DHF/DSS were considered severe disease. The Mann-Whitney test was used to compare maternal age, according to gestational period, and severity of disease. A chi-square test was utilized to evaluate the differences in the proportion of dengue severity between pregnant and non-pregnant women. Univariate analysis was performed to compare outcome variables (severe dengue and non-severe dengue) and explanatory variables (pregnancy, gestational age and trimester) using the Wald test. A multivariate analysis was performed to assess the independence of statistically significant variables in the univariate analysis. A p-value, 0.05 was considered statistically significant.
   A higher percentage of severe dengue infection among pregnant women was found, p = 0.0001. Final analysis demonstrated that pregnant women are 3.4 times more prone to developing severe dengue (OR: 3.38; CI: 2.10-5.42). Mortality among pregnant women was superior to non-pregnant women.
   Conclusion: Pregnant women have an increased risk of developing severe dengue infection and dying of dengue.
C1 [Machado, Carolina Romero; Campos, Dayse Pereira; de Oliveira, Robson Bruniera; Brasil, Patricia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Machado, Elizabeth Stankiewicz] Univ Fed Rio de Janeiro, Serv Doencas Infecciosas & Parasitarias, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Rohloff, Roger Denis] Maternidade Municipal Fernando Magalhaes, Rio De Janeiro, Brazil.
   [Azevedo, Marina] Secretaria Municipal Saude & Defesa Civil Rio de, Rio De Janeiro, Brazil.
RP Machado, CR (corresponding author), Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
EM emachado@infolink.com.br
RI Machado, Carlos Renato/H-1043-2015; amsalu, ribka/G-8780-2019
OI Machado, Carlos Renato/0000-0002-8724-3165; 
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   [Anonymous], NASC VIV
   Brasil, 2006, DENG INV FORM SINAN
   Brasil, 2007, DENG DIAGN CLIN MAN
   Brasil. Casos de dengue, 2009, CAS DENG BRAS GRAND
   Cardoso IM, 2011, REV SOC BRAS MED TRO, V44, P430, DOI 10.1590/s0037-86822011005000044
   Chesnutt AN, 2004, CRIT CARE CLIN, V20, P609, DOI 10.1016/j.ccc.2004.06.001
   Kariyawasam S, 2010, J INFECT DEV COUNTR, V4, P767, DOI 10.3855/jidc.908
   da Mota AKM, 2012, CAD SAUDE PUBLICA, V28, P1057, DOI 10.1590/S0102-311X2012000600005
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 14
TC 45
Z9 45
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2013
VL 7
IS 5
AR e2217
DI 10.1371/journal.pntd.0002217
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 158SW
UT WOS:000319994400022
PM 23675548
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Daumas, RP
   Passos, SRL
   Oliveira, RVC
   Nogueira, RMR
   Georg, I
   Marzochi, KBF
   Brasil, P
AF Daumas, Regina P.
   Passos, Sonia R. L.
   Oliveira, Raquel V. C.
   Nogueira, Rita M. R.
   Georg, Ingebourg
   Marzochi, Keyla B. F.
   Brasil, Patricia
TI Clinical and laboratory features that discriminate dengue from other
   febrile illnesses: a diagnostic accuracy study in Rio de Janeiro, Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue/diagnosis; Signs and symptoms; Sensitivity and specificity;
   Fever/diagnosis
ID RAPID IMMUNOCHROMATOGRAPHIC ASSAYS; ANTIGEN-CAPTURE ELISA;
   VIRUS-INFECTION; DIFFERENTIATE DENGUE; LOGISTIC-REGRESSION;
   HEMORRHAGIC-FEVER; ENDEMIC-AREA; EPIDEMIC; CHILDREN; HOSPITALIZATION
AB Background: Dengue is an acute febrile illness caused by an arbovirus that is endemic in more than 100 countries. Early diagnosis and adequate management are critical to reduce mortality. This study aims to identify clinical and hematological features that could be useful to discriminate dengue from other febrile illnesses (OFI) up to the third day of disease.
   Methods: We conducted a sectional diagnostic study with patients aged 12 years or older who reported fever lasting up to three days, without any evident focus of infection, attending an outpatient clinic in the city of Rio de Janeiro, Brazil, between the years 2005 and 2008. Logistic regression analysis was used to identify symptoms, physical signs, and hematological features valid for dengue diagnosis. Receiver-operating characteristic (ROC) curve analyses were used to define the best cut-off and to compare the accuracy of generated models with the World Health Organization (WHO) criteria for probable dengue.
   Results: Based on serological tests and virus genome detection by polymerase chain reaction (PCR), 69 patients were classified as dengue and 73 as non-dengue. Among clinical features, conjunctival redness and history of rash were independent predictors of dengue infection. A model including clinical and laboratory features (conjunctival redness and leukocyte counts) achieved a sensitivity of 81% and specificity of 71% and showed greater accuracy than the WHO criteria for probable dengue.
   Conclusions: We constructed a predictive model for early dengue diagnosis that was moderately accurate and performed better than the current WHO criteria for suspected dengue. Validation of this model in larger samples and in other sites should be attempted before it can be applied in endemic areas.
C1 [Daumas, Regina P.] Oswaldo Cruz Fdn Fiocruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, BR-21041210 Rio De Janeiro, Brazil.
   [Passos, Sonia R. L.; Oliveira, Raquel V. C.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Clin Res Inst, Lab Clin Epidemiol, BR-21040361 Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.] Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Flavivirus Lab, BR-21040190 Rio De Janeiro, Brazil.
   [Georg, Ingebourg] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Clin Res Inst, Serv Immunol, BR-21040361 Rio De Janeiro, Brazil.
   [Marzochi, Keyla B. F.; Brasil, Patricia] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Clin Res Inst, Lab Acute Febrile Illnesses, Rio De Janeiro, Brazil.
RP Daumas, RP (corresponding author), Oswaldo Cruz Fdn Fiocruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, BR-21041210 Rio De Janeiro, Brazil.
EM regina.daumas@gmail.com
RI Passos, Sonia/C-5292-2013; DAUMAS, REGINA/M-9387-2013; Oliveira, Raquel
   de V C de/S-7443-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Oliveira, Raquel de V C
   de/0000-0001-9387-8645
CR Diaz-Quijano FA, 2011, REV PANAM SALUD PUBL, V30, P248, DOI 10.1590/S1020-49892011000900009
   Diaz-Quijano FA, 2010, J CLIN VIROL, V49, P11, DOI 10.1016/j.jcv.2010.06.011
   Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562
   Blacksell SD, 2006, T ROY SOC TROP MED H, V100, P775, DOI 10.1016/j.trstmh.2005.10.018
   Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   Daumas RP, 2011, INFECTION, V39, P135, DOI 10.1007/s15010-011-0101-0
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Deparis X, 1998, TROP MED INT HEALTH, V3, P859
   Díaz Fredi Alexander, 2006, Biomédica, V26, P22
   Diaz-Quijano FA, 2005, ENFERM INFEC MICR CL, V23, P593
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Harris E, 2003, EMERG INFECT DIS, V9, P1003
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Phuong HL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-123
   Kapoor HK, 2006, CAN J OPHTHALMOL, V41, P741, DOI 10.1139/I06-069
   Kumarasamy V, 2007, SMJ Singapore Medical Journal, V48, P669
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lauritsen JM, 2003 2004 EPIDATA VE
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martínez Ruth Aralí, 2005, Biomédica, V25, P412
   Martinez-Vega RA, 2006, REV MED CHILE, V134, P1153, DOI 10.4067/S0034-98872006000900010
   McBride WJH, 1998, EPIDEMIOL INFECT, V121, P151, DOI 10.1017/S0950268898001058
   Nga TTT, 2007, CLIN VACCINE IMMUNOL, V14, P799, DOI 10.1128/CVI.00483-06
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nunes-Araujo FRF, 2003, ANN TROP MED PARASIT, V97, P415, DOI 10.1179/000349803235002263
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P476
   Passos SRL, 2008, INFECTION, V36, P570, DOI 10.1007/s15010-008-7334-6
   Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004
   Ploner M, LOGISTF FIRTHS BIAS
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Ramos MM, 2009, T ROY SOC TROP MED H, V103, P878, DOI 10.1016/j.trstmh.2008.11.009
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Robin X, PROC DISPLAY ANAL RO
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Seet RCS, 2007, J CLIN VIROL, V38, P101, DOI 10.1016/j.jcv.2006.11.002
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196
   Teoh S. C. B., 2006, Dengue Bulletin, V30, P184
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
NR 52
TC 32
Z9 34
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 8
PY 2013
VL 13
AR 77
DI 10.1186/1471-2334-13-77
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA 096KP
UT WOS:000315403000001
PM 23394216
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lupi, O
   Netto, MAC
   Avelar, K
   Romero, C
   Bruniera, R
   Brasil, P
AF Lupi, Otilia
   Carvalho Netto, Marco Antonio
   Avelar, Katia
   Romero, Carolina
   Bruniera, Robson
   Brasil, Patricia
TI Cluster of leptospirosis cases among military personnel in Rio de
   Janeiro, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Brazil; Leptospira; Leptospirosis; Military troops; Rural areas
AB We report two cases of leptospirosis in military personnel in southeastern Brazil. The cases were hospitalized following field training exercises, and presented with acute meningoencephalitis, respiratory illnesses, and skin rash. Leptospira interrogans serovars Icterohaemorrhagiae, Hebdomadis, Patoc, and Cynopteri were identified in the cases by microscopic agglutination test and PCR. (C) 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Lupi, Otilia; Bruniera, Robson] Fundacao Oswaldo Cruz, Ctr Strateg Informat Hlth Surveillance, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Carvalho Netto, Marco Antonio] Municipal Dept Epidemiol Surveillance, Resende, Brazil.
   [Avelar, Katia] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Romero, Carolina; Brasil, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Inst Clin Res, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Lupi, O (corresponding author), Fundacao Oswaldo Cruz, Ctr Strateg Informat Hlth Surveillance, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM otilia.lupi@ipec.fiocruz.br
FU Fundacao Oswaldo Cruz [FIOTEC VPAAPS 006LIV 10-02-08]
FX This research was funded by an internal grant from the Fundacao Oswaldo
   Cruz (FIOTEC VPAAPS 006LIV 10-02-08). The funders had no role in the
   study design, data collection, analysis, decision to publish, or
   preparation of the manuscript.
CR Brazilian Ministry of Health, 2010, EL EP B, V10
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   LINS ZC, 1984, T ROY SOC TROP MED H, V78, P124, DOI 10.1016/0035-9203(84)90191-3
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Sanjee J, 2010, J INFECT DEV COUNTR, V4, P179
NR 5
TC 3
Z9 4
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2013
VL 17
IS 2
BP E129
EP E131
DI 10.1016/j.ijid.2012.10.007
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA 085WA
UT WOS:000314643800009
PM 23195639
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Queiroz, REB
   de Oliveira, LSN
   de Albuquerque, CA
   Santana, CD
   Brasil, PM
   Carneiro, LLR
   Liborio, AB
AF Bayas Queiroz, Rafaela Elizabeth
   Nobre de Oliveira, Leilane Siqueira
   de Albuquerque, Claudio Alves
   Santana, Caroline de Alencar
   Brasil, Patricia Maia
   Rodrigues Carneiro, Luzia Layla
   Liborio, Alexandre Braga
TI Acute kidney injury risk in patients with ST-segment elevation
   myocardial infarction at presentation to the ED
SO AMERICAN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
ID SYMPATHETIC-NERVOUS-SYSTEM; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; TERM
   OUTCOMES; MORTALITY; CRITERIA; DISEASE
AB Introduction: Acute kidney injury (AKI) is common in acute myocardial infarction (AMI) patients and has serious prognostic implications. The early identification of patients at risk of developing AKI at the emergency department (ED) can reduce its incidence.
   Methods: Patients with ST-segment elevation myocardial infarction (STEMI) at the ED were included. Associated factors playing a role at ED presentation and during hospitalization were collected, and independent risk factors of developing AKI were assessed.
   Results: Mean age among patients (n = 406, 69.7% male) was 62.5 +/- 12.5 years. At ED admission, the mean glomerular filtration rate (GFR) was 70.5 +/- 28.1 mL/min per 1.73m(2), and 140 (34.5%) patients had a GFR <60 mL/min per 1.73m(2). Eighty-three patients (20.4%) developed AKI: 47 (11.6%) with stage 1, 26 (6.4%) with stage 2 and 10 (2.5%) with stage 3. Mortality was 11.8% and was higher in patients with AKI (34.9% vs 5.9%, P < .0001). Univariate analysis disclosed age, reduced GFR at presentation, severe Killip class, heart rate and longer door-to-needle time as risk factors to develop AKI. Moreover, these patients received less beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker in the ED. Multivariate analysis revealed that age, Killip class, heart rate, door-to-needle time, and beta-blocker non-use were independent factors associated with AKI. These factors provided the ED physician with good accuracy in identifying patients at high risk of developing AKI.
   Conclusion: Factors associated with AKI in STEMI patients allowed physicians to identify patients at high risk in the ED. Moreover, reduced door-to-needle time and beta-blocker use were associated with renal protection in AMI patients. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Liborio, Alexandre Braga] Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil.
   [Nobre de Oliveira, Leilane Siqueira; de Albuquerque, Claudio Alves; Santana, Caroline de Alencar; Brasil, Patricia Maia; Rodrigues Carneiro, Luzia Layla] Univ Fortaleza, Med Course, Fortaleza, Ceara, Brazil.
   [Bayas Queiroz, Rafaela Elizabeth] Escolade Saude Publ Ceara, Fortaleza, Ceara, Brazil.
RP Liborio, AB (corresponding author), Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil.
EM alexandreliborio@yahoo.com.br
CR Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740
   Fox CS, 2012, CIRCULATION, V125, P497, DOI 10.1161/CIRCULATIONAHA.111.039909
   Fujii T, 2003, EUR J PHARMACOL, V481, P241, DOI 10.1016/j.ejphar.2003.09.036
   Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055
   Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295
   Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169
   Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590
   Hwang SH, 2011, INT J CARDIOL, V150, P99, DOI 10.1016/j.ijcard.2011.03.039
   Kakoki M, 2000, HYPERTENS RES, V23, P527, DOI 10.1291/hypres.23.527
   Ko B, 2012, EUR HEART J
   LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159
   Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551
   Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267
   Palomba H, 2007, KIDNEY INT, V72, P624, DOI 10.1038/sj.ki.5002419
   Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987
   Salman IM, 2010, PATHOLOGY, V42, P259, DOI 10.3109/00313021003631304
   Seeliger E, 2012, EUR HEART J
   Shaw A, 2011, CONTRIB NEPHROL, V174, P156, DOI 10.1159/000329387
   Wada M, 2011, CLIN J AM SOC NEPHRO, V6, P2792, DOI 10.2215/CJN.06780711
NR 21
TC 17
Z9 23
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0735-6757
J9 AM J EMERG MED
JI Am. J. Emerg. Med.
PD NOV
PY 2012
VL 30
IS 9
BP 1921
EP 1927
DI 10.1016/j.ajem.2012.04.011
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA 049QD
UT WOS:000311997600037
PM 22795418
DA 2020-12-01
ER

PT J
AU Pedro, RS
   Guaraldo, L
   Campos, DP
   Costa, AP
   Daniel-Ribeiro, CT
   Brasil, P
AF Pedro, Renata S.
   Guaraldo, Lusiele
   Campos, Dayse P.
   Costa, Anielle P.
   Daniel-Ribeiro, Claudio T.
   Brasil, Patricia
TI Plasmodium vivax malaria relapses at a travel medicine centre in Rio de
   Janeiro, a non-endemic area in Brazil
SO MALARIA JOURNAL
LA English
DT Article
DE Plasmodium vivax malaria; Relapse; Therapeutic failure; Weight-based
   dosing
ID ANTIMALARIAL-DRUGS; RADICAL CURE; PRIMAQUINE; CHLOROQUINE;
   PHARMACOKINETICS; RESISTANCE; ADHERENCE; DIAGNOSIS; INDONESIA; THERAPY
AB Background: Malaria is a potentially severe disease widely distributed in tropical and subtropical regions worldwide. Clinically, the progression of the disease can be life-threatening if it is not promptly diagnosed and properly treated. Through treatment, the radical cure of Plasmodium vivax infection can be achieved, thus preventing potential relapses and the emergence of new cases outside the Amazon region in Brazil. Surveillance for therapeutic failure in non-endemic areas is advantageous, as it is unlikely that recurrence of the disease can be attributed to a new malaria infection in these regions.
   Methods: An observational study of 53 cases of P. vivax and mixed (P. vivax and Plasmodium falciparum) malaria was conducted at a travel medicine centre between 2005 and 2011 in Rio de Janeiro and a descriptive analysis of the potential factors related to recurrence of P. vivax malaria was performed. Groups with different therapeutic responses were compared using survival analysis based on the length of time to recurrence and a set of independent variables thought to be associated with recurrence.
   Results: Twenty-one relapses (39.6%) of P. vivax malaria were observed. The overall median time to relapse, obtained by the Kaplan-Meier method, was 108 days, and the survival analysis demonstrated an association between non-weight-adjusted primaquine dosing and the occurrence of relapse (p<0.03). Primaquine total dose at 3.6 mg/kg gave improved results in preventing relapses.
   Conclusions: A known challenge to individual cure and environmental control of malaria is the possibility of an inappropriate, non-weight-based primaquine dosing, which should be considered a potential cause of P. vivax malaria relapse. Indeed, the total dose of primaquine associated with non-occurrence of relapses was higher than recommended by Brazilian guidelines.
C1 [Pedro, Renata S.; Guaraldo, Lusiele; Campos, Dayse P.; Costa, Anielle P.; Brasil, Patricia] Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas IPEC, BR-21045900 Rio De Janeiro, Brazil.
   [Pedro, Renata S.; Guaraldo, Lusiele; Costa, Anielle P.; Daniel-Ribeiro, Claudio T.; Brasil, Patricia] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas IPEC, Av Brasil 4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM patbr@uol.com.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work is part of RSP's MSc research and was supported by Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CTDR is a
   Productivity Research Fellowship from the CNPq and a "Cientista do nosso
   Estado" from Faperj.
CR Abdon N P, 2001, Rev Soc Bras Med Trop, V34, P343
   Nogueira FHA, 2011, REV SOC BRAS MED TRO, V44, P582, DOI 10.1590/S0037-86822011000500010
   [Anonymous], 2001, GUID TREATM MAL US
   Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09
   Baird JK, 1997, AM J TROP MED HYG, V56, P621, DOI 10.4269/ajtmh.1997.56.621
   BOULOS M, 1991, REV I MED TROP, V33, P143, DOI 10.1590/S0036-46651991000200009
   Brasil Ministerio da Saude, 2009, GUIA PRAT TRAT MAL B
   Brasil Ministerio da Saude, 2008, SIT EO MAL BRAS AN 2
   Brasil Ministerio da Saude, 2001, MAN TER MAL
   Brasil MS, 2005, MAN DIAGN LAB MAL, P112
   Brasil P, 2007, B FARMACOVIGILANCIA, V4, P2
   Rodrigues LNC, 2008, REV SOC BRAS MED TRO, V41, P41, DOI 10.1590/S0037-86822008000100008
   *CDC, 2007, MAL GUID HLTH PROF N
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0
   Daniel-Ribeiro CT, 2008, B SOC PATHOL EXOT, V101, P243
   Duarte EC, 2003, TROP MED INT HEALTH, V8, P518, DOI 10.1046/j.1365-3156.2003.01042.x
   Duarte EC, 2001, AM J TROP MED HYG, V65, P471, DOI 10.4269/ajtmh.2001.65.471
   Fairhust MR, 2009, MANDELL DOUGLAS BENN, P3437
   Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351
   Galappaththy GNL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub2
   Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148
   Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4
   Kitchener S, 2005, J TRAVEL MED, V12, P133, DOI 10.2310/7060.2005.12306
   Lacerda MV, 2007, THESIS U BRASILIA BR
   Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003
   Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5
   Mangoni ED, 2003, AM J TROP MED HYG, V68, P159, DOI 10.4269/ajtmh.2003.68.159
   MIHALY GW, 1985, BRIT J CLIN PHARMACO, V19, P745, DOI 10.1111/j.1365-2125.1985.tb02709.x
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Muhamad P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-44
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pedro RS, 2011, THESIS I PESQUISA CL
   RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3
   Santos JB, 2010, REV SOC BRAS MED TRO, V43, P749, DOI 10.1590/S0037-86822010000600033
   Schwartz E, 2000, AM J TROP MED HYG, V62, P393, DOI 10.4269/ajtmh.2000.62.393
   SCHWARTZ IK, 1991, NEW ENGL J MED, V324, P927
   Signorini L, 1996, AM J TROP MED HYG, V55, P472, DOI 10.4269/ajtmh.1996.55.472
   Song JY, 2007, AM J TROP MED HYG, V77, P609, DOI 10.4269/ajtmh.2007.77.609
   WARD SA, 1985, BRIT J CLIN PHARMACO, V19, P751, DOI 10.1111/j.1365-2125.1985.tb02710.x
   Warrell D.A., 2002, ESSENTIAL MALARIOLOG, P192
   Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   World Health Organization (WHO), 2010, GUID TREATM MAL
   Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x
NR 45
TC 19
Z9 21
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JUL 28
PY 2012
VL 11
AR 245
DI 10.1186/1475-2875-11-245
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 986OJ
UT WOS:000307351700001
PM 22839416
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lacerda, MVG
   Mourao, MPG
   Alexandre, MAA
   Siqueira, AM
   Magalhaes, BML
   Martinez-Espinosa, FE
   Santana, FS
   Brasil, P
   Ventura, AMRS
   Tada, MS
   Couto, VSCD
   Silva, AR
   Silva, RSU
   Alecrim, MGC
AF Lacerda, Marcus V. G.
   Mourao, Maria P. G.
   Alexandre, Marcia A. A.
   Siqueira, Andre M.
   Magalhaes, Belisa M. L.
   Martinez-Espinosa, Flor E.
   Santana Filho, Franklin S.
   Brasil, Patricia
   Ventura, Ana M. R. S.
   Tada, Mauro S.
   Couto, Vanja S. C. D.
   Silva, Antonio R.
   Silva, Rita S. U.
   Alecrim, Maria G. C.
TI Understanding the clinical spectrum of complicated Plasmodium vivax
   malaria: a systematic review on the contributions of the Brazilian
   literature
SO MALARIA JOURNAL
LA English
DT Review
DE Malaria; Plasmodium vivax; Brazil; Severity; Clinical aspects; Anaemia;
   Systematic review
ID SEVERE FALCIPARUM-MALARIA; PAPUA-NEW-GUINEA; AMAZON REGION;
   PULMONARY-EDEMA; ENDEMIC AREA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE
   DEFICIENCY; UNCOMPLICATED MALARIA; NORTHWESTERN INDIA; CONCURRENT
   DENGUE; OXIDATIVE STRESS
AB The resurgence of the malaria eradication agenda and the increasing number of severe manifestation reports has contributed to a renewed interested in the Plasmodium vivax infection. It is the most geographically widespread parasite causing human malaria, with around 2.85 billion people living under risk of infection. The Brazilian Amazon region reports more than 50% of the malaria cases in Latin America and since 1990 there is a marked predominance of this species, responsible for 85% of cases in 2009. However, only a few complicated cases of P. vivax have been reported from this region. A systematic review of the Brazilian indexed and non-indexed literature on complicated cases of vivax malaria was performed including published articles, masters' dissertations, doctoral theses and national congresses' abstracts. The following information was retrieved: patient characteristics (demographic, presence of co-morbidities and, whenever possible, associated genetic disorders); description of each major clinical manifestation. As a result, 27 articles, 28 abstracts from scientific events' annals and 13 theses/dissertations were found, only after 1987. Most of the reported information was described in small case series and case reports of patients from all the Amazonian states, and also in travellers from Brazilian non-endemic areas. The more relevant clinical complications were anaemia, thrombocytopaenia, jaundice and acute respiratory distress syndrome, present in all age groups, in addition to other more rare clinical pictures. Complications in pregnant women were also reported. Acute and chronic co-morbidities were frequent, however death was occasional. Clinical atypical cases of malaria are more frequent than published in the indexed literature, probably due to a publication bias. In the Brazilian Amazon (considered to be a low to moderate intensity area of transmission), clinical data are in accordance with the recent findings of severity described in diverse P. vivax endemic areas (especially anaemia in Southeast Asia), however in this region both children and adults are affected. Finally, gaps of knowledge and areas for future research are opportunely pointed out.
C1 [Lacerda, Marcus V. G.; Mourao, Maria P. G.; Alexandre, Marcia A. A.; Siqueira, Andre M.; Magalhaes, Belisa M. L.; Martinez-Espinosa, Flor E.; Santana Filho, Franklin S.; Alecrim, Maria G. C.] Fundacao Med Trop Dr Heitor Vieira Dourado, BR-69040000 Manaus, Amazonas, Brazil.
   [Lacerda, Marcus V. G.; Mourao, Maria P. G.; Alexandre, Marcia A. A.; Siqueira, Andre M.; Magalhaes, Belisa M. L.; Martinez-Espinosa, Flor E.; Santana Filho, Franklin S.; Alecrim, Maria G. C.] Univ Estado Amazonas, BR-69040000 Manaus, Amazonas, Brazil.
   [Lacerda, Marcus V. G.; Mourao, Maria P. G.; Alexandre, Marcia A. A.; Alecrim, Maria G. C.] Univ Nilton Lins, BR-69058040 Manaus, Amazonas, Brazil.
   [Martinez-Espinosa, Flor E.] FIOCRUZ Amazonia, Inst Leonidas & Maria Deane, BR-69057070 Manaus, Amazonas, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, BR-21040360 Rio De Janeiro, Brazil.
   [Ventura, Ana M. R. S.] Inst Evandro Chagas, BR-67030000 Ananindeua, Brazil.
   [Tada, Mauro S.] Inst Pesquisas Patol Tropicais, Porto Velho, Rondonia, Brazil.
   [Couto, Vanja S. C. D.] Secretaria Saude Amapa, BR-68900000 Macapa, Amapa, Brazil.
   [Silva, Antonio R.] Univ Fed Maranhao, BR-65025560 Sao Luis, Maranhao, Brazil.
   [Silva, Rita S. U.] Univ Fed Acre, BR-69915900 Rio Branco Acre, Brazil.
RP Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
EM marcuslacerda.br@gmail.com
RI amsalu, ribka/G-8780-2019; ventura, ana maria r s/E-4027-2017; Siqueira,
   Andre M/G-1340-2010; Idn, Inct/J-8385-2013
OI ventura, ana maria r s/0000-0002-4737-1533; Siqueira, Andre
   M/0000-0003-2208-0294; 
FU PRONEX Malaria Network; Brazilian Ministry of Science and Technology
   (MCT); National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian Ministry of Health (DECIT/SCTIE/MS); FAPEAM;
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); FAPEPA; FAPEMAT; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG)
FX We acknowledge the organizers of the 47th Congress of the Brazilian
   Society of Tropical Medicine, held in Natal (Rio Grande do Norte) on
   23-26 March, 2011, especially its President Dr. Kleber Luz, for
   embracing and supporting the 1st Brazilian Workshop on Severe P. vivax
   as part of its official programme, from whose reflections this review
   was written. The workshop was supported by the PRONEX Malaria Network,
   funded by the Brazilian Ministry of Science and Technology (MCT),
   National Council for Scientific and Technological Development (CNPq),
   Brazilian Ministry of Health (DECIT/SCTIE/MS) and the Research Support
   Foundations from the states (FAPEAM, FAPERJ, FAPESP, FAPEPA, FAPEMAT,
   FAPEMIG). MVGL is a level 2 productivity fellow from CNPq.
CR Albuquerque BC, 2003, REV SOC BRAS MED TRO, V36, P280
   Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67
   Alecrim MGC, 1995, REV SOC BRAS MED TRO, V28, P151
   Alecrim MGC, 2000, THESIS U BRASILIA
   Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685
   Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Andrade BB, 2010, J IMMUNOL, V185, P1196, DOI 10.4049/jimmunol.0904179
   Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650
   Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13
   Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756
   Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003
   Aragao PS, 2001, REV SOC BRAS MED TRO, V34, P341
   Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001
   AUSTIN SC, 1992, JAMA-J AM MED ASSOC, V268, P516, DOI 10.1001/jama.268.4.516
   Bassat Q, 2011, NAT MED, V17, P48, DOI 10.1038/nm0111-48
   Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x
   Bastos CJC, 2007, REV SOC BRAS MED TRO, V40, P146
   Batista D, 1946, PALUDISME AMAZON CON
   Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
   Borzacov LMP, 2008, REV SOC BRAS MED TRO, V41, P221
   BOTELHO C, 1987, REV I MED TROP, V29, P337, DOI 10.1590/S0036-46651987000600002
   Braga Marcus Davis Machado, 2004, Rev. Soc. Bras. Med. Trop., V37, P53, DOI 10.1590/S0037-86822004000100014
   Bussaratid V, 2000, TROP DOCT, V30, P211, DOI 10.1177/004947550003000410
   Cabral P. H. O., 2006, CASE REPORTS CLIN PR, V7, P220
   Caicedo O, 2009, AM J TROP MED HYG, V80, P146, DOI 10.4269/ajtmh.2009.80.146
   Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327
   Campos LRP, 2007, REV SOC BRAS MED TRO, V40, P141
   Cardoso GA, 2008, REV SOC BRAS MED TRO, V41, P221
   CARDOSO MA, 1994, EUR J CLIN NUTR, V48, P326
   Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815
   Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167
   Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011
   Cavasini M T, 2000, Rev Soc Bras Med Trop, V33, P489, DOI 10.1590/S0037-86822000000500011
   Chagas C, 1903, THESIS MANGUINHOS I
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1153, DOI 10.3201/eid1107.041352
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Costa FTM, 2011, MEM I OSWALDO CRUZ, V106, P79, DOI 10.1590/S0074-02762011000900010
   Curlin ME, 1999, CLIN INFECT DIS, V28, P1166, DOI 10.1086/517767
   da Fonseca JCF, 2007, REV SOC BRAS MED TRO, V40, P672, DOI 10.1590/S0037-86822007000600015
   Chagas ECD, 2009, REV PANAM SALUD PUBL, V26, P203
   de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026
   Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7
   Echeverri Marcela, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P29, DOI 10.1590/S0036-46652003000100006
   Erel O, 2001, CLIN BIOCHEM, V34, P341, DOI 10.1016/S0009-9120(01)00221-1
   Evangelista NMA, 2002, REV SOC BRAS MED TRO, V35, P344
   Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012
   Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55
   Gonçalves Maria Jacirema Ferreira, 2004, Rev. salud pública, V6, P156
   Ferreira MU, 2007, AM J PUBLIC HEALTH, V97, P237, DOI 10.2105/AJPH.2005.078121
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   Fragoso SCP, 2011, HAEMOPHILIA, V17, P159, DOI 10.1111/j.1365-2516.2010.02350.x
   Fragoso SCP, 2010, THESIS U AMAZONAS ST
   Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9
   Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020
   Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127
   Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008
   Grynberg P, 2007, CLIN MICROBIOL INFEC
   Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774
   Guerreiro NSV, 2006, THESIS FEDERAL U PAR
   de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P96, DOI 10.1590/S0037-86822007000100023
   de Lacerda MVG, 2008, REV SOC BRAS MED TRO, V41, P522, DOI 10.1590/S0037-86822008000500021
   de Lacerda MVG, 2009, REV SOC BRAS MED TRO, V42, P79, DOI 10.1590/S0037-86822009000100017
   Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007
   Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066
   Gurgel RL, 2007, REV SOC BRAS MED TRO, V40, P147
   Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003
   Hamel CT, 2002, ACTA TROP, V82, P1, DOI 10.1016/S0001-706X(02)00025-6
   Illamperuma C, 2007, INFECTION, V35, P374, DOI 10.1007/s15010-007-6108-x
   Jarude Regina, 2003, Rev. Bras. Ginecol. Obstet., V25, P149, DOI 10.1590/S0100-72032003000300002
   Kalmar EMN, 1998, REV SOC BRAS MED TRO, V31, P56
   Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9
   Katsuragawa Tony H., 2004, Rev. Bras. Hematol. Hemoter., V26, P268, DOI 10.1590/S1516-84842004000400007
   Katsuragawa TH, 2009, CAD SAUDE PUBLICA, V25, P1486, DOI 10.1590/S0102-311X2009000700006
   Khan FY, 2010, INT J INFECT DIS, V14, pE217, DOI 10.1016/j.ijid.2009.07.018
   Kochar D K, 2003, J Assoc Physicians India, V51, P1069
   Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194
   Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308
   Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633
   Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519
   Kochar SK, 2009, J VECTOR DIS, V46, P307
   Kumar A, 1995, Indian Pediatr, V32, P243
   Lacerda MVG, 2004, ACTA TROP, V90, P187, DOI 10.1016/j.actatropica.2003.12.001
   Lacerda MVG, 2003, REV SOC BRAS MED TRO, V36, P281
   Lacerda MVG, 2007, THESIS U BRASILIA
   Lakhkar B B, 1996, Indian Pediatr, V33, P971
   Lampah DA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001032
   Lanca EFC, 2011, THESIS U AMAZONAS ST
   Lee JH, 2010, AM J TROP MED HYG, V82, P219, DOI 10.4269/ajtmh.2010.09-0439
   Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283
   Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8
   Lomar André V., 2005, Braz J Infect Dis, V9, P425, DOI 10.1590/S1413-86702005000500011
   Albuquerque SRL, 2010, PARASITOL RES, V106, P1049, DOI 10.1007/s00436-010-1745-x
   Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X
   Marques H H, 1996, J Pediatr (Rio J), V72, P103
   Marques HO, 2004, THESIS FEDERAL U SAO
   Martinez-Espinosa FE, 2004, MEM I OSWALDO CRUZ, V99, P19, DOI 10.1590/S0074-02762004000100003
   Martinez-Espinosa FE, 2006, REV SOC BRAS MED TRO, V39, P107
   Mello GS, 2006, REV SOC BRAS MED TRO, V39, P106
   Melo AMN, 2004, T ROY SOC TROP MED H, V98, P485, DOI 10.1016/j.trstmh.2003.12.007
   Melo GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011206
   Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192
   Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97
   Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044
   Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997
   Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07
   Moura ACL, 2002, REV SOC BRAS MED TRO, V35, P369
   Moura EFA, 1987, J PEDIAT RIO J, V62, P279
   Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604
   Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X
   Neves JJO, 2002, THESIS FEDERAL U PAR
   Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2
   Ohnishi MDO, 2008, REV SOC BRAS MED TRO, V41, P215
   Ohnishi MDO, 2010, REV SOC BRAS MED TRO, V43, P84
   Oliveira MS, 2004, THESIS U AMAZONAS ST
   Oliveira RSM, 2006, REV SOC BRAS MED TRO, V39, P109
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH
   Quintero JP, 2011, MEM I OSWALDO CRUZ, V106, P91, DOI 10.1590/S0074-02762011000900012
   PARK CHL, 2002, REV SOC BRAS MED S1, V35, P370
   Pereira MSS, 2006, THESIS FEDERAL U AMA
   Pereira Paulo C. M., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P19, DOI 10.1590/S0036-46651995000100004
   Pessoa SB, 1967, PARASITOLOGIA MED, P11
   Picot S, 2006, MED MALADIES INFECT, V36, P406, DOI 10.1016/j.medmal.2006.06.001
   Pinheiro MCN, 2002, REV PARA MED, V16, P25
   Piyaphanee Watcharapong, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P616
   POELS PJE, 1993, TROP GEOGR MED, V45, P83
   Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743
   Poespoprodjo JR, 2009, CLIN INFECT DIS
   Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79
   Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1
   Pukrittayakamee S, 1998, T ROY SOC TROP MED H, V92, P421, DOI 10.1016/S0035-9203(98)91075-6
   Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017
   Raposo CCBS, 2006, THESIS U BRASILIA
   Reiter P, 2000, EMERG INFECT DIS, V6, P1
   Rodriguez-Morales AJ, 2006, J TROP PEDIATRICS, V52, P49, DOI 10.1093/tropej/fmi069
   Rogerson SJ, 2008, PLOS MED, V5, P875, DOI 10.1371/journal.pmed.0050136
   Sahoo Saddichha, 2007, Am J Ther, V14, P406, DOI 10.1097/MJT.0b013e31802e4b0e
   Santana MS, 2007, REV SOC BRAS MED TRO, V40, P533, DOI 10.1590/S0037-86822007000500008
   Santana MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005259
   Santana VD, 2010, REV SOC BRAS MED TRO, V43, P508, DOI 10.1590/S0037-86822010000500007
   Santos-Ciminera PD, 2007, EMERG INFECT DIS, V13, P1597, DOI 10.3201/eid1310.070052
   Santos-Ciminera PD, 2007, ACTA TROP
   Sardinha YF, 1998, REV SOC BRAS MED TRO, V31, P144
   Severo V, 1994, J BRAS MED, V67, P141
   SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O
   Silva IBA, 2004, REV SOC BRAS MED TRO, V37, P275
   Silva IBA, 2003, REV SOC BRAS MED TRO, V36, P273
   Silva IBA, 2004, THESIS FEDERAL U PAR
   Silva Mônica C.M., 2004, Rev. Soc. Bras. Med. Trop., V37, P215, DOI 10.1590/S0037-86822004000300004
   Silva SBR, 2009, THESIS FEDERAL U MAT
   Silva SCL, 2010, REV SOC BRAS MED TRO, V43, P215
   SILVA SL, 2000, REV SOC BRAS MED S1, V33, P348
   Siqueira AM, 2010, AM J TROP MED HYG, V83, P271, DOI 10.4269/ajtmh.2010.10-0027
   Siqueira-Batista R, 1998, E AFR MED J, V75, P117
   Song JY, 2007, AM J TROP MED HYG, V77, P609, DOI 10.4269/ajtmh.2007.77.609
   Ferreira MES, 2011, REV SOC BRAS MED TRO, V44, DOI 10.1590/S0037-86822011000100026
   Srinivas R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-42
   Stoppacher R, 2003, J FORENSIC SCI, V48, P404
   Takaki K, 1991, Kansenshogaku Zasshi, V65, P488
   Talhari S, 2005, REV SOC BRAS MED TRO, V38, P362, DOI 10.1590/S0037-86822005000400021
   Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1
   Tavares AM, 2004, REV SOC BRAS MED TRO, V37, P270
   Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128
   Urbaez-Brito JD, 1995, THESIS U BRASILIA
   Ventura A M, 1999, J Pediatr (Rio J), V75, P187
   Vermehren R, 2005, J BRAS NEFROL, V27
   Viana GMC, 2002, REV SOC BRAS MED TRO, V35, P367
   VICTORIA MB, 1998, REV SOC BRAS MED S1, V31, P55
   Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230
   Walsh DS, 2004, CLIN INFECT DIS, V39, P1095, DOI 10.1086/424508
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
   Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072
   Wildig J, 2006, J INFECT DIS, V194, P146, DOI 10.1086/505082
   Williams TN, 1997, QJM-INT J MED, V90, P751
   World Health Organization, 2015, GUIDELINES TREATMENT
   Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004
   Zumpano JF, 1998, REV SOC BRAS MED TRO, V31, P46
NR 177
TC 86
Z9 88
U1 0
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 9
PY 2012
VL 11
AR 12
DI 10.1186/1475-2875-11-12
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 893LY
UT WOS:000300358600001
PM 22230294
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ribeiro, CF
   Silami, VG
   Brasil, P
   Nogueira, RMR
AF Ribeiro, Christiane Fernandes
   Silami, Vania Gloria
   Brasil, Patricia
   Ribeiro Nogueira, Rita Maria
TI Sickle-cell erythrocytes in the placentas of dengue-infected women
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Ribeiro, Christiane Fernandes; Silami, Vania Gloria] Univ Fed Fluminense, Dept Pathol, BR-24033900 Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fiocruz MS, Inst Clin Res Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Flavirus Lab, BR-21045900 Rio De Janeiro, Brazil.
RP Ribeiro, CF (corresponding author), Univ Fed Fluminense, Dept Pathol, 303 Marques de Parana St, BR-24033900 Rio De Janeiro, Brazil.
EM chrisribeiro@vm.uff.br
CR Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   Alvares Filho Firmino, 1995, Sangre (Saragossa), V40, P97
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Carroll I Dale, 2007, Travel Med Infect Dis, V5, P183, DOI 10.1016/j.tmaid.2006.11.002
   Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505
   Limonta Daniel, 2009, Int J Infect Dis, V13, pe77, DOI 10.1016/j.ijid.2008.06.028
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   WADDY RB, 1948, LANCET, V252, P950, DOI 10.1016/S0140-6736(48)91636-5
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 10
TC 11
Z9 11
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JAN
PY 2012
VL 16
IS 1
BP E72
EP E72
DI 10.1016/j.ijid.2011.09.005
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 875EM
UT WOS:000299013200013
PM 21999908
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Gibson, G
   Santos, R
   Honorio, N
   Cruz, O
   Pacheco, A
   Brasil, P
   Carvalho, M
   Kubelka, C
AF Gibson, G.
   Santos, R.
   Honorio, N.
   Cruz, O.
   Pacheco, A.
   Brasil, P.
   Carvalho, M.
   Kubelka, C.
TI Clinical profile pre-hospitalization of severe Dengue fever: a household
   case-control study
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Gibson, G.; Santos, R.] Escola Nacl Saude Publ ENSP FIOCRUZ, Rio De Janeiro, Brazil.
   [Honorio, N.] Lab Transmissores Hematozoarios IOC FIOCRUZ, Rio De Janeiro, Brazil.
   [Cruz, O.; Pacheco, A.; Carvalho, M.] Programa Comp Cient PROCC FIOCRUZ, Rio De Janeiro, Brazil.
   [Brasil, P.] Inst Pesquisa Clin Evabdro Chagas IPEC FIOCRUZ, Rio De Janeiro, Brazil.
   [Kubelka, C.] Lab Imunol Viral IOC FIOCRUZ, Rio De Janeiro, Brazil.
RI Pacheco, Antonio Guilherme/E-6378-2013
OI Pacheco, Antonio Guilherme/0000-0003-3095-1774
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2011
VL 16
SU 1
SI SI
BP 74
EP 74
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 828RC
UT WOS:000295519100208
DA 2020-12-01
ER

PT J
AU Daumas, RP
   Brasil, P
   Oliveira, RDC
   Carvalho, BBG
   Bressan, C
   Georg, I
   Nogueira, R
   Wakimoto, M
   Carneiro, DV
   Passos, SRL
AF Daumas, R. P.
   Brasil, P.
   de V Carvalhaes Oliveira, R.
   Carvalho, B. B. G.
   Bressan, C.
   Georg, I.
   Nogueira, R.
   Wakimoto, M.
   Carneiro, D. V.
   Lambert Passos, S. R.
TI ACCURACY OF CLINICAL AND LABORATORY SIGNS FOR DENGUE DIAGNOSIS
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Meeting Abstract
C1 [Daumas, R. P.; Brasil, P.; de V Carvalhaes Oliveira, R.; Carvalho, B. B. G.; Bressan, C.; Georg, I.; Nogueira, R.; Wakimoto, M.; Carneiro, D. V.; Lambert Passos, S. R.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RI Passos, Sonia/C-5292-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2011
VL 65
SU 1
BP A42
EP A43
DI 10.1136/jech.2011.142976b.21
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 807MG
UT WOS:000293901800121
OA Bronze
DA 2020-12-01
ER

PT J
AU Daumas, RP
   Brasil, P
   Bressan, CS
   Oliveira, RVC
   Carvalho, BBG
   Carneiro, DV
   Passos, SRL
AF Daumas, R. P.
   Brasil, P.
   Bressan, C. S.
   Oliveira, R. V. C.
   Carvalho, B. B. G.
   Carneiro, D. V.
   Passos, S. R. L.
TI Interobserver agreement on signs and symptoms of patients with acute
   febrile illness
SO INFECTION
LA English
DT Article
DE Reproducibility of results; Physical examination; Medical
   history-taking/methods; Fever; Acute diseases
ID DEVELOPING-COUNTRIES
AB To assess the interobserver agreement on clinical history and physical examination when using a semi-structured questionnaire to evaluate patients with an acute febrile illness (AFI).
   A cross-sectional study was conducted with outpatients aged 12 years and over, presenting with an AFI defined as fever up to 7 days and no evident focus of infection. Clinical data were collected independently by two physicians using a semi-structured questionnaire. Interobserver agreement was estimated using kappa coefficients with a 95% confidence interval (CI).
   A total of 140 patients (age range 13-73 years; 56.4% females) were enrolled. All symptoms showed weighted kappa values significantly greater than 0.6, indicating an at least substantial agreement. As most physical signs were infrequent and of mild intensity, they were recoded and analyzed as absent/present. Of the signs with prevalence a parts per thousand yen15%, exanthema, pallor, lymph node enlargement, and eye congestion showed agreements significantly greater than 0.6, while kappa confidence limits for pharyngeal erythema and dehydration included values classified as regular.
   High agreement was observed for most of the clinical data assessed, and symptom grading was feasible. Some physical findings were rare and their inclusion in a structured form may not be justified in this setting. The questionnaire application showed good reliability for the most frequent signs and symptoms and may prove to be useful at gathering data for surveillance and research at sentinel sites.
C1 [Daumas, R. P.; Oliveira, R. V. C.; Carvalho, B. B. G.; Carneiro, D. V.; Passos, S. R. L.] Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil.
   [Brasil, P.; Bressan, C. S.] Fundacao Oswaldo Cruz, Lab Acute Febrile Dis, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil.
RP Daumas, RP (corresponding author), Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Evandro Chagas Clin Res Inst, Av Brasil 4365, Rio De Janeiro, Brazil.
EM regina.daumas@gmail.com
RI DAUMAS, REGINA/M-9387-2013; Passos, Sonia/C-5292-2013
OI DAUMAS, REGINA/0000-0002-8923-7711; Passos, Sonia/0000-0001-9947-2291
FU Fundacao Oswaldo Cruz, Programa de Desenvolvimento e Inovacao
   Tecnologica em Saude Publica [PDTSP-Dengue-RDCL 05]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico, CNPqNational Council for
   Scientific and Technological Development (CNPq) [MS-SCTIE-DECIT 25/2006]
FX We are grateful to: Liliane Alves Reis and Marlene da Conceicao Rezende
   for the administrative support; Patricia Rosana de Souza for
   contribution to the data collection; Joao Claudio Arnaldo Alves e Flavia
   Lattario Ribeiro for help with the data entry; emergency medical staff,
   laboratory personnel, epidemiology service team, and the director of the
   Lourenco Jorge Municipal Hospital for all of the support provided. This
   work was supported by grants from the Fundacao Oswaldo Cruz, Programa de
   Desenvolvimento e Inovacao Tecnologica em Saude Publica
   (PDTSP-Dengue-RDCL 05 Project) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, CNPq (MS-SCTIE-DECIT 25/2006).
CR Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232
   Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428
   Dassanayake DLB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-48
   Fleiss JL, 1981, STAT METHODS RATES P
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   Kasper D, 2005, HARRISONS PRINCIPLES
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAURITSEN JM, 2003, COMPREHENSIVE TOOL V
   Manterola C, 2002, J CLIN EPIDEMIOL, V55, P1041, DOI 10.1016/S0895-4356(02)00454-7
   Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308
   Marzochi Keyla Belizia Feldman, 2004, Rev. Soc. Bras. Med. Trop., V37, P413, DOI 10.1590/S0037-86822004000500009
   Passos SRL, 2008, INFECTION, V36, P570, DOI 10.1007/s15010-008-7334-6
   Peat G, 2003, J CLIN EPIDEMIOL, V56, P1030, DOI 10.1016/S0895-4356(03)00204-X
   Porto CC, 2005, SEMIOLOGIA MED
   Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404
   SCHECHTER M, 1998, DOENCAS INFECCIOSAS
   Schwartz K, 2004, J CLIN EPIDEMIOL, V57, P142, DOI 10.1016/S0895-4356(03)00249-X
   StataCorp LP, 2005, STAT STAT SOFTW REL
   Streiner D., 1995, HLTH MEASUREMENT SCA
   Takemura Y, 2007, TOHOKU J EXP MED, V213, P121, DOI 10.1620/tjem.213.121
NR 23
TC 4
Z9 4
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD APR
PY 2011
VL 39
IS 2
BP 135
EP 140
DI 10.1007/s15010-011-0101-0
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 753TZ
UT WOS:000289803900008
PM 21487790
DA 2020-12-01
ER

PT J
AU Brasil, P
   Costa, AD
   Pedro, RS
   Bressan, CD
   da Silva, S
   Tauil, PL
   Daniel-Ribeiro, CT
AF Brasil, Patricia
   Costa, Anielle de Pina
   Pedro, Renata Saraiva
   Bressan, Clarisse da Silveira
   da Silva, Sidnei
   Tauil, Pedro Luiz
   Daniel-Ribeiro, Claudio Tadeu
TI MALARIA LONG INCUBATION PERIOD, WITHOUT THE USE OF PROPHYLAXIS, IN
   PATIENTS DIAGNOSED OUTSIDE THE TRANSMISSION AREAS IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Brasil, Patricia; Costa, Anielle de Pina; Pedro, Renata Saraiva; Bressan, Clarisse da Silveira; da Silva, Sidnei; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil.
   [Tauil, Pedro Luiz] Univ Brasilia, Brasilia, DF, Brazil.
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 970
BP 290
EP 290
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701337
DA 2020-12-01
ER

PT J
AU Costa, AD
   Bressan, CD
   Pedro, RS
   Valls-de-Souza, R
   da Silva, S
   de Souza, PR
   Guaraldo, L
   Ferreira-da-Cruz, MD
   Daniel-Ribeiro, CT
   Brasil, P
AF Costa, Anielle de Pina
   Bressan, Clarisse da Silveira
   Pedro, Renata Saraiva
   Valls-de-Souza, Rogerio
   da Silva, Sidnei
   de Souza, Patrecia Rosana
   Guaraldo, Lusiele
   Ferreira-da-Cruz, Maria de Fatima
   Daniel-Ribeiro, Claudio Tadeu
   Brasil, Patricia
TI Delayed diagnosis of malaria in a dengue endemic area in the Brazilian
   extra-Amazon: recent experience of a malaria surveillance unit in State
   of Rio de Janeiro
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Malaria; Dengue; Diagnosis; Surveillance
ID PLASMODIUM-FALCIPARUM; EPIDEMIOLOGIC ASPECTS; SAO-PAULO; INFECTIONS;
   ANEMIA; VIVAX; STANDARDIZATION; INDIVIDUALS
AB Introduction: The mortality of malaria in the extra-Amazon region is about 80 times higher than in the Amazon region, where malaria is concentrated (99.8% of cases). In areas of dengue transmission, delay in the diagnosis and treatment of malaria in patients with fever who reside in areas of malaria transmission can be due to the confusion between the clinical diagnoses of both diseases by non-specialist doctors, among other factors. This work presents some of the consequences of delayed diagnosis in three patients with malaria by Plasmodium falciparum, P. malariae and P. vivax, who, after following the usual route for Dengue treatment, sought our institution, where they were correctly diagnosed and adequately treated. Methods: Description of three cases of malaria with delayed diagnosed malaria referred to the Outpatient Clinic for Acute Febrile Diseases, IPEC/FIOCRUZ-RJ, between 2007 and 2008. Results: A Brazilian from Mozambique, primo-infected with P. falciparum was diagnosed with malaria six days after the onset of fever and died of cerebral malaria and shock. Another patient with P. malariae malaria presented a severe and prolonged course, but was cured after specific treatment. A third patient, with delayed diagnosis of P. vivax malaria, acquired it in the Atlantic Forest region in the state of Rio. Conclusions: Health professionals from non-endemic areas for malaria should be trained to optimize the surveillance and early treatment of malaria and prevent morbid and fatal outcomes. An investigation of outbreaks of autochthonous malaria in the State of Rio de Janeiro is suggested.
C1 [Costa, Anielle de Pina; Bressan, Clarisse da Silveira; Valls-de-Souza, Rogerio; de Souza, Patrecia Rosana; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Serv Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Pedro, Renata Saraiva; Guaraldo, Lusiele] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Serv Farmacovigilancia, Rio De Janeiro, Brazil.
   [da Silva, Sidnei] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Serv Parasitol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Serv Vigilancia Saude, Rio De Janeiro, Brazil.
   [Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [Costa, Anielle de Pina; Bressan, Clarisse da Silveira; Pedro, Renata Saraiva; da Silva, Sidnei; Guaraldo, Lusiele; Ferreira-da-Cruz, Maria de Fatima; Daniel-Ribeiro, Claudio Tadeu; Brasil, Patricia] Fundacao Oswaldo Cruz, Ctr Pesquisa Diagnost & Treinamento Malaria, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Fiocruz MS, IPEC, Serv Doencas Febris Agudas & Vigilancia Saude, Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM patricia.brasil@ipec.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015
CR Marques GRAM, 2008, REV SOC BRAS MED TRO, V41, P386, DOI 10.1590/S0037-86822008000400012
   Alves A, 2007, REV BRAS TER INTENSI, V19, P232
   Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001
   BRASIL P, 2007, B FARMACOVIGILIANCIA, V4
   Bruce-Chwatt L.J., 1985, ESSENTIAL MALARIOLOG
   Centres for Disease Control and Prevention, DENG
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   CERUTTIJUNIOR C, 2007, THESIS U SAO PAULO
   Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008
   Costa APCM, 2009, REV SOC BRAS MED TRO, V42, P477
   Cunha R.V., 2005, DINAMICA DOENCAS INF, P1767
   Cunha RV, 1998, REV SOC BRAS MED TRO, V31, P409
   Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564
   KRUGSTAD DJ, 2005, CECIL TRATADO MED IN, P2421
   *MIN SAUD FUND NAC, 2001, MAN TER MAL
   *MIN SAUD SECR VIG, 2008, GUIA PRAT TRAT MAL B
   *MIN SAUD SECR VIG, 2006, SIT EP MAL BRAS
   *MIN SAUD SECR VIG, 2005, MAN DIAGN LAB MAL A
   *MIN SAUD SECR VIG, 2003, PROGR NAC PREV CON C
   *MIN SAUD SECR VIG, 2007, SIT EP MAL BRAS
   Ministerio da Saude, 2009, PORT SAUD
   Ministerio da Saude - Secretaria de Vigilancia em Saude, 2005, GUIA VIG EP A
   Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   *ORG MUND SAUD, 2009, MAL
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   SUAREZMUTIS MC, 2005, DINAMICA DOENCAS INF, P833
   *SUP VIG SAUD, 2008, COORD VIG EP
   TEIXEIRA MG, 2002, DENGUE B, V26, P70
   Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8
   WANDERLEY DMV, 1994, REV SAUDE PUBL, V28, P192, DOI 10.1590/S0034-89101994000300005
   Zalis MG, 1996, PARASITOL RES, V82, P612, DOI 10.1007/s004360050173
NR 34
TC 24
Z9 26
U1 0
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2010
VL 43
IS 5
BP 571
EP 574
DI 10.1590/S0037-86822010000500020
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 684XX
UT WOS:000284589700020
PM 21085872
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Oliveira-Ferreira, J
   Lacerda, MVG
   Brasil, P
   Ladislau, JLB
   Tauil, PL
   Daniel-Ribeiro, CT
AF Oliveira-Ferreira, Joseli
   Lacerda, Marcus V. G.
   Brasil, Patricia
   Ladislau, Jose L. B.
   Tauil, Pedro L.
   Daniel-Ribeiro, Claudio Tadeu
TI Malaria in Brazil: an overview
SO MALARIA JOURNAL
LA English
DT Review
ID MEROZOITE SURFACE PROTEIN-1; NATURALLY ACQUIRED ANTIBODIES;
   PLASMODIUM-VIVAX INFECTIONS; ENDEMIC AREA;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; CIRCUMSPOROZOITE PROTEIN;
   CLINICAL IMMUNITY; HIGH PREVALENCE; AMAZON BASIN; FALCIPARUM
AB Malaria is still a major public health problem in Brazil, with approximately 306 000 registered cases in 2009, but it is estimated that in the early 1940s, around six million cases of malaria occurred each year. As a result of the fight against the disease, the number of malaria cases decreased over the years and the smallest numbers of cases to-date were recorded in the 1960s. From the mid-1960s onwards, Brazil underwent a rapid and disorganized settlement process in the Amazon and this migratory movement led to a progressive increase in the number of reported cases. Although the main mosquito vector (Anopheles darlingi) is present in about 80% of the country, currently the incidence of malaria in Brazil is almost exclusively (99,8% of the cases) restricted to the region of the Amazon Basin, where a number of combined factors favors disease transmission and impair the use of standard control procedures. Plasmodium vivax accounts for 83,7% of registered cases, while Plasmodium falciparum is responsible for 16,3% and Plasmodium malariae is seldom observed. Although vivax malaria is thought to cause little mortality, compared to falciparum malaria, it accounts for much of the morbidity and for huge burdens on the prosperity of endemic communities. However, in the last few years a pattern of unusual clinical complications with fatal cases associated with P. vivax have been reported in Brazil and this is a matter of concern for Brazilian malariologists. In addition, the emergence of P. vivax strains resistant to chloroquine in some reports needs to be further investigated. In contrast, asymptomatic infection by P. falciparum and P. vivax has been detected in epidemiological studies in the states of Rondonia and Amazonas, indicating probably a pattern of clinical immunity in both autochthonous and migrant populations. Seropidemiological studies investigating the type of immune responses elicited in naturally-exposed populations to several malaria vaccine candidates in Brazilian populations have also been providing important information on whether immune responses specific to these antigens are generated in natural infections and their immunogenic potential as vaccine candidates. The present difficulties in reducing economic and social risk factors that determine the incidence of malaria in the Amazon Region render impracticable its elimination in the region. As a result, a malaria-integrated control effort - as a joint action on the part of the government and the population - directed towards the elimination or reduction of the risks of death or illness, is the direction adopted by the Brazilian government in the fight against the disease.
C1 [Oliveira-Ferreira, Joseli; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, BR-21045900 Rio De Janeiro, Brazil.
   [Oliveira-Ferreira, Joseli; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu] Fiocruz MS, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, BR-21045900 Rio De Janeiro, Brazil.
   [Ladislau, Jose L. B.] SVS MS, Programa Nacl Controle Malaria, Esplanada Minist, BR-70058900 Brasilia, DF, Brazil.
   [Lacerda, Marcus V. G.] Fundacao Med Trop Amazonas, BR-69040000 Manaus, Amazonas, Brazil.
   [Brasil, Patricia] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Tauil, Pedro L.] Univ Brasilia, Fac Med, Area Med Social, BR-70910900 Brasilia, DF, Brazil.
   [Oliveira-Ferreira, Joseli] Fiocruz MS, Lab Imunoparasitol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
RP Daniel-Ribeiro, CT (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Pavilhao Leonidas Deane 5 Andar,Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM ribeiro@ioc.fiocruz.br
RI Daniel-Ribeiro, Claudio Tadeu/G-2216-2015; Oliveira-Ferreira,
   Joseli/E-7942-2014
OI Oliveira-Ferreira, Joseli/0000-0002-6063-465X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (Faperj), BrazilCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX The authors wish to thank Professor Cor Jesus Fontes (Universidade do
   Mato Grosso) for critically reviewing the manuscript. We are also
   indebted to Doctors Carlos Jose Mangabeira da Silva and Rui Moreira Braz
   (from the National Programme for Malaria Control, SVS - Brasilia) for
   providing data on malaria transmission, morbidity and mortality in the
   Amazon. CTDR is recipient of a "Research Productivity" fellowship from
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   and is a Cientista do Nosso Estado from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (Faperj), Brazil.
CR ALECRIM M, 1999, REV SOC BRAS MED TRO, V32, P303
   Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67
   Alecrim MdGC, 2000, ESTUDO CLIN RESISTEN
   ALEXANDRE A, 2004, ESTUDO CLIN EPIDEMIO
   Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Arruda ME, 2007, MEM I OSWALDO CRUZ, V102, P367, DOI 10.1590/S0074-02762007005000041
   Azevedo AL, 1997, ASPECTOS EPIDEMIOLOG
   Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366
   BANIC DM, 1992, MEM I OSWALDO CRUZ, V87, P159, DOI 10.1590/S0074-02761992000700025
   Banic DM, 1998, AM J TROP MED HYG, V58, P768, DOI 10.4269/ajtmh.1998.58.768
   Barata R C, 1995, Cad Saude Publica, V11, P128
   Barros-Barreto J, 1940, MALARIA DOUTRINA PRA
   Braga EM, 2002, AM J TROP MED HYG, V66, P299, DOI 10.4269/ajtmh.2002.66.299
   Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461
   Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021
   BRESSAN CCA, 2009, REV SOC BRAS MED TRO, V42, P119
   Bruce-Chwatt L.J., 1985, ESSENTIAL MALARIOLOG
   Cabral P. H. O., 2006, CASE REPORTS CLIN PR, V7, P220
   Caicedo O, 2009, AM J TROP MED HYG, V80, P146, DOI 10.4269/ajtmh.2009.80.146
   Camargo EP, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00941-1
   CASTILLA REF, 1993, SOC SCI MED, V37, P1137
   Cavasini M T, 2000, Rev Soc Bras Med Trop, V33, P489, DOI 10.1590/S0037-86822000000500011
   Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   COSTA APB, 2009, REV SOC BRAS MED TRO, V42, P191
   Costa APCM, 2009, REV SOC BRAS MED TRO, V42, P477
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888
   Curado I, 1997, MEM I OSWALDO CRUZ, V92, P235, DOI 10.1590/S0074-02761997000200017
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   DANIELRIBERIO CT, 2007, REPERTOIRE GROUPS CO, P116
   de Arruda M, 1998, T ROY SOC TROP MED H, V92, P628, DOI 10.1016/S0035-9203(98)90788-X
   de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   Deane LM, 1992, REV SOC BRAS MED S2, V25, P12
   DeArruda ME, 1996, ANN TROP MED PARASIT, V90, P135
   Costa MRF, 2008, REV SOC BRAS MED TRO, V41, P381, DOI 10.1590/S0037-86822008000400011
   Gonçalves Maria Jacirema Ferreira, 2004, Rev. salud pública, V6, P156
   FERREIRA MU, 1993, MEM I OSWALDO CRUZ, V88, P263, DOI 10.1590/S0074-02761993000200014
   Ferreira MU, 1998, ANN TROP MED PARASIT, V92, P245, DOI 10.1080/00034989859807
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   *FUND UIA, REG AM
   Gadelha P., 1994, Parassitologia (Rome), V36, P175
   GARNHAM PCC, 1975, B WORLD HEALTH ORGAN, V52, P21
   Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127
   de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P96, DOI 10.1590/S0037-86822007000100023
   Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x
   Jacobson KC, 1998, AM J TROP MED HYG, V59, P208, DOI 10.4269/ajtmh.1998.59.208
   Kirchgatter K, 2005, AN ACAD BRAS CIENC, V77, P455, DOI 10.1590/S0001-37652005000300008
   Kochar D. K., 2007, Journal of Vector Borne Diseases, V44, P281
   Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519
   KREMSNER PG, 1992, T ROY SOC TROP MED H, V86, P23, DOI 10.1016/0035-9203(92)90423-A
   Lacerda MV, 2007, CLIN MANIFESTATIONS
   Lacerda MVG, 2004, ACTA TROP, V90, P187, DOI 10.1016/j.actatropica.2003.12.001
   Ladeia-Andrade S, 2007, MEM I OSWALDO CRUZ, V102, P943, DOI 10.1590/S0074-02762007000800009
   LADISLAU JL, 2006, EPIDEMOL SERVICOS SA, P9
   LEVITUS G, 1994, AM J TROP MED HYG, V51, P68, DOI 10.4269/ajtmh.1994.51.68
   Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   Lomar André V., 2005, Braz J Infect Dis, V9, P425, DOI 10.1590/S1413-86702005000500011
   Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025
   *MAL SVS MS, 2009, MAL DOENC A Z
   MARELLLI MT, 1997, MEM I O CRUZ, V92, P268
   Marques A C, 1979, Rev Bras Malariol Doencas Trop, V31, P137
   Marques A C, 1986, Rev Bras Malariol Doencas Trop, V38, P51
   MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0
   MARTINEZESPINOS.FE, 2005, REV SOC BRASMED TROP, V38, P362
   MERTENS F, 1993, AM J TROP MED HYG, V49, P383, DOI 10.4269/ajtmh.1993.49.383
   Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x
   Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582
   Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07
   Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006
   OLIVEIRAFERREIRA J, 1992, AM J TROP MED HYG, V46, P720, DOI 10.4269/ajtmh.1992.46.720
   *OMS, 1993, INF EST OMS APPL PLA, P61
   PRATA A, 1998, REV INST MED TROP SP, V51, P54
   Pratt-Riccio LR, 2005, AM J TROP MED HYG, V73, P1096, DOI 10.4269/ajtmh.2005.73.1096
   QARI SH, 1993, LANCET, V341, P780, DOI 10.1016/0140-6736(93)90559-Y
   Rodriguez-Morales AJ, 2009, TRAVEL MED INFECT DI, V7, P44, DOI 10.1016/j.tmaid.2008.09.006
   Rojanasthien Sophark, 1992, Journal of the Medical Association of Thailand, V75, P190
   ROSENBERG R, 1989, SCIENCE, V245, P973, DOI 10.1126/science.2672336
   SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297
   Santana MS, 2007, REV SOC BRAS MED TRO, V40, P533, DOI 10.1590/S0037-86822007000500008
   Santana MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005259
   Santos-Ciminera PD, 2007, EMERG INFECT DIS, V13, P1597, DOI 10.3201/eid1310.070052
   Scopel KKG, 2005, EXP PARASITOL, V109, P124, DOI 10.1016/j.exppara.2004.12.002
   Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002
   Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357
   Song JY, 2007, AM J TROP MED HYG, V77, P609, DOI 10.4269/ajtmh.2007.77.609
   Tauil P.L., 1998, Research and Reviews in Parasitology, V58, P163
   Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406
   Tran TM, 2005, AM J TROP MED HYG, V73, P244, DOI 10.4269/ajtmh.2005.73.244
   Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230
   INDICADORES DADOS BA
NR 93
TC 256
Z9 260
U1 1
U2 44
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 30
PY 2010
VL 9
AR 115
DI 10.1186/1475-2875-9-115
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 617DM
UT WOS:000279261100001
PM 20433744
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

EF